0001628280-18-006282.txt : 20180508 0001628280-18-006282.hdr.sgml : 20180508 20180508171800 ACCESSION NUMBER: 0001628280-18-006282 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 110 CONFORMED PERIOD OF REPORT: 20180330 FILED AS OF DATE: 20180508 DATE AS OF CHANGE: 20180508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VARIAN MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000203527 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 942359345 STATE OF INCORPORATION: DE FISCAL YEAR END: 0929 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-07598 FILM NUMBER: 18815806 BUSINESS ADDRESS: STREET 1: 3100 HANSEN WAY CITY: PALO ALTO STATE: CA ZIP: 94304-1000 BUSINESS PHONE: 650-424-5834 MAIL ADDRESS: STREET 1: 3100 HANSEN WAY CITY: PALO ALTO STATE: CA ZIP: 94304-1000 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN ASSOCIATES INC /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN DELAWARE INC DATE OF NAME CHANGE: 19761123 10-Q 1 var10qq22018.htm 10-Q Document


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ____________________________________________________________
FORM 10-Q
 ____________________________________________________________
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 30, 2018
or
¨
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number 1-7598
 ____________________________________________________________ 
VARIAN MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
 ____________________________________________________________ 
Delaware
 
94-2359345
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification Number)
 
 
 
3100 Hansen Way,
Palo Alto, California
 
94304-1038
(Address of principal executive offices)
 
(Zip Code)
(650) 493-4000
(Registrant’s telephone number, including area code)
 ____________________________________________________________ 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  ý    No  ¨
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.  
Large Accelerated filer
 
x
  
Accelerated filer
 
o
Non-Accelerated filer
 
o  (Do not check if a smaller reporting company)
  
Smaller reporting company
 
o
Emerging growth company
 
o
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No   ý
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 91,504,711 shares of common stock, par value $1 per share, outstanding as of April 27, 2018.
 



VARIAN MEDICAL SYSTEMS, INC.
FORM 10-Q for the Quarter Ended March 30, 2018
INDEX
 
Part I.
 
 
 
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
 
 
 
 
 
Item 3.
 
 
 
 
 
Item 4.
 
 
 
 
 
Part II.
 
 
 
 
 
Item 1.
 
 
 
 
 
Item 1A.
 
 
 
 
 
Item 2.
 
 
 
 
 
Item 3.
 
 
 
 
 
Item 4.
 
 
 
 
 
Item 5.
 
 
 
 
 
Item 6.
 
 
 
 
 

2


PART I
FINANCIAL INFORMATION

Item 1. Unaudited Financial Statements

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)
(Unaudited)

 
Three Months Ended
 
Six Months Ended
 
March 30,
 
March 31,
 
March 30,
 
March 31,
(In millions, except per share amounts)
2018
 
2017
 
2018
 
2017
Revenues:
 
 
 
 
 
 
 
Product
$
393.8

 
$
364.9

 
$
759.4

 
$
674.1

Service
336.1

 
298.3

 
649.0

 
590.6

Total revenues
729.9

 
663.2

 
1,408.4

 
1,264.7

Cost of revenues:
 
 
 
 
 
 
 
Product
264.2

 
246.9

 
488.1

 
453.1

Service
147.2

 
140.7

 
299.0

 
269.0

Total cost of revenues
411.4

 
387.6

 
787.1

 
722.1

Gross margin
318.5

 
275.6

 
621.3

 
542.6

Operating expenses:
 
 
 
 
 
 
 
Research and development
58.9

 
53.3

 
114.8

 
103.2

Selling, general and administrative
134.5

 
131.6

 
258.5

 
292.7

Impairment charges
11.1

 
—

 
11.1

 
38.3

Acquisition-related expenses
19.7

 
0.6

 
21.2

 
0.9

Total operating expenses
224.2

 
185.5

 
405.6

 
435.1

Operating earnings
94.3

 
90.1

 
215.7

 
107.5

Interest income
3.6

 
2.7

 
6.8

 
7.5

Interest expense
(2.3
)
 
(2.4
)
 
(4.4
)
 
(5.3
)
Earnings from continuing operations before taxes
95.6

 
90.4

 
218.1

 
109.7

Taxes on earnings
22.4

 
20.9

 
257.1

 
32.2

Net earnings (loss) from continuing operations
73.2

 
69.5

 
(39.0
)
 
77.5

Net loss from discontinued operations
—

 
(13.3
)
 
—

 
(6.8
)
Net earnings (loss)
73.2

 
56.2

 
(39.0
)
 
70.7

Less: Net (loss) earnings attributable to noncontrolling interests
—

 
(0.1
)
 
0.1

 
0.5

Net earnings (loss) attributable to Varian
$
73.2

 
$
56.3

 
$
(39.1
)
 
$
70.2

 
 
 
 
 
 
 
 
Net earnings (loss) per share - basic
 
 
 
 
 
 
 
Continuing operations
$
0.80

 
$
0.75

 
$
(0.43
)
 
$
0.83

Discontinued operations
—

 
(0.15
)
 
—

 
(0.08
)
Net earnings (loss) per share - basic
$
0.80

 
$
0.60

 
$
(0.43
)
 
$
0.75

 
 
 
 
 
 
 
 
Net earnings (loss) per share - diluted
 
 
 
 
 
 
 
Continuing operations
$
0.79

 
$
0.74

 
$
(0.43
)
 
$
0.82

Discontinued operations
—

 
(0.14
)
 
—

 
(0.08
)
Net earnings (loss) per share - diluted
$
0.79

 
$
0.60

 
$
(0.43
)
 
$
0.74

 
 
 
 
 
 
 
 
Shares used in the calculation of net earnings per share:
 
 
 
 
 
 
 
Weighted average shares outstanding - basic
91.5

 
93.0

 
91.6

 
93.2

Weighted average shares outstanding - diluted
92.6

 
93.7

 
91.6

 
93.9

See accompanying notes to the condensed consolidated financial statements.

3


VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
(Unaudited)
 
 
Three Months Ended
 
Six Months Ended
 
March 30,
 
March 31,
 
March 30,
 
March 31,
(In millions)
2018
 
2017
 
2018
 
2017
Net earnings (loss)
$
73.2

 
$
56.2

 
$
(39.0
)
 
$
70.7

Other comprehensive earnings (loss), net of tax:
 
 
 
 
 
 
 
Defined benefit pension and post-retirement benefit plans:
 
 
 
 
 
 
 
Amortization of prior service cost included in net periodic benefit cost, net of tax benefit of $0.0* and $0.1 for the three and six months ended March 30, 2018, respectively, and $0.0* and $0.1 for the corresponding periods of fiscal year 2017, respectively.
(0.3
)
 
(0.1
)
 
(0.5
)
 
(0.2
)
Amortization of net actuarial loss included in net periodic benefit cost, net of tax expense of ($0.1) and ($0.3) for three and six months ended March 30, 2018, respectively, and ($0.2) and ($0.4) for the corresponding periods of fiscal year 2017, respectively.
0.7

 
0.9

 
1.2

 
1.8

 
0.4

 
0.8

 
0.7

 
1.6

Derivative instruments:
 
 
 
 
 
 
 
Change in unrealized loss, net of tax benefit of $0.2 and $0.3 for the three and six months ended March 30, 2018.
(0.4
)
 
—

 
(0.6
)
 
—

Reclassification adjustments, net of tax expense of ($0.3) for both the three and six months ended March 30, 2018.
0.7

 
—

 
0.6

 
—

 
0.3

 
—

 
—

 
—

Currency translation adjustment
6.6

 
2.9

 
9.7

 
(10.2
)
Other comprehensive earnings (loss)
7.3

 
3.7

 
10.4

 
(8.6
)
Comprehensive earnings (loss)
80.5

 
59.9

 
(28.6
)
 
62.1

Less: Comprehensive (loss) earnings attributable to noncontrolling interests
—

 
(0.1
)
 
0.1

 
0.5

Comprehensive earnings (loss) attributable to Varian
$
80.5

 
$
60.0

 
$
(28.7
)
 
$
61.6

 
* Tax expense or benefit related to the periods presented are not material.

See accompanying notes to the condensed consolidated financial statements.

4


VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
 
March 30,
 
September 29,
(In millions, except par values)
2018
 
2017
Assets
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
739.9

 
$
716.2

Trade and unbilled receivables, net of allowance for doubtful accounts of $40.3 at March 30, 2018 and $45.9 at September 29, 2017
936.7

 
961.5

Inventories
433.8

 
417.7

Prepaid expenses and other current assets
226.4

 
190.3

Current assets of discontinued operations
8.6

 
11.1

Total current assets
2,345.4

 
2,296.8

Property, plant and equipment, net
247.0

 
255.3

Goodwill
236.2

 
222.6

Intangible assets
82.0

 
71.6

Deferred tax assets
114.9

 
147.3

Other assets
282.0

 
300.8

Total assets
$
3,307.5

 
$
3,294.4

Liabilities and Equity
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
164.9

 
$
162.3

Accrued liabilities
365.1

 
374.9

Deferred revenues
766.5

 
755.4

Short-term borrowings
230.0

 
350.0

Current liabilities of discontinued operations
3.7

 
2.5

Total current liabilities
1,530.2

 
1,645.1

Other long-term liabilities
320.7

 
127.4

Total liabilities
1,850.9

 
1,772.5

Commitments and contingencies (Note 10)

 

Equity:
 
 
 
Varian stockholders' equity:
 
 
 
Preferred stock of $1 par value: 1.0 shares authorized; none issued and outstanding
—

 
—

Common stock of $1 par value: 189.0 shares authorized; 91.7 shares issued and outstanding at both March 30, 2018, and at September 29, 2017, respectively
91.7

 
91.7

Capital in excess of par value
754.7

 
716.1

Retained earnings
664.2

 
778.6

Accumulated other comprehensive loss
(58.4
)
 
(68.8
)
Total Varian stockholders' equity
1,452.2

 
1,517.6

Noncontrolling interests
4.4

 
4.3

Total equity
1,456.6

 
1,521.9

Total liabilities and equity
$
3,307.5

 
$
3,294.4


See accompanying notes to the condensed consolidated financial statements.

5


VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
Six Months Ended
 
March 30,
 
March 31,
(In millions)
2018
 
2017
Cash flows from operating activities:
 
 
 
Net (loss) earnings
$
(39.0
)
 
$
70.7

Adjustments to reconcile net earnings to net cash provided by operating activities:
 

 
 

Share-based compensation expense
21.2

 
23.6

Depreciation
25.4

 
31.9

Amortization of intangible assets
10.4

 
9.1

Deferred taxes
41.8

 
(7.5
)
Loss on hedges related to the Sirtex acquisition
16.4

 
—

Provision for doubtful accounts receivable
2.0

 
38.8

Impairment charges
11.1

 
38.3

Other, net
—

 
(0.7
)
Changes in assets and liabilities:
 

 
 
Trade and unbilled receivables
28.4

 
(14.5
)
Inventories
(10.9
)
 
(14.3
)
Prepaid expenses and other assets
—

 
(55.5
)
Accounts payable
0.9

 
(9.9
)
Accrued liabilities and other long-term liabilities
125.3

 
(25.5
)
Deferred revenues
11.5

 
29.9

Net cash provided by operating activities
244.5

 
114.4

Cash flows from investing activities:
 

 
 

Purchases of property, plant and equipment
(17.8
)
 
(32.1
)
Acquisitions, net of cash acquired
(29.6
)
 
—

Issuance of notes receivable
—

 
(11.5
)
Principal payments on notes receivable
5.2

 
—

Investment in available-for-sale securities
(6.0
)
 
(1.1
)
Sale of available-for-sale securities
8.0

 
—

Loans to CPTC
(5.3
)
 
—

Purchase of foreign currency option related to the Sirtex acquisition
(5.5
)
 
—

Investment in privately-held companies
(3.1
)
 
(5.0
)
Amounts paid to deferred compensation plan trust account
(1.3
)
 
(4.4
)
Other, net
0.3

 
0.9

Net cash used in investing activities
(55.1
)
 
(53.2
)
Cash flows from financing activities:
 

 
 

Repurchases of common stock
(92.7
)
 
(222.3
)
Proceeds from issuance of common stock to employees
44.6

 
25.4

Employees' taxes withheld and paid for restricted stock and restricted stock units
(11.1
)
 
(10.5
)
Cash received from Varex Imaging Corporation
—

 
200.0

Cash and cash equivalents contributed to Varex Imaging Corporation
—

 
(81.3
)
Borrowings under credit facility agreement
234.3

 
90.0

Repayments under credit facility agreement
(209.3
)
 
(100.0
)
Net repayments under the credit facility agreements with maturities less than 90 days
(120.0
)
 
(107.0
)
Other
—

 
0.7

Net cash used in financing activities
(154.2
)
 
(205.0
)
Effects of exchange rate changes on cash and cash equivalents
(11.5
)
 
7.3

Net increase (decrease) in cash and cash equivalents
23.7

 
(136.5
)
Cash and cash equivalents at beginning of period
716.2

 
843.5

Cash and cash equivalents at end of period
$
739.9

 
$
707.0


See accompanying notes to the condensed consolidated financial statements.

6


VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
 
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business
Varian Medical Systems, Inc. (“VMS”) and subsidiaries (collectively, the “Company”) designs, manufactures, sells and services hardware and software products for treating cancer with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Software solutions also include informatics software for information management, clinical knowledge exchange, patient care management, practice management and decision-making support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices. The Company also develops, designs, manufactures, sells and services proton therapy products and systems for cancer treatment.
Distribution
On January 28, 2017 (the "Distribution Date"), the Company completed the separation and distribution (the "Distribution") of Varex Imaging Corporation ("Varex"), the Company's former Imaging Components business segment. On the Distribution Date, each of Varian's stockholder of record as of the close of business on January 20, 2017 (the "Record Date") received 0.4 of a share of Varex common stock for every one share of Varian common stock as of the Record Date. Varex is now an independent publicly traded company and is listed on The NASDAQ Global Select Market under the ticker “VREX.” Varian continues to trade on the New York Stock Exchange under the ticker “VAR.” See Note 2, "Discontinued Operations" for additional information.
Basis of Presentation
The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended September 29, 2017 (the “2017 Annual Report”). In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s financial position as of March 30, 2018 and September 29, 2017, results of operations and statements of comprehensive earnings (loss) for the three and six months ended March 30, 2018 and March 31, 2017, and cash flows for the six months ended March 30, 2018 and March 31, 2017. The results of operations for the six months ended March 30, 2018 are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period.
At the beginning of the Company's fiscal year 2018, the Company early adopted the new revenue recognition Accounting Standard Codification 606 "Revenues from Contracts with Customers" ("ASC 606") by using the full retrospective method. All financial statements and disclosures have been recast to comply with ASC 606. See "Recently Adopted Accounting Pronouncements" below for further information.
The historical financial position and results of operations of the Imaging Components business and costs relating to the Distribution are reported in the condensed consolidated financial statements as discontinued operations for all the periods presented. Information in the accompanying notes to the condensed consolidated financial statements have been recast to reflect the effect of the Distribution. The Condensed Consolidated Statements of Comprehensive Earnings (Loss) and Cash Flows have not been recast to reflect the effect of the Distribution.
Fiscal Year
The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September 30. Fiscal year 2018 is the 52-week period ending September 28, 2018. Fiscal year 2017 was the 52-week period that ended on September 29, 2017. The fiscal quarters ended March 30, 2018 and March 31, 2017 were both 13-week periods.

7
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


Principles of Consolidation
The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Significant Accounting Policies
The Company's significant accounting policies are detailed in "Note 1: Summary of Significant Accounting Policies" within Item 8 of the Company's Annual Report on Form 10-K for the year ended September 29, 2017. Significant changes to these accounting policies as a result of adoption of ASC 606 are discussed below:
Revenue Recognition
The Company's revenues are derived primarily from the sale of radiotherapy and proton therapy hardware and software products, support, training and maintenance of all those products, installation services and the sale of parts. The Company accounts for a contract with a customer when there is approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
The Company's revenues are measured based on consideration specified in the contract with each customer, net of any sales incentives and amounts collected on behalf of third parties such as sales taxes. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.
The majority of the Company's revenue arrangements consist of multiple performance obligations including hardware, software, and services. Determining the stand-alone selling price ("SSP") and allocation of consideration from an arrangement to the individual performance obligations, and the appropriate timing of revenue recognition are significant judgments with respect to these arrangements.
The Company's products are generally not sold with a right of return, and the Company does not provide credits or incentives, which may be required to be accounted for as variable consideration when estimating the amount of revenue to be recognized.
The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the Company expects the benefit of those costs to be longer than one year. The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less. These costs mainly include the Company's internal sales force compensation program; under the terms of these programs these are generally earned and the costs are recognized at the time the revenue is recognized.
The majority of the Company’s products and services are sold in bundled arrangements (e.g., hardware, software, and services). For bundled arrangements, the Company accounts for individual products and services separately if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their individual SSP. The SSP is determined based on observable prices at which the Company separately sells the products and services. If an SSP is not directly observable, then the Company will estimate the SSP considering marketing conditions, entity-specific factors, and information about the customer or class of customer that is reasonably available.

8
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


The following is a description of the principal activities, separated by reportable segment, from which the Company generates its revenues.
Oncology Systems
The Company's Oncology Systems linear accelerators are generally sold in a bundled arrangement with hardware and software accessory products that enhance efficiency and enable delivery of advanced radiotherapy and radiosurgery treatments, however, certain products are occasionally sold on a stand-alone basis. The majority of machine and software sales include installation services and training. Delivery of different elements in a revenue arrangement often span more than one reporting period. For example, a linear accelerator and software may be delivered in one reporting period, but the related installation of those products may be completed in a later period. Hardware and software extended maintenance and service contracts are occasionally sold during the initial product sale, but the majority are sold separately near or at the end of the initial warranty period. Revenues related to extended warranty and service contracts are earned after the expiration of the initial warranty period.
Payment terms and conditions vary by contract type, although terms are generally commensurate with a significant milestone, such as contract signing, shipment, delivery, acceptance or service commencement. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts generally do not include a significant financing component. The primary purpose of the Company's invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company's products and services, not to receive financing from the Company's customers, such as invoicing at the beginning of a contract term with revenue recognized ratably over the contract period for a service contract. Payment terms can also vary based on the type of customer, such as government purchases. There are occasions where the Company provides extended payment terms in which case a portion of the transaction price is allocated to imputed interest income.
From time to time, the Company's contracts are modified to account for additional, or change existing, performance obligations. The Company's contract modifications are generally accounted for prospectively.
Hardware Products and Installation
Hardware products may include software that the hardware is dependent on and highly interrelated with and cannot operate without. The Company typically has a standard base configuration for its hardware products, but there are typically multiple options and configuration choices. Revenues from the sale of hardware are recognized when the Company transfers control to the customer.
Product installation includes uncrating, moving the machine to the treatment room, connection and validating configuration. In addition, a number of testing protocols are completed to confirm the equipment is performing to the contracted specifications. The Company recognizes revenues for hardware installation over time as the customer receives and consumes benefits provided as the Company performs the installation services.
Software Products and Installation
Software products include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. Software installation includes transferring software to the customer’s computers, configuration of the software and potentially data migration. The Company recognizes revenues for software and software installation upon the customer's acceptance of the software and installation services.
Service
Service revenues include revenues from initial and extended software support agreements, extended hardware warranty agreements, training, paid service arrangements when a customer does not have an extended warranty and parts that are sold by the service department.
Revenues from hardware and software support agreements are accounted for ratably over the term of the agreement. Services and training revenues are recognized in the period the services and training are performed. Revenues for sales of parts are recognized when the parts are delivered to the customer and control is transferred.

9
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


Warranties
The Company's sale of hardware includes a one-year warranty. The Company uses the cost accrual method to account for assurance-type warranties. The standard warranty provision further includes services in addition to an assurance-type warranty (preventative maintenance inspections, help desk support, when and if available operating system upgrades). These service-type warranty features are recorded as a separate performance obligation and recognized ratably over the one-year warranty period.
Varian Particle Therapy ("VPT")
The manufacturing of the major components of a proton therapy system, installation, and commissioning typically lasts 18 to 24 months. The Company's proton therapy system is highly customized. A proton therapy system typically includes hardware, software that the hardware is dependent upon and highly interrelated with, and without which the hardware cannot operate, and installation. The Company also sells software products that include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software, and software installation.
The Company provides operations and maintenance services related to the proton therapy system under a separate arrangement. These contracts are typically executed at or about the same time as the proton therapy system contracts; however, the pricing and performance of the proton therapy system contracts are not typically related to the pricing or performance of the operations and maintenance contracts. Therefore, the Company recognizes operations and maintenance services as a separate performance obligation.
Under the typical payment terms of the Company's fixed-price contracts, the customer pays the Company an up-front advance payment and then performance-based payments based on quantifiable measures of performance or on the achievement of specified events or milestones. As the revenue is recognized over time relative to the costs incurred and the customer billing milestones are typically event driven, this may result in revenue recognized in excess of billings at some point during the contract which the Company presents as unbilled receivables on the Condensed Consolidated Balance Sheets. Amounts billed and due from the Company's customers are classified as trade accounts receivable on the Condensed Consolidated Balance Sheets. In most contracts, the Company is entitled to receive an advance payment at the beginning of the contract. The Company recognizes a liability for these advance payments in excess of revenue recognized and presents it as deferred revenues on the Condensed Consolidated Balance Sheets. The advance payment typically is not considered a significant financing component because it is used to ensure the customer's commitment to the project.
The Company recognizes revenue for its proton therapy systems over time because the customer controls the work in process, the Company's performance does not create an asset with an alternative use to the Company, and the Company has an enforceable right to payment for performance completed to date.
Due to the nature of the work required to be performed on many of the Company's performance obligations, the estimation of total revenues and costs at completion is complex, subject to many variables and requires significant judgment. The Company's contracts generally do not include award fees, incentive fees or other provisions that may be considered variable consideration.
The Company has a standard quarterly progress review process in which management reviews the progress and execution of the Company's performance obligations. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and costs to achieve the schedule (e.g., the number and type of milestone events), technical and other contract requirements. Management must make assumptions and estimates regarding the complexity of the work to be performed, the availability of materials and outside services, the length of time to complete the performance obligation and labor and overhead cost rates, among other significant judgments. Based on this analysis, any quarterly adjustments to revenues, cost of revenues, and the related impact to operating earnings are recognized as necessary in the period they become known on a cumulative catch-up basis. When estimates of total costs to be incurred on a performance obligation exceed total estimates of revenues to be earned, a provision for the entire loss on the performance obligation is recognized in the period the loss is determined.
Similar to the Oncology Systems segment, the Company recognizes VPT revenues for software and installation upon completion and acceptance of the software and installation services.

10
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


Unfulfilled Performance Obligations for Oncology Systems and VPT
The following table represents the Company's unfulfilled performance obligations as of March 30, 2018 and the estimated revenue expected to be recognized in the future related to these unfulfilled performance obligations:
 
Fiscal years of revenue recognition
(In millions)
2018
 
2019
 
2020
 
Thereafter
Unfulfilled Performance Obligations
$
1,060.8

 
$
2,089.5

 
$
729.4

 
$
1,276.3

The table above includes both product and service unfulfilled performance obligations, which includes a component of service performance obligations which have not been invoiced. The time bands reflect management’s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers’ facilities for installation, installation requirements, and availability of products or customer acceptance terms.
As part of the Company's adoption of ASC 606, the Company elected to use the following practical expedients (i) to exclude disclosures of transaction prices allocated to remaining performance obligations when the Company expects to recognize such revenue for all periods prior to the date of initial application of ASC 606 (ii) not to adjust the promised amount of consideration for the effects of a significant financing component when the Company expects, at contract inception, that the period between the Company's transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less (iii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less, which mainly includes the Company's internal sales force compensation program and certain partner sales incentive programs (iv) not to recast revenue for contracts that begin and end in the same fiscal period, and (v) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.
Contract Balances
The timing of revenue recognition, billings and cash collections results in trade and unbilled receivables, and deferred revenues on the Condensed Consolidated Balance Sheet. In Oncology Systems, the Company often collects an advance payment and the balance is typically billed on a combination of delivery and/or acceptance. In VPT, the Company usually collects an advance payment and additional amounts are billed as work progresses in accordance with agreed-upon contractual terms upon achievement of contractual milestones. Service contracts are usually billed at the beginning of the contract period or at periodic intervals (e.g. monthly or quarterly) during the contract which could result in a contract asset and contract liability. At times, billing occurs subsequent to revenue recognition, resulting in an unbilled receivable which represents a contract asset. However, when the Company receives advances or deposits from customers, which can be higher in the initial stages of the contract, particularly international contracts in the case of Oncology Systems, before revenue is recognized, this results in deferred revenues which represents a contract liability. These contract assets and liabilities are reported as unbilled receivables and deferred revenues, respectively, on the Condensed Consolidated Balance Sheet on a contract-by-contract basis at the end of each reporting period.
Recently Adopted Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board ("FASB") issued ASC 606. Under the standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration the entity expects to receive in exchange for those goods or services. Effective September 30, 2017, the Company elected to early adopt the requirements of ASC 606 using the full retrospective method, which required the Company to recast the prior reporting periods presented.
The most significant impacts on adoption were in the Oncology Systems segment and are primarily due to the removal of the contingent revenue cap which limited revenue recognition to the amount of cash received from the customer, the elimination of the mandatory revenue deferral for software sold with extended payment terms and the removal of the vendor-specific objective evidence requirement for the separation of bundled software products. The Company also identified additional performance obligations for training and certain elements of warranty that are recognized as separate performance obligations, and identified that certain new performance obligations were previously accounted for as part of hardware products and will result in a change in classification of revenues from product to service. In preparation for adoption of the standard, the Company implemented internal controls and key system functionalities to enable the preparation of financial information.

11
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


The Company has recast its condensed consolidated financial statements from amounts previously reported due to the adoption of ASC 606. Select Condensed Consolidated Statements of Earnings (Loss) line items, which reflect the adoption of ASC 606 are as follows:
 
Three Months Ended
 
Six Months Ended
 
March 31, 2017
 
March 31, 2017
(In millions, except per share amounts)
As Previously Reported
 
Adjustments
 
As Adjusted
 
As Previously Reported
 
Adjustments
 
As Adjusted
Revenues:
 
 
 
 
 
 
 
 
 
 
 
Product
$
386.1

 
$
(21.2
)
 
$
364.9

 
$
729.7

 
$
(55.6
)
 
$
674.1

Service
268.9

 
29.4

 
298.3

 
537.1

 
53.5

 
590.6

Total revenues
655.0

 
8.2

 
663.2

 
1,266.8

 
(2.1
)
 
1,264.7

Cost of revenues:
 
 
 
 
 
 
 
 
 
 
 
Product
254.2

 
(7.3
)
 
246.9

 
478.6

 
(25.5
)
 
453.1

Service
125.5

 
15.2

 
140.7

 
237.2

 
31.8

 
269.0

Total cost of revenues
379.7

 
7.9

 
387.6

 
715.8

 
6.3

 
722.1

Gross margin
275.3

 
0.3

 
275.6

 
551.0

 
(8.4
)
 
542.6

Earnings from continuing operations before taxes
90.1

 
0.3

 
90.4

 
118.1

 
(8.4
)
 
109.7

Taxes on earnings
20.8

 
0.1

 
20.9

 
34.3

 
(2.1
)
 
32.2

Net earnings from continuing operations
69.3

 
0.2

 
69.5

 
83.8

 
(6.3
)
 
77.5

Net loss from discontinued operations
(13.3
)
 
—

 
(13.3
)
 
(6.8
)
 
—

 
(6.8
)
Net earnings
$
56.0

 
$
0.2

 
$
56.2

 
$
77.0

 
$
(6.3
)
 
$
70.7

Net earnings attributable to Varian
$
56.1

 
$
0.2

 
$
56.3

 
$
76.5

 
$
(6.3
)
 
$
70.2

 
 
 
 
 
 
 
 
 
 
 
 
Diluted net earnings per share from continuing operations attributable to Varian
$
0.74

 
$
—

 
$
0.74

 
$
0.89

 
(0.07
)
 
$
0.82

Select Condensed Consolidated Statements of Balance Sheet line items, which reflect the adoption of ASC 606 are as follows:
 
September 29, 2017
(In millions)
As Previously Reported
 
Adjustments
 
As Adjusted
Assets:
 
 
 
 
 
Trade and unbilled receivables, net
$
823.5

 
$
138.0

 
$
961.5

Inventories
439.7

 
(22.0
)
 
417.7

Prepaid expenses and other current assets
199.8

 
(9.5
)
 
190.3

Deferred tax assets
138.8

 
8.5

 
147.3

 
 
 
 
 
 
Liabilities and Equity:
 
 
 
 
 
Accrued liabilities
394.7

 
(19.8
)
 
374.9

Deferred revenues
640.6

 
114.8

 
755.4

Other long-term liabilities
130.0

 
(2.6
)
 
127.4

Retained earnings
756.0

 
22.6

 
778.6


12
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


In addition, the cumulative effect of ASC 606 to the Company's retained earnings at October 2, 2015 was $56.7 million. Adoption of ASC 606 had no impact to net cash from or used in operating, investing or financing activities in the Company's Condensed Consolidated Statements of Cash Flows.
In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance which targeted improvements to the accounting for hedging activities. The guidance allows companies to more accurately present the economic effects of risk management activities in the financial statements. This amendment is required to be applied prospectively. The primary impact of the adoption is the required disclosure changes. The adoption of the new guidance did not have a material impact on the Company's condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company adopted the FASB guidance related to employee share-based payments. The amendment simplifies several aspects of the accounting for employee share-based payments including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The Company elected to use the prospective transition method for the presentation of excess tax benefits on the statement of cash flows. Under the new standard, excess tax benefits are now included in taxes on earnings in the Consolidated Statement of Earnings (Loss). The Company elected to recognize forfeitures as they occur, and the impact of this change in accounting policy was recorded as a $0.4 million reduction, net, to its beginning retained earnings balance as of September 30, 2017. See Note 12, "Income Taxes" for more information on the impact of this accounting guidance. The remaining provisions of this amendment did not have a material impact on the Company's condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company adopted the FASB accounting guidance related to inventory measurement. The amendment requires inventory measured using first-in, first-out (FIFO) or average cost to be subsequently measured at the lower of cost and net realizable value, thereby simplifying the current guidance that requires an entity to measure inventory at the lower of cost or market. This amendment is required to be applied prospectively. The adoption of this new guidance did not have a material impact to the Company’s condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance on the definition of a business in accounting for transactions when determining whether they represent acquisitions or disposals of assets or of a business. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company’s condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance simplifying the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company’s condensed consolidated financial statements.
Recent Accounting Standards or Updates Not Yet Effective
In February 2018, the FASB amended its guidance that will allow companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2020. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In May 2017, the FASB provided guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The guidance is effective for the Company beginning in the first quarter of fiscal 2019. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its condensed consolidated financial statements.
In March 2017, the FASB amended its guidance on the accounting related to defined benefit plans and other post-retirement benefits. This amendment requires the service cost component of net periodic pension and post-retirement benefit cost be presented in the same line item as other employee compensation costs, while the other components be presented separately as non-operating income (expense). The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In November 2016, the FASB amended its guidance on the classification and presentation of restricted cash in the statement of cash flow. The amendment requires entities to include restricted cash and restricted cash equivalents in its cash and cash

13
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


equivalents in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively. The amendment is not expected to have a material impact to the Company’s condensed consolidated financial statements.
In October 2016, the FASB amended its guidance for tax accounting for intra-entity asset transfers. The amendment removes the prohibition against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The amendment is required to be adopted on a modified retrospective basis. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In August 2016, the FASB issued an amendment to its accounting guidance related to the classification of certain cash receipts and cash payments. The amendment was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively unless it is impracticable. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In June 2016, the FASB issued an amendment to its accounting guidance related to impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021 with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In February 2016, the FASB issued a new standard on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company is evaluating the impact of adopting this new standard to its condensed consolidated financial statements.
In January 2016, the FASB issued an amendment to its accounting guidance related to recognition and measurement of financial assets and financial liabilities. The amendment addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
2. DISCONTINUED OPERATIONS
On January 28, 2017, the Company completed the Distribution of Varex. In connection with the Distribution, the Company and Varex entered into a separation and distribution agreement as well as various other agreements that governs the relationships between the parties, including a transition services agreement, a tax matters agreement, an employee matters agreement, an intellectual property matters agreement, a trademark license agreement and supply/distribution agreements. The separation and distribution agreement and other agreements related to the separation were entered into on January 27, 2017. Services under the transition services agreement were for 60 days to 24 months following the Distribution Date, depending on the service provided.
On January 25, 2017, the Company entered into a term facility ("Varex Term Facility"), and on the same day drew down $203.0 million under the facility. In conjunction with the Distribution, the Company used $200.0 million of those proceeds to repay a portion of its outstanding 2013 Revolving Credit Facility. At the Distribution Date, the Company contributed $81.3 million in cash and cash equivalents to Varex as part of the distribution and transfer of certain legal entities. In fiscal year 2017, the Company received $38.7 million from Varex for excess cash and cash equivalents contributed at the Distribution Date. In fiscal year 2017, the Company recorded a $334.1 million reduction to retained earnings as a result of the Distribution of Varex, which included assets and liabilities transferred to Varex on the Distribution Date, including $203.0 million of debt outstanding under the Varex Term Facility.
Following the Distribution, Varex retained a specified amount of cash that would enable Varex to pay the Company consideration for certain net assets outside of the United States that were required to be transferred to Varex but which did not occur on the Distribution Date due to not having received regulatory approvals for such transfers. Once those regulatory

14
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


approvals are received, the Company will receive a cash payment from Varex in consideration for such net asset transfers. At March 30, 2018, the Company had $4.9 million in assets (net of liabilities) on its Condensed Consolidated Balance Sheet related to Varex net assets to be transferred. The Company expects the remainder of Varex's net assets will be transferred in fiscal year 2018. If the Company does not receive the necessary regulatory approvals during a specified time period, Varex will be required to transfer such cash amounts to Varian.
The financial results of Varex are presented as net earnings from discontinued operations on the Condensed Consolidated Statements of Earnings (Loss), and primarily include the financial results of the Company's former Imaging Components operating segment and costs relating to the Distribution. Corporate costs previously allocated to the Company's Imaging Components operating segment are not included in discontinued operations. See Note 17, "Segment Information" for more information related to corporate allocated costs.
The following table summarizes the key components of net loss from discontinued operations:
 
Three Months Ended (1)
 
Six Months Ended
(In millions)
March 31,
2017
 
March 31,
2017
Revenues
$
42.5

 
$
194.0

Cost of revenues
24.6

 
117.3

Gross margin
17.9

 
76.7

Operating expenses (2)
29.7

 
76.1

Operating earnings
(11.8
)
 
0.6

Taxes on earnings
1.5

 
7.4

Net loss from discontinued operations
(13.3
)
 
(6.8
)
Less: Net earnings from discontinued operations attributable to noncontrolling interests
—

 
0.1

Net loss from discontinued operations attributable to Varian
$
(13.3
)
 
$
(6.9
)
(1) 
There was no activity in net loss from discontinued operations during the three and six months ended March 30, 2018.
(2) 
Operating expenses included separation costs of $19.3 million and $34.2 million during the three and six months ended March 31, 2017, respectively. Separation costs include expenses for transaction advisory services, consulting services, restructuring and other expenses.
The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in the Company's Condensed Consolidated Balance Sheets:
(In millions)
March 30,
2018
 
September 29,
2017
Assets:
 
 
 
Trade accounts receivable, net
$
7.1

 
$
8.1

Inventories
1.1

 
2.9

Prepaid expenses and other current assets
0.4

 
0.1

Current assets of discontinued operations
8.6

 
11.1

Total assets of discontinued operations
$
8.6

 
$
11.1

Liabilities:
 
 
 
Accounts payable
$
2.0

 
$
2.0

Accrued liabilities
1.7

 
0.5

Current liabilities of discontinued operations
3.7

 
2.5

Total liabilities of discontinued operations
$
3.7

 
$
2.5


15
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


The following table presents supplemental cash flow information of discontinued operations:
 
Six Months Ended (1)
(In millions)
March 31,
2017
Operating activities:
 
Share-based compensation expense
$
2.0

Depreciation expense
4.4

Amortization expense
1.8

Investing activities:
 
Purchases of property, plant and equipment
$
(6.3
)
(1) 
There was no significant cash flow activity from discontinued operations during the six months ended March 30, 2018.
3. BUSINESS COMBINATIONS
Sirtex
On January 30, 2018, the Company signed an agreement to acquire Sirtex Medical Limited ("Sirtex"), an Australian company that is listed on the Australian Securities Exchange, for A$28 per share or approximately A$1.6 billion ($1.2 billion as of March 30, 2018). Sirtex is an Australian-based global life sciences company focused on interventional oncology therapies. The Company plans to fund the acquisition primarily using its 2018 Revolving Credit Facility, as well as cash on hand. The transaction has received all necessary regulatory approvals, is subject to the approval of the Sirtex shareholders, the Federal Court of Australia and the satisfaction of other customary closing conditions.

On May 4, 2018, Sirtex received an unsolicited non-binding, indicative and conditional proposal from CDH Investments ("CDH"), a China-based alternative asset manager, for the acquisition of all of the issued shares in Sirtex for A$33.60 per share. The Sirtex board of directors has determined to engage with CDH to further understand the conditions associated with the CDH proposal. As a result, the meeting of Sirtex shareholders to approve the acquisition by Varian, which was scheduled to occur on Monday, May 7, 2018 (Sydney time), was adjourned to a time and date to be determined.
Other Acquisitions
In fiscal year 2018, the Company acquired two privately-held software companies for a purchase price of $29.6 million. The purchase price primarily consisted of $20.4 million in finite-lived intangible assets and $11.5 million in goodwill. The Company has integrated these two acquisitions into its Oncology Systems reporting unit.
Other Information
The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisitions completed above. The Company believes the factors that contributed to goodwill include synergies that are specific to the Company's acquisitions completed and not available to market participants and the acquisition of a talented workforce. The goodwill for the recent acquisitions mentioned above is deductible for income tax purposes.

The fair value of assets acquired and liabilities assumed has been determined on a preliminary basis, and the Company will finalize these amounts as it obtains the information necessary to complete the measurement process. Any changes resulting from facts and circumstances that existed as of the date of the acquisitions may result in adjustments to the amounts of goodwill, intangible assets and deferred revenue balances recorded. The Company expects to finalize these amounts no later than one year from the date of each acquisition.
The condensed consolidated financial statements include the operating results from the date of acquisition. The impact of the acquisitions completed to the periods presented was not material. Pro forma results of operations for the acquisitions completed

16
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


have not been presented because the effects of the acquisitions, individually and in the aggregate, were not material to the Company's condensed consolidated financial statements.
4. BALANCE SHEET COMPONENTS 
The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers:
(In millions)
March 30,
2018
 
September 29,
2017
Unbilled receivables - current
$
311.5

 
$
259.1

Unbilled receivables - long-term (1)
28.2

 
10.9

Deferred revenues - current
(766.5
)
 
(755.4
)
Deferred revenues - long-term (2)
(9.1
)
 
(7.2
)
Total net unbilled receivables (deferred revenues)
$
(435.9
)
 
$
(492.6
)
(1) 
Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2) 
Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.
During the six months ended March 30, 2018, unbilled receivables net of deferred revenues increased by $56.7 million primarily due to the contractual timing of billings occurring after the revenues were recognized, as well as the timing of milestone payments.
During the three and six months ended March 30, 2018, the Company recognized revenues of $108.8 million and $305.2 million, respectively, which was included in the deferred revenues balance at September 29, 2017. During the three and six months ended March 31, 2017, the Company recognized revenues of $127.2 million and $346.0 million, respectively, which was included in the deferred revenues balance at September 30, 2016.
The Company did not have any impairment losses on its unbilled receivables during the six months ended March 30, 2018. The Company recognized an impairment loss of $17.2 million from long-term unbilled receivables during the six months ended March 31, 2017. See Note 16, "VPT Loans and Securities" for further information.
The following table summarizes the Company's inventories:
(In millions)
March 30,
2018
 
September 29,
2017
Raw materials and parts
$
306.5

 
$
296.5

Work-in-process
54.1

 
47.7

Finished goods
73.2

 
73.5

Total inventories
$
433.8

 
$
417.7


17
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


The following tables summarize the Company's available-for-sale securities:
 
March 30, 2018
(In millions)
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
APTC securities (1)
$
6.1

 
$
—

 
$
—

 
$
6.1

GPTC securities (2)
4.6

 
—

 
—

 
4.6

   Total available-for-sale securities
$
10.7

 
$
—

 
$
—

 
$
10.7

 
September 29, 2017
(In millions)
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Original CPTC loans (2)
$
47.4

 
$
—

 
$
—

 
$
47.4

DRTC securities (2)
8.3

 
—

 
—

 
8.3

GPTC securities (2)
4.4

 
—

 
—

 
4.4

   Total available-for-sale securities
$
60.1

 
$
—

 
$
—

 
$
60.1

(1) 
Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets because the Company has the ability and intent to sell this security in the next twelve months.
(2) 
Included in other assets on the Company's Condensed Consolidated Balance Sheets because the maturity dates are greater than one year and the Company does not have the intent and ability to collect or sell all or a portion of its loans or securities in the next twelve months.
See Note 5, "Fair Value" and Note 16, "VPT Loans and Securities" for more information on the Original California Proton Treatment Center, LLC (“Original CPTC”) Loans, Alabama Proton Therapy Center ("APTC"), Delray Radiation Therapy Center (“DRTC”), and Georgia Proton Treatment Center ("GPTC") Securities.
The following table summarizes the Company's other long-term liabilities:
(In millions)
March 30,
2018
 
September 29,
2017
Long-term income taxes payable
$
208.1

 
$
48.6

Deferred income taxes
26.4

 
17.1

Long-term debt
25.0

 
—

Other
61.2

 
61.7

Total other long-term liabilities
$
320.7

 
$
127.4



18
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


5. FAIR VALUE
Assets/Liabilities Measured at Fair Value on a Recurring Basis
In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
 
 
Fair Value Measurement Using
 
 
Quoted Prices in
Active Markets
for Identical
Instruments
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
Total
Type of Instruments
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Balance
(In millions)
 
 
 
 
 
 
 
 
Assets at March 30, 2018:
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
APTC securities
 
$
—

 
$
6.1

 
$
—

 
$
6.1

GPTC securities
 
—

 
4.6

 
—

 
4.6

Derivative assets
 
—

 
0.5

 
—

 
0.5

Total assets measured at fair value
 
$
—

 
$
11.2

 
$
—

 
$
11.2

 
 
 
 
 
 
 
 
 
Liabilities at March 30, 2018:
 
 
 
 
 
 
 
 
Derivative liabilities
 
$
—

 
$
(12.4
)
 
$
—

 
$
(12.4
)
Contingent consideration
 
—

 
—

 
(2.8
)
 
(2.8
)
Total liabilities measured at fair value
 
$
—

 
$
(12.4
)
 
$
(2.8
)
 
$
(15.2
)
 
 
 
 
 
 
 
 
 
Assets at September 29, 2017:
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
Original CPTC loans
 
$
—

 
$
—

 
$
47.4

 
$
47.4

DRTC securities
 
—

 
8.3

 
—

 
8.3

GPTC securities
 
—

 
4.4

 
—

 
4.4

Total assets measured at fair value
 
$
—

 
$
12.7

 
$
47.4

 
$
60.1

The Company's Level 2 available-for-sale securities consist of bonds for APTC, GPTC, and DRTC. The observable inputs for these securities are comparable bond issues, broker/dealer quotations for the same or similar investments in active markets and other observable inputs such as yields, credit risks, default rates, and volatility. As of March 30, 2018 and September 29, 2017, the carrying amount of the Level 2 available-for-sale securities approximated their fair value. See Note 16, "VPT Loans and Securities" for further information about these bonds.
The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads. The Company’s derivative instruments are generally short-term in nature, typically one month to thirteen months in duration. See Note 9, "Derivative Instruments and Hedging Activities" for more information about the Company's derivative instruments.
The Company measures the fair value of its Level 3 contingent consideration liabilities based on the income approach by using a discounted cash flow model with key assumptions that include estimated sales units or revenues of the acquired business or completion of certain milestone targets during the earn-out period, volatility, and estimated discount rates corresponding to the periods of expected payments. If the estimated sales units, revenues or probability of completing certain milestones were to increase or decrease during the respective earn-out period, the fair value of the contingent consideration would increase or decrease, respectively. If the estimated discount rates were to increase or decrease, the fair value of contingent consideration would decrease or increase, respectively. Changes in volatility may result in an increase or decrease in the fair value of contingent consideration. The Company's contingent consideration are from its business combinations in fiscal year 2018 and is included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets.

19
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


In December 2017, the Original CPTC loans were modified and partially satisfied resulting in a Term Loan of $53.5 million, as defined in Note 16, "VPT Loans and Securities". One of the modifications was that the loan agent no longer has the option to purchase these loans from the Company, therefore, the Original CPTC loans are no longer classified as an available-for-sale security. The Company had no unrealized gains or unrealized losses associated with the Original CPTC loans recorded in its other comprehensive income. The modification to the Original CPTC Loans had no impact on the Company's Condensed Consolidated Statements of Earnings (Loss) for the three months ended December 29, 2017. As of September 29, 2017, the Company classified the Original CPTC loans as available-for-sale securities, the fair value of which was based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks associated with the loans as well as underlying cash flow assumptions. However, the Company did not increase the fair value of the Original CPTC loans above their par values as ORIX Capital Markets, LLC (“ORIX”), the loan agent, had the option to purchase these loans from the Company under the original terms and conditions at par value.
The following table presents the reconciliation for all assets and liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):
(In millions)
Available-for-sale Securities
 
Contingent
Consideration
Balance at September 29, 2017
$
47.4

 
$
—

Additions from business combinations
—

 
(2.8
)
Reclassification of Original CPTC Loans to Term Loan
(47.4
)
 
—

Balance at March 30, 2018
$
—

 
$
(2.8
)
There were no transfers of assets or liabilities between fair value measurement levels during either the three and six months ended March 30, 2018, or the three and six months ended March 31, 2017. Transfers between fair value measurement levels are recognized at the end of the reporting period.
Fair Value of Other Financial Instruments
The fair values of certain of the Company’s financial instruments, including bank deposits included in cash and cash equivalents, trade and unbilled receivables, net of allowance for doubtful accounts, short-term notes receivable, revolving loan to CPTC, RPTC senior secured debt, accounts payable, and short-term borrowings approximate their carrying amounts due to their short maturities.
As of March 30, 2018, the fair value of the Company's long-term debt approximated its carrying value of $25.0 million because it is carried at a market observable interest rate that resets periodically and is categorized as Level 2 in the fair value hierarchy.
As of March 30, 2018, the fair value of the Term Loan with CPTC approximated its carrying value of $44.0 million. See Note 16, "VPT Loans and Securities" for further information. The carrying value is based on the present value of expected future cash payments discounted at a rate reflecting the nature and duration of the loans, risks involved with CPTC, and its industry. As a result, the Term Loan is categorized as Level 3 in the fair value hierarchy.
The fair value of the outstanding long-term notes receivable, including accrued interest, approximated their carrying value of $62.6 million and $100.2 million at March 30, 2018 and September 29, 2017, respectively, because they are based on terms of recent comparable transactions and are categorized as Level 3 in the fair value hierarchy. The fair value is based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks as well as underlying cash flow assumptions. See Note 6, "Receivables" for information on the long-term notes receivable.


20
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


6. RECEIVABLES
The following table summarizes the Company's trade and unbilled receivables, net and notes receivable:
(In millions)
March 30,
2018
 
September 29,
2017
Trade and unbilled receivables, gross
$
1,008.8

 
$
1,039.2

Allowance for doubtful accounts
(40.3
)
 
(63.1
)
Trade and unbilled receivables, net
$
968.5

 
$
976.1

Short-term
$
936.7

 
$
961.5

Long-term (1) 
$
31.8

 
$
14.6

 
 
 
 
Notes receivable
$
87.9

 
$
105.2

Short-term (2) 
$
25.3

 
$
5.0

Long-term (1) (3)
$
62.6

 
$
100.2

(1) 
Balances are included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2) 
Balances are included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets.
(3) 
Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.
A financing receivable represents a financing arrangement with a contractual right to receive money, on demand or on fixed or determinable dates, and that is recognized as an asset on the Company’s Condensed Consolidated Balance Sheets. The Company’s financing receivables consist of trade receivables with contractual maturities of more than one year and notes receivable. A small portion of the Company's financing trade receivables are included in short-term trade accounts receivable.
As of March 30, 2018, the allowance for doubtful accounts is entirely related to short-term trade and unbilled receivables. As of September 29, 2017, the allowance for doubtful accounts included $45.9 million related to short-term trade and unbilled receivables and $17.2 million related to long-term unbilled receivables, which was written off in the first quarter of fiscal year 2018.
See Note 16, "VPT Loans and Securities" for more information on the Company's short-term and long-term notes receivable balances.
7. GOODWILL AND INTANGIBLE ASSETS
The following table reflects the activity of goodwill by reportable operating segment: 
(In millions)
Oncology
Systems
 
Varian Particle Therapy
 
Total
Balance at September 29, 2017
$
170.2

 
$
52.4

 
$
222.6

Business combinations
11.5

 
—

 
11.5

Foreign currency translation adjustments
—

 
2.1

 
2.1

Balance at March 30, 2018
$
181.7

 
$
54.5

 
$
236.2

See Note 3, "Business Combinations" for more information on the Company's acquisitions in fiscal year 2018.

21
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets: 
 
March 30, 2018
 
September 29, 2017
(In millions)
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Technologies and patents
$
118.0

 
$
(67.7
)
 
$
50.3

 
$
102.0

 
$
(60.9
)
 
$
41.1

Customer contracts and supplier relationship
38.2

 
(16.4
)
 
21.8

 
33.9

 
(14.3
)
 
19.6

Other
5.7

 
(4.6
)
 
1.1

 
5.5

 
(3.4
)
 
2.1

Total intangible with finite lives
161.9

 
(88.7
)
 
73.2

 
141.4

 
(78.6
)
 
62.8

In-process research and development with indefinite lives
8.8

 
—

 
8.8

 
8.8

 
—

 
8.8

Total intangible assets
$
170.7

 
$
(88.7
)
 
$
82.0

 
$
150.2

 
$
(78.6
)
 
$
71.6

Amortization expense for intangible assets was $4.1 million and $3.5 million during the three months ended March 30, 2018 and March 31, 2017, respectively, and $10.4 million and $7.3 million during the six months ended March 30, 2018 and March 31, 2017, respectively.
As of March 30, 2018, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions):
Fiscal Years:
Remaining Amortization Expense
Remainder of 2018
$
10.9

2019
15.2

2020
12.7

2021
10.4

2022
9.0

Thereafter
15.0

Total remaining amortization for intangible assets
$
73.2

8. BORROWINGS
The following table summarizes the Company's short-term borrowings and long-term debt:
 
March 30, 2018
 
September 29, 2017
(In millions, except for percentages)
Amount
 
Weighted-Average Interest Rate
 
Amount
 
Weighted-Average Interest Rate
Short-term borrowings:
 
 
 
 
 
 
 
2017 Revolving Credit Facility
$
230.0

 
2.79
%
 
$
350.0

 
2.36
%
Total short-term borrowings
$
230.0

 
 
 
$
350.0

 
 
 
 
 
 
 
 
 
 
Long-term debt:
 
 
 
 
 
 
 
2017 Revolving Credit Facility
$
25.0

 
4.88
%
 
$
—

 
—
%
Total long-term debt
$
25.0

 
 
 
$
—

 
 
The Company entered into an agreement, dated September 1, 2017, ("Credit Agreement") with certain lenders and Bank of America, N.A. (“BofA”) as administrative agent ("Debt Lenders"). The Credit Agreement provides for a five-year revolving credit facility (the "2017 Revolving Credit Facility") in an aggregate principal amount of up to $600.0 million. The Company

22
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


incurred $1.8 million in debt issuance costs for its 2017 Revolving Credit Facility, which will be amortized over the five-year term. Debt issuance costs are recorded in prepaid expenses and other current assets and other assets on the Condensed Consolidated Balance Sheets.
On April 3, 2018, the Company replaced its 2017 Revolving Credit Facility with a new credit agreement ("2018 Credit Agreement"). See Note 18, "Subsequent Events" for more information on the 2018 Revolving Credit Facility.
Borrowings under the 2017 Revolving Credit Facility accrue interest based on either (i) the Eurodollar Rate plus a margin of 1.125% to 1.875% based on a leverage ratio involving funded indebtedness and EBITDA, or (ii) a base rate of (a) the federal funds rate plus 0.50%, (b) BofA’s announced prime rate, or (c) the Eurodollar Rate plus 1.00%, whichever is highest, plus a margin of 0.125% to 0.875% based on the same leverage ratio, depending upon instructions from the Company. Borrowings under the 2017 Revolving Credit Facility have a contract repayment date of twelve months, or less, and a final maturity of five years if based on the Eurodollar Rate and all overnight borrowings on the base rate would also have a final maturity of five years.
The Company must pay a commitment fee on the unused portion of the 2017 Revolving Credit Facility at a rate from 0.125% to 0.25% based on a leverage ratio. The Company may prepay, reduce or terminate the commitments without penalty. Swing line loans under the 2017 Credit Facility will bear interest at the base rate plus the then applicable margin for base rate loans.
The Credit Agreement provides that certain material domestic subsidiaries must guarantee the 2017 Revolving Credit Facility, subject to certain limitations on the amount secured. As of March 30, 2018, no subsidiary guaranties were required to be executed under the Credit Agreement.
The Credit Agreement contains provisions that limit the Company's ability to, among other things, incur future indebtedness, contingent obligations or liens, guarantee indebtedness, make certain investments and capital expenditures, sell stock or assets and pay dividends, and consummate certain mergers or acquisitions.
The Credit Agreement contains affirmative and negative covenants applicable to the Company and its subsidiaries that are typical for credit facilities of this type, and that are subject to materiality and other qualifications, carve-outs, baskets and exceptions. The Company has also agreed to maintain certain financial covenants including (i) a maximum consolidated leverage ratio, involving funded indebtedness and EBITDA, and (ii) a minimum consolidated interest coverage ratio. The Company was in compliance with all financial covenants under the Credit Agreement for all periods within these condensed consolidated financial statements.
VMS’s Japanese subsidiary (“VMS KK”) has an unsecured uncommitted credit agreement with Sumitomo that enables VMS KK to borrow and have outstanding at any given time a maximum of 3.0 billion Japanese Yen (the “Sumitomo Credit Facility”). In February 2018, the Sumitomo Credit Facility was extended and will expire in February 2019. Borrowings under the Sumitomo Credit Facility accrue interest based on the basic loan rate announced by the Bank of Japan plus a margin of 0.5%.


23
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


9. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company measures all derivatives at fair value on the Condensed Consolidated Balance Sheets. The accounting for gains or losses resulting from changes in the fair value of those derivatives depends upon the use of the derivative and whether it qualifies for hedge accounting.
The fair value of derivative instruments reported on the Condensed Consolidated Balance Sheets was as follows:
 
Balance Sheet
 
March 30, 2018
(In millions)
Location
 
Fair Value
Derivatives not designated as hedging instruments:
 
 
 
Foreign exchange option contract
Prepaid expenses and other current assets
 
$
0.5

Foreign exchange forward contracts
Accrued liabilities
 
(12.4
)
Total derivatives
 
 
$
(11.9
)
At March 30, 2018, and September 29, 2017, the Company did not have any outstanding derivatives designated as hedging instruments. As of September 29, 2017, the fair value of the Company's derivatives not designated as hedging instruments was not material. See Note 5, "Fair Value" for the valuation of the Company’s derivative instruments. Also, see Note 1, "Summary of Significant Accounting Policies" in the Consolidated Financial Statements in the Company’s 2017 Annual Report for the credit risk associated with the Company’s derivative instruments.
Offsetting of Derivatives
The Company presents its derivative assets and derivative liabilities on a gross basis on the Condensed Consolidated Balance Sheets. However, under agreements containing provisions on netting with certain counterparties of foreign exchange contracts, subject to applicable requirements, the Company is allowed to net-settle transactions in the same currency, with a single net amount payable by one party to the other. As of March 30, 2018, and September 29, 2017, there were no potential effects of rights of setoff associated with derivative instruments. The Company is neither required to pledge nor entitled to receive cash collateral related to these derivative transactions.
Cash Flow Hedging Activities
The Company has many transactions denominated in foreign currencies and addresses certain of those financial exposures through a risk management program that includes the use of derivative financial instruments. The Company sells products throughout the world, often in the currency of the customer’s country, and may hedge certain of the larger foreign currency transactions when they are either not denominated in the relevant subsidiary’s functional currency or the U.S. Dollar. These foreign currency sales transactions are hedged using foreign currency forward contracts. The Company may use other derivative instruments in the future. The Company does not enter into foreign currency forward contracts for speculative or trading purposes. Foreign currency forward contracts are entered into up to several times a quarter and range from one to thirteen months in maturity.
The hedges of foreign currency denominated forecasted revenues are designated and accounted for as cash flow hedges. The designated cash flow hedges de-designate when the anticipated revenues associated with the transactions are recognized and the change in fair value of the derivatives in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets is reclassified to revenues in the Condensed Consolidated Statements of Earnings (Loss). Subsequent changes in fair value of the derivative instrument are recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings (Loss) to offset changes in fair value of the resulting non-functional currency receivables. For derivative instruments that are designated and qualified as cash flow hedges, the Company formally documents for each derivative instrument at the hedge’s inception, the relationship between the hedging instrument (foreign currency forward contract) and hedged item (forecasted foreign currency revenues), the nature of the risk being hedged and its risk management objective and strategy for undertaking the hedge. The Company records the gain or loss on the derivative instruments that are designated and qualified as cash flow hedges in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets and reclassifies these amounts into revenues in the Condensed Consolidated Statements of Earnings (Loss) in the period in which the hedged transaction is recognized in earnings. The Company assesses hedge effectiveness both at the onset of the hedge and

24
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


on an ongoing basis using regression analysis. The time value of the derivative and hedged item is included in the assessment of hedge effectiveness.
At the inception of the hedge relationship and quarterly thereafter, the Company assesses whether the likelihood of meeting the forecasted cash flow is highly probable. As of March 30, 2018, the Company did not have any outstanding foreign currency forward contracts designated as cash flow hedges.
During the three and six months ended March 30, 2018, the Company recognized an unrealized loss of $0.6 million and $0.9 million, respectively, in other comprehensive earnings (loss) on foreign currency forward contracts designated as cash flow hedges. The Company did not have any foreign currency forward contracts designated as cash flow hedges during the three and six months ended March 31, 2017.
The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings (Loss) was as follows:
 
Location and Amount Recognized in Earnings (Loss) on Cash Flow Hedging Relationships
 
Three Months Ended
 
Six Months Ended
 
March 30, 2018
 
March 30, 2018
(In millions)
Revenues
 
Revenues
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings (Loss) in which the effects of fair value and cash flow hedges are recorded
$
729.9

 
$
1,408.4

 
 
 
 
Loss on cash flow hedge relationships:
 
 
 
Foreign currency forward contracts:
 
 
 
Amount of loss reclassified from accumulated other comprehensive loss into earnings (loss)
$
(1.0
)
 
$
(0.9
)
Balance Sheet Hedging Activities
The Company also hedges balance sheet exposures from its various subsidiaries and business units where the U.S. Dollar is the functional currency. The Company enters into foreign currency forward contracts to minimize the short-term impact of foreign currency fluctuations on monetary assets and liabilities denominated in currencies other than the U.S. Dollar functional currency. The foreign currency forward contracts are short term in nature, typically with a maturity of approximately one month, and are based on the net forecasted balance sheet exposure. For derivative instruments not designated as hedging instruments, changes in their fair values are recognized in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings (Loss). Changes in the values of these hedging instruments are offset by changes in the values of foreign-currency-denominated assets and liabilities. Variations from the forecasted foreign currency assets or liabilities, coupled with a significant currency rate movement, may result in a material gain or loss if the hedges are not effectively offsetting the change in value of the foreign currency asset or liability. Other than foreign exchange hedging activities, the Company has no other free-standing or embedded derivative instruments.

25
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


The Company had the following outstanding foreign currency forward contracts relating to balance sheet hedging activities:
 
March 30, 2018
(In millions)
Notional
Value Sold
 
Notional
Value Purchased
Australian Dollar
$
35.1

 
$
—

Brazilian Real
7.7

 
—

British Pound
33.0

 
—

Canadian Dollar
12.3

 
—

Danish Krone
9.9

 
0.5

Euro
246.6

 
—

Hungarian Forint
1.9

 
—

Indian Rupee
17.8

 
—

Japanese Yen
69.5

 
—

Polish Zloty
18.6

 
—

Singapore Dollar
—

 
5.1

Swedish Krona
12.1

 
—

South African Rand

8.9

 
—

Swiss Franc
—

 
36.2

Thai Baht
3.9

 
—

Totals
$
477.3

 
$
41.8

The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings (Loss) related to the foreign currency forward contracts that are not designated as hedging instruments.
Location of Gain (Loss) Recognized in Income on Derivative Instruments
 
Amount of Gain (Loss) Recognized in Net Earnings (Loss) on Derivative Instruments
 
 
Three Months Ended
 
Six Months Ended
(In millions)
 
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Selling, general and administrative expenses
 
$
(7.5
)
 
$
(7.5
)
 
$
(12.2
)
 
$
7.4

The gains (losses) on these derivative instruments were significantly offset by the gains (losses) resulting from the re-measurement of monetary assets and liabilities denominated in currencies other than the U.S. Dollar functional currency.
Foreign Currency Forward and Option Contracts related to the Acquisition of Sirtex
In February 2018, the Company entered into foreign currency forward contracts and a foreign currency option contract to economically hedge its foreign currency exchange rate risk on the consideration to be paid for the Sirtex acquisition. The foreign currency forward contracts allow the Company to purchase a notional amount of A$793.0 million for $621.0 million on May 25, 2018. The quoted forward exchange rate on March 30, 2018 would provide that the same amount of Australian Dollars would cost $609.6 million. The Company paid a premium of $5.5 million for a foreign currency option that allows the Company to purchase a notional amount of A$792.0 million for $641.5 million that will expire on May 23, 2018. As of March 30, 2018, the foreign currency option has a fair value of $0.5 million.
The foreign currency forward contracts and option contract do not qualify for hedge accounting. As such, changes in the fair value will be recognized in acquisition-related expenses on the Condensed Consolidated Statements of Earnings. In the three months ended March 30, 2018, the Company recorded losses of $11.4 million on the foreign currency forward contracts and $5.0 million on the foreign currency option contract.

26
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


Contingent Features
Certain of the Company’s derivative instruments are subject to master agreements which contain provisions that require the Company, in the event of a default, to settle the outstanding contracts in net liability positions by making settlement payments in cash or by setting off amounts owed to the counterparty against any credit support or collateral held by the counterparty. As of March 30, 2018, and September 29, 2017, the Company did not have any outstanding derivative instruments with credit-risk-related contingent features that were in a net liability position in the Company’s outstanding balance sheet hedges.
10. COMMITMENTS AND CONTINGENCIES
Product Warranty
The following table reflects the changes in the Company’s accrued product warranty:
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
Accrued product warranty, at beginning of period
$
41.3

 
$
41.9

Charged to cost of revenues
26.3

 
17.4

Actual product warranty expenditures
(26.5
)
 
(23.2
)
Accrued product warranty, at end of period
$
41.1

 
$
36.1

Accrued product warranty was included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets.
Contingencies
Environmental Remediation Liabilities
The Company’s operations and facilities, past and present, are subject to environmental laws, including laws that regulate the handling, storage, transport and disposal of hazardous substances. Certain of those laws impose cleanup liabilities on the Company in connection with its past and present operations. Those include facilities sold as part of the Company’s electron devices business in 1995 and thin film systems business in 1997. As a result, the Company oversees various environmental cleanup projects and receives reimbursements from third parties for a portion of the costs of its cleanup activities.
The Company also reimburses certain third parties for cleanup activities. The Company spent $0.2 million and $0.1 million (net of amounts borne by third parties) in the three months ended March 30, 2018 and March 31, 2017, respectively, on environmental cleanup costs, third-party claim costs, project management costs and legal costs. The Company spent $0.4 million and $0.3 million (net of amounts borne by third parties) in the six months ended March 30, 2018 and March 31, 2017, respectively, on such costs.
With respect to some of these facilities, inherent uncertainties make it difficult to estimate the likelihood of the cost of future cleanup, third-party claims, project management and legal services for the cleanup sites (“Group A Sites”). Nonetheless, as of March 30, 2018, the Company estimated that, net of third parties’ indemnification obligations, future costs associated with the environmental remediation liabilities for the Group A Sites would range in total from $1.0 million to $7.9 million. The time frames over which these cleanup project costs are estimated vary, ranging from one year to thirty years as of March 30, 2018. Management believes that no amount in that range is more probable of being incurred than any other amount and therefore accrued $1.0 million for these cleanup projects as of March 30, 2018. The accrued amount has not been discounted to present value due to the uncertainties that make it difficult to develop a single best estimate.
In addition to the Group A Sites, there are other past and present facilities (“Group B Sites”) where the Company believes it has gained sufficient knowledge to better estimate the scope and cost of monitoring, cleanup and management activities. This, in part, is based on agreements with other parties and also cleanup plans approved by or completed in accordance with the requirements of, the governmental agencies having jurisdiction. As of March 30, 2018, the Company estimated that the Company’s future exposure on the Group B Sites, net of third parties’ indemnification obligations, for the costs at these

27
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


facilities, and reimbursements of third-party’s claims for these facilities, ranged in total from $3.4 million to $19.3 million. The time frames over which these costs are estimated to be incurred vary, ranging from one year to thirty years as of March 30, 2018. As to each of these facilities, management determined that a particular amount within the range of estimated costs was a better estimate than any other amount within the range, and that the amount and timing of these future costs were reliably determinable. The best estimate within that range was $5.5 million at March 30, 2018. Accordingly, the Company had accrued $4.7 million as of March 30, 2018 for these costs, which represented the best estimate discounted at 4%, net of inflation. This accrual is in addition to the $1.0 million accrued for the Group A Sites.
These amounts are only estimates of anticipated future costs. The amounts the Company will actually spend may be greater than the estimates. The Company believes its reserve is adequate; however, as the scope of the Company’s obligations becomes more clearly defined, the Company may modify the reserve, and charge or credit future earnings accordingly. Based on information currently known to management, management believes the costs of these environmental-related matters are not reasonably likely to have a material adverse effect on the consolidated financial statements of the Company in any one fiscal year.
The Company evaluates its liability for investigation and cleanup costs in light of the obligations and financial strength of potential third parties and insurance companies the Company believes it has rights to indemnity or reimbursement. The Company has an agreement with an insurance company under which that insurer has agreed to pay a portion of the Company’s past and future environmental-related expenditures. Receivables, net of the portion due to third parties who reimburse the Company, from that insurer amounted to $1.4 million and $1.6 million at March 30, 2018 and September 29, 2017, respectively, with the respective current portion included in prepaid expenses and other current assets and the respective noncurrent portion included in other assets. The payable portion to that insurer is included in other long-term liabilities on the Condensed Consolidated Balance Sheets. The Company believes that this receivable is recoverable because it is based on a binding, written settlement agreement with an insurance company who appears to be financially viable and who has paid the Company’s claims in the past.
Other Matters
From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations and other legal matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value). A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. 
In addition to the above, the Company is involved in other legal matters. However, such matters are subject to many uncertainties and outcomes are not predictable with assurance. The Company is unable to estimate a loss or a range of reasonably possible losses with respect to such matters. There can be no assurances as to whether the Company will become subject to significant additional claims and liabilities with respect to ongoing or future proceedings. If actual liabilities significantly exceed the estimates made, the Company’s consolidated financial position, results of operations or cash flows could be materially adversely affected. Legal expenses relating to legal matters are expensed as incurred.
Restructuring Charges
In the first quarter of fiscal year 2017, the Company offered an enhanced retirement program to its qualifying employees and implemented a workforce reduction (collectively, the "2017 Restructuring Plan"), primarily in its Oncology Systems and VPT segments, to improve operational performance. The Company did not incur any restructuring charges during the three and six months ended March 30, 2018, respectively, and incurred $2.5 million and $6.3 million in restructuring charges during the three and six months ended March 31, 2017, respectively. As of March 30, 2018, the Company plans to complete this plan in fiscal year 2018 and does not expect any additional restructuring charges under this plan.

28
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


The following table provides a summary of changes in the restructuring liability related to the Company's restructuring plans:
(In millions)
September 29,
2017
 
Restructuring Charges
 
Cash Payments
 
March 30,
2018
2017 Restructuring Plan
$
3.9

 
$
—

 
$
(3.3
)
 
$
0.6

Total
$
3.9

 
$
—

 
$
(3.3
)
 
$
0.6

The restructuring charges are included in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings (Loss).
11. RETIREMENT PLANS
The Company sponsors five defined benefit pension plans for regular full-time employees in Germany, Japan, Switzerland and the United Kingdom. The Company also sponsors a post-retirement benefit plan that provides healthcare benefits to certain eligible retirees in the United States.
The components of net defined benefit costs were as follows:
 
Three Months Ended
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Defined Benefit Plans
 
 
 
 
 
 
 
Service cost
$
1.7

 
$
1.8

 
$
3.3

 
$
3.5

Interest cost
0.8

 
0.6

 
1.6

 
1.2

Expected return on plan assets
(2.0
)
 
(1.8
)
 
(4.0
)
 
(3.5
)
Amortization of prior service cost
(0.2
)
 
—

 
(0.3
)
 
(0.1
)
Recognized actuarial loss
0.7

 
1.1

 
1.4

 
2.2

Net periodic benefit cost
$
1.0

 
$
1.7

 
$
2.0

 
$
3.3

12. INCOME TAXES
The Company’s effective tax rate was 23.4% and 23.1% for the three months ended March 30, 2018 and March 31, 2017, respectively, and 117.9% and 29.4% for the six months ended March 30, 2018 and March 31, 2017, respectively. The increase in the Company’s effective tax rate for the three and six months ended March 30, 2018, compared to the year-ago periods, was primarily due to the tax effect of the Tax Cuts and Jobs Act (the "Act"), which was signed into law on December 22, 2017. The Company’s effective tax rate for the six months ended March 31, 2017 was also high due to the impairment of the CPTC loans in December 2016, which were made by one of the Company's Swiss subsidiaries, which has a low tax rate, and a significant portion of the expense associated with the allowance for doubtful accounts recorded in the period being attributable to one of the Company's German subsidiaries which has a full valuation allowance.
The Act was signed into law on December 22, 2017. Among other changes, the Act reduces the U.S. corporate tax rate from 35% to 21%, and imposes a one-time transition tax on the unremitted earnings of the Company's foreign subsidiaries. U.S. GAAP generally requires that the tax effect of a change in tax laws or rates be accounted for in the period of enactment.
The reduction in the U.S. corporate tax rate was effective January 1, 2018. As the Company has a September fiscal year end, the lower corporate tax rate will be phased in, resulting in a U.S. corporate rate of approximately 24.6% for the Company's fiscal year ending September 28, 2018, and 21% for subsequent fiscal years. The reduction in the rate requires the Company to re-measure its net deferred tax assets that were originally recorded assuming a future tax benefit at the 35% rate. Because the rate change is phased in, a portion of the tax impact was included in the period of enactment and a portion is included gradually during the year of enactment. During the three and six months ended March 30, 2018, the Company recorded a provisional discrete tax expense of $2.4 million and $40.2 million, respectively, related to re-measuring its net deferred tax assets as a result of the rate reduction.

29
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


As part of the transition to a modified territorial system, the Act imposes a one-time transition tax on the unremitted earnings of the Company's foreign subsidiaries. During the three and six months ended March 30, 2018, the Company recorded a provisional discrete tax expense of $3.8 million and $173.1 million, respectively, related to the one-time transition tax. The Company intends to elect to pay this tax over the eight-year period allowed for in the Act. The transition to a modified territorial regime and the one-time transition tax on unremitted earnings has also caused the Company to re-evaluate its intentions with respect to the unremitted earnings of foreign subsidiaries. In the past, the Company did not accrue U.S. taxes on certain undistributed profits of certain foreign subsidiaries because the earnings were considered to be indefinitely reinvested. In light of the changes to the taxation of foreign earnings in the Act, the Company no longer considers the earnings of its foreign subsidiaries to be indefinitely reinvested.
Other provisions of the Act include a new minimum tax on certain foreign earnings (the Global Intangibles Low-taxed Income, or "GILTI"), a new tax on certain payments to foreign related parties (the Base Erosion Anti-avoidance Tax, or "BEAT"), a new incentive for Foreign-derived Intangibles Income ("FDII"), changes to the limitation on the deductibility of certain executive compensation, and new limitations on the deductibility of interest expense. Generally, these other provisions take effect for the Company in the fiscal year ending September 27, 2019.
On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”). This guidance allows registrants a “measurement period,” not to exceed one year from the date of enactment, to complete their accounting for the tax effects of the Act. SAB 118 further directs that during the measurement period, registrants who are able to make reasonable estimates of the tax effects of the Act should include those amounts in their financial statements as “provisional” amounts. Registrants should reflect adjustments over subsequent periods as they are able to refine their estimates and complete their accounting for the tax effects of the Act. The amounts of the tax effects related to the Act described in the paragraphs above represent the Company’s current reasonable estimates and are provisional amounts within the meaning of SAB 118. Also, it is expected that the U.S. Treasury will issue regulations and other guidance on the application of certain provisions of the Act. In subsequent periods, but within the measurement period, the Company will analyze that guidance and other necessary information, including the amount of foreign earnings and profits, pools of foreign tax, and the Company's foreign cash position, to refine its estimates and complete its accounting for the tax effects of the Act.
The Company adopted the FASB guidance related to employee share-based payments in the first quarter of fiscal year 2018. Among other changes, this standard changes the treatment of the tax effect of the excess stock deduction. For a share-based compensation instrument, the excess stock deduction is the difference between the amount of the deduction for taxable income and the amount of expense in the financial statements related to that instrument. Under the prior standard, the tax effect of the excess stock deduction related to share-based compensation was recorded to additional paid-in capital in the equity section on the Condensed Consolidated Balance Sheets. Under the new standard, the tax effect of the excess stock deduction related to share-based compensation is recorded as a discrete item to Taxes on Earnings in the Condensed Consolidated Statements of Earnings (Loss). For the three and six months ended March 30, 2018, the Company recorded a discrete tax benefit of $4.7 million and $6.2 million, respectively, related to excess stock deduction activity. The Company expects that the new standard may cause its effective tax rate to be less predictable and more volatile going forward.
The Company’s effective income tax rate differs from the U.S. federal statutory rate primarily because the Company’s foreign earnings are taxed at rates that are, on average, lower than the U.S. federal rate, and because the Company’s domestic earnings are subject to state income taxes. The total amount of unrecognized tax benefits increased by $11.6 million during the six months ended March 30, 2018, primarily due to the impact of the Act on the Company's unrecognized tax benefits. The impact of this increase in tax expense is included in the amount of the provisional discrete expense related to the one-time transition tax above. In addition, the amount of unrecognized tax benefits has increased as a result of positions taken during the current and prior years, and has decreased as the result of the expiration of the statute of limitations in various jurisdictions.


30
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


13. STOCKHOLDERS’ EQUITY AND NONCONTROLLING INTERESTS
Share Repurchase Program
In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. Share repurchases under the Company's authorizations may be made in open market purchases, in privately negotiated transactions (including accelerated share repurchase (“ASR”) programs), or under Rule 10b5-1 share repurchase plans, and may be made from time to time in one or more blocks. All shares that were repurchased under the Company's share repurchase programs have been retired. As of March 30, 2018, approximately 4.4 million shares of VMS common stock remained available for repurchase under the November 2016 authorization.
The Company repurchased shares of VMS common stock under various authorizations during the periods presented as follows:
 
Three Months Ended
 
Six Months Ended
(In millions, except per share amounts)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Number of shares
0.3

 
2.0

 
0.8

 
2.5

Average repurchase price per share
$
110.52

 
$
86.42

 
$
109.06

 
$
88.93

Total cost
$
36.0

 
$
172.8

 
$
92.7

 
$
222.3

Other Comprehensive Earnings
The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:
(In millions)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans
 
Net
Unrealized
Gains
(Losses)
Cash Flow
Hedging
Instruments
 
Cumulative
Translation
Adjustment
 
Accumulated
Other
Comprehensive
Loss
Balance at September 29, 2017
$
(44.1
)
 
$
—

 
$
(24.7
)
 
$
(68.8
)
Other comprehensive earnings (loss) before reclassifications
—

 
(0.9
)
 
9.7

 
8.8

Amounts reclassified out of other comprehensive earnings (loss)
0.9

 
0.9

 
—

 
1.8

Tax expense
(0.2
)
 
—

 
—

 
(0.2
)
Balance at March 30, 2018
$
(43.4
)
 
$
—

 
$
(15.0
)
 
$
(58.4
)
(In millions)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans
 
Cumulative
Translation
Adjustment
 
Accumulated
Other
Comprehensive Earnings
(Loss)
Balance at September 30, 2016
$
(63.3
)
 
$
(37.5
)
 
$
(100.8
)
Other comprehensive loss before reclassifications
—

 
(10.2
)
 
(10.2
)
Amounts reclassified out of other comprehensive earnings (loss)
1.9

 
—

 
1.9

Tax expense
(0.3
)
 
—

 
(0.3
)
Balance at March 31, 2017
$
(61.7
)
 
$
(47.7
)
 
$
(109.4
)

31
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


The amounts reclassified out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings (Loss), with line item location, during each period were as follows: 
 
Three Months Ended
 
Six Months Ended
 
 
 (In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
 
 
Comprehensive Earnings Components
Loss Before Taxes
 
Loss Before Taxes
 
Line Item in Statements of Earnings (Loss)
Unrealized loss on defined benefit pension and post-retirement benefit plans
$
(0.5
)
 
$
(1.0
)
 
$
(0.9
)
 
$
(1.9
)
 
Cost of revenues & Operating expenses
Unrealized loss on cash flow hedging instruments
(1.0
)
 
—

 
(0.9
)
 
—

 
Revenues
Total amounts reclassified out of other comprehensive earnings (loss)
$
(1.5
)
 
$
(1.0
)
 
$
(1.8
)
 
$
(1.9
)
 
 
 
Noncontrolling Interests
In connection with the Distribution of Varex in January 2017, the Company's redeemable noncontrolling interests relating to MeVis Medical Solutions AG ("MeVis") were transferred to Varex.
Changes in noncontrolling interests and redeemable noncontrolling interests relating to MeVis and other subsidiaries of the Company were as follows:
 
Six Months Ended
 
March 30, 2018
 
March 31, 2017
 (In millions)
Noncontrolling Interests
 
Noncontrolling Interests
 
Redeemable Noncontrolling Interests
Beginning of Period
$
4.3

 
$
3.7

 
$
10.3

Net earnings attributable to noncontrolling interests
0.1

 
0.4

 
0.1

Transfer of redeemable noncontrolling interests in MeVis to Varex
—

 
—

 
(10.3
)
Other
—

 
—

 
(0.1
)
End of Period
$
4.4

 
$
4.1

 
$
—

14. EMPLOYEE STOCK PLANS
The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:
 
Three Months Ended
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Cost of revenues - Product
$
0.8

 
$
0.8

 
$
1.5

 
$
1.6

Cost of revenues - Service
1.0

 
1.1

 
2.0

 
2.1

Research and development
1.2

 
1.4

 
2.4

 
2.6

Selling, general and administrative
7.5

 
8.1

 
15.3

 
15.3

Total share-based compensation expense
$
10.5

 
$
11.4

 
$
21.2

 
$
21.6

Income tax benefit for share-based compensation
$
(2.6
)
 
$
(3.4
)
 
$
(4.7
)
 
$
(6.4
)
The Company adopted new accounting guidance in the first quarter of 2018 where it elected to change its accounting policy to account for forfeitures as they occur rather than estimating expected forfeitures. Share-based compensation expense for the three and six months ended March 31, 2017 was recorded net of estimated forfeitures. See Note 1, "Summary of Significant Accounting Policies" for further information.

32
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


The fair value of options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Three Months Ended
 
Six Months Ended
 
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Employee Stock Option Plans
 
 
 
 
 
 
 
Expected term (in years)
3.83

 
3.99

 
3.83

 
3.99

Risk-free interest rate
2.4
%
 
1.7
%
 
2.2
%
 
1.7
%
Expected volatility
19.2
%
 
21.8
%
 
19.0
%
 
21.8
%
Expected dividend
—
%
 
—
%
 
—
%
 
—
%
Weighted average fair value at grant date
$
21.48

 
$
16.13

 
$
20.73

 
$
16.13

The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Six Months Ended
 
March 30,
2018
 
March 31,
2017
Employee Stock Purchase Plan
 
 
 
Expected term (in years)
0.50

 
0.50

Risk-free interest rate
1.2
%
 
0.5
%
Expected volatility
17.9
%
 
22.3
%
Expected dividend
—
%
 
—
%
Weighted average fair value at grant date
$
20.97

 
$
19.37

A summary of share-based awards available for grant is as follows:
(In millions)
Shares Available for Grant
Balance at September 29, 2017
2.5

Authorized (1)
6.0

Granted
(1.7
)
Cancelled or expired
0.3

Balance at March 30, 2018
7.1

(1) 
On February 8, 2018, the Company's stockholders approved its Fifth Amended and Restated 2005 Omnibus Stock Plan ("2005 Plan") to increase the number of shares authorized for issuance by 6.0 million shares.
For purposes of the total number of shares available for grant under the 2005 Plan, any shares subject to awards of stock options and performance stock options are counted against the available-for-grant limit as one share for every one share subject to the award. Awards other than stock options and performance stock options are counted against the available-for-grant limit as 2.6 shares for every one share awarded on or after February 9, 2012. The shares available for grant limit is further adjusted to reflect a maximum payout that could be issued for each performance grant. The maximum payouts that could be issued for each performance grant are 2.0 shares beginning in fiscal year 2018, 1.75 shares in fiscal years 2017 and 2016, and 2.0 shares in fiscal year 2015. All awards may be subject to restrictions on transferability and continued employment as determined by the Compensation and Management Development Committee.

33
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


Activity under the Company’s employee stock plans related to stock options is presented below: 
 
Options Outstanding
(In millions, except per share amounts)
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term (in years)
 
Aggregate
Intrinsic
Value (1)
Balance at September 29, 2017
2.3

 
$
74.08

 
 
 
 
Granted
0.6

 
111.43

 
 
 
 
Cancelled or expired (2)
—

 
75.69

 
 
 
 
Exercised
(0.5
)
 
70.67

 
 
 
 
Balance at March 30, 2018
2.4

 
$
85.00

 
5.1
 
$
89.3

 
 
 
 
 
 
 
 
Exercisable at March 30, 2018
1.1

 
$
73.65

 
4.0
 
$
52.0

(1) 
The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of $122.65 as of March 29, 2018, the last trading date of the second quarter of fiscal year 2018, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.
(2) 
The cancelled and expired shares were not material for disclosure.
As of March 30, 2018, there was $18.0 million of total unrecognized compensation expense related to stock options granted under the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of 2.2 years.
The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:
(In millions, except per share amounts)
Number of
Shares
 
Weighted Average
Grant-Date Fair
Value
Balance at September 29, 2017
0.9

 
$
75.37

Granted
0.3

 
111.81

Vested
(0.3
)
 
76.33

Cancelled or expired
(0.1
)
 
84.16

Balance at March 30, 2018
0.8

 
$
88.61

As of March 30, 2018, unrecognized compensation expense totaling $46.9 million was related to awards of restricted stock units, deferred stock units and performance units granted under the Company's employee stock plans. This unrecognized share-based compensation expense is expected to be recognized over a weighted average period of 2.1 years.

34
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


15. EARNINGS PER SHARE
Basic net earnings per share is computed by dividing net earnings attributable to Varian by the weighted average number of shares of VMS common stock outstanding for the period. Diluted net earnings per share is computed by dividing net earnings attributable to Varian by the sum of the weighted average number of common shares outstanding and dilutive common shares under the treasury stock method.
The following table sets forth the computation of basic and diluted net earnings per share:
 
Three Months Ended
 
Six Months Ended
(In millions, except per share amounts)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Net earnings (loss) from continuing operations
$
73.2

 
$
69.5

 
$
(39.0
)
 
$
77.5

Less: Net (loss) earnings from continuing operations attributable to noncontrolling interests
—

 
(0.1
)
 
0.1

 
0.4

Net earnings (loss) from continuing operations attributable to Varian
$
73.2

 
$
69.6

 
$
(39.1
)
 
$
77.1

 
 
 
 
 
 
 
 
Net loss from discontinued operations
$
—

 
$
(13.3
)
 
$
—

 
$
(6.8
)
Less: Net earnings from discontinued operations attributable to noncontrolling interests
—

 
—

 
—

 
0.1

Net loss from discontinued operations attributable to Varian
$
—

 
$
(13.3
)
 
$
—

 
$
(6.9
)
Net earnings (loss) attributable to Varian
$
73.2

 
$
56.3

 
$
(39.1
)
 
$
70.2

 
 
 
 
 
 
 
 
Weighted average shares outstanding - basic
91.5

 
93.0

 
91.6

 
93.2

Dilutive effect of potential common shares
1.1

 
0.7

 
—

 
0.7

Weighted average shares outstanding - diluted
92.6

 
93.7

 
91.6

 
93.9

 
 
 
 
 
 
 
 
Net earnings (loss) per share attributable to Varian - basic
 
 
 
 
 
 
 
Continuing operations
$
0.80

 
$
0.75

 
$
(0.43
)
 
$
0.83

Discontinued operations
—

 
(0.15
)
 
—

 
(0.08
)
Net earnings (loss) per share - basic
$
0.80

 
$
0.60

 
$
(0.43
)
 
$
0.75

 
 
 
 
 
 
 
 
Net earnings (loss) per share attributable to Varian - diluted
 
 
 
 
 
 
 
Continuing operations
$
0.79

 
$
0.74

 
$
(0.43
)
 
$
0.82

Discontinued operations
—

 
(0.14
)
 
—

 
(0.08
)
Net earnings (loss) per share - diluted
$
0.79

 
$
0.60

 
$
(0.43
)
 
$
0.74

Anti-dilutive employee share-based awards, excluded
0.6

 
0.6

 
3.2

 
0.6

The Company excludes potentially dilutive common shares (consisting of shares underlying stock options and the employee stock purchase plan) from the computation of diluted weighted average shares outstanding if the per share value, either the exercise price of the awards or the sum of (a) the exercise price of the awards and (b) the amount of the compensation cost attributed to future services and not yet recognized and (c) the amount of tax benefit or shortfall that would be recorded in additional paid-in capital when the award becomes deductible, is greater than the average market price of the shares, because the inclusion of the shares underlying these stock awards would be anti-dilutive to earnings per share. For the six months ended March 30, 2018, the diluted net loss per share is the same as the basic net loss per share as the effects of all potential common stock equivalents are anti-dilutive.

35
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


16. VPT LOANS AND INVESTMENT
In limited cases, the Company participates, along with other investors and at market terms, in the financing of proton therapy centers. Over time the Company has divested some of its investments, including investments in CPTC, NYPC and DRTC.
The following table lists the Company's outstanding loans and investments, including accrued interest, and commitments for funding development, construction and operations of various proton therapy centers:
 
 
March 30, 2018
 
September 29, 2017
(In millions)
 
Balance
 
Commitment
 
 Balance
 
Commitment
Notes receivable and secured debt:
 
 
 
 
 
 
 
 
MPTC loans (1)
 
$
58.9

 
$
—

 
$
67.4

 
$
—

RPTC senior secured debt (2)
 
26.4

 
—

 
25.4

 
—

NYPC loan (3)
 
26.2

 
—

 
24.6

 
—

PI loan (3)
 
2.6

 
—

 
3.1

 
—

CPTC DIP loan (3)
 
—

 
—

 
5.1

 
2.2

 
 
$
114.1

 
$
—

 
$
125.6

 
$
2.2

Available-for-sale Securities:
 
 
 
 
 
 
 
 
APTC securities (2)
 
$
6.1

 
$
—

 
$
—

 
$
—

GPTC securities (3)
 
4.6

 
11.8

 
4.4

 
11.8

Original CPTC loans (3)
 
—

 
—

 
47.4

 
—

DRTC securities (4)
 
—

 
—

 
8.3

 
—

 
 
$
10.7

 
$
11.8

 
$
60.1

 
$
11.8

 
 
 
 
 
 
 
 
 
CPTC Loans and Investment:
 
 
 
 
 
 
 
 
Short-term revolving loan (2)
 
$
3.1

 
$
4.1

 
$
—

 
$
—

Term loan (3)

 
44.0

 
—

 
—

 
—

Equity investment in CPTC (3)
 
9.5

 
—

 
—

 
—

 
 
$
56.6

 
$
4.1

 
$
—

 
$
—

(1) 
Includes $33.8 million and $42.3 million in other assets at March 30, 2018 and September 29, 2017, respectively, and $25.1 million in prepaid and other current assets at March 30, 2018 and other assets at September 29, 2017 on the Company's Condensed Consolidated Balance Sheets.
(2) 
Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets.
(3) 
Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(4) 
Included in other assets at September 29, 2017 on the Company's Condensed Consolidated Balance Sheets.
Alabama Proton Therapy Center ("APTC") Securities
In December 2017, the Company purchased $6.0 million in Subordinate Revenue Bonds from the Public Finance Authority which is financing the APTC. The Subordinate Revenue Bonds carry an interest rate of 8.5% and pay interest semi-annually. The Company is scheduled, based upon the terms, to start receiving annual principal payments on the Subordinate Revenue Bonds beginning on November 1, 2022. The Subordinate Revenue Bonds will mature on October 1, 2047.
Rinecker Proton Therapy Center ("RPTC") Senior Secured Debt
In July 2017, the Company purchased the outstanding senior secured debt related to the RPTC in Munich, Germany for 21.5 million Euros or $24.5 million. By purchasing the senior secured debt, the Company has a right to 89 million Euros in claims against all of RPTC's assets. In September 2017, the management of RPTC filed for bankruptcy in Germany. In January 2018, the final insolvency proceedings commenced, and the Company expects the insolvency proceedings to be finalized within the next twelve months. Upon finalization of bankruptcy proceedings, the Company believes it is probable it will recover its outstanding senior secured debt balance and trade accounts receivable, net.

36
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


At both March 30, 2018, and September 29, 2017, the Company had $4.5 million, in trade receivables, net for RPTC, which does not include any unbilled receivables.
Georgia Proton Treatment Center ("GPTC") Security
In July 2017, the Company committed to purchase up to $16.1 million in Senior Capital Appreciation Bonds ("Senior Bonds") from the Atlanta Development Authority, which is financing the GPTC. In July 2017, the Company purchased $4.3 million of the Senior Bonds that carry an interest rate of 8.0% per annum with interest accruing up to the principal amount of $6.6 million until January 1, 2023 and then will pay cash interest semi-annually. The Company will purchase the remaining commitment in July 2018. The Company is scheduled, based upon the original terms, to start receiving annual principal payments on the Senior Bonds beginning on January 1, 2024. The Senior Bonds will mature on January 1, 2028.
In addition to the outstanding loan, the Company had $6.4 million as of March 30, 2018 in trade and unbilled receivables, which included $6.2 million in unbilled receivables from GPTC. The Company did not have any trade and unbilled receivables as of September 29, 2017 from GPTC.
Delray Radiation Therapy Center ("DRTC") Securities and Loan
In April 2017, the Company purchased $8.0 million in Subordinate Bonds from the Public Finance Authority, which is financing the DRTC. The Subordinate Bonds carried an interest rate of 8.5% and paid interest semi-annually. In January 2018, the Company sold all of its Subordinate Bonds for $8.5 million, which included accrued interest.
In addition to the purchase of the Subordinate Bonds, the Company also loaned $3.0 million to Proton International LLC ("PI") to allow PI to purchase $3.0 million in Subordinate Bonds from the Public Finance Authority. The loan to PI carries an interest rate of 8.5% per annum, paid semi-annually and matures on April 30, 2022, subject to early repayment as proceeds are received by PI from the bonds purchased, and is secured by the related bonds. In the first quarter of fiscal year 2018, the Company received a principal payment of $0.5 million.
New York Proton Center ("NYPC") Loan
In July 2015, the Company committed to loan up to $91.5 million to MM Proton I, LLC in connection with a purchase agreement to supply a proton system to equip the NYPC. In June 2016, the Company assigned $73.0 million of this loan to Deutsche Bank AG. The remaining balance is comprised of an $18.5 million “Subordinate Loan” with a six-and-a-half-year term at up to 13.5% interest. The principal balance and accrued interest on the Subordinate Loan are due in full at maturity in January 2022.
In addition to the outstanding loan, the Company had $13.8 million and $13.3 million, as of March 30, 2018, and September 29, 2017, respectively, in trade and unbilled receivables, which included $13.8 million and $1.3 million in unbilled receivables as of March 30, 2018 and September 29, 2017, respectively, from NYPC.
Maryland Proton Treatment Center ("MPTC") Loans
In May 2015, the Company committed to loan up to $35.0 million to MPTC. The Company completed its funding requirements per the loan agreement in the first quarter of fiscal year 2017. Varian's lending is in the form of a subordinated loan that is due, with accrued interest, in three annual payments from 2020 to 2022. The interest on the loan accrues at 12.0%. In the second quarter of fiscal year 2018, the Company recorded an $11.1 million impairment charge on its MPTC subordinated loan, which included accrued interest, due to the expected difference in value between the security currently held by the Company and the value of the new security that will be issued to the Company in exchange as part of the refinancing expected in the second half of fiscal year 2018.
In addition, the Company had previously entered into an agreement with MPTC to supply it with a proton system, which included a deferral of up to $25.1 million of equipment payments when triggered by achievement of delivery milestones under the contract. As of March 30, 2018, the Company has recorded $25.1 million as a notes receivable related to this deferred payment arrangement. The notes receivable is due September 30, 2018.
As of March 30, 2018, and September 29, 2017, the Company had zero net trade and unbilled receivables from MPTC.

37
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


Variable Interest Entities
The Company has determined that MM Proton I, LLC, MPTC, and RPTC are variable interest entities and that the Company holds a significant variable interest of each of the entities through its participation in the loan facilities and its agreements to supply and service the proton therapy equipment. The Company has concluded that it is not the primary beneficiary of any of these entities. The Company has no voting rights, has no approval authority or veto rights for these centers' budget, and does not have the power to direct patient recruitment, clinical operations and management of these Centers, which the Company believes are the matters that most significantly affect their economic performance. The Company’s exposure to loss as a result of its involvement with MM Proton I, LLC, MPTC, and RPTC is limited to the carrying amounts of the above-mentioned assets on its Condensed Consolidated Balance Sheets.
California Proton Therapy Center ("CPTC") Loans and Investment
Between September 2011 and November 2015, the Company, ORIX and J.P. Morgan (“the Lenders”) committed to loan up to $185.0 million (the “Original CPTC Loans”), of which the Company's commitment was $84.7 million, to fund the development, construction, initial operations, and working capital needs of the Scripps Proton Therapy Center in San Diego, California. ORIX is the loan agent. In November 2015, the Lenders and California Proton Treatment Center ("Original CPTC") entered into a forbearance agreement whereby the Lenders agreed not to enforce their rights to principal and interest payments until April 2017, subject to Original CPTC maintaining certain covenants and achieving certain targets, with additional extensions through September 2017 based on hitting additional targets largely around patient volume and cash flow.
As of December 30, 2016, even though patient volumes continued to increase, Original CPTC was not in compliance with one of the patient volume covenants in the forbearance agreement, which would allow the Lenders to cease funding and terminate the forbearance agreement. In January 2017, the Company was informed of actions taken by Original CPTC and the loan agent, including Original CPTC obtaining shareholder consents for voluntary bankruptcy filing and the loan agent deciding that no additional funding would be available outside of a bankruptcy process. As a result of this information and the Company’s analysis that these actions would likely lead to insolvency or bankruptcy proceedings of Original CPTC, the Company determined that it was appropriate to record a $38.3 million impairment, as determined by the discounted cash flow model using a single best estimate methodology, of its Original CPTC Loans on the Condensed Consolidated Statements of Earnings in the first quarter of fiscal year 2017. As a result of this impairment, the Original CPTC Loans were written down to their estimated fair value of $60.0 million and reclassified from short-term investments to other assets on the Company's Condensed Consolidated Balance Sheet because the Company did not expect to collect or sell all or a portion of these loans in the next twelve months.
In March 2017, Original CPTC filed for bankruptcy and concurrently entered into a Debtor-in-Possession facility (the "DIP Facility") with the Lenders for up to $16.0 million of additional financing during the bankruptcy process. The Company's pro-rata share of the DIP Facility was $7.3 million. In December 2017, the Company completed its funding commitment under the DIP Facility. The DIP Facility carried an interest rate at the London Interbank Offer Rate (“LIBOR”) plus 9.0% per annum and had a senior secured position ahead of the Original CPTC Loans.
Between April 2017 and August 2017, the Company did not become aware of any new information that warranted an impairment assessment. In September 2017, the Lenders and Scripps signed a Transition Agreement to transition the operations of the center from Scripps to Proton Doctors Professional Corporation (“Practice”). Based on the terms of the Transition Agreement, a slower projected growth in patient volume, an increase in additional projected capital needs and the Company's analysis, the Company determined that an additional $13.1 million impairment charge was deemed appropriate on its Original CPTC Loans which was recorded on the Consolidated Statements of Earnings in the fourth quarter of fiscal year 2017.
Pursuant to an order of the Bankruptcy Court, Original CPTC conducted an auction of the Scripps Proton Therapy Center. On December 6, 2017 (“Closing Date”), the Bankruptcy Court approved the sale of Scripps Proton Therapy Center to California Proton Therapy Center, LLC (“CPTC”), an entity owned by the Lenders. The Lenders purchased all assets and assumed $112.0 million of Original CPTC’s outstanding liabilities. On December 13, 2017, the Bankruptcy Court dismissed the bankruptcy filing of Original CPTC.

38
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


On the Closing Date, the Lenders entered into a Credit Agreement with Original CPTC of which the terms of the Original CPTC Loans, DIP Facility and accrued interest (collectively “Former Loans”) have been modified. In addition to the partially satisfied Original CPTC Loans reinstated by the Bankruptcy Court, the Company received a 47.08% equity ownership in CPTC. Original CPTC has assigned all its Former Loans to CPTC at an amount of $112.0 million, the partially satisfied loan balance. Per the terms of the Credit Agreement, the Company's portion of the $112.0 million is $53.5 million; the remainder is allocated between ORIX and J.P. Morgan. The $53.5 million is composed of four Tranches: Tranche A of $2.0 million, Tranche B of $7.2 million, Tranche C of $15.6 million, and Tranche D of $28.7 million (collectively the "Term Loan"). The maturity date of the Term Loan is three years from the Closing Date. The Term Loan is secured by the assets of CPTC.
In addition, the Lenders have committed to lend up to $15.0 million in a Revolving Loan with a maturity date of one year from the Closing Date. The Company's share of the funding commitment from the Revolving Loan is $7.2 million, and as of March 30, 2018, the Company has funded $3.1 million.
All of the Tranches accrue paid-in-kind interest at 7.5% per annum, except the Tranche B and Revolving Loan which accrue paid-in-kind interest at 10% per annum. The seniority of these loans is as follows: Revolving Loan, Tranche A, Tranche B, Tranche C and Tranche D. If CPTC is in default, the interest rate of the Tranche A, C and D will increase to 9.5% and the interest rate on the Tranche B and the Revolving Loan will increase to 12.0%.
Considering Original CPTC’s financial difficulties, the modification of the original terms of the Former Loans, and the Lenders agreement to grant a concession on the Original CPTC Loans, the Company classified the transaction above as a troubled debt restructuring (“TDR”). The Company does not have any unamortized fees from the Former Loans and any prepayment penalties. As a result, the cost basis and fair value of the Company's outstanding Term Loan as of March 30, 2018 is $53.5 million, which approximates the carrying value of the Former Loans prior to the TDR.
The Company, using a discounted cash flow approach, determined that the fair value of CPTC's equity as of Closing Date is $20.1 million. The Company's 47.08% ownership percentage amounts to a $9.5 million equity interest in CPTC. Since the common stock received were in addition to a loan receivable partially satisfied through the bankruptcy proceedings, in accordance with the TDR accounting guidance, the Company recorded the equity interest at fair value and as an offset to the reinstated loan balance. The equity investment in CPTC is accounted for under the equity method of accounting, and the Company accounts for its equity method share of the income or loss of CPTC on a quarter lag basis. The Company recorded a loss of $0.9 million in the three months ended March 30, 2018 in selling, general and administrative expenses on the Condensed Consolidated Statement of Earnings.
Per the terms of the Former Loans, as of September 29, 2017, ORIX had the option to purchase the Company's share of the Original CPTC Loans at par, and therefore they were accounted for as available-for-sale securities. Per the terms of the new agreement, ORIX no longer has the option to purchase the Company’s share of the Term Loan at par. As a result, the Term Loan no longer qualified for available-for-sale classification as of December 29, 2017.
Further, the Company has determined that CPTC is a variable interest entity because of the Company's participation in the loan facilities, equity ownership and its operations and maintenance agreement. The Company has one board seat out of five, has no special approval authority or veto rights for CPTC’s budget, and does not have the power to direct patient recruitment, clinical operations and management of CPTC, which the Company believes are the matters that most significantly affect their economic performance. Therefore, the Company does not have majority voting rights and no power to direct activities at CPTC as a result it is not the primary beneficiary of CPTC.
17. SEGMENT INFORMATION
The Company has two reportable operating segments: Oncology Systems and VPT. The operating segments were determined based on how the Company’s Chief Executive Officer, its Chief Operating Decision Maker (“CODM”), views and evaluates the Company’s operations. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings.
Description of Segments
The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments such as fixed field intensity-modulated radiation therapy (“IMRT”), image-guided radiation therapy (“IGRT”), VMAT, stereotactic radiosurgery (“SRS”), stereotactic body radiotherapy (“SBRT”) and brachytherapy. Products include linear accelerators, brachytherapy afterloaders, treatment simulation and

39
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


verification equipment and accessories; as well as information management, treatment planning and image processing, clinical knowledge exchange, patient care management, decision-making support and practice management software. Oncology Systems’ products enable radiation oncology departments in hospitals and clinics to perform conventional radiotherapy treatments and offer advanced treatments such as IMRT, IGRT, VMAT, SRS and SBRT, as well as to treat patients using brachytherapy techniques, which involve temporarily implanting radioactive sources. The Company’s Oncology Systems products are also used by neurosurgeons to perform stereotactic radiosurgery. Oncology Systems’ customers worldwide include university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices and cancer care clinics.
The VPT segment develops, designs, manufactures, sells and services products and systems for delivering proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer.
Accordingly, the following information is provided for purposes of achieving an understanding of operations, but may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.
The Company allocates corporate costs to its operating segments based on the relative revenues of Oncology Systems and VPT. The Company allocates these costs excluding certain corporate related costs, transactions or adjustments that the Company's CODM considers to be non-operational, such as restructuring and impairment charges, significant litigation charges or benefits and legal costs, acquisition-related expenses and benefits. Although the Company excludes these amounts from segment operating earnings and loss, they are included in the consolidated operating earnings and included in the reconciliation below.
The following table summarizes select operating results information for each reportable segment:
 
Three Months Ended
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Revenues
 
 
 
 
 
 
 
Oncology Systems
$
698.0

 
$
631.9

 
$
1,347.4

 
$
1,203.1

Varian Particle Therapy
31.9

 
31.3

 
61.0

 
61.6

Total Company
$
729.9

 
$
663.2

 
$
1,408.4

 
$
1,264.7

Operating Earnings
 
 
 
 
 
 
 
Oncology Systems
$
143.1

 
$
122.9

 
$
281.3

 
$
239.0

Varian Particle Therapy
(17.5
)
 
(19.8
)
 
(32.7
)
 
(70.1
)
Total reportable segments
125.6

 
103.1

 
248.6

 
168.9

Unallocated corporate
(31.3
)
 
(13.0
)
 
(32.9
)
 
(61.4
)
Total Company
$
94.3

 
$
90.1

 
$
215.7

 
$
107.5


40
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


Disaggregation of Revenues
The Company disaggregates its revenues from contracts by major product categories and by geographic region for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.
Total Revenues by product type
Three Months Ended
March 30, 2018
 
Six Months Ended
March 30, 2018
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Hardware
$
311.6

 
$
30.1

 
$
341.7

 
$
604.7

 
$
57.4

 
$
662.1

Software (1)
126.7

 
—

 
126.7

 
241.8

 
—

 
241.8

Service
259.7

 
1.8

 
261.5

 
500.9

 
3.6

 
504.5

Total Revenues
$
698.0

 
$
31.9

 
$
729.9

 
$
1,347.4

 
$
61.0

 
$
1,408.4

(1)
Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).
Total Revenues by product type
Three Months Ended
March 31, 2017
 
Six Months Ended
March 31, 2017
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Hardware
$
284.5

 
$
30.1

 
$
314.6

 
$
523.1

 
$
56.9

 
$
580.0

Software (1)
118.4

 
—

 
118.4

 
230.6

 
—

 
230.6

Service
229.0

 
1.2

 
230.2

 
449.4

 
4.7

 
454.1

Total Revenues
$
631.9

 
$
31.3

 
$
663.2

 
$
1,203.1

 
$
61.6

 
$
1,264.7

(1) 
Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).
Total Revenues by geographical region
Three Months Ended
March 30, 2018
 
Six Months Ended
March 30, 2018
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Americas
$
321.2

 
$
19.0

 
$
340.2

 
$
658.6

 
$
38.3

 
$
696.9

EMEA
241.2

 
12.6

 
253.8

 
424.7

 
22.1

 
446.8

APAC
135.6

 
0.3

 
135.9

 
264.1

 
0.6

 
264.7

Total Revenues
$
698.0

 
$
31.9

 
$
729.9

 
$
1,347.4

 
$
61.0

 
$
1,408.4

 
 
 
 
 
 
 
 
 
 
 
 
North America
$
299.6

 
$
19.0

 
$
318.6

 
$
625.9

 
$
38.3

 
$
664.2

International
398.4

 
12.9

 
411.3

 
721.5

 
22.7

 
744.2

Total Revenues
$
698.0

 
$
31.9

 
$
729.9

 
$
1,347.4

 
$
61.0

 
$
1,408.4


41
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


Total Revenues by geographical region
Three Months Ended
March 31, 2017
 
Six Months Ended
March 31, 2017
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Americas
$
332.0

 
$
9.6

 
$
341.6

 
$
622.8

 
$
17.0

 
$
639.8

EMEA
167.5

 
17.8

 
185.3

 
336.5

 
32.8

 
369.3

APAC
132.4

 
3.9

 
136.3

 
243.8

 
11.8

 
255.6

Total Revenues
$
631.9

 
$
31.3

 
$
663.2

 
$
1,203.1

 
$
61.6

 
$
1,264.7

 
 
 
 
 
 
 
 
 
 
 
 
North America
$
309.7

 
$
9.6

 
319.3

 
$
584.7

 
$
17.0

 
601.7

International
322.2

 
21.7

 
343.9

 
618.4

 
44.6

 
663.0

Total Revenues
$
631.9

 
$
31.3

 
$
663.2

 
$
1,203.1

 
$
61.6

 
$
1,264.7

Timing of revenue recognition
Three Months Ended
March 30, 2018
 
Six Months Ended
March 30, 2018
(In millions)
Products transferred at a point in time
 
Products and Services transferred over time

 
Total
 
Products transferred at a point in time
 
Products and Services transferred over time

 
Total
Oncology Systems
$
363.7

 
$
334.3

 
$
698.0

 
$
702.0

 
$
645.4

 
$
1,347.4

Varian Particle Therapy
—

 
31.9

 
31.9

 
—

 
61.0

 
61.0

Total Revenues
$
363.7

 
$
366.2

 
$
729.9

 
$
702.0

 
$
706.4

 
$
1,408.4

Timing of revenue recognition
Three Months Ended
March 31, 2017
 
Six Months Ended
March 31, 2017
(In millions)
Products Transferred at a Point in Time
 
Products and Services Transferred Over Time

 
Total
 
Products Transferred at a Point in Time
 
Products and Services Transferred Over Time

 
Total
Oncology Systems
$
334.8

 
$
297.1

 
$
631.9

 
$
617.2

 
$
585.9

 
$
1,203.1

Varian Particle Therapy
—

 
31.3

 
31.3

 
—

 
61.6

 
61.6

Total Revenues
$
334.8

 
$
328.4

 
$
663.2

 
$
617.2

 
$
647.5

 
$
1,264.7

18. SUBSEQUENT EVENTS

Sirtex. On January 30, 2018, the Company signed an agreement to acquire Sirtex, an Australian company that is listed on the Australian Securities Exchange, for A$28 per share or approximately A$1.6 billion ($1.2 billion as of March 30, 2018). The transaction has received all necessary regulatory approvals, is subject to the approval of the Sirtex shareholders, the Federal Court of Australia and the satisfaction of other customary closing conditions.

On May 4, 2018, Sirtex received an unsolicited non-binding, indicative and conditional proposal from CDH, a China-based alternative asset manager, for the acquisition of all of the issued shares in Sirtex for A$33.60 per share. The Sirtex board of directors has determined to engage with CDH to further understand the conditions associated with the CDH proposal. As a result, the meeting of Sirtex shareholders to approve the acquisition by Varian, which was scheduled to occur on Monday, May 7, 2018 (Sydney time), was adjourned to a time and date to be determined.

Borrowings. On April 3, 2018, the Company entered into the 2018 Credit Agreement with certain lenders and Bank of America, N.A. as administrative agent. The 2018 Credit Agreement provides for a five-year revolving credit facility (the "2018 Revolving Credit Facility") in an aggregate principal amount of up to $1.8 billion. The 2018 Revolving Credit Facility also includes a $50.0 million sub-facility for the issuance of letters of credit and permits swing line loans of up to $25 million. Under the 2018 Revolving Credit Facility, the Company has the right to make (i) a request to increase the aggregate commitments by an aggregate amount for all such requests of up to $100.0 million and (ii) request an additional increase in the commitments or establish one or more term loans, provided that, in each case, the lenders are willing to provide such new or increased commitments and certain other conditions are met. The proceeds of the 2018 Revolving Credit Facility may be used for working capital, capital expenditures, to pay the consideration for the Sirtex acquisition, Company share repurchases,

42
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)


permitted acquisitions and other corporate purposes, as well as to satisfy the outstanding obligation under the 2017 Revolving Credit Facility.
The 2018 Revolving Credit Facility replaces the 2017 Revolving Credit Facility of $600 million. The Company borrowed $255.0 million under the 2018 Revolving Credit Facility and repaid in full the $255.0 million then outstanding principal balance on its 2017 Revolving Credit Facility, plus accrued interest and fees.


43


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and
Stockholders of Varian Medical Systems, Inc.:


We have reviewed the accompanying condensed consolidated balance sheet of Varian Medical Systems, Inc. and its subsidiaries as of March 30, 2018, and the related condensed consolidated statements of earnings (loss) and of comprehensive earnings (loss) for the three-month and six-month periods ended March 30, 2018 and March 31, 2017 and the condensed consolidated statement of cash flows for the six-month periods ended March 30, 2018 and March 31, 2017. These interim financial statements are the responsibility of the Company’s management.

We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should be made to the accompanying condensed consolidated interim financial statements for them to be in conformity with accounting principles generally accepted in the United States of America.

We previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet as of September 29, 2017, and the related consolidated statements of earnings and of comprehensive earnings, of equity, and of cash flows for the year then ended (not presented herein), and in our report dated November 27, 2017, we expressed an unqualified opinion on those consolidated financial statements. As discussed in Note 1 to the accompanying condensed consolidated interim financial statements, the Company adopted Accounting Standard Codification 606, Revenue from contracts with customers. The accompanying September 29, 2017 condensed consolidated balance sheet reflects this change.

/s/ PRICEWATERHOUSECOOPERS LLP
PricewaterhouseCoopers LLP
San Jose, California
May 8, 2018

44


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, which provides a “safe harbor” for statements about future events, products and future financial performance that are based on the beliefs of, estimates made by, and information currently available to the management of Varian Medical Systems, Inc. (“VMS”) and its subsidiaries (collectively “we,” “our” or the “Company”). The outcome of the events described in these forward-looking statements is subject to risks and uncertainties. Actual results and the outcome or timing of certain events may differ significantly from those projected in these forward-looking statements or management’s current expectations due to the factors cited in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”), the Risk Factors listed under Part II, Item 1A of this Quarterly Report on Form 10-Q, and other factors described from time to time in our other filings with the Securities and Exchange Commission (“SEC”), or other reasons. For this purpose, statements concerning: Varian's planned acquisition of Sirtex, the expected synergies, accretive expectations, and estimated closing date of the Sirtex acquisition and Varian's financing plans for the Sirtex acquisition; growth strategies; industry or market segment outlook; market acceptance of or transition to new products or technology such as fixed field intensity-modulated radiation therapy, image-guided radiation therapy, stereotactic radiosurgery, volumetric modulated arc therapy, brachytherapy, software, treatment techniques, and proton therapy; growth drivers; future orders, revenues, backlog, earnings or other financial results; and any statements using the terms “believe,” “expect,” “anticipate,” “can,” “should,” “would,” “could,” “estimate,” “may,” “intended,” “potential,” and “possible” or similar statements are forward-looking statements that involve risks and uncertainties that could cause our actual results and the outcome and timing of certain events to differ materially from those projected or management’s current expectations. By making forward-looking statements, we have not assumed any obligation to, and you should not expect us to, update or revise those statements because of new information, future events or otherwise.
Overview
We, Varian Medical Systems, Inc., are a Delaware corporation originally incorporated in 1948 as Varian Associates, Inc. We are the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy, brachytherapy and proton therapy. Our mission is to combine the ingenuity of people with the power of data and technology to achieve new victories against cancer. To meet this challenge, we offer comprehensive solutions for fighting cancer.
We have two reportable operating segments: Oncology Systems and Varian Particle Therapy ("VPT"). The operating segments were determined based on how our Chief Executive Officer, who is our Chief Operating Decision Maker (“CODM”), views and evaluates our operations. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings.
Long-term growth and value creation strategy. We are focused on cancer care solutions and well-positioned to positively influence more and more patients globally every day by bringing smarter and simpler solutions to healthcare providers. Our long-term growth and value creation strategy is to transform our company from the global leader in radiation therapy to become the global leader in multidisciplinary, integrated cancer care solutions. We intend to leverage our deep customer relationships, human-centered design, scale and financial strength to selectively broaden our capabilities to capitalize on industry trends. To achieve these long-term objectives, we are focused on driving growth through strengthening our leadership in radiation therapy, extending our global footprint and expanding into other addressable markets.
Adoption of ASC 606. At the beginning of our fiscal year 2018, we early adopted the new revenue recognition Accounting Standard Codification 606 "Revenues from Contracts with Customers" ("ASC 606") and used the full retrospective method. All financial statements and disclosures have been recast to comply with ASC 606. See Note 1, "Summary of Significant Accounting Policies" of the Notes to the condensed consolidated financial statements, for additional information.
Change in Gross Orders Policy. In the first quarter of fiscal year 2018, we decided to retroactively change our policy on how we record services gross orders. Under the new policy, services gross orders do not include changes in deferred services revenue. We made the change to more accurately reflect the operational performance of the services business and to eliminate variations in orders reporting due to the timing of services billings. This policy change also impacts backlog, which no longer reflects the deferred revenue related to purchasable services. These changes only impact the Oncology Systems gross orders. All prior periods gross orders and backlog have been recast to reflect this policy change.

45


Distribution. On January 28, 2017 (the "Distribution Date"), we completed the separation and distribution (the "Distribution") of Varex Imaging Corporation ("Varex"), our former Imaging Components business segment. The historical financial position and results of operations of the Imaging Components business and costs relating to the Distribution are reported in the condensed consolidated financial statements as discontinued operations for all the periods presented. Unless otherwise noted, the financial information herein has been recast to reflect the effect of the Distribution. The Condensed Consolidated Statements of Comprehensive Earnings (Loss) and the Statements of Cash Flows have not been recast to reflect the effect of the Distribution. See Note 2, "Discontinued Operations" of the Notes to the condensed consolidated financial statements, for additional information.
Acquisition of Sirtex Medical Limited. On January 30, 2018, we signed an agreement to acquire Sirtex Medical Limited ("Sirtex"), an Australian company that is listed on the Australian Securities Exchange, for A$28 per share or approximately A$1.6 billion ($1.2 billion as of March 30, 2018). Sirtex is an Australian-based global life sciences company focused on interventional oncology therapies. We plan to finance the acquisition primarily using proceeds from our 2018 Revolving Credit Facility as well as cash on hand. The transaction has received all necessary regulatory approvals, is subject to the approval of the Sirtex shareholders, the Federal Court of Australia and the satisfaction of other customary closing conditions.

On May 4, 2018, Sirtex received an unsolicited non-binding, indicative and conditional proposal from CDH Investments ("CDH"), a China-based alternative asset manager, for the acquisition of all of the issued shares in Sirtex for A$33.60 per share. The Sirtex board of directors has determined to engage with CDH to further understand the conditions associated with the CDH proposal. As a result, the meeting of Sirtex shareholders to approve the acquisition by Varian, which was scheduled to occur on Monday, May 7, 2018 (Sydney time), was adjourned to a time and date to be determined. The Scheme Implementation Deed (the “Agreement”) may be terminated by either party under specified circumstances. If Varian or Sirtex terminates the Agreement, the terminating party may be required to pay a termination fee up to 1% of the total consideration under certain circumstances.
2018 Revolving Credit Facility. On April 3, 2018, we entered into a credit agreement ("2018 Credit Agreement") with certain lenders and Bank of America, N.A. The 2018 Credit Agreement provides for a five-year revolving credit facility (the "2018 Revolving Credit Facility") in an aggregate principal amount of up to $1.8 billion. The proceeds of the 2018 Revolving Credit Facility may be used for working capital, capital expenditures, to pay the consideration for the Sirtex acquisition, share repurchases, permitted acquisitions and other corporate purposes, as well as to satisfy the outstanding obligation under the prior 2017 Revolving Credit Facility. The 2018 Revolving Credit Facility replaces the 2017 Revolving Credit Facility. See, Liquidity and Capital Resources, herein for more information.
Tariff Measures. The Trump Administration has implemented tariffs on U.S. imports of certain steel and aluminum products from certain countries, and also proposed certain tariff measures on U.S. imports from China for a broad range of products, potentially including Varian products. As a result, China implemented and proposed certain retaliatory tariffs. Currently, such tariffs have not had a material impact on our business. The scope of tariffs that may be imposed in the future is not certain and may have a material adverse effect on our business and results of operations.
Financial Information. Total revenues increased 10%, gross margin percentage increased 2.0%, the effective tax rate increased by 0.3 percentage points, net earnings from continuing operations increased 5%, and net earnings from continuing operations per diluted share increased 6%, in the second quarter of fiscal year 2018, compared to the year-ago period.
Gross orders increased 5% in Oncology Systems in the second quarter of fiscal year 2018, compared to the year-ago period. Our total backlog at March 30, 2018 was 9% higher than at the end of the second quarter of fiscal year 2017.
In order to assist with the assessment of how our underlying businesses performed, we compare the percentage change in revenues and Oncology Systems gross orders from one period to another, excluding the effect of foreign currency fluctuations (i.e., using constant currency exchange rates). To present this information on a constant currency basis, we convert current period revenues and gross orders in currencies other than U.S. Dollars into U.S. Dollars using the comparable prior period’s average exchange rate. Percentage changes in revenue and gross orders are not adjusted for constant currency unless indicated.
Currency fluctuations had a $30.1 million and $22.1 million favorable impact on total revenues and Oncology Systems gross orders, respectively, in the second quarter of fiscal year 2018, compared to the year-ago period. We expect that fluctuations of non-U.S. Dollar currencies against the U.S. Dollar may cause variability in our financial performance.
The Americas region includes North America (primarily United States and Canada) and Latin America. The EMEA region includes Europe, Russia, the Middle East, India and Africa. The APAC region primarily includes East and Southeast Asia and Australia.

46



The Tax Cuts and Jobs Act (the "Act") was signed into U.S. law on December 22, 2017. Two provisions of the new law had an immediate impact.

First, the U.S. corporate tax rate was reduced from 35% to 21%. This rate reduction required us to re-measure our net deferred tax assets, which were originally recorded assuming a future tax benefit at the 35% rate. We estimate that the total impact of this re-measurement of our net deferred tax assets will be about $46.7 million. During the three and six months ended March 30, 2018, we recorded a provisional discrete tax expense of $2.4 million and $40.2 million, respectively, related to re-measuring our net deferred tax assets as a result of the rate reduction. As we have a September fiscal year end, the change to the lower corporate tax rate will be phased in. As a result of this phase in, the remainder, or about $6.5 million, will be charged to income tax expense over the balance of fiscal year 2018.
Second, as part of the transition to a modified territorial system, the Act imposes a one-time transition tax on the unremitted earnings of our foreign subsidiaries. During the three and six months ended March 30, 2018, we recorded a provisional discrete tax expense of $3.8 million and $173.1 million, respectively, related to the one-time transition tax. We intend to elect to pay this tax over an eight-year period.
The Securities and Exchange Commission has issued guidance allowing companies a measurement period, not to exceed one-year from the date of enactment, to refine their estimates of the tax impact of the new law. We fully expect that we will true up our estimates of these tax impacts of the Act over the measurement period.
On January 22, 2018, a continuing budget resolution was signed into law that included a provision to extend the moratorium on the 2.3% medical device excise tax for two more years, or until January 1, 2020. This tax has had, and may continue to have, a negative impact on our gross margin when the moratorium expires.
Oncology Systems. Our Oncology Systems business designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiotherapy, and advanced treatments, such as fixed field intensity-modulated radiation therapy ("IMRT"), image-guided radiation therapy ("IGRT"), volumetric modulated arc therapy ("VMAT"), stereotactic radiotherapy, stereotactic body radiotherapy and brachytherapy. Our software solutions also include informatics software for information management, clinical knowledge exchange, patient care management, practice management and decision-making support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices.
Our primary goal in the Oncology Systems business is to promote the adoption of more advanced and effective cancer treatments. In our view, the fundamental market forces that drive long-term growth in our Oncology Systems business are the rise in cancer cases; technology advances and product developments that are leading to improvements in patient care; customer demand for the more advanced and effective cancer treatments that we enable; competitive conditions among hospitals and clinics to offer such advanced treatments; continued improvement in safety and cost efficiency in delivering radiation therapy; and underserved medical needs outside of the United States. Approximately half of Oncology Systems gross orders and revenues come from international markets, within which certain emerging markets typically can have lower gross margins and longer installation cycles since a significant number of the hardware products go into new sites for which treatment vaults need to be constructed. We have also seen an increased portion of gross orders and revenues coming from services and software licenses, both of which have higher gross margin percentages than our hardware products. We have also been investing a higher portion of our Oncology Systems research and development budget in software and software-related products.
The radiation oncology market in North America is largely characterized by replacements of older machines, with periodic increases in demand driven by the introduction of new technologies. Reimbursement rates in the United States have generally supported a favorable return on investment for the purchase of new radiotherapy equipment and technologies. While we believe that improved product functionality, greater cost-effectiveness and prospects for better clinical outcomes with new capabilities such as IMRT, IGRT and VMAT tend to drive demand for radiotherapy products, large changes in reimbursement rates or reimbursement structure can affect customer demand and cause market shifts. We do not know the full impact of the Affordable Care Act or its potential repeal, or the possible impact of changes in policy resulting from President Trump's administration, will have on long-term growth or demand for our products and services. We believe, however, that growth of the radiation oncology market in the United States could be impacted as customers’ decision-making processes are complicated by the uncertainties surrounding the Affordable Care Act, or its replacement, and reimbursement rates for radiotherapy and radiosurgery, and that this uncertainty will likely continue in future fiscal years. We believe this uncertainty could impact transaction size, timing and purchasing processes, and also contribute to increased quarterly business variability. Given all the dynamic elements affecting this market, as outlined above, we believe the North America market will continue to grow in the low to mid-single digit range.

47


In the radiation oncology markets outside of North America, we expect the EMEA market to grow over the long term with mixed performance across the region. In APAC, we expect China to lead longer-term regional growth, with slower growth in the Japanese market. Latin America is currently experiencing volatility; however, our long-term outlook is cautiously optimistic. Overall, we believe the global radiation oncology market can grow over the long-term, in constant currencies, in the low to mid-single-digit range.
In the second quarter of fiscal year 2018, Oncology Systems revenues increased 10% and gross margin percentage increased by 1.7 percentage points compared to the year-ago period.
In the second quarter of fiscal year 2018, Oncology Systems gross orders increased 5%, compared to the year-ago period, primarily due to an increase in gross orders of 12% from our international regions, partially offset by a decrease of 3% from our North America region. On a constant currency basis, Oncology Systems gross orders and international gross orders increased 1% and 5%, respectively, in the second quarter of fiscal year 2018, compared to the year-ago period.
Varian Particle Therapy. Our VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams, for the treatment of cancer.
In the second quarter of fiscal year 2018, VPT revenues increased $0.6 million and gross orders decreased $26.1 million compared to the year-ago period.
In the second quarter of fiscal year 2018, we recorded an $11.1 million impairment charge on our Maryland Proton Treatment Center ("MPTC') subordinated loan due to the expected difference in value between the security currently held by us and the value of the new security that will be issued to us in exchange as part of the refinancing expected in the second half of fiscal year 2018.
In March 2017, California Proton Treatment Center, LLC (“Original CPTC”) filed for bankruptcy and concurrently entered into a Debtor-in-Possession facility (the "DIP Facility") with ORIX Capital Markets, LLC, J.P. Morgan and Varian (the “Lenders”).
In September 2017, the Lenders to the Scripps Proton Therapy Center ("Scripps") signed a Transition Agreement to transition the operations of the center from Scripps to a new operator. On December 6, 2017 (“Closing Date”), the Bankruptcy Court approved the sale of Original CPTC to the California Proton Therapy Center, LLC (“CPTC”), an entity owned by the Lenders. The Lenders purchased all assets and assumed $112.0 million (“Term Loan”) of Original CPTC’s outstanding liabilities. On December 13, 2017, the Bankruptcy Court dismissed the bankruptcy filing of Original CPTC.
On the Closing Date, the Lenders entered into a Credit Agreement with Original CPTC of which the terms of the Original CPTC Loans, DIP Facility and accrued interest (collectively “Former Loans”) were modified. As a result, we received a 47.08% equity ownership in CPTC. Original CPTC has assigned all its Former Loans to CPTC at an amount of $112.0 million, the partially satisfied loan balance.
Per the terms of the Credit Agreement, our portion of the $112.0 million is $53.5 million; the remainder is allocated between ORIX and J.P. Morgan. The $53.5 million is composed of four Tranches: Tranche A of $2.0 million, Tranche B of $7.2 million, Tranche C of $15.6 million, and Tranche D of $28.7 million (collectively the "Term Loan"). The maturity date of the Term Loan is three years from the Closing Date. The Term Loan is secured by the assets of CPTC.
In addition, the Lenders have committed to lend up to $15.0 million in Revolving Loans. Our share of the funding commitment from the Revolving Loan is $7.2 million and as of March 30, 2018, we have funded $3.1 million. The Revolving Loan accrues paid-in-kind interest at 10% per annum and has a maturity date one year from the Closing Date.

All of the Tranches of the Term Loan accrue paid-in-kind interest at 7.5% per annum, except the Tranche B, which accrues paid-in-kind interest at 10% per annum. The seniority of these loans is as follows: Revolving Loan, Tranche A, Tranche B, Tranche C and Tranche D. If CPTC is in default, the interest of the Tranche A, C and D will increase to 9.5% and the interest of the Tranche B and the Revolving Loan will increase to 12.0%.

Considering Original CPTC’s financial difficulties, the modification of the original terms of the Former Loans, and the Lenders agreement to grant a concession on the Original CPTC Loans, we classified this transaction as a troubled debt restructuring (“TDR”). We did not have any unamortized fees from the Former Loans and any prepayment penalties. As a result, the cost basis and fair value of our outstanding term loan as of December 29, 2017 to CPTC is $53.5 million, which approximates the carrying value of the Former Loans prior to TDR.

48



We used a discounted cash flow approach and determined the fair value of CPTC's equity as of Closing Date was $20.1 million. Our 47.08% ownership percentage amounts to a $9.5 million equity interest in CPTC. Since the common stock received was in addition to a loan receivable partially satisfied through the bankruptcy proceedings, in accordance with the TDR accounting guidance, we recorded the equity interest at fair value and as an offset to the reinstated loan balance. The equity investment in CPTC is accounted for under the equity method of accounting and we will account for our equity method share of the income or loss of CPTC on a quarter lag basis. We recorded a loss of $0.9 million in the three months ended March 30, 2018 in selling, general and administrative expenses on the Condensed Consolidated Statement of Earnings (Loss).
As of March 30, 2018, we had a total of $56.6 million in loans outstanding to CPTC and $124.8 million carrying value of loans outstanding to VPT customers, including accrued interest, available-for-sale securities, notes receivable and short-term senior secured debt. See Note 16, "VPT Loans and Securities" of the Notes to the Condensed Consolidated Financial Statements for further information.
This discussion and analysis of our financial condition and results of operations is based upon and should be read in conjunction with the Condensed Consolidated Financial Statements and the Notes included elsewhere in this Quarterly Report on Form 10-Q and the Consolidated Financial Statements, the Notes to the Consolidated Financial Statements and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended September 29, 2017 (the “2017 Annual Report”), as well as the information contained under Part I, Item 1A "Risk Factors" of the 2017 Annual Report and Part II, Item 1A "Risk Factors" of this Quarterly Report on Form 10-Q and our Quarterly Report for the quarter ended December 29, 2017, and other information provided from time to time in our other filings with the SEC.
Critical Accounting Estimates
The preparation of our financial statements and related disclosures in conformity with accounting principles generally accepted in the United States (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on historical experience and on various other factors that we believe are reasonable under the circumstances. We periodically review our accounting policies, estimates and assumptions and make adjustments when facts and circumstances dictate. In addition to the accounting policies that are more fully described in the Notes to the Consolidated Financial Statements included in our 2017 Annual Report on Form 10-K, we consider the critical accounting policies described below to be affected by critical accounting estimates. Our critical accounting policies that are affected by accounting estimates include revenue recognition, share-based compensation expense, valuation of allowance for doubtful accounts, impairment of investments and notes receivable, valuation of inventories, assessment of recoverability of goodwill and intangible assets, valuation of warranty obligations, assessment of loss contingencies, valuation of defined benefit pension and post-retirement benefit plans, valuation of derivative instruments, and taxes on earnings. Such accounting policies require us to use judgments, often as a result of the need to make estimates and assumptions regarding matters that are inherently uncertain, and actual results could differ materially from these estimates. For a discussion of how these estimates and other factors may affect our business, see Part II, Item 1A, “Risk Factors.”
Revenue Recognition
Our revenues are derived primarily from the sale of hardware and software products, and services from our Oncology Systems and VPT businesses. We recognize revenues net of any value added or sales tax and net of sales discounts.
We frequently enter into revenue arrangements with customers that contain multiple performance obligations including hardware, software, and services. Judgments as to the stand alone selling price and allocation of consideration from an arrangement to the individual performance obligations, and the appropriate timing of revenue recognition are critical with respect to these arrangements.
Changes to the elements in an arrangement and the amounts allocated to each element could affect the timing and amount of revenue recognition. Revenue recognition also depends on the timing of shipment, readiness of customers’ facilities for installation, installation requirements, and availability of products or customer acceptance terms. If shipments or installations are not made on scheduled timelines or if the products are not accepted by the customer in a timely manner, our reported revenues may differ materially from expectations.
Service revenues include revenues from hardware service contracts, software service agreements, bundled support arrangements, paid services and trainings, and parts that are sold by our service department. Revenues allocated to service contracts are generally recognized ratably over the period of the related contracts.

49


We recognize revenues on proton therapy contracts over the life of the project as costs are incurred. We recognize revenue related to our proton therapy systems over time because the customer controls the work in process, the Company's performance does not create an asset with alternative use to the Company, and the Company has an enforceable right to payment for performance completed to date. Changes in estimates of total contract revenue, total contract cost or the extent of progress towards completion are recognized in the period in which the changes in estimates are identified. Estimated losses on contracts are recognized in the period in which the loss is identified. In circumstances in which the final outcome of a contract cannot be reliably estimated but a loss on the contract is not expected, we recognize revenues to the extent of costs incurred until reliable estimates can be made. If and when we can make reliable estimates, revenues and costs of revenues are adjusted in the same period. Recognizing revenue over time based on costs incurred requires the use of estimates in determining revenues, costs and profits and in assigning the dollar amounts to relevant accounting periods. Because the estimates must be periodically reviewed and appropriately adjusted, if our estimates prove to be inaccurate or circumstances change over time, we may be forced to adjust revenues or even record a contract loss in later periods.
For a discussion of the impact of ASC 606 on our revenue recognition, please see Note 1, "Summary of Significant Accounting Policies" of the Notes to the condensed consolidated financial statements.
Share-based Compensation Expense
We grant our employees restricted stock units, stock options, performance units and performance options, permit employees to purchase shares under the VMS employee stock purchase plan and grant our directors restricted stock units. We value our stock options and performance options granted and the option component of the shares of VMS common stock purchased under the employee stock purchase plan using the Black-Scholes option-pricing model. We value our performance units that were granted prior to fiscal year 2018, which contain a market condition, using the Monte Carlo simulation model. The determination of fair value of share-based payment awards on the date of grant under both the Black-Scholes option-pricing model and the Monte Carlo simulation model is affected by VMS’s stock price, as well as the input of other subjective assumptions, including the expected terms of share-based awards and the expected price volatilities of shares of VMS common stock and peer companies that are used to assess certain performance targets over the expected term of the awards, and the expected dividend yield of shares of VMS common stock. For the performance units granted in fiscal year 2018, we value them at fair market value and adjust the value according to the contingent market condition as specified in the terms and conditions of those awards.
The expected term of our stock options is based on the observed and expected time to post-vesting exercise and post-vesting cancellations of stock options by our employees. We use a blended volatility in deriving the expected volatility assumption for our stock options. Blended volatility represents the weighted average of implied volatility and historical volatility. Implied volatility is derived based on traded options on VMS common stock. In determining the grant date fair value of our performance units, historical volatilities of shares of VMS common stock, as well as the shares of common stock of peer companies, were used to assess certain performance targets. The risk-free interest rate assumption is based upon observed interest rates appropriate for the term of our stock awards. The dividend yield assumption is based on our history and expectation of no dividend payouts. If factors change and we employ different assumptions in future periods, the compensation expense that we record may differ significantly from what we have recorded in the current period.
Beginning in the first quarter of fiscal year 2018, we now record forfeitures as they occur. We estimate the probability that certain performance conditions that affect the vesting of performance units will be achieved, and recognize expense only for those awards expected to vest. If the actual number of performance units that vest based on achievement of performance conditions are materially different from our estimates, the share-based compensation expense could be significantly different from what we have recorded in the current period.
Allowance for Doubtful Accounts
We evaluate the creditworthiness of our customers prior to authorizing shipment for all major sale transactions. Except for government tenders, group purchases and orders with letters of credit in Oncology Systems our payment terms often require payment of a small portion of the total amount due when the customer signs the purchase order, a significant amount upon transfer of risk of loss to the customer and the remaining amount upon completion of the installation. On a quarterly basis, we evaluate aged items in the accounts receivable aging report and provide an allowance in an amount we deem adequate for doubtful accounts. If our evaluation of our customers’ financial conditions does not reflect our future ability to collect outstanding receivables, additional provisions may be needed and our operating results could be negatively affected.

50


Impairment of Investments and Notes Receivable
We recognize an impairment charge when the declines in the fair values of our available-for-sale investments below their cost basis are determined to be other than temporary impairments (“OTTI”). We monitor our available-for-sale investments for possible OTTI on an ongoing basis. When there has been a decline in fair value of a debt security below the amortized cost basis, we recognize OTTI if: (i) we have the intention to sell the security; (ii) it is more likely than not that we will be required to sell the security before recovery of the entire amortized cost basis; or (iii) we do not expect to recover the entire amortized cost basis of the security. We assess the fair value of our available-for-sale securities, which are classified in the level 3 fair value hierarchy based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks associated with the loans, as well as underlying cash flow assumptions. As of March 30, 2018, we did not have any available-for-sale investments classified as level 3 in the fair value hierarchy. As of September 29, 2017, we had $47.4 million, which comprised of the fair value our Original CPTC Loans, of available-for-sale investments classified as level 3 in the fair value hierarchy. See Note 5, "Fair Value" and Note 16, "VPT Loans and Securities" of the Notes to the Condensed Consolidated Financial Statements.
We also have investments in privately-held companies, some of which are in the startup or development stages. We monitor these investments for events or circumstances indicative of potential impairment, and we make appropriate reductions in carrying values if we determine that an impairment charge is required, based primarily on the financial condition, near-term prospects and recent financing activities of the investee. These investments are inherently risky because the markets for the technologies or products these companies are developing are typically in the early stages and may never materialize.
At times, we advance notes to third parties, including our customers. We regularly assess these notes for collectability by considering internal factors such as historical experience, credit quality, age of the note balances as well as external factors such as economic conditions that may affect the note holder's ability to pay.
Our ongoing consideration of all the factors described above could result in impairment charges in the future, which could adversely affect our operating results.
Inventories
Our inventories include high technology parts and components that are highly specialized in nature and that are subject to rapid technological obsolescence. We have programs to minimize the required inventories on hand and we regularly review inventory quantities on hand and on order and adjust for excess and obsolete inventory based primarily on historical usage rates and our estimates of product demand and production. Actual demand may differ from our estimates, in which case we may have understated or overstated the provision required for obsolete and excess inventory, which would have an impact on our operating results.
Goodwill, Intangible Assets and Impairment Assessment
Goodwill represents the excess of the purchase price in a business over the fair value of net tangible and intangible assets acquired. The determination of the value of the intangible assets acquired involves certain judgments and estimates. These judgments can include, but are not limited to, the cash flows that an asset is expected to generate in the future and the appropriate discount weighted-average cost of capital ("WACC"). Each period, we evaluate the estimated remaining useful lives of purchased intangible assets and whether events or changes in circumstances warrant a revision to the remaining periods of amortization.
Goodwill is allocated to reporting units expected to benefit from the business combination. We evaluate our reporting units when changes in our operating structure occur, and if necessary, reassign goodwill using a relative fair value allocation approach. Goodwill is tested for impairment at the reporting unit level on an annual basis or whenever events or changes in circumstances indicate its carrying value may not be recoverable. We can opt to perform a qualitative assessment to test a reporting unit’s goodwill for impairment or we can directly perform a quantitative assessment. Various factors are considered in the qualitative assessment, including macroeconomic conditions, industry and market considerations, financial performance and other relevant events affecting the reporting unit. Based on our qualitative assessment, if we determine that the fair value of a reporting unit is more likely than not (i.e., a likelihood of more than 50 percent) to be less than its carrying amount, the quantitative assessment will be performed. The quantitative assessment compares the fair value of a reporting unit against its carrying amount, including the goodwill allocated to each reporting unit. We determine the fair value of our reporting units based on a combination of income and market valuation approaches. The income approach is based on the present value of estimated future cash flows that the reporting unit is expected to generate, and the market approach is based on a market

51


multiple calculated for each reporting unit based on market data of other companies engaged in similar business. Any excess of the reporting unit's carrying value over its fair value will be recorded as an impairment loss.
Determining the fair value of a reporting unit involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates, operating margins and working capital needs to calculate projected future cash flows, WACC, future economic and market conditions, estimation of the long-term rate of growth for our business and determination of appropriate market comparables. We base our fair value estimates on assumptions we believe to be reasonable but that are inherently uncertain. Actual future results related to assumed variables could differ from these estimates. In addition, we make certain judgments and assumptions in allocating assets and liabilities to determine the carrying values for each reporting unit.
We have two reporting units: (i) Oncology Systems and (ii) VPT, with $181.7 million and $54.5 million in goodwill, respectively, as of March 30, 2018. Based upon the most recent annual goodwill analysis during the fourth quarter of fiscal year 2017, VPT's fair value was 21% in excess of its carrying value, and we believe each of the assumptions used to calculate VPT’s fair value to be reasonable. However, VPT could be at risk for goodwill impairment because adjustments to revenue growth rates, operating margins, WACC and/or our working capital used in the fair value calculation could lead to an impairment.
Warranty Obligations
We warrant most of our products for a specific period of time, usually 12 months from installation, against material defects. We provide for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent our best estimate at the time of sale of the total costs that we will incur to repair or replace product parts that fail while still under warranty. The amount of accrued estimated warranty costs obligation for established products is primarily based on historical experience as to product failures adjusted for current information on repair costs. For new products, estimates will include historical experience of similar products, as well as reasonable allowance for start-up expenses. Actual warranty costs could differ from the estimated amounts. On a quarterly basis, we review the accrued balances of our warranty obligations and update the historical warranty cost trends, if required. If we were required to accrue additional warranty costs in the future, it would have a negative effect on our operating results.
Loss Contingencies
From time to time, we are a party to or otherwise involved in legal proceedings, claims and government inspections or investigations or other legal matters, both inside and outside the United States, arising in the ordinary course of our business or otherwise. We accrue amounts, to the extent they can be reasonably estimated, that we believe are adequate to address any liabilities related to legal proceedings and other loss contingencies that we believe will result in a probable loss. Such matters are subject to many uncertainties, outcomes are not predictable with assurance, and actual liabilities could significantly exceed our estimates of potential liabilities. In addition, we are subject to a variety of environmental laws around the world. Those laws regulate multiple aspects of our operations, including the handling, storage, transport and disposal of hazardous substances. They impose costs on our operations. In connection with our past and present operations and facilities, we record environmental remediation liabilities when we conclude that environmental assessments or remediation efforts are probable and we believe we can reasonably estimate the costs of those efforts. Our accrued environmental costs represent our best estimate of the total costs of assessments and remediation and the time period over which we expect to incur those costs. We review these accrued balances quarterly. If we were required to increase or decrease the accrued environmental costs in the future, it would adversely or favorably impact our operating results.
Defined Benefit Pension Plans
We sponsor five defined benefit pension plans in Germany, Japan, Switzerland and the United Kingdom covering employees who meet the applicable eligibility requirements in these countries. Several statistical and other factors that attempt to anticipate future events are used in calculating the expenses and liabilities related to the aforementioned plans. These factors include assumptions about the discount rate, expected return on plan assets, and rate of future compensation increases, all of which we determine within certain guidelines. In addition, we also use assumptions, such as withdrawal and mortality rates, to calculate the expenses and liabilities. The actuarial assumptions we use are long-term assumptions and may differ materially from actual experience particularly in the short term due to changing market and economic conditions and changing participant demographics. These differences may have a significant impact on the amount of defined benefit pension plan expenses we record.
The expected rates of return on the various defined benefit pension plans’ assets are based on the asset allocation of each plan and the long-term projected return on those assets. The discount rate enables us to state expected future cash flows at a present

52


value on the measurement date. The discount rates used for defined benefit plans are primarily based on the current effective yield of long-term corporate bonds that are of high quality with satisfactory liquidity and credit rating with durations corresponding to the expected durations of the benefit obligations. A change in the discount rate may cause the present value of benefit obligations to change significantly.
Valuation of Derivative Instruments
We use foreign currency forward contracts to reduce the effects of currency rate fluctuations on sales transactions denominated in foreign currencies and on net monetary assets and liabilities denominated in foreign currencies. These foreign currency forward contracts are derivative instruments and are measured at fair value. There are three levels of inputs that may be used to measure fair value (see Note 5, "Fair Value" of the Notes to the Consolidated Financial Statements). The fair value of foreign currency forward contracts is calculated primarily using Level 2 inputs, which include currency spot and forward rates, interest rate and credit or non-performance risk. The spot rate for each currency is the same spot rate used for all balance sheet translations at the measurement date and sourced from our major trading banks. The forward point values for each currency and the London Interbank Offered Rate (“LIBOR”) to discount assets and liabilities are interpolated from commonly quoted broker services. One-year credit default swap spreads of the counterparty at the measurement date are used to adjust derivative assets, all of which mature in 13 months or less, for non-performance risk. We are required to adjust derivative liabilities to reflect the potential non-performance risk to lenders based on our incremental borrowing rate. Each contract is individually adjusted using the counterparty credit default swap rates (for net assets) or our borrowing rate (for net liabilities). The use of Level 2 inputs in determining fair values requires certain management judgment and subjectivity. Changes to these Level 2 inputs could have a material impact on the valuation of our derivative instruments. There were no transfers of assets or liabilities between fair value measurement levels during the first half of fiscal years 2018 and 2017.
Taxes on Earnings
We are subject to taxes on earnings in both the United States and numerous foreign jurisdictions. As a global taxpayer, significant judgments and estimates are required in evaluating our tax positions and determining our provision for taxes on earnings. We account for uncertainty in income taxes following a two-step approach for recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether the weight of available evidence indicates that it is more likely than not that, based on the technical merits, the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. Recognition and measurement are based on management’s best judgment given the facts, circumstances and information available at the end of the accounting period.
Generally, the carrying value of our net deferred tax assets assumes that we will be able to generate sufficient future taxable earnings in the applicable tax jurisdictions to utilize these deferred tax assets. Should we conclude it is more likely than not that we will be unable to recover our deferred tax assets in these tax jurisdictions, we would increase our valuation allowance and our tax provision would increase in the period in which we make such a determination. The Act was signed into law on December 22, 2017. Among other changes, the Act reduces the U.S. corporate tax rate from 35% to 21%. The reduction in the rate required us to re-measure our net deferred tax assets that were originally recorded assuming a future tax benefit at the 35% rate. During the three and six months ended March 30, 2018, we recorded a provisional discrete tax expense of $2.4 million and $40.2 million, respectively, related to re-measuring our net deferred tax assets as a result of the rate reduction.
Our foreign earnings are taxed at rates that are, on average, lower than U.S. rates. Our effective tax rate is impacted by existing tax laws in both the United States and in the respective countries in which our foreign subsidiaries do business. In addition, a decrease in the percentage of our total earnings from foreign countries, or a change in the mix of foreign countries among particular tax jurisdictions could increase or decrease our effective tax rate.
As part of the transition to a modified territorial system, the Act imposes a one-time transition tax on the unremitted earnings of our foreign subsidiaries. During the three and six months ended March 30, 2018, we recorded a provisional discrete tax expense of $3.8 million and $173.1 million, respectively, related to the one-time transition tax. We intend to elect to pay this tax over an eight-year period. The transition to a modified territorial regime and the one-time transition tax on unremitted earnings has caused us to re-evaluate our intentions with respect to the unremitted earnings of our foreign subsidiaries. In the past, we did not accrue U.S. taxes on certain undistributed profits of certain foreign subsidiaries because the earnings were considered to be indefinitely reinvested. In light of the changes to the taxation of foreign earnings in the Act, we no longer consider the earnings of our foreign subsidiaries to be indefinitely reinvested.
On December 22, 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 (“SAB 118”). This guidance allows registrants a “measurement period,” not to exceed one year from the date of enactment, to complete their

53


accounting for the tax effects of the Act. SAB 118 further directs that during the measurement period, registrants who are able to make reasonable estimates of the tax effects of the Act should include those amounts in their financial statements as “provisional” amounts. Registrants should reflect adjustments over subsequent periods as they are able to refine their estimates and complete their accounting for the tax effects of the Act. We have made reasonable estimates and recorded provisional amounts within the meaning of SAB 118. Also, it is expected that the U.S. Treasury will issue regulations and other guidance on the application of certain provisions of the Act. In subsequent periods, but within the measurement period, we will analyze that guidance and other necessary information to refine our estimates and complete our accounting for the tax effects of the Act.

Results of Operations
Fiscal Year
Our fiscal year is the 52- or 53-week period ending on the Friday nearest September 30. Fiscal year 2018 is the 52-week period ending September 28, 2018, and fiscal year 2017 was the 52-week period that ended on September 29, 2017. The fiscal quarters ended March 30, 2018 and March 31, 2017 were both 13-week periods.
Discussion of Results of Operations for the Second Quarter and First Half of Fiscal Year 2018 Compared to the Second Quarter and First Half of Fiscal Year 2017
Total Revenues 
Revenues by sales classification
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
March 30,
2018
 
March 31,
2017
 
Percent Change
Product
$
393.8

 
$
364.9

 
8
%
 
$
759.4

 
$
674.1

 
13
%
Service
336.1

 
298.3

 
13
%
 
649.0

 
590.6

 
10
%
Total Revenues
$
729.9

 
$
663.2

 
10
%
 
$
1,408.4

 
$
1,264.7

 
11
%
Product as a percentage of total revenues
54
%
 
55
%
 
 
 
54
%
 
53
%
 

Service as a percentage of total revenues
46
%
 
45
%
 
 
 
46
%
 
47
%
 
 
Total product and service revenues increased in the second quarter and first half of fiscal year 2018, compared to the year-ago periods, primarily due to an increase in revenues from Oncology Systems.

54


Revenues by geographical region
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
Constant Currency (1)
 
March 30,
2018
 
March 31,
2017
 
Percent Change
 
Constant Currency (1)
Americas
$
340.2

 
$
341.6

 
—
%
 
(1
)%
 
$
696.9

 
$
639.8

 
9
%
 
9
%
EMEA
253.8

 
185.3

 
37
%
 
23
 %
 
446.8

 
369.3

 
21
%
 
11
%
APAC
135.9

 
136.3

 
—
%
 
(3
)%
 
264.7

 
255.6

 
4
%
 
3
%
Total Revenues
$
729.9

 
$
663.2

 
10
%
 
6
 %
 
$
1,408.4

 
$
1,264.7

 
11
%
 
8
%
 
 
 
 
 
 
 
 
 
 
 
 
 


 
 
North America
$
318.6

 
$
319.3

 
—
%
 
—
 %
 
$
664.2

 
$
601.7

 
10
%
 
10
%
International (2)
411.3

 
343.9

 
20
%
 
11
 %
 
744.2

 
663.0

 
12
%
 
6
%
Total Revenues
$
729.9

 
$
663.2

 
10
%
 
6
 %
 
$
1,408.4

 
$
1,264.7

 
11
%
 
8
%
North America as a percentage of total revenues
43
%
 
48
%
 
 
 
 
 
47
%
 
48
%
 
 
 
 
International as a percentage of total revenues
57
%
 
52
%
 
 
 
 
 
53
%
 
52
%
 
 
 
 
(1) 
Constant currency is the percent change excluding the effect of foreign currency fluctuations against the U.S. Dollar.
(2) 
We consider international revenues to be revenues outside of North America.
The Americas revenues were essentially flat in the second quarter of fiscal year 2018, compared to the year-ago period, due to a decrease in revenues from Oncology Systems being offset by an increase in revenues from VPT. The Americas revenues increased in the first half of fiscal year 2018, compared to the year-ago period, due to increases from Oncology Systems and VPT.
EMEA revenues increased in the second quarter and first half of fiscal year 2018, compared to the year-ago periods, due to an increase in revenues from Oncology Systems, partially offset by a decrease in revenues from VPT.
APAC revenues were essentially flat in the second quarter of fiscal year 2018, compared to the year-ago period, due to a decrease in revenues from VPT being mostly offset by an increase in revenues from Oncology Systems. APAC revenues increased in the first half of fiscal year 2018, compared to the year-ago period, due to an increase in revenues from Oncology Systems, partially offset by a decrease in revenues from VPT.
Oncology Systems Revenues 
Revenues by sales classification
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
Constant Currency
 
March 30,
2018
 
March 31,
2017
 
Percent Change
 
Constant Currency
Product
$
363.7

 
$
334.8

 
9
%
 
7
%
 
$
702.0

 
$
617.2

 
14
%
 
10
%
Service
334.3

 
297.1

 
13
%
 
11
%
 
645.4

 
585.9

 
10
%
 
7
%
Total Oncology Systems Revenues
$
698.0

 
$
631.9

 
10
%
 
6
%
 
$
1,347.4

 
$
1,203.1

 
12
%
 
9
%
Product as a percentage of total Oncology Systems revenues
52
%
 
53
%
 

 
 
 
52
%
 
51
%
 


 
 
Service as a percentage of total Oncology Systems revenues
48
%
 
47
%
 
 
 
 
 
48
%
 
49
%
 
 

 
 
Oncology Systems revenues as a percentage of total revenues
96
%
 
95
%
 
 
 
 
 
96
%
 
95
%
 
 
 
 

55


Oncology Systems product revenues increased in the second quarter and first half of fiscal year 2018, compared to the year-ago periods, primarily due to an increase in revenues from higher volumes of hardware unit shipments, and to a lesser extent, an increase in revenues from our software products.
Oncology Systems service revenues, which now include performance obligations for installation, training and warranty, increased in the second quarter and first half of fiscal year 2018, compared to the year-ago periods, primarily due to ongoing customer adoption of service contracts as the warranty periods on our TrueBeam systems expire and an increase in the number of customers as the installed base of our products continues to grow.
Revenues by geographical region
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
Constant Currency
 
March 30,
2018
 
March 31,
2017
 
Percent Change
 
Constant Currency
Americas
$
321.2

 
$
332.0

 
(3
)%
 
(3
)%
 
$
658.6

 
$
622.8

 
6
%
 
6
%
EMEA
241.2

 
167.5

 
44
 %
 
29
 %
 
424.7

 
336.5

 
26
%
 
16
%
APAC
135.6

 
132.4

 
2
 %
 
—
 %
 
264.1

 
243.8

 
8
%
 
8
%
Total Oncology Systems Revenues
$
698.0

 
$
631.9

 
10
 %
 
6
 %
 
$
1,347.4

 
$
1,203.1

 
12
%
 
9
%
 
 
 
 
 
 
 
 
 
 
 
 
 


 
 
North America
$
299.6

 
$
309.7

 
(3
)%
 
(3
)%
 
$
625.9

 
$
584.7

 
7
%
 
7
%
International
398.4

 
322.2

 
24
 %
 
15
 %
 
721.5

 
618.4

 
17
%
 
11
%
Total Oncology Systems Revenues
$
698.0

 
$
631.9

 
10
 %
 
6
 %
 
$
1,347.4

 
$
1,203.1

 
12
%
 
9
%
North America as a percentage of total Oncology Systems revenues
43
%
 
48
%
 
 
 
 
 
46
%
 
49
%
 
 
 
 
International as a percentage of total Oncology Systems revenues
57
%
 
52
%
 
 
 
 
 
54
%
 
51
%
 
 
 
 
Americas Oncology Systems revenues decreased in the second quarter of fiscal year 2018, compared to the year-ago period, primarily due to a decrease in revenues from hardware products and decreases in North America revenues from software licenses and services. Americas Oncology Systems revenues increased in the first half of fiscal year 2018, compared to the year-ago period, primarily due to higher volumes of hardware unit shipments in North America in the first quarter of 2018, and to a lesser extent, an increase in revenues from services in North America, partially offset by a decrease in revenues from software licenses in North America and hardware products in Latin America.
EMEA Oncology Systems revenues increased in the second quarter and first half of fiscal year 2018, compared to the year-ago periods, primarily due to an increase in revenues from hardware products in the second quarter of 2018, and to a lesser extent, increases in revenues from services and software licenses. EMEA revenues were further impacted by a favorable foreign currency exchange impact in fiscal year 2018.
APAC Oncology Systems revenues increased in the second quarter and first half of fiscal year 2018, compared to the year-ago periods, primarily due to an increase in revenues from services partially offset by decreases in revenues from hardware products in the second quarter of fiscal year 2018 and software licenses in both the second quarter and first half of fiscal year 2018.
Variations of higher and lower revenues between the North America and international regions are impacted by regional factors influencing our gross orders, which recently have included government stimulus programs, economic and political instability in some countries, uncertainty created by health care reform (such as the excise tax on the sale of most medical devices, Medicare reimbursement rates and consolidation of free standing clinics in the United States), and different technology adoption cycles. See further discussion of orders under “Gross Orders.”

56


Varian Particle Therapy 
Revenues by sales classification
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
March 30,
2018
 
March 31,
2017
 
Percent Change
Product
$
30.1

 
$
30.1

 
—
 %
 
$
57.4

 
$
56.9

 
1
 %
Service
1.8

 
1.2

 
61
 %
 
3.6

 
4.7

 
(22
)%
Total Varian Particle Therapy Revenues
$
31.9

 
$
31.3

 
2
 %
 
$
61.0

 
$
61.6

 
(1
)%
VPT revenues as a percentage of total revenues
4
%
 
5
%
 
 
 
4
%
 
5
%
 
 
Revenues from VPT were flat in both the second quarter and first half of fiscal year 2018, compared to the year-ago periods.
Gross Margin
Dollars by segment
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
March 30,
2018
 
March 31,
2017
 
Percent Change
Oncology Systems
$
317.3

 
$
276.8

 
15
%
 
$
617.8

 
$
538.9

 
15
 %
Varian Particle Therapy
1.2

 
(1.2
)
 
204
%
 
3.5

 
3.7

 
(6
)%
Gross margin
$
318.5

 
$
275.6

 
16
%
 
$
621.3

 
$
542.6

 
15
 %
 
 
 
 
 
 
 
 
 
 
 
 
Percentage by segment
 
 
 
 
 
 
 
 
 
 
 
Oncology Systems
45.5
%
 
43.8
 %
 
 
 
45.9
%
 
44.8
%
 
 
Varian Particle Therapy
3.7
%
 
(3.6
)%
 
 
 
5.8
%
 
6.1
%
 
 
Total Company
43.6
%
 
41.6
 %
 
 
 
44.1
%
 
42.9
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage by sales classification
 
 
 
 
 
 
 
 
 
 
 
Total Company - Product
32.9
%
 
32.4
 %
 
 
 
35.7
%
 
32.8
%
 
 
Total Company - Service
56.2
%
 
52.8
 %
 
 
 
53.9
%
 
54.4
%
 
 
Oncology Systems product gross margin percentage decreased to 35.1% in the second quarter of fiscal year 2018, from 35.6% in the year-ago period, primarily due to higher freight costs resulting from an increase in shipment volume in the second quarter of 2018. Oncology Systems product gross margin percentage increased to 37.8% in the first half of fiscal year 2018, from 35.5% in the year-ago period, primarily due to more revenues from higher margin hardware products and software licenses.
Oncology Systems service gross margin percentage increased to 56.8% in the second quarter of fiscal year 2018, from 53.1% in the year-ago period, primarily due to an increase in the installed base of our higher margin products. Oncology Systems service gross margin percentage was 54.6% in both the first half of fiscal year 2018 and the respective year-ago period.
VPT gross margin percentage increased in the second quarter of fiscal year 2018 compared to the year-ago period, primarily due to more revenues from higher margin projects. VPT gross margin decreased in the first half of fiscal year 2018 compared to the year-ago period, primarily due to a decrease in service revenues mostly offset by more revenues from higher margin projects.
Research and Development
 
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
March 30,
2018
 
March 31,
2017
 
Percent Change
Research and development
$
58.9

 
$
53.3

 
10
%
 
$
114.8

 
$
103.2

 
11
%
Research and development as a percentage of total revenues
8
%
 
8
%
 
 
 
8
%
 
8
%
 
 

57


Research and development expenses increased $5.6 million and $11.6 million in the second quarter and first half of fiscal year 2018, compared to the year-ago periods, primarily due to an increase in investments in new product development projects and the enhancement of existing products in Oncology Systems.
Selling, General and Administrative, Impairment Charges, and Acquisition-Related Expenses
 
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
March 30,
2018
 
March 31,
2017
 
Percent Change
Selling, general and administrative
$
134.5

 
$
131.6

 
2
%
 
$
258.5

 
$
292.7

 
(12
)%
Impairment charges
$
11.1

 
$
—

 
n/m

 
$
11.1

 
$
38.3

 
n/m

Acquisition-related expenses
$
19.7

 
$
0.6

 
n/m

 
$
21.2

 
$
0.9

 
n/m

Selling, general and administrative as a percentage of total revenues
18
%
 
20
%
 
 
 
18
%
 
23
%
 
 
Impairment charges as a percentage of total revenues
2
%
 
—
%
 
 
 
1
%
 
3
%
 
 
Acquisition-related expenses as a percentage of total revenues
3
%
 
—
%
 
 
 
2
%
 
—
%
 
 
n/m = not meaningful
Selling, general and administrative expenses increased $2.9 million in the second quarter of fiscal year 2018, compared to the year-ago period, primarily due to a $7.2 million increase in employee-related costs largely due to an increase in headcount and accrued bonuses, and a $2.4 million unfavorable impact when foreign-currency denominated expenses were translated into U.S. dollars, partially offset by a $2.7 million decrease in litigation expenses primarily as a result of the settlement with Elekta in April 2017, a $2.4 million decrease in restructuring charges, and a $2.0 million decrease in international commissions paid to third-party distributors who sell our products.
Selling, general and administrative expenses decreased $34.2 million in the first half of fiscal year 2018, compared to the year-ago period, primarily due to a $36.9 million decrease in the allowance for doubtful accounts that was mostly for CPTC and another proton center in the first quarter of fiscal year 2017, an $8.8 million decrease in litigation expenses primarily as a result of the settlement with Elekta in April 2017, a $6.0 million decrease in restructuring charges, and a $2.1 million decrease in international commissions paid to third-party distributors who sell our products, partially offset by a $15.9 million increase in employee-related costs largely due to an increase in headcount and accrued bonuses, and a $3.7 million unfavorable impact when foreign-currency denominated expenses were translated into U.S. dollars.
In the second quarter of fiscal year 2018, we recorded an impairment charge of $11.1 million related to our MPTC subordinated loan. In the first quarter of fiscal year 2017, we recorded a $38.3 million impairment charge related to our Original CPTC loans. See Note 16, "VPT Loans and Securities" in our Notes to the Condensed Consolidated Financial Statements for additional information.
Acquisition-related expenses increased $19.1 million and $20.3 million in the second quarter and first half of fiscal year 2018, compared to the year-ago period, primarily due to a $16.4 million loss related to hedging the Australian dollar purchase price of the Sirtex acquisition. See, Note 9, "Derivative Instruments and Hedging Activities" in our Notes to the Condensed Consolidated Financial Statements for additional information.
Interest Income, Net 
 
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
March 30,
2018
 
March 31,
2017
 
Percent Change
Interest income, net
$
1.3

 
$
0.3

 
396
%
 
$
2.4

 
$
2.2

 
6
%
Interest income, net of interest expense, increased in the second quarter of fiscal year 2018, compared to the year-ago period, primarily due to an increase in interest income generated from our VPT loans and available-for-sale investments and additional interest income generated from our cash holdings due to higher interest rates in fiscal year 2018.

58


Interest income, net of interest expense in the first half of fiscal year 2018, compared to the year-ago period, slightly increased primarily due to a decrease in interest expense associated with a decrease in borrowings from our credit facility in fiscal year 2018 and additional interest income generated from our cash holdings due to higher interest rates in fiscal year 2018, being mostly offset by a decrease in interest income generated from our VPT loans and available-for-sale investments primarily related to the Original CPTC loan impairment charge in the first quarter of 2017.
Taxes on Earnings 
 
Three Months Ended
 
Six Months Ended
 
March 30,
2018
 
March 31,
2017
 
Change
 
March 30,
2018
 
March 31,
2017
 
Change
Effective tax rate
23.4
%
 
23.1
%
 
0.3
%
 
117.9
%
 
29.4
%
 
88.5
%
Our effective tax rate increased in the second quarter and first half of fiscal year 2018, compared to the year ago periods, primarily due to the enactment of the Act, which was signed into U.S. law on December 22, 2017.
Two provisions of the new law had an immediate impact:

First, the U.S. corporate tax rate was reduced from 35% to 21%. This rate reduction required us to re-measure our net deferred tax assets which were originally recorded assuming a future tax benefit at the 35% rate. We estimate that the total impact of this re-measurement of our net deferred tax assets will be about $46.7 million. During the three and six months ended March 30, 2018, we recorded a provisional discrete tax expense of $2.4 million and $40.2 million, respectively, related to re-measuring our net deferred tax assets as a result of the rate reduction. As we have a September fiscal year end, the change to the lower corporate tax rate will be phased in. As a result of this phase in, the remainder, or about $6.5 million, will be charged to income tax expense over the balance of fiscal year 2018.
Second, as part of the transition to a modified territorial system, the new law imposes a one-time transition tax on the unremitted earnings of our foreign subsidiaries. During the second quarter and first half of fiscal year 2018, we recorded a provisional discrete tax expense of $3.8 million and $173.1 million, respectively, related to the one-time transition tax. We intend to elect to pay this tax over an eight-year period.
The SEC has issued guidance allowing companies a measurement period, not to exceed one-year from the date of enactment, to refine their estimates of the tax impact of the new law. We fully expect that we will true up our estimates of these tax impacts from the new tax legislation over the measurement period.
We adopted the guidance related to employee share-based payments during the period ended December 29, 2017. Under the prior standard, the tax effect of the “excess stock deduction” related to stock-based compensation was recorded to Additional Paid-in Capital in the equity section on the Balance Sheet. For a stock-based compensation instrument, the excess stock deduction is the difference between the amount of the deduction for taxable income and the amount of book expense related to that instrument. Under the new standard, the tax effect of the “excess stock deduction” related to stock-based compensation is recorded as a discrete item to Taxes on Earnings in the Condensed Consolidated Statements of Earnings (Loss). In the second quarter and first half of fiscal year 2018, we recorded a discrete tax benefit of $4.7 million and $6.2 million, respectively, related to excess stock deduction activity. We expect that the new standard may cause our effective tax rate to be less predictable and more volatile going forward.
Our effective tax rate is impacted by the percentage of our total earnings that comes from our international region, the mix of particular tax jurisdictions within our international region, changes in the valuation of our deferred tax assets or liabilities, and changes in tax laws or interpretations of those laws. We also expect that our effective tax rate may experience increased fluctuations from period to period. See Note 14, “Taxes on Earnings” of the Notes to the Consolidated Financial Statements in our 2017 Annual Report.

59


Discontinued Operations
The following table summarizes the key components of net loss from discontinued operations:
 
Three Months Ended (1)
 
Six Months Ended
(In millions)
March 31,
2017
 
March 31,
2017
Revenues
$
42.5

 
$
194.0

Cost of revenues
24.6

 
117.3

Gross margin
17.9

 
76.7

Operating expenses (2)
29.7

 
76.1

Operating earnings
(11.8
)
 
0.6

Taxes on earnings
1.5

 
7.4

Net loss from discontinued operations
$
(13.3
)
 
$
(6.8
)
(1) 
There was no activity in net loss from discontinued operations during the second quarter and first half of fiscal year 2018.
(2) 
Operating expenses from discontinued operations included separation costs of $19.3 million and $34.2 million in the second quarter and first half of fiscal year 2017. Separation costs include expenses for transaction advisory services, consulting services, restructuring and other expenses.
Diluted Net Earnings (Loss) Per Share
 
Three Months Ended
 
Six Months Ended
 
March 30,
2018
 
March 31,
2017
 
Percent Change
 
March 30,
2018
 
March 31,
2017
 
Percent Change
Diluted net earnings (loss) per share - continuing operations
$
0.79

 
$
0.74

 
6
%
 
$
(0.43
)
 
$
0.82

 
(152
)%
Diluted net loss per share - discontinued operations
—

 
(0.14
)
 
n/m

 
—

 
(0.08
)
 
n/m

Total - Diluted net earnings (loss) per share
$
0.79

 
$
0.60

 
32
%
 
$
(0.43
)
 
$
0.74

 
(157
)%
n/m = not meaningful
Diluted net earnings per share from continuing operations increased in the second quarter of fiscal year 2018, compared to the year-ago period, primarily due to an increase in operating earnings from continuing operations and a reduction in the number of diluted shares of common stock outstanding due to share repurchases.
Diluted net earnings (loss) per share from continuing operations decreased in the first half of fiscal year 2018, compared to the year-ago period, primarily due to an increase in income tax expense as a result of the Act signed in December 2017, partially offset by an increase in operating earnings from continuing operations and a reduction in the number of diluted shares of common stock outstanding due to share repurchases.
Gross Orders
Total Gross Orders by segment
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
March 30,
2018
 
March 31,
2017
 
Percent Change
Oncology Systems
$
664.1

 
$
635.0

 
5
 %
 
$
1,284.0

 
$
1,211.7

 
6
%
Varian Particle Therapy
1.9

 
28.0

 
(93
)%
 
48.1

 
32.3

 
49
%
Total Gross Orders
$
666.0

 
$
663.0

 
—
 %
 
$
1,332.1

 
$
1,244.0

 
7
%
Gross orders are defined as new orders recorded during the period adjusted for any revisions to existing orders during the period. New orders are recorded for the total contractual amount, excluding certain pass-through items, once a written

60


agreement for the delivery of goods or provision of services is in place and, other than VPT, when shipment of the product is expected to occur within two years, so long as any contingencies are deemed perfunctory. For our VPT business, we record orders when construction of the related proton therapy treatment center is reasonably expected to start within two years, but only if any contingencies are deemed perfunctory. We will not record VPT orders if there are major financing contingencies, if a substantial portion of the financing for the project is not reasonably assured or if customer board approval contingencies are pending. We perform a quarterly review to verify that outstanding orders remain valid. If an order is no longer expected to be converted to revenue, we record a backlog adjustment which reduces backlog but does not impact gross orders for the period.
Gross orders in any period may not be directly correlated to the level of revenues in any particular future quarter or period since the timing of revenue recognition will vary significantly based on the delivery requirements of individual orders, acceptance schedules and the readiness of individual customer sites for installation of our products. Moreover, certain types of orders, such as orders for software or newly introduced products in our Oncology Systems segment, typically take more time from order to completion of installation and acceptance than hardware or older products. Because an order for a proton therapy system can be relatively large, an order in one fiscal period will cause gross orders in our VPT business to vary significantly, making comparisons between fiscal periods more difficult.
Oncology Systems Gross Orders
Gross Orders by geographical region
Three Months Ended
 
Six Months Ended
(Dollars in millions)
March 30,
2018
 
March 31,
2017
 
Percent Change
 
Constant Currency
 
March 30,
2018
 
March 31,
2017
 
Percent Change
 
Constant Currency
Americas
$
341.4

 
$
335.2

 
2
 %
 
2
 %
 
$
640.9

 
$
628.8

 
2
%
 
2
%
EMEA
199.3

 
180.3

 
11
 %
 
—
 %
 
389.7

 
340.4

 
14
%
 
6
%
APAC
123.4

 
119.5

 
3
 %
 
1
 %
 
253.4

 
242.5

 
4
%
 
3
%
Total Oncology Systems Gross Orders
$
664.1

 
$
635.0

 
5
 %
 
1
 %
 
$
1,284.0

 
$
1,211.7

 
6
%
 
3
%
 


 


 


 
 
 


 


 


 
 
North America
$
306.2

 
$
314.7

 
(3
)%
 
(3
)%
 
$
584.9

 
$
586.9

 
—
%
 
—
%
International
357.9

 
320.3

 
12
 %
 
5
 %
 
699.1

 
624.8

 
12
%
 
7
%
Total Oncology Systems Gross Orders
$
664.1

 
$
635.0

 
5
 %
 
1
 %
 
$
1,284.0

 
$
1,211.7

 
6
%
 
3
%
The Americas Oncology Systems gross orders increased in the second quarter and first half of fiscal year 2018, compared to the year-ago period, primarily due to growth in orders for our products in Latin America and orders for our services in North America, partially offset by decreases in orders for products in North America.
EMEA Oncology Systems gross orders increased in the second quarter and first half of fiscal year 2018, compared to the year-ago period, primarily due to success in large government tenders resulting in increases in gross orders for our products and services.
APAC Oncology Systems gross orders increased in the second quarter and first half of fiscal year 2018, compared to the year-ago period, due to an increase in gross orders for both our products and services.


61


The trailing 12 months' growth in gross orders for Oncology Systems at the end of the second quarter of fiscal year 2018 and at the end of each of the previous three fiscal quarters was:
 
Trailing 12 Months Ended
 
March 30, 2018
 
December 29, 2017
 
September 29, 2017
 
June 30, 2017
Americas
1%
 
1%
 
1%
 
4%
EMEA
15%
 
14%
 
12%
 
1%
APAC
2%
 
3%
 
7%
 
14%
North America
2%
 
3%
 
4%
 
2%
International
8%
 
7%
 
7%
 
7%
Total Oncology Systems Gross Orders
5%
 
5%
 
5%
 
5%
Consistent with the historical pattern, we expect that Oncology Systems gross orders will continue to experience regional fluctuations. Over the long-term, we expect international gross orders, specifically from emerging markets, will grow as a percentage of overall orders. Oncology Systems gross orders are affected by foreign currency fluctuations which could impact the demand for our products. In addition, government programs that stimulate the purchase of healthcare products could affect the demand for our products from period to period, and could therefore make it difficult to compare our financial results.
Varian Particle Therapy Gross Orders
VPT gross orders decreased in the second quarter and increased in the first half of fiscal year 2018, compared to the year-ago periods. There were no VPT proton therapy system orders in the second quarter of fiscal year 2018 compared to one proton therapy system orders in the second quarter of fiscal year 2017. There were two VPT proton therapy system orders in the first half of fiscal year 2018 compared to one proton therapy system order in the first half of fiscal year 2017.
Backlog
Backlog is the accumulation of all gross orders for which revenues have not been recognized and are still considered valid. Backlog is stated at historical foreign currency exchange rates and revenue is released from backlog at current exchange rates, with any difference recorded as a backlog adjustment. Our backlog at March 30, 2018 was $2.9 billion, which includes approximately $313 million in VPT backlog, which was an increase of 9% over the backlog at March 31, 2017. Our Oncology Systems backlog at March 30, 2018 was 7% higher than the backlog at March 31, 2017, which reflected an increase of 11% and 2% for the international regions and North America, respectively.
We perform a quarterly review to verify that outstanding orders in the backlog remain valid. Aged orders that are not expected to ultimately convert to revenues are deemed dormant and are reflected as a reduction in the backlog amounts in the period identified. Backlog adjustments are comprised of dormancies, cancellations, foreign currency exchange rate adjustments, backlog acquired from our acquisitions, and other adjustments. Gross orders do not include backlog adjustments. Backlog adjustments totaled $29.7 million and $79.7 million in the second quarter and first half of fiscal year 2018, compared to $50.4 million and $68.7 million, in the year-ago periods.
Liquidity and Capital Resources
Liquidity is the measurement of our ability to meet potential cash requirements, including ongoing commitments to repay borrowings, acquire businesses or make other investments or loans, repurchase shares of VMS common stock, and fund continuing operations and capital expenditures. Our sources of cash have included operations, borrowings, stock option exercises, and employee stock purchases. Our cash usage is actively managed on a daily basis to ensure the maintenance of sufficient funds to meet our needs.

62


Cash and Cash Equivalents
The following table summarizes our cash and cash equivalents:
(In millions)
March 30,
2018
 
September 29,
2017
 
Increase
 Total cash and cash equivalents
$
739.9

 
$
716.2

 
$
23.7

The increase in cash and cash equivalents in the first half of fiscal year 2018 was primarily due to $244.5 million of cash provided by operating activities and $44.6 million in proceeds from the issuance of common stock to employees, partially offset by debt repayments, net of borrowings, of $95.0 million under our credit facility agreement, $92.7 million used for the repurchase of shares of VMS common stock, $29.6 million used for acquisitions, $17.8 million used for purchases of property, plant, and equipment and $11.1 million used for employee taxes withheld and paid for restricted stock units.
At March 30, 2018, we had approximately $36 million, or 5%, of cash and cash equivalents in the United States and approximately $704 million, or 95%, of cash and cash equivalents was held abroad. As a result of the transition to a modified territorial system and the one-time transition tax on the unremitted earnings of our foreign subsidiaries in the Act, we expect that the cash and cash equivalents held by our foreign subsidiaries will no longer be subject to U.S. federal income tax upon a subsequent actual repatriation to the United States. However, a portion of this cash may still be subject to foreign and state income taxes upon future remittance. In light of the changes to the taxation of foreign earnings in the Act, we no longer consider the earnings of our foreign subsidiaries to be indefinitely reinvested. As a result, we have accrued for the foreign and state income taxes that we expect would be imposed upon a future remittance.
As of March 30, 2018, most of our cash and cash equivalents that was held abroad was in U.S. Dollars and was primarily held as bank deposits. In addition to cash flows generated from operations, a significant portion of which are generated in the United States, we have used our credit facilities to meet our cash needs from time to time and expect to continue to do so in the future. Borrowings under our credit facilities may be used for working capital, capital expenditures, VMS share repurchases, acquisitions and other corporate purposes.
Cash Flows
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
Net cash flow provided by (used in):
 
 
 
Operating activities
$
244.5

 
$
114.4

Investing activities
(55.1
)
 
(53.2
)
Financing activities
(154.2
)
 
(205.0
)
Effects of exchange rate changes on cash and cash equivalents
(11.5
)
 
7.3

Net increase (decrease) in cash and cash equivalents
$
23.7

 
$
(136.5
)
Our primary cash inflows and outflows for the first half of fiscal year 2018, as compared to the first half of fiscal year 2017, were as follows:
•
In the first half of fiscal year 2018, we generated net cash from operating activities of $244.5 million compared to $114.4 million in the first half of fiscal year 2017. The $130.1 million increase in net cash from operating activities was driven by a $245.0 million increase in the net change from operating assets and liabilities partially offset by a $109.7 million decrease in net earnings and a $5.2 million decrease from non-cash items.
•
The major contributors to the net change in operating assets and liabilities in the first half of fiscal year 2018 were as follows:
◦
Accrued liabilities and other long-term liabilities increased $125.3 million primarily due to an increase in a long-term income tax liability that resulted from the enactment of the Act.

63


◦
Trade and unbilled receivables decreased $28.4 million primarily due to higher collections than billings partially offset by an increase in unbilled receivables.
◦
Deferred revenues increased $11.5 million primarily due to advance payments received from VPT customers partially offset by a decrease in deferred service revenues in Oncology Systems.
◦
Inventory increased $10.9 million primarily due an increase in hardware product inventory in Oncology Systems and an increase in inventory for current projects in VPT.
We expect that cash provided by operating activities may fluctuate in future periods as a result of a number of factors, including fluctuations in our operating results, timing of product shipments, product installation or customer acceptance, trade receivable collections, inventory management, and the timing and amount of tax and other payments. For additional discussion, please refer to the “Risk Factors” in Item 1A herein and in Part I, Item 1A of our 2017 Annual Report.
•
In the first half of fiscal year 2018, cash used for investing activities was $55.1 million, compared to cash used of $53.2 million in the first half of fiscal year 2017. In the first half of fiscal year 2018, cash used for investing activities primarily included $29.6 million used for business acquisitions, $17.8 million for the purchases of property, plant and equipment, a $6.0 million investment in an available-for-sale security, $5.5 million for the purchase of a foreign currency option for the Sirtex acquisition, $5.3 million in loans to CPTC, and a $3.1 million investment in privately-held companies, partially offset by $8.0 million received from the sale of an available-for-sale security and $5.2 million received from repayments on notes receivables. In the first half of fiscal year 2017, cash used for investing activities primarily included $32.1 million for the purchases of property, plant and equipment, an $11.5 million issuance of a notes receivable, a $5.0 million investment in a privately-held company and $4.4 million paid to our deferred compensation plan trust account.
•
In the first half of fiscal year 2018, cash used for financing activities was $154.2 million compared to $205.0 million used in the first half of fiscal year 2017. In the first half of fiscal year 2018, cash used for financing activities primarily included $95.0 million in debt repayments, net of borrowings, $92.7 million for the repurchase of VMS common stock, partially offset by $44.6 million received from the issuance of common stock to employees. In the first half of fiscal year 2017, cash used for financing activities primarily included $222.3 million for the repurchase of VMS common stock, $117.0 million in debt repayments, net of borrowings, under our credit facility agreements and $81.3 million contributed to Varex, partially offset by $200.0 million received from Varex and $25.4 million received from the issuance of common stock to employees.
We expect our total fiscal year 2018 capital expenditures, which typically represent construction and/or purchases of facilities, manufacturing equipment, office equipment and furniture and fixtures, as well as capitalized costs related to the implementation of software applications, will be approximately 2% of revenues in fiscal year 2018.
We entered into an agreement, dated September 1, 2017, ("Credit Agreement") with certain lenders and Bank of America, N.A. (“BofA”) as administrative agent ("Debt Lenders"). The Credit Agreement provided for a five-year revolving credit facility (the "2017 Revolving Credit Facility") in an aggregate principal amount of up to $600.0 million.
On April 3, 2018, we entered into the 2018 Revolving Credit Facility with certain lenders and Bank of America, N.A. as administrative agent. The 2018 Revolving Credit Facility provides for a five-year revolving credit facility in an aggregate principal amount of up to $1.8 billion. The 2018 Revolving Credit Facility also includes a $50.0 million sub-facility for the issuance of letters of credit and permits swing line loans of up to $25 million. Under the 2018 Revolving Credit Facility, we have the right to make (i) a request to increase the aggregate commitments by an aggregate amount for all such requests of up to $100.0 million and (ii) request an additional increase in the commitments or establish one or more term loans, provided that, in each case, the lenders are willing to provide such new or increased commitments and certain other conditions are met. The proceeds of the 2018 Revolving Credit Facility may be used for working capital, capital expenditures, to pay the consideration for the Sirtex acquisition, share repurchases, permitted acquisitions and other corporate purposes, as well as to satisfy the outstanding obligation under the 2017 Revolving Credit Facility.
The 2018 Revolving Credit Facility replaces the 2017 Revolving Credit Facility of $600 million. We borrowed $255.0 million under the 2018 Revolving Credit Facility and repaid in full the $255.0 million then outstanding principal balance on our 2017 Revolving Credit Facility, plus accrued interest and fees.

64


In addition, our Japanese subsidiary (“VMS KK”) has an unsecured uncommitted credit agreement with Sumitomo Mitsui Banking Corporation that enables VMS KK to borrow and have outstanding at any given time a maximum of 3.0 billion Japanese Yen (the “Sumitomo Credit Facility”). The Sumitomo Credit Facility will expire in February 2019.
The following table summarizes our short-term borrowings and long-term debt:
 
March 30, 2018
 
September 29, 2017
(Dollars in millions)
Amount
 
Weighted-Average Interest Rate
 
Amount
 
Weighted-Average Interest Rate
Short-term borrowings:
 
 
 
 
 
 
 
2017 Revolving Credit Facility
$
230.0

 
2.79
%
 
$
350.0

 
2.36
%
Total short-term debt
$
230.0

 
 
 
$
350.0

 
 
 
 
 
 
 
 
 
 
Long-term debt:
 
 
 
 
 
 
 
2017 Revolving Credit Facility
$
25.0

 
4.88
%
 
$
—

 
—
%
Total long-term debt
$
25.0

 
 
 
$
—

 
 
See Note 8, "Borrowings" of the Notes to the Condensed Consolidated Financial Statements for further information regarding the 2017 Revolving Credit Facility and the Sumitomo Credit Facility.
The following table provides additional information regarding our short-term borrowings:
(Dollars in millions)
Second Quarter of Fiscal Year 2018
Amount outstanding (at end of period)
$
230.0

Weighted average interest rate (at end of period)
2.79
%
Average amount outstanding (during period)
$
293.6

Weighted average interest rate (during period)
2.66
%
Maximum month-end amount outstanding during period
$
335.0

Our liquidity is affected by many factors, some of which result from the normal ongoing operations of our business and some of which arise from uncertainties and conditions in the United States and global economies. Although our cash requirements will fluctuate as a result of the shifting influences of these factors, we believe that existing cash and cash equivalents, cash to be generated from operations, and current or future credit facilities will be sufficient to satisfy anticipated commitments for capital expenditures, and other cash requirements for at least the next 12 months and into the foreseeable future. We currently anticipate that we will continue to utilize our available liquidity and cash flows from operations, as well as borrowed funds, to make strategic acquisitions, invest in the growth of our business, invest in advancing our systems and processes, repurchase VMS common stock, fund loan commitments and other strategic investments.
Total debt as a percentage of total capital decreased to 14.9% at March 30, 2018 from 18.7% at September 29, 2017, primarily due to a net loss incurred during the first half of fiscal year 2018 and a decrease in borrowings. The ratio of current assets to current liabilities increased to 1.53 to 1 at March 30, 2018 from 1.40 to 1 at September 29, 2017, primarily due to a decrease in borrowings.
Days Sales Outstanding
Our Oncology Systems trade and unbilled receivables days sales outstanding (“DSO”) decreased to 103 days at March 30, 2018 from 118 days at March 31, 2017. Our accounts receivable and DSO are impacted by a number of factors, primarily including: the timing of product shipments, product installation or customer acceptance, collections performance, payment terms, the mix of revenues from different regions, and the effects of economic instability. VPT's DSO is not meaningful because it is highly variable. As of March 30, 2018, approximately 3% of our net trade and unbilled receivables balance was related to customer contracts with remaining terms of more than one year.

65


Share Repurchase Program
We repurchased shares of VMS common stock under various authorizations during the periods presented as follows:
 
Three Months Ended
 
Six Months Ended
(In millions, except per share amounts)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Number of shares
0.3

 
2.0

 
0.8

 
2.5

Average repurchase price per share
$
110.52

 
$
86.42

 
$
109.06

 
$
88.93

Total cost
$
36.0

 
$
172.8

 
$
92.7

 
$
222.3

In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. As of March 30, 2018, approximately 4.4 million shares of VMS common stock remained available for repurchase under the November 2016 authorization.
Stock repurchases may be made in the open market, in privately negotiated transactions (including accelerated share repurchase programs), or under Rule 10b5-1 share repurchase plans, and also may be made from time to time or in one or more larger blocks. All shares that were repurchased under our share repurchase programs have been retired.
For more details see Note 13, "Stockholders' Equity and Noncontrolling Interests" of the Notes to the Condensed Consolidated Financial Statements for further discussion.
Contractual Obligations
Long-term income taxes payable includes the liability for uncertain tax positions, including interest and penalties, the noncurrent portion of the one-time transition tax on unremitted foreign earnings under the Act, and may also include other long-term tax liabilities. As of March 30, 2018, our liability for uncertain tax positions was $61.2 million, of which we do not anticipate making any payments in the next 12 months. We are unable to reliably estimate the timing of the remainder of future payments related to uncertain tax positions; we believe that existing cash and cash equivalents, cash to be generated from operations, and current or future credit facilities will be sufficient to satisfy any payment obligations that may arise related to our liability for uncertain tax positions. The Act allows taxpayers to elect to pay the one-time transition tax over a period of 8 years as follows: 8% per year for each of the first five years and 15%, 20%, and 25%, in years 6 through 8, respectively. As of March 30, 2018, the noncurrent portion of the one-time transition tax on unremitted foreign earnings was $146.9 million.
As of March 30, 2018, we had accrued liabilities of $5.7 million for environmental remediation liabilities. The amount accrued represents estimates of anticipated future costs and the timing and amount of actual future environmental remediation costs may vary as the scope of our obligations become more clearly defined. For more details see Note 10, "Commitments and Contingencies" of the Notes to the Condensed Consolidated Financial Statements for further discussion.
As of March 30, 2018, our outstanding commitments for the GPTC securities was $11.8 million and $4.1 million for the short-term revolving loan to CPTC, both of which are expected to be drawn down in the next 12 months. For more details see Note 16, "VPT Loans and Securities" of the Notes to the Condensed Consolidated Financial Statements for further discussion.
Except for the change in the outstanding balance under our term loan facility and the other items discussed above, there has been no significant change to the other contractual obligations we reported in our 2017 Annual Report.
Subsequent Events
See Note 18, "Subsequent Events" of the Notes to the Condensed Consolidated Financial Statements for a discussion of our subsequent events.
Contingencies
Environmental Remediation Liabilities
For a discussion of environmental remediation liabilities, see Note 10, "Commitments and Contingencies" of the Notes to the Condensed Consolidated Financial Statements, which discussion is incorporated herein by reference.


66


Other Matters
From time to time, we are a party to or otherwise involved in legal proceedings, claims and government inspections or investigations and other legal matters both inside and outside the United States, arising in the ordinary course of our business or otherwise. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. See Note 10, "Commitments and Contingencies" of the Notes to the Condensed Consolidated Financial Statements, which discussion is incorporated herein by reference.
Off-Balance Sheet Arrangements
In conjunction with the sale of our products in the ordinary course of business, we provide standard indemnification of business partners and customers for losses suffered or incurred for property damages, death and injury and for patent, copyright or any other intellectual property infringement claims by any third parties with respect to our products. The terms of these indemnification arrangements are generally perpetual. Except for losses related to property damages, the maximum potential amount of future payments we could be required to make under these arrangements is unlimited. As of March 30, 2018, we have not incurred any significant costs since the spin-off of Varian, Inc. and Varian Semiconductor Equipment Associates, Inc. in 1999 or the Distribution to defend lawsuits or settle claims related to these indemnification arrangements. As a result, we believe the estimated fair value of these arrangements is minimal.
We have entered into indemnification agreements with our directors and officers and certain of our employees that serve as officers or directors of our foreign subsidiaries that may require us to indemnify our directors and officers and those certain employees against liabilities that may arise by reason of their status or service as directors or officers, and to advance their expenses incurred as a result of any legal proceeding against them as to which they could be indemnified.
Recent Accounting Standards or Updates Not Yet Effective
See Note 1, "Summary of Significant Accounting Policies" of the Notes to the Condensed Consolidated Financial Statements for a description of recent accounting standards, including the expected dates of adoption and the estimated effects on our consolidated financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to three primary types of market risks: credit risk and counterparty risk, foreign currency exchange rate risk and interest rate risk.
Credit Risk and Counterparty Risk
We are exposed to credit loss in the event of nonperformance by counterparties on the foreign currency forward contracts used in hedging activities. These counterparties are large international and regional financial institutions and to date, no such counterparty has failed to meet its financial obligation to us under such contracts.
We are also exposed to credit loss in the event of default by counterparties of our financing receivables and our loans to VPT customers such as:
As of March 30, 2018, the Term Loan with CPTC was $53.5 million. The $53.5 million is composed of four Tranches: Tranche A of $2.0 million, Tranche B of $7.2 million, Tranche C of $15.6 million, and Tranche D of $28.7 million. All of the Tranches accrue paid-in-kind interest at 7.5% per annum, except the Tranche B which accrues paid-in-kind interest at 10% per annum. The maturity date of the Term Loan is three years from the Closing Date. The Term Loan is secured by the assets of CPTC.
In addition, the Lenders have committed to lend up to $15.0 million in Revolving Loans. Our share of the funding commitment from the Revolving Loan is $7.2 million and as of March 30, 2018, we have funded $3.1 million. The Revolving Loan accrues paid-in-kind interest at 10% per annum and has a maturity date one year from the Closing Date.
The seniority of these loans is as follows: Revolving Loan, Tranche A, Tranche B, Tranche C and Tranche D. If CPTC is in default, the interest on Tranche A, C and D will increase to 9.5% and the interest on Tranche B and the Revolving Loan will increase to 12.0%.
In May 2015, we committed to loan $35.0 million to the Maryland Proton Treatment Center ("MPTC"). Our subordinated loan is due, with accrued interest, in three annual payments from 2020 to 2022. The interest on the outstanding loan accrues at 12%.

67


In the second quarter of fiscal year 2018, we recorded an $11.1 million impairment charge on our MPTC subordinated loan, which included accrued interest, due to the expected difference in value between the security currently held by us and the value of the new security that will be issued to us in exchange as part of the refinancing expected in the second half of fiscal year 2018. As of March 30, 2018, the MPTC subordinated loan totaled, $33.8 million. We also have $25.1 million as short-term notes receivable related to a deferred payment arrangement with MPTC. The notes receivable carries an interest rate of 15% and is due in September 30, 2018.
We also have loans, including accrued interest, associated with the New York Proton Center, and Proton International LLC totaling $26.2 million and $2.6 million, respectively.
In July 2017, we purchased the outstanding senior secured debt related to the Rinecker Proton Therapy Center ("RPTC") in Munich, Germany for 21.5 million Euros or $24.5 million. By purchasing the senior secured debt, we have a right to 89 million Euros in claims against all of RPTC's assets. In September 2017, the management of RPTC filed for bankruptcy in Germany. In January 2018, the final insolvency proceedings commenced and we expect the insolvency proceedings to be finalized within the next twelve months. Upon finalization of bankruptcy proceedings, we believe it is probable we will recover its outstanding senior secured debt balance and trade accounts receivable, net.
See Note 16, "VPT Loans and Securities" of the Notes to the Condensed Consolidated Financial Statements for further information on loans to VPT customers.
In addition, cash and cash equivalents held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. We also may need to rely on our credit facilities as described below under “Interest Rate Risk.” Our access to our cash and cash equivalents or ability to borrow could be reduced if one or more financial institutions with which we have deposits or from which we borrow should fail or otherwise be adversely impacted by conditions in the financial or credit markets. Conditions such as those we experienced as a result of the last economic downturn and accompanying contraction in the credit markets heighten these risks. Concerns over economic instability could make it more difficult for us to collect outstanding receivables and could adversely impact our liquidity.
Foreign Currency Exchange Rate Risk
As a global entity, we are exposed to movements in foreign currency exchange rates. These exposures may change over time as business practices evolve. Adverse foreign currency rate movements could have a material negative impact on our financial results. Our primary exposures related to foreign currency denominated sales and purchases are in Europe, Asia, Australia and Canada.
We have many transactions denominated in foreign currencies and address certain of those financial exposures through a risk management program that includes the use of derivative financial instruments. We sell products throughout the world, often in the currency of the customer’s country, and may hedge certain of these larger foreign currency sale transactions when they are not transacted in the subsidiaries’ functional currency or in U.S. Dollars. The foreign currency transactions that fit our risk management policy criteria are hedged with foreign currency forward contracts. We may use other derivative instruments in the future. We enter into foreign currency forward contracts primarily to reduce the effects of fluctuating foreign currency exchange rates. We do not enter into foreign currency forward contracts for speculative or trading purposes. The forward contracts range from one to thirteen months in maturity.
We also hedge the balance sheet exposures from our various foreign subsidiaries and business units. We enter into foreign currency forward contracts to minimize the short-term impact of currency fluctuations on assets and liabilities denominated in currencies other than the subsidiaries' functional currency or the U.S. Dollar.
The notional values of our sold and purchased foreign currency forward contracts outstanding as of March 30, 2018 were $477.3 million and $41.8 million, respectively. The notional amounts of foreign currency forward contracts are not a measure of our exposure. The fair value of forward contracts generally reflects the estimated amounts that we would receive or pay to terminate the contracts at the reporting date, thereby taking into account and approximating the current unrealized and realized gains or losses of the open contracts. A move in foreign currency exchange rates would change the fair value of the contracts, and the fair value of the underlying exposures hedged by the contracts would change in a similar offsetting manner.
In addition to our foreign currency forward contracts mentioned above, we entered into foreign currency forward contracts and a foreign currency option contract to economically hedge our foreign currency exchange rate risk on the consideration to be paid for the Sirtex acquisition. The foreign currency forward contracts allow us to purchase a notional amount of A$793.0 million or $621.0 million on May 25, 2018. The quoted forward exchange rate on March 30, 2018 would provide that the same

68


amount of Australian dollars would cost $609.6 million. As of March 30, 2018, the foreign currency forward contracts have a fair value of $609.6 million. We paid a premium of $5.5 million for a foreign currency option that allows us to purchase a notional amount of A$792.0 million or $641.5 million that will expire on May 23, 2018. As of March 30, 2018, the foreign currency option has a fair value of $0.5 million.
The foreign currency forward contracts and option contract do not qualify for hedge accounting. As such, changes in the fair value will be recognized in acquisition-related expenses on the Condensed Consolidated Statements of Earnings. In the three months ended March 30, 2018, we recorded losses of $11.4 million and $5.0 million on the foreign currency forward contracts and the foreign currency option contract, respectively.
Interest Rate Risk
Our market risk exposure to changes in interest rates depends primarily on our investment portfolio and borrowings. Our investment portfolio primarily consisted of cash and cash equivalents and available-for-sale investments as of March 30, 2018. The principal amount of cash and cash equivalents in continuing operations at March 30, 2018 totaled $739.9 million with a weighted average interest rate of 0.53%. At March 30, 2018, our available-for-sale investments, which include accrued interest, are the $6.1 million in Subordinate Revenue Bonds with a fixed interest rate to finance the Alabama Proton Therapy Center ("APTC') and the $4.6 million in Senior Capital Appreciation Bonds to finance the Georgia Proton Treatment Center ("GPTC"). The APTC Subordinate Revenue bear an interest rate of 8.5% per annum and the GPTC Senior Capital Appreciation Bonds bear an interest rate of 8.0% per annum. Our available-for-sale investments are carried at fair value.
Borrowings under the 2017 Revolving Credit Facility accrue interest at either (i) based on the Eurodollar Rate plus a margin of 1.125% to 1.875% based on a leverage ratio involving funded indebtedness and EBITDA, or (ii) based upon a base rate of (a) the federal funds rate plus 0.50%, (b) BofA’s announced prime rate, or (c) the Eurodollar Rate plus 1.00%, whichever is highest, plus a margin of 0.125% to 0.875% based on the same leverage ratio, depending upon instructions from the Company. Borrowings under the 2017 Revolving Credit Facility have a contract repayment date of twelve months, or less, and a final maturity of five years if based on the Eurodollar Rate and all overnight borrowings on the base rate would also have a final maturity of five years.
We are affected by market risk exposure primarily through the effect of changes in interest rates on amounts payable under our 2017 Revolving Credit Facility. As of March 30, 2018, short-term borrowings under the 2017 Revolving Credit Facility totaled $230.0 million with a weighted average interest rate of 2.79%. In addition, as of March 30, 2018, long-term debt under the 2017 Revolving Credit Facility totaled $25.0 million with a weighted average interest rate of 4.88%. If the amount outstanding under our 2017 Revolving Credit Facility remained at this level for an entire year and interest rates increased or decreased by 1%, our annual interest expense would increase or decrease, respectively, by an additional $2.6 million. See Note 8, "Borrowings" of the condensed consolidated financial statements for a discussion regarding the 2017 Credit Facility.
In addition, the Sumitomo Credit Facility allows VMS KK to borrow up to a maximum amount of 3.0 billion Japanese Yen. Borrowings under the Sumitomo Credit Facility accrue interest based on the basic loan rate announced by the Bank of Japan plus a margin of 0.5% per annum. As of March 30, 2018, the there was no outstanding balance under the Sumitomo Credit Facility.
To date, we have not used derivative financial instruments to hedge the interest rate within our investment portfolio, borrowings, but may consider the use of derivative instruments in the future. In addition, although payments under certain of our operating leases for our facilities are tied to market indices, these operating leases do not expose us to material interest rate risk.
Item 4. Controls and Procedures
(a)
Disclosure controls and procedures. Based on the evaluation of our disclosure controls and procedures (as defined in the Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) required by Exchange Act Rules 13a-15(b) or 15d-15(b), our principal executive officer and principal financial officer have concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by us in such reports is accumulated and communicated to our management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

69


(b)
Changes in internal control over financial reporting. There were no changes in our internal control over financial reporting that occurred during the second quarter of fiscal year 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II
OTHER INFORMATION
Item 1. Legal Proceedings
We are subject to various legal proceedings and claims that are discussed in Note 10, "Commitments and Contingencies" to the Condensed Consolidated Financial Statements, which discussion is incorporated by reference into this item.
Item 1A. Risk Factors
There were no material changes during the period covered in this report to the risk factors previously disclosed in Part I, Item 1A, of our 2017 Annual Report on Form 10-K and Part II, Item 1A, of our Quarterly Report on Form 10Q for the quarter ended December 29, 2017, except as follows:
The Tax Cuts and Jobs Act of 2017, the enactment of legislation implementing changes in taxation of international business activities, and the adoption of other tax legislation and policies could materially impact our financial position and results of operations.
The Tax Cuts and Jobs Act of 2017 (the “Act”) is expected to have a significant impact on our financial position and results of operations. The Act reduced the U.S. corporate income tax rate from 35% to 21%. This rate reduction requires us to re-measure our net deferred tax assets which were originally recorded assuming a future tax benefit at the 35% rate. We estimate that the total impact of this re-measurement of our net deferred tax assets will be about $46.7 million. The impacts to our three- and six-month periods ended March 30, 2018, were charges to income tax expense of $2.4 million and $40.2 million, respectively. Since we have a September fiscal year end, the change to the lower corporate tax rate will be phased in. As a result of this phase in, the remainder, or about $6.5 million, will be charged to income tax expense over the balance of fiscal year 2018.
In addition, as part of the transition to a modified territorial system, the new law imposes a one-time transition tax on the unremitted earnings of our foreign subsidiaries. During the three- and six-month periods ended March 30, 2018, we recorded a provisional discrete tax expense of $3.8 million and $173.1 million, respectively, related to the one-time transition tax.
We intend to make the election to pay this tax over an eight-year period. The transition to a modified territorial regime and the one-time transition tax on unremitted earnings has also caused us to re-evaluate our intentions with respect to the unremitted earnings of our foreign subsidiaries. In the past, we did not accrue U.S. taxes on certain undistributed profits of certain foreign subsidiaries because the earnings were considered to be indefinitely reinvested. In light of the changes to the taxation of foreign earnings in the Act, we no longer consider the earnings of our foreign subsidiaries to be indefinitely reinvested.
The amounts of the tax effects related to the Act described above represent our reasonable estimates. Also, it is expected that the U.S. Treasury will issue regulations and other guidance on the application of certain provisions of the Act, which could cause us to significantly revise the provisional amounts we have recorded.
On January 22, 2018, a continuing budget resolution was signed into law that included a provision to extend the moratorium on the 2.3% medical device excise tax for two more years, or until January 1, 2020. This tax has had, and may continue to have, a negative impact on our gross margin when the moratorium expires.
A significant portion of our earnings is generated from activity outside the United States. As a result, any substantial changes in international policies regarding corporate taxation or legislative initiatives may materially and adversely affect our business, the amount of taxes we are required to pay and our financial condition and results of operations generally.

70


The proposed acquisition of Sirtex Medical Limited may not be completed within the expected timeframe, or at all, and the failure to complete the acquisition could adversely affect our business.
On January 30, 2018, we signed an agreement to acquire Sirtex Medical Limited ("Sirtex"), an Australian company that is listed on the Australian Securities Exchange, for A$28 per share or approximately A$1.6 billion (approximately $1.2 billion as of March 30, 2018). Sirtex is an Australian-based global life sciences company focused on interventional oncology therapies.
The transaction has received all necessary regulatory approvals, is subject to the approval of the Sirtex shareholders, the Federal Court of Australia and the satisfaction of other customary closing conditions. There is no guarantee that these conditions will be satisfied in a timely manner or at all. If any of the conditions to the proposed acquisition are not satisfied (or waived by the other party), the acquisition may not be completed.
On May 4, 2018, Sirtex received an unsolicited non-binding, indicative and conditional proposal from CDH Investments ("CDH"), a China-based alternative asset manager, for the acquisition of all of the issued shares in Sirtex for A$33.60 per share. The Sirtex board of directors has determined to engage with CDH to further understand the conditions associated with the CDH proposal. As a result the meeting of Sirtex shareholders to approve the acquisition by Varian, which was scheduled to occur on Monday, May 7, 2018 (Sydney time), was adjourned to a time and date to be determined.
The Scheme Implementation Deed (the “Agreement”) may be terminated under specified circumstances. Our failure to complete the acquisition could delay our plan to expand into the interventional oncology market and adversely affect our business. We could be required to pay a termination fee up to 1% of the total consideration under certain circumstances as described in the Agreement . In addition, our stock price may also suffer as the failure to consummate the acquisition may result in negative perception in the investment community.
Uncertainty associated with the completion of the merger may cause substantial disruptions in our business and Sirtex’s business.
Uncertainty associated with the completion of the acquisition may cause substantial disruptions in our business and Sirtex’s business, which could have an adverse effect on Sirtex's results prior to the closing and our financial results after the closing. Among other things, such uncertainty may affect our relationships with customers, potential customers and suppliers and our ability to recruit prospective employees or to retain and motivate existing employees. Sirtex may face similar disruptions to its business, which could adversely impact their financial results prior to closing and over the long term. The adverse effect of such disruptions could be exacerbated by the recently announced delay in the completion of the acquisition or termination of the Agreement.
Our efforts to integrate acquisitions may not be successful, and this may adversely impact our profitability and sales growth.
As part of our strategy to develop and identify new technologies, products and services, we have made and may continue to acquire new businesses and technologies. Our integration of the operations of acquired businesses requires significant efforts, including the coordination of information technologies, research and development, sales and marketing, operations, manufacturing and finance. In particular, if our proposed acquisition of Sirtex is completed, success of the acquisition will depend, in part, on our ability to successfully integrate the business and operations and fully realize the anticipated benefits and synergies from combining our businesses and Sirtex’s business. If we are not able to achieve these objectives following the acquisition, the anticipated benefits and synergies of the transactions may not be realized fully or at all or may take longer to realize than expected. Our efforts to successfully integrate acquisitions may result in additional expenses and divert significant amounts of management’s time from other projects.
Our failure to manage successfully and coordinate the growth of the acquired companies could also have an adverse impact on our business. In addition, there is no guarantee that some of the businesses we acquire will become profitable or remain so. If our acquisitions do not meet our initial expectations, we may record impairment charges.
Factors that will affect the success of our acquisitions include:
•
our ability to retain key employees of the acquired company;
•
the performance of the acquired business, technology, product or service;
•
our ability to integrate operations, financial and other systems;

71


•
the ability of the combined company to achieve synergies among its constituent companies, such as increasing sales of the combined company’s products and services, achieving expected cost savings and effectively combining technologies to develop new products and services;
•
any disruption in order fulfillment or loss of sales due to integration processes;
•
the presence or absence of adequate internal controls and/or significant fraud in the financial systems of acquired companies;
•
any decrease in customer and distributor loyalty and product orders caused by dissatisfaction with the acquired companies’ product lines and sales and marketing practices, including price increases; and
•
our assumption of known contingent liabilities that are realized, known liabilities that prove greater than anticipated, or unknown liabilities that come to light, to the extent that the realization of any of these liabilities increases our expenses or adversely affects our business or financial position.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(a)
Not applicable
(b)
Not applicable
(c)
The following table provides information with respect to the shares of common stock repurchased by us during the second quarter of fiscal year 2018 (in millions, except per share amounts):
Period
Total Number of
Shares Purchased
 
Average Price
Paid Per Share
 
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
 
Maximum Number
of Shares that May
Yet Be Purchased
Under the Plans or
Programs (1)
December 30, 2017 - January 26, 2018
0.3

 
$
110.52

 
0.3

 
4.4

January 27, 2018 - February 23, 2018
—

 
$
—

 
—

 
4.4

February 24, 2018 - March 30, 2018
—

 
$
—

 
—

 
4.4

Total
0.3

 
$
110.52

 
0.3

 
4.4

(1) 
In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. Share repurchases may be made in the open market, in privately negotiated transactions (including accelerated share repurchase programs), or under Rule 10b5-1 share repurchase plans, and also may be made from time to time or in one or more larger blocks. All shares that were repurchased under the Company's share repurchase programs have been retired.
The preceding table excludes an immaterial number of shares of VMS common stock that were withheld by VMS in satisfaction of tax withholding obligations upon the vesting of restricted stock units granted under our employee stock plans.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.


72


Item 6. Exhibits
The exhibits listed below are filed or incorporated by reference as part of this Form 10-Q:
Exhibit
No.
  
Description
 
 
 
2.1
 
 
 
 
10.1
 

 
 
 
10.2
 

 
 
 
15.1*
  
 
 
 
31.1*
  
 
 
 
31.2*
  
 
 
 
32.1*
  
 
 
 
32.2*
  
 
 
 
101.INS
  
XBRL Instance Document
 
 
 
101.SCH
  
XBRL Taxonomy Extension Schema Document
 
 
 
101.CAL
  
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
101.DEF
  
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
101.LAB
  
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
101.PRE
  
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
 
 
 
 
 
 
 
 
 
*
 
Filed herewith

73


SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
VARIAN MEDICAL SYSTEMS, INC.
 
 
 
 
(Registrant)
 
 
 
 
 
Dated:
May 8, 2018
By:
 
/s/ GARY E. BISCHOPING JR.
 
 
 
 
Gary E. Bischoping Jr.
 
 
 
 
Senior Vice President and
 
 
 
 
Chief Financial Officer
 
 
 
 
(Duly Authorized Officer and
 
 
 
 
Principal Financial Officer)

74
 EX-15.1 2 exhibit151-2018q2.htm EXHIBIT 15.1 Exhibit


Exhibit 15.1


May 8, 2018


Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549


Commissioners:

We are aware that our report dated May 8, 2018 on our review of interim financial information of Varian Medical Systems, Inc. for the three and six month periods ended March 30, 2018 and March 31, 2017 and included in the Company's quarterly report on Form 10-Q for the quarter ended March 30, 2018 is incorporated by reference in its Registration Statements on Form S-3 (No. 333-221763) and Form S‑8 (No. 333-223143, No. 333-220078, No.333-188693, No.333-168444, No. 333-168443, No. 333-146176, No. 333-130001, No. 333-152903, No. 333-123778, No. 333-75531, No. 333-57006, No. 333-57008, No. 333-57010, and No. 333-161307).

Very truly yours,


/S/ PRICEWATERHOUSECOOPERS LLP
PricewaterhouseCoopers LLP


PricewaterhouseCoopers LLP, 488 Almaden Boulevard, Suite 1800, San Jose, CA 95110
T: (408) 817 3700, F: (408) 817 5050, www.pwc.com/us


 EX-31.1 3 exhibit311-2018q2.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Dow R. Wilson, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Varian Medical Systems, Inc. (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonable likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Dated:
May 8, 2018
/s/
Dow R. Wilson
 
 
 
Dow R. Wilson
 
 
 
President
 
 
 
and Chief Executive Officer



 EX-31.2 4 exhibit312-2018q2.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Gary E. Bischoping Jr., certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Varian Medical Systems, Inc. (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonable likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Dated:
May 8, 2018
/s/
Gary E. Bischoping Jr.
 
 
 
Gary E. Bischoping Jr.
 
 
 
Senior Vice President and
 
 
 
Chief Financial Officer



 EX-32.1 5 exhibit321-2018q2.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report of Varian Medical Systems, Inc. (the “Company”), on Form 10-Q for the quarter ended March 30, 2018 (the “Report”), I, Dow R. Wilson, President and Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:
(1)
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:
May 8, 2018
/s/
Dow R. Wilson
 
 
 
Dow R. Wilson
 
 
 
President
 
 
 
and Chief Executive Officer



 EX-32.2 6 exhibit322-2018q2.htm EXHIBIT 32.2 Exhibit


Exhibit 32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report of Varian Medical Systems, Inc. (the “Company”), on Form 10-Q for the quarter ended March 30, 2018 (the “Report”), I, Gary E. Bischoping Jr., Senior Vice President and Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:
(1)
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:
May 8, 2018
/s/
Gary E. Bischoping Jr.
 
 
 
Gary E. Bischoping Jr.
 
 
 
Senior Vice President and
 
 
 
Chief Financial Officer



 EX-101.INS 7 var-20180330.xml XBRL INSTANCE DOCUMENT 0000203527 2017-09-30 2018-03-30 0000203527 2018-04-27 0000203527 2016-10-01 2017-03-31 0000203527 2016-12-31 2017-03-31 0000203527 2017-12-30 2018-03-30 0000203527 2018-03-30 0000203527 2017-09-29 0000203527 2016-09-30 0000203527 2017-03-31 0000203527 us-gaap:ScenarioPreviouslyReportedMember 2017-09-29 0000203527 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RestatementAdjustmentMember 2017-09-29 0000203527 2020-10-03 2018-03-30 0000203527 2018-09-29 2018-03-30 0000203527 2018-03-31 2018-03-30 0000203527 2019-09-28 2018-03-30 0000203527 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2015-10-02 2015-10-02 0000203527 us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember var:VarexImagingMember 2017-01-28 2017-01-28 0000203527 var:AccountingStandardsUpdate201609ForfeitureRateMember us-gaap:RetainedEarningsMember 2017-09-30 0000203527 us-gaap:MaximumMember 2017-09-30 2018-03-30 0000203527 us-gaap:MinimumMember 2017-09-30 2018-03-30 0000203527 us-gaap:ScenarioPreviouslyReportedMember 2016-10-01 2017-03-31 0000203527 us-gaap:ScenarioPreviouslyReportedMember 2016-12-31 2017-03-31 0000203527 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RestatementAdjustmentMember 2016-12-31 2017-03-31 0000203527 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RestatementAdjustmentMember 2016-10-01 2017-03-31 0000203527 var:VarexTermFacilityMember 2016-10-01 2017-09-29 0000203527 var:VarexImagingMember us-gaap:RetainedEarningsMember 2016-10-01 2017-09-29 0000203527 us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember var:VarexImagingMember 2018-03-30 0000203527 var:VarexImagingMember 2016-10-01 2017-09-29 0000203527 var:VarexImagingMember us-gaap:MaximumMember 2017-01-28 2017-01-28 0000203527 us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember var:VarexImagingMember 2016-10-01 2017-09-29 0000203527 var:VarexTermFacilityMember 2017-01-25 2017-01-25 0000203527 var:VarexImagingMember us-gaap:MinimumMember 2017-01-28 2017-01-28 0000203527 2017-01-28 2017-01-28 0000203527 us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember 2017-09-29 0000203527 us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember 2018-03-30 0000203527 us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember 2016-12-31 2017-03-31 0000203527 us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember 2016-10-01 2017-03-31 0000203527 var:SirtexMedicalLimitedMember 2018-01-30 2018-01-30 0000203527 var:OtherAcquisitionsMember 2017-09-30 2018-03-30 0000203527 var:SirtexMedicalLimitedMember 2018-03-30 2018-03-30 0000203527 var:OtherAcquisitionsMember 2018-03-30 0000203527 var:SirtexMedicalLimitedMember us-gaap:SubsequentEventMember 2018-05-04 0000203527 var:SirtexMedicalLimitedMember 2018-01-30 0000203527 var:APTCSecuritiesMember 2018-03-30 0000203527 var:GPTCSecuritiesMember 2018-03-30 0000203527 var:DRTCSecuritiesMember 2017-09-29 0000203527 var:CorporateDebtSecuritiesCaliforniaProtonTreatmentCenterLLCMember 2017-09-29 0000203527 var:GPTCSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel2Member 2018-03-30 0000203527 us-gaap:NotesReceivableMember 2018-03-30 0000203527 var:CPTCMember var:TermLoanMember 2018-03-30 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember 2017-12-06 0000203527 us-gaap:NotesReceivableMember 2017-09-29 0000203527 var:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-29 0000203527 var:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 2018-03-30 0000203527 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AvailableforsaleSecuritiesMember 2017-09-30 2018-03-30 0000203527 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AvailableforsaleSecuritiesMember 2017-09-29 0000203527 var:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2018-03-30 0000203527 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AvailableforsaleSecuritiesMember 2018-03-30 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember var:DRTCSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-09-29 0000203527 us-gaap:FairValueMeasurementsRecurringMember 2018-03-30 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueMeasurementsRecurringMember var:DRTCSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2018-03-30 0000203527 us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2018-03-30 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-03-30 0000203527 us-gaap:FairValueMeasurementsRecurringMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-03-30 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-03-30 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2018-03-30 0000203527 us-gaap:FairValueMeasurementsRecurringMember var:GPTCSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember var:GPTCSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember var:GPTCSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember var:DRTCSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember var:DRTCSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember var:GPTCSecuritiesMember 2018-03-30 0000203527 us-gaap:FairValueMeasurementsRecurringMember var:GPTCSecuritiesMember 2018-03-30 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember var:GPTCSecuritiesMember 2018-03-30 0000203527 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2018-03-30 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember var:GPTCSecuritiesMember 2017-09-29 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember var:GPTCSecuritiesMember 2018-03-30 0000203527 us-gaap:TechnologyBasedIntangibleAssetsMember 2017-09-29 0000203527 us-gaap:OtherIntangibleAssetsMember 2017-09-29 0000203527 us-gaap:CustomerRelationshipsMember 2018-03-30 0000203527 us-gaap:CustomerRelationshipsMember 2017-09-29 0000203527 us-gaap:OtherIntangibleAssetsMember 2018-03-30 0000203527 us-gaap:TechnologyBasedIntangibleAssetsMember 2018-03-30 0000203527 us-gaap:SegmentContinuingOperationsMember 2016-12-31 2017-03-31 0000203527 us-gaap:SegmentContinuingOperationsMember 2016-10-01 2017-03-31 0000203527 us-gaap:SegmentContinuingOperationsMember 2017-12-30 2018-03-30 0000203527 us-gaap:SegmentContinuingOperationsMember 2017-09-30 2018-03-30 0000203527 var:OncologySystemsMember 2018-03-30 0000203527 var:VarianParticleTherapyMember 2017-09-29 0000203527 var:VarianParticleTherapyMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember 2018-03-30 0000203527 var:OncologySystemsMember 2017-09-30 2018-03-30 0000203527 var:OncologySystemsMember 2017-09-29 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember us-gaap:EurodollarMember 2017-09-30 2018-03-30 0000203527 var:A2017RevolvingCreditFacilityMember 2017-09-01 2017-09-01 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember us-gaap:MaximumMember us-gaap:EurodollarMember 2017-09-30 2018-03-30 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember us-gaap:MaximumMember 2017-09-30 2018-03-30 0000203527 var:SumitomoCreditFacilityMember us-gaap:BaseRateMember 2017-09-30 2018-03-30 0000203527 var:A2017RevolvingCreditFacilityMember 2017-09-01 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember 2017-09-01 0000203527 var:SumitomoCreditFacilityMember 2018-03-30 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember us-gaap:MaximumMember var:EurodollarPlus1Member 2017-09-30 2018-03-30 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember us-gaap:MinimumMember var:EurodollarPlus1Member 2017-09-30 2018-03-30 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember 2017-09-30 2018-03-30 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember us-gaap:MinimumMember 2017-09-30 2018-03-30 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember 2017-09-30 2018-03-30 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2017RevolvingCreditFacilityMember us-gaap:MinimumMember us-gaap:EurodollarMember 2017-09-30 2018-03-30 0000203527 var:A2017RevolvingCreditFacilityMember 2017-09-29 0000203527 var:A2017RevolvingCreditFacilityMember 2018-03-30 0000203527 var:A2017RevolvingCreditFacilityMember 2018-03-30 0000203527 var:A2017RevolvingCreditFacilityMember 2017-09-29 0000203527 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-09-30 2018-03-30 0000203527 us-gaap:SalesRevenueNetMember 2017-12-30 2018-03-30 0000203527 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-30 2018-03-30 0000203527 us-gaap:SalesRevenueNetMember 2017-09-30 2018-03-30 0000203527 var:SirtexMedicalLimitedMember us-gaap:ForeignExchangeOptionMember 2018-02-28 0000203527 var:SirtexMedicalLimitedMember us-gaap:ForeignExchangeOptionMember 2018-02-01 2018-02-28 0000203527 var:SirtexMedicalLimitedMember us-gaap:ForeignExchangeForwardMember 2018-02-28 0000203527 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-30 2018-03-30 0000203527 var:SirtexMedicalLimitedMember us-gaap:ForeignExchangeForwardMember 2018-03-30 0000203527 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-09-30 2018-03-30 0000203527 var:SirtexMedicalLimitedMember us-gaap:ForeignExchangeOptionMember us-gaap:AcquisitionRelatedCostsMember 2017-12-30 2018-03-30 0000203527 var:SirtexMedicalLimitedMember us-gaap:ForeignExchangeOptionMember 2018-03-30 0000203527 var:SirtexMedicalLimitedMember us-gaap:ForeignExchangeForwardMember us-gaap:AcquisitionRelatedCostsMember 2017-12-30 2018-03-30 0000203527 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2018-03-30 0000203527 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-03-30 0000203527 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeOptionMember us-gaap:NondesignatedMember 2018-03-30 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-12-30 2018-03-30 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-10-01 2017-03-31 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-09-30 2018-03-30 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-12-31 2017-03-31 0000203527 currency:PLN us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:EUR us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:DKK us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:CAD us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:EUR us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:CHF us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:CHF us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:GBP us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:INR us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:ZAR us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:INR us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:BRL us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:SGD us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:DKK us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:SEK us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:PLN us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:AUD us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:GBP us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:CAD us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:SEK us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:AUD us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:THB us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:SGD us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:HUF us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 currency:THB us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:BRL us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:HUF us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2018-03-30 0000203527 currency:ZAR us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2018-03-30 0000203527 var:A2017RestructuringPlanMember 2018-03-30 0000203527 var:A2017RestructuringPlanMember 2017-09-30 2018-03-30 0000203527 var:A2017RestructuringPlanMember 2017-09-29 0000203527 var:GroupASitesMember us-gaap:MaximumMember 2018-03-30 0000203527 var:GroupASitesMember us-gaap:MinimumMember 2017-09-30 2018-03-30 0000203527 var:GroupBSitesMember us-gaap:MaximumMember 2018-03-30 0000203527 var:GroupBSitesMember 2018-03-30 0000203527 var:A2017RestructuringPlanMember 2016-12-31 2017-03-31 0000203527 var:A2017RestructuringPlanMember 2016-10-01 2017-03-31 0000203527 var:GroupBSitesMember us-gaap:MinimumMember 2017-09-30 2018-03-30 0000203527 var:GroupASitesMember 2018-03-30 0000203527 var:GroupBSitesMember us-gaap:MinimumMember 2018-03-30 0000203527 var:GroupASitesMember us-gaap:MaximumMember 2017-09-30 2018-03-30 0000203527 var:GroupBSitesMember us-gaap:MaximumMember 2017-09-30 2018-03-30 0000203527 var:GroupASitesMember us-gaap:MinimumMember 2018-03-30 0000203527 us-gaap:PensionPlansDefinedBenefitMember 2016-12-31 2017-03-31 0000203527 us-gaap:PensionPlansDefinedBenefitMember 2017-09-30 2018-03-30 0000203527 us-gaap:PensionPlansDefinedBenefitMember 2017-12-30 2018-03-30 0000203527 us-gaap:PensionPlansDefinedBenefitMember 2016-10-01 2017-03-31 0000203527 us-gaap:ForeignPlanMember 2018-03-30 0000203527 us-gaap:ScenarioForecastMember 2017-09-30 2018-09-28 0000203527 var:November2016Member 2018-03-30 0000203527 var:November2016Member 2016-11-30 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-30 2018-03-30 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-03-30 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-29 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-30 2018-03-30 0000203527 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-29 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-30 2018-03-30 0000203527 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-30 2018-03-30 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-03-30 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-29 0000203527 us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2018-03-30 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-29 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-03-30 0000203527 us-gaap:NoncontrollingInterestMember 2017-09-30 2018-03-30 0000203527 us-gaap:NoncontrollingInterestMember 2016-10-01 2017-03-31 0000203527 us-gaap:NoncontrollingInterestMember 2017-03-31 0000203527 us-gaap:NoncontrollingInterestMember 2017-09-29 0000203527 us-gaap:NoncontrollingInterestMember 2018-03-30 0000203527 us-gaap:NoncontrollingInterestMember 2016-09-30 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-12-30 2018-03-30 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2016-10-01 2017-03-31 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-12-31 2017-03-31 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2016-10-01 2017-03-31 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-10-01 2017-03-31 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-30 2018-03-30 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2016-12-31 2017-03-31 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-09-30 2018-03-30 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-30 2018-03-30 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2016-12-31 2017-03-31 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-30 2018-03-30 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2016-09-30 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2016-10-01 2017-03-31 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2016-09-30 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2016-10-01 2017-03-31 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-03-31 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2016-09-30 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2017-03-31 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2017-03-31 0000203527 us-gaap:ResearchAndDevelopmentExpenseMember 2017-09-30 2018-03-30 0000203527 us-gaap:GeneralAndAdministrativeExpenseMember 2016-12-31 2017-03-31 0000203527 var:CostOfRevenuesProductMember 2016-10-01 2017-03-31 0000203527 var:CostOfRevenuesServiceMember 2016-10-01 2017-03-31 0000203527 us-gaap:ResearchAndDevelopmentExpenseMember 2016-10-01 2017-03-31 0000203527 us-gaap:ResearchAndDevelopmentExpenseMember 2016-12-31 2017-03-31 0000203527 us-gaap:GeneralAndAdministrativeExpenseMember 2017-12-30 2018-03-30 0000203527 var:CostOfRevenuesProductMember 2017-12-30 2018-03-30 0000203527 us-gaap:ResearchAndDevelopmentExpenseMember 2017-12-30 2018-03-30 0000203527 var:CostOfRevenuesServiceMember 2017-12-30 2018-03-30 0000203527 var:CostOfRevenuesProductMember 2016-12-31 2017-03-31 0000203527 var:CostOfRevenuesServiceMember 2016-12-31 2017-03-31 0000203527 var:CostOfRevenuesServiceMember 2017-09-30 2018-03-30 0000203527 var:CostOfRevenuesProductMember 2017-09-30 2018-03-30 0000203527 us-gaap:GeneralAndAdministrativeExpenseMember 2016-10-01 2017-03-31 0000203527 us-gaap:GeneralAndAdministrativeExpenseMember 2017-09-30 2018-03-30 0000203527 var:EmployeeStockPurchasePlanMember 2016-10-01 2017-03-31 0000203527 var:EmployeeStockPurchasePlanMember 2017-09-30 2018-03-30 0000203527 us-gaap:EmployeeStockOptionMember var:FourthAmendedTwoThousandAndFivePlanMember 2018-03-30 0000203527 var:RestrictedStockRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsMember 2018-03-30 0000203527 var:RestrictedStockRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsMember 2017-09-30 2018-03-30 0000203527 var:BeginningFiscalYear2018Member var:FourthAmendedTwoThousandAndFivePlanMember 2018-03-30 0000203527 us-gaap:EmployeeStockOptionMember 2018-03-30 0000203527 var:BeginningInFiscal2015Member var:FourthAmendedTwoThousandAndFivePlanMember 2018-03-30 0000203527 var:BeginningFiscalYear2017Member var:FourthAmendedTwoThousandAndFivePlanMember 2018-03-30 0000203527 var:FourthAmendedTwoThousandAndFivePlanMember 2018-03-30 0000203527 us-gaap:EmployeeStockOptionMember 2017-09-30 2018-03-30 0000203527 us-gaap:EmployeeStockOptionMember 2017-12-30 2018-03-30 0000203527 us-gaap:EmployeeStockOptionMember 2016-10-01 2017-03-31 0000203527 us-gaap:EmployeeStockOptionMember 2016-12-31 2017-03-31 0000203527 var:PerformanceStockOptionsMember var:FourthAmendedTwoThousandAndFivePlanMember 2018-03-30 0000203527 var:BeginningFiscalYear2016Member var:FourthAmendedTwoThousandAndFivePlanMember 2018-03-30 0000203527 var:CPTCLoanMember 2017-09-29 0000203527 us-gaap:LoansReceivableMember var:CPTCDIPLoanMember 2017-09-29 0000203527 var:DRTCLoansMember 2017-09-29 0000203527 us-gaap:LoansReceivableMember var:MarylandProtonTherapyCenterMPTCMember 2017-09-29 0000203527 var:CPTCMember var:RevolvingLoanMember 2018-03-30 0000203527 us-gaap:LoansReceivableMember 2018-03-30 0000203527 us-gaap:LoansReceivableMember var:MMProtonILLCMember 2018-03-30 0000203527 us-gaap:LoansReceivableMember var:RPTCSecuritiesMember 2018-03-30 0000203527 var:DRTCLoansMember 2018-03-30 0000203527 us-gaap:LoansReceivableMember 2017-09-29 0000203527 var:CPTCMember 2018-03-30 0000203527 us-gaap:LoansReceivableMember var:CPTCDIPLoanMember 2018-03-30 0000203527 var:CPTCMember 2017-09-29 0000203527 var:CPTCMember var:TermLoanMember 2017-09-29 0000203527 var:APTCSecuritiesMember 2017-09-29 0000203527 var:APTCSecuritiesMember 2018-03-30 0000203527 us-gaap:LoansReceivableMember var:MarylandProtonTherapyCenterMPTCMember 2018-03-30 0000203527 var:CPTCLoanMember 2018-03-30 0000203527 var:CPTCMember var:RevolvingLoanMember 2017-09-29 0000203527 var:GPTCSecuritiesMember 2018-03-30 0000203527 us-gaap:LoansReceivableMember var:ProtonInternationalMember 2017-09-29 0000203527 us-gaap:LoansReceivableMember var:ProtonInternationalMember 2018-03-30 0000203527 var:GPTCSecuritiesMember 2017-09-29 0000203527 us-gaap:LoansReceivableMember var:MMProtonILLCMember 2017-09-29 0000203527 us-gaap:LoansReceivableMember var:RPTCSecuritiesMember 2017-09-29 0000203527 us-gaap:LoansReceivableMember var:MarylandProtonTherapyCenterMPTCMember 2017-12-30 2018-03-30 0000203527 var:VarianMedicalSystemsInc.Member var:CPTCMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-12-30 2018-03-30 0000203527 us-gaap:LoansReceivableMember var:CPTCMember var:RevolvingLoanMember 2017-09-30 2018-03-30 0000203527 var:NewYorkProtonCenterMember 2018-03-30 0000203527 var:SeniorFirstLienLoanMember var:MMProtonILLCMember 2016-06-30 0000203527 var:VarianMedicalSystemsInc.Member var:CPTCMember us-gaap:AvailableforsaleSecuritiesMember 2011-09-01 2015-11-30 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember var:TrancheBLoansMember 2017-12-06 0000203527 var:VarianMedicalSystemsInc.Member var:CPTCMember 2018-03-30 0000203527 us-gaap:LoansReceivableMember us-gaap:OtherAssetsMember var:MarylandProtonTherapyCenterMPTCMember 2018-03-30 0000203527 var:GeorgiaProtonTherapyCenterMember 2018-03-30 0000203527 var:CPTCMember 2017-09-29 0000203527 us-gaap:LoansReceivableMember var:MarylandProtonTherapyCenterMPTCMember 2015-05-31 0000203527 us-gaap:LoansReceivableMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember var:MarylandProtonTherapyCenterMPTCMember 2018-03-30 0000203527 var:APTCSecuritiesMember 2017-12-03 0000203527 us-gaap:LoansReceivableMember var:ProtonCenterMunichMember 2017-07-01 2017-07-31 0000203527 var:GeorgiaProtonTherapyCenterMember us-gaap:AvailableforsaleSecuritiesMember 2017-07-31 0000203527 var:CPTCMember 2017-07-01 2017-09-29 0000203527 us-gaap:SeniorSubordinatedLoansMember var:MMProtonILLCMember 2015-07-31 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember var:TrancheCLoansMember 2017-12-06 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember var:TrancheBLoansMember 2017-09-30 2018-03-30 0000203527 var:MarylandProtonTherapyCenterMPTCMember 2018-03-30 0000203527 var:NewYorkProtonCenterMember 2017-09-29 0000203527 var:CPTCMember 2017-12-06 0000203527 var:CPTCLoanMember 2016-12-31 2017-03-31 0000203527 var:CPTCMember 2018-03-30 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember var:TrancheALoansMember 2017-09-30 2018-03-30 0000203527 var:CPTCLoanMember 2016-12-30 0000203527 var:CPTCMember us-gaap:AvailableforsaleSecuritiesMember 2011-09-01 2015-11-30 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember 2018-03-30 0000203527 var:DRTCLoansMember us-gaap:SeniorSubordinatedNotesMember var:ProtonInternationalMember 2017-12-30 2018-03-30 0000203527 us-gaap:LoansReceivableMember var:CPTCMember 2017-12-06 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember var:TrancheBLoansMember 2018-03-30 0000203527 var:DRTCLoansMember us-gaap:SeniorSubordinatedNotesMember var:ProtonInternationalMember 2017-04-30 0000203527 var:GeorgiaProtonTherapyCenterMember us-gaap:AvailableforsaleSecuritiesMember us-gaap:ScenarioForecastMember 2023-01-01 0000203527 var:TermLoanMember var:CPTCMember 2017-12-06 2017-12-06 0000203527 var:RPTCSecuritiesMember 2018-03-30 0000203527 var:DRTCLoansMember 2018-01-01 2018-01-31 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember var:TrancheALoansMember 2017-12-06 0000203527 var:ProtonInternationalMember var:DRTCLoansMember us-gaap:SeniorSubordinatedNotesMember var:PublicFinanceAuthorityMember 2017-04-30 0000203527 var:RPTCSecuritiesMember 2017-07-31 0000203527 var:DRTCLoansMember 2017-04-30 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember var:TrancheDLoansMember 2017-12-06 0000203527 us-gaap:LoansReceivableMember var:MMProtonILLCMember 2015-07-31 0000203527 var:GeorgiaProtonTherapyCenterMember us-gaap:AvailableforsaleSecuritiesMember 2017-07-01 2017-07-31 0000203527 var:VarianMedicalSystemsInc.Member var:CPTCMember 2017-09-29 0000203527 us-gaap:LoansReceivableMember var:MarylandProtonTherapyCenterMPTCMember var:ReclassificationFromLongTermAccountsReceivableInJune2016Member 2018-03-30 0000203527 us-gaap:LoansReceivableMember us-gaap:OtherAssetsMember var:MarylandProtonTherapyCenterMPTCMember 2017-09-29 0000203527 var:DRTCSecuritiesMember 2017-04-30 0000203527 var:VarianMedicalSystemsInc.Member us-gaap:LoansReceivableMember var:CPTCMember var:RevolvingLoanMember 2017-09-30 2018-03-30 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember var:TrancheDLoansMember 2017-09-30 2018-03-30 0000203527 var:VarianMedicalSystemsInc.Member var:TermLoanMember var:CPTCMember var:TrancheCLoansMember 2017-09-30 2018-03-30 0000203527 var:MarylandProtonTherapyCenterMPTCMember 2017-09-29 0000203527 var:RPTCSecuritiesMember 2017-09-29 0000203527 var:GeorgiaProtonTherapyCenterMember 2017-09-29 0000203527 us-gaap:LoansReceivableMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember var:MarylandProtonTherapyCenterMPTCMember 2017-09-29 0000203527 us-gaap:SeniorSubordinatedLoansMember var:MMProtonILLCMember 2015-07-31 2015-07-31 0000203527 var:OncologySystemsMember 2016-10-01 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:EMEAMember 2016-10-01 2017-03-31 0000203527 var:VarianParticleTherapyMember var:InternationalMember 2016-10-01 2017-03-31 0000203527 us-gaap:EMEAMember 2016-10-01 2017-03-31 0000203527 var:VarianParticleTherapyMember 2016-12-31 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:AsiaPacificMember 2016-12-31 2017-03-31 0000203527 us-gaap:AsiaPacificMember 2016-12-31 2017-03-31 0000203527 us-gaap:AmericasMember 2016-10-01 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:NorthAmericaMember 2016-12-31 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:AsiaPacificMember 2016-12-31 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:NorthAmericaMember 2016-10-01 2017-03-31 0000203527 var:OncologySystemsMember 2016-12-31 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:EMEAMember 2016-12-31 2017-03-31 0000203527 us-gaap:AmericasMember 2016-12-31 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:AmericasMember 2016-10-01 2017-03-31 0000203527 var:InternationalMember 2016-10-01 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:TransferredOverTimeMember 2016-10-01 2017-03-31 0000203527 var:OncologySystemsMember var:InternationalMember 2016-12-31 2017-03-31 0000203527 var:VarianParticleTherapyMember var:InternationalMember 2016-12-31 2017-03-31 0000203527 var:InternationalMember 2016-12-31 2017-03-31 0000203527 us-gaap:AsiaPacificMember 2016-10-01 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:AmericasMember 2016-12-31 2017-03-31 0000203527 us-gaap:NorthAmericaMember 2016-10-01 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:AmericasMember 2016-12-31 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:EMEAMember 2016-12-31 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:AsiaPacificMember 2016-10-01 2017-03-31 0000203527 us-gaap:EMEAMember 2016-12-31 2017-03-31 0000203527 var:VarianParticleTherapyMember 2016-10-01 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:AmericasMember 2016-10-01 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:AsiaPacificMember 2016-10-01 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:NorthAmericaMember 2016-12-31 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:NorthAmericaMember 2016-10-01 2017-03-31 0000203527 var:OncologySystemsMember var:InternationalMember 2016-10-01 2017-03-31 0000203527 us-gaap:NorthAmericaMember 2016-12-31 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:EMEAMember 2016-10-01 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:TransferredAtPointInTimeMember 2016-12-31 2017-03-31 0000203527 us-gaap:TransferredAtPointInTimeMember 2016-12-31 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:TransferredAtPointInTimeMember 2016-12-31 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:TransferredOverTimeMember 2016-12-31 2017-03-31 0000203527 us-gaap:TransferredOverTimeMember 2016-12-31 2017-03-31 0000203527 us-gaap:TransferredAtPointInTimeMember 2016-10-01 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:TransferredOverTimeMember 2016-10-01 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:TransferredOverTimeMember 2016-12-31 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:TransferredAtPointInTimeMember 2016-10-01 2017-03-31 0000203527 us-gaap:TransferredOverTimeMember 2016-10-01 2017-03-31 0000203527 var:VarianParticleTherapyMember us-gaap:TransferredAtPointInTimeMember 2016-10-01 2017-03-31 0000203527 var:SoftwareMember var:OncologySystemsMember 2016-12-31 2017-03-31 0000203527 var:HardwareMember 2016-10-01 2017-03-31 0000203527 var:SoftwareMember 2016-10-01 2017-03-31 0000203527 var:ServiceMember var:OncologySystemsMember 2016-10-01 2017-03-31 0000203527 var:HardwareMember var:OncologySystemsMember 2016-12-31 2017-03-31 0000203527 var:SoftwareMember 2016-12-31 2017-03-31 0000203527 var:ServiceMember 2016-12-31 2017-03-31 0000203527 var:HardwareMember var:OncologySystemsMember 2016-10-01 2017-03-31 0000203527 var:SoftwareMember var:OncologySystemsMember 2016-10-01 2017-03-31 0000203527 var:ServiceMember var:VarianParticleTherapyMember 2016-12-31 2017-03-31 0000203527 var:HardwareMember var:VarianParticleTherapyMember 2016-10-01 2017-03-31 0000203527 var:ServiceMember 2016-10-01 2017-03-31 0000203527 var:HardwareMember 2016-12-31 2017-03-31 0000203527 var:SoftwareMember var:VarianParticleTherapyMember 2016-10-01 2017-03-31 0000203527 var:ServiceMember var:OncologySystemsMember 2016-12-31 2017-03-31 0000203527 var:SoftwareMember var:VarianParticleTherapyMember 2016-12-31 2017-03-31 0000203527 var:ServiceMember var:VarianParticleTherapyMember 2016-10-01 2017-03-31 0000203527 var:HardwareMember var:VarianParticleTherapyMember 2016-12-31 2017-03-31 0000203527 var:SoftwareMember var:VarianParticleTherapyMember 2017-09-30 2018-03-30 0000203527 var:HardwareMember var:VarianParticleTherapyMember 2017-12-30 2018-03-30 0000203527 var:HardwareMember 2017-12-30 2018-03-30 0000203527 var:ServiceMember 2017-12-30 2018-03-30 0000203527 var:SoftwareMember 2017-09-30 2018-03-30 0000203527 var:SoftwareMember var:VarianParticleTherapyMember 2017-12-30 2018-03-30 0000203527 var:ServiceMember var:VarianParticleTherapyMember 2017-09-30 2018-03-30 0000203527 var:OncologySystemsMember 2017-12-30 2018-03-30 0000203527 var:SoftwareMember var:OncologySystemsMember 2017-09-30 2018-03-30 0000203527 var:ServiceMember var:VarianParticleTherapyMember 2017-12-30 2018-03-30 0000203527 var:VarianParticleTherapyMember 2017-12-30 2018-03-30 0000203527 var:HardwareMember var:OncologySystemsMember 2017-09-30 2018-03-30 0000203527 var:SoftwareMember 2017-12-30 2018-03-30 0000203527 var:ServiceMember var:OncologySystemsMember 2017-12-30 2018-03-30 0000203527 var:HardwareMember 2017-09-30 2018-03-30 0000203527 var:HardwareMember var:VarianParticleTherapyMember 2017-09-30 2018-03-30 0000203527 var:SoftwareMember var:OncologySystemsMember 2017-12-30 2018-03-30 0000203527 var:HardwareMember var:OncologySystemsMember 2017-12-30 2018-03-30 0000203527 var:ServiceMember 2017-09-30 2018-03-30 0000203527 var:ServiceMember var:OncologySystemsMember 2017-09-30 2018-03-30 0000203527 us-gaap:OperatingSegmentsMember var:OncologySystemsMember 2017-09-30 2018-03-30 0000203527 us-gaap:CorporateMember 2016-10-01 2017-03-31 0000203527 us-gaap:OperatingSegmentsMember var:OncologySystemsMember 2016-10-01 2017-03-31 0000203527 us-gaap:OperatingSegmentsMember var:VarianParticleTherapyMember 2016-12-31 2017-03-31 0000203527 us-gaap:OperatingSegmentsMember 2016-10-01 2017-03-31 0000203527 us-gaap:CorporateMember 2016-12-31 2017-03-31 0000203527 us-gaap:OperatingSegmentsMember var:VarianParticleTherapyMember 2016-10-01 2017-03-31 0000203527 us-gaap:OperatingSegmentsMember 2017-09-30 2018-03-30 0000203527 us-gaap:OperatingSegmentsMember var:OncologySystemsMember 2016-12-31 2017-03-31 0000203527 us-gaap:CorporateMember 2017-09-30 2018-03-30 0000203527 us-gaap:OperatingSegmentsMember 2017-12-30 2018-03-30 0000203527 us-gaap:OperatingSegmentsMember var:OncologySystemsMember 2017-12-30 2018-03-30 0000203527 us-gaap:OperatingSegmentsMember var:VarianParticleTherapyMember 2017-12-30 2018-03-30 0000203527 us-gaap:OperatingSegmentsMember var:VarianParticleTherapyMember 2017-09-30 2018-03-30 0000203527 us-gaap:CorporateMember 2017-12-30 2018-03-30 0000203527 us-gaap:OperatingSegmentsMember 2016-12-31 2017-03-31 0000203527 var:OncologySystemsMember us-gaap:TransferredOverTimeMember 2017-12-30 2018-03-30 0000203527 us-gaap:TransferredAtPointInTimeMember 2017-12-30 2018-03-30 0000203527 us-gaap:TransferredOverTimeMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:TransferredAtPointInTimeMember 2017-09-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:TransferredAtPointInTimeMember 2017-12-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:TransferredOverTimeMember 2017-09-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:TransferredOverTimeMember 2017-09-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:TransferredAtPointInTimeMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:TransferredAtPointInTimeMember 2017-12-30 2018-03-30 0000203527 us-gaap:TransferredOverTimeMember 2017-12-30 2018-03-30 0000203527 us-gaap:TransferredAtPointInTimeMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:TransferredOverTimeMember 2017-12-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:AsiaPacificMember 2017-12-30 2018-03-30 0000203527 us-gaap:EMEAMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:EMEAMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:AmericasMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:AsiaPacificMember 2017-09-30 2018-03-30 0000203527 us-gaap:AsiaPacificMember 2017-12-30 2018-03-30 0000203527 us-gaap:NorthAmericaMember 2017-09-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:EMEAMember 2017-12-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:EMEAMember 2017-09-30 2018-03-30 0000203527 us-gaap:AmericasMember 2017-09-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:NorthAmericaMember 2017-09-30 2018-03-30 0000203527 us-gaap:EMEAMember 2017-12-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:AmericasMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:AsiaPacificMember 2017-12-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:AmericasMember 2017-12-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:NorthAmericaMember 2017-09-30 2018-03-30 0000203527 us-gaap:AmericasMember 2017-12-30 2018-03-30 0000203527 var:VarianParticleTherapyMember var:InternationalMember 2017-12-30 2018-03-30 0000203527 var:OncologySystemsMember var:InternationalMember 2017-09-30 2018-03-30 0000203527 var:InternationalMember 2017-12-30 2018-03-30 0000203527 us-gaap:AsiaPacificMember 2017-09-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:AsiaPacificMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:NorthAmericaMember 2017-12-30 2018-03-30 0000203527 var:OncologySystemsMember var:InternationalMember 2017-12-30 2018-03-30 0000203527 var:InternationalMember 2017-09-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:AmericasMember 2017-12-30 2018-03-30 0000203527 var:OncologySystemsMember us-gaap:NorthAmericaMember 2017-12-30 2018-03-30 0000203527 var:VarianParticleTherapyMember var:InternationalMember 2017-09-30 2018-03-30 0000203527 us-gaap:NorthAmericaMember 2017-12-30 2018-03-30 0000203527 var:VarianParticleTherapyMember us-gaap:EMEAMember 2017-12-30 2018-03-30 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2018RevolvingCreditFacilityMember us-gaap:SubsequentEventMember 2018-04-03 0000203527 var:A2017RevolvingCreditFacilityMember 2018-03-30 2018-03-30 0000203527 var:A2018RevolvingCreditFacilityMember 2018-03-30 2018-03-30 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2018RevolvingCreditFacilityMember var:SwingLineLoansMember us-gaap:SubsequentEventMember 2018-04-03 0000203527 var:A2018RevolvingCreditFacilityMember us-gaap:SubsequentEventMember 2018-04-03 2018-04-03 0000203527 us-gaap:RevolvingCreditFacilityMember var:A2018RevolvingCreditFacilityMember us-gaap:LetterOfCreditMember us-gaap:SubsequentEventMember 2018-04-03 0000203527 var:A2018RevolvingCreditFacilityMember us-gaap:SubsequentEventMember 2018-04-03 iso4217:JPY var:company xbrli:pure iso4217:USD iso4217:USD xbrli:shares xbrli:shares iso4217:AUD xbrli:shares iso4217:AUD iso4217:EUR var:plan var:installment var:tranche var:board_seat var:segment false --09-28 Q2 2018 2018-03-30 10-Q 0000203527 91504711 Large Accelerated Filer VARIAN MEDICAL SYSTEMS INC VAR 609600000 621000000 793000000 641500000 792000000 162300000 164900000 1039200000 1008800000 976100000 968500000 961500000 138000000 823500000 936700000 14600000 31800000 1000000 4700000 0.04 374900000 -19800000 394700000 365100000 -68800000 -58400000 716100000 754700000 11400000 8100000 1400000 800000 1100000 21600000 15300000 2600000 1600000 2100000 10500000 7500000 1200000 800000 1000000 21200000 15300000 2400000 1500000 2000000 63100000 40300000 45900000 40300000 17200000 3500000 9100000 1800000 7300000 4100000 10400000 10400000 600000 600000 600000 3200000 0 38300000 11100000 11100000 11100000 3294400000 3307500000 2296800000 2345400000 0 12700000 47400000 60100000 0 11200000 0 11200000 4900000 11100000 8600000 11100000 11100000 8600000 8600000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 60100000 0 47400000 8300000 4400000 0 0 0 0 8300000 4400000 47400000 0 0 47400000 8300000 4400000 47400000 8300000 4400000 10700000 6100000 0 0 4600000 0 0 6100000 4600000 0 0 6100000 4600000 6100000 4600000 3000000 8000000 6000000 60000000 60100000 47400000 8300000 4400000 10700000 6100000 4600000 6600000 28 600000 900000 19700000 21200000 20400000 0 17200000 0 0 716200000 739900000 843500000 707000000 716200000 739900000 -136500000 23700000 1 1 189000000.0 189000000 91700000 91700000 91700000 91700000 91700000 91700000 60000000 61600000 80500000 -28700000 -100000 500000 0 100000 59900000 62100000 80500000 -28600000 259100000 311500000 10900000 28200000 492600000 435900000 755400000 114800000 640600000 766500000 56700000 7200000 9100000 127200000 346000000 108800000 305200000 246900000 -7300000 254200000 453100000 -25500000 478600000 264200000 488100000 387600000 7900000 379700000 722100000 6300000 715800000 411400000 787100000 140700000 15200000 125500000 269000000 31800000 237200000 147200000 299000000 400000 56700000 350000000 230000000 0.01875 0.00875 0.01125 0.00125 0.005 0.005 P5Y P3Y P5Y P1Y P5Y 0.0000 0.0236 0.0488 0.0279 7300000 16000000.0 0.09 1800000 147300000 8500000 138800000 114900000 -7500000 41800000 17100000 26400000 -1100000 -2200000 -700000 -1400000 0 -100000 -200000 -300000 1800000 3500000 2000000 4000000 600000 1200000 800000 1600000 1700000 3300000 1000000 2000000 1800000 3500000 1700000 3300000 31900000 4400000 25400000 0 35100000 0 7700000 0 12300000 36200000 0 500000 9900000 0 246600000 0 33000000 0 1900000 0 17800000 0 69500000 0 18600000 0 12100000 5100000 0 0 3900000 0 8900000 41800000 477300000 0 500000 0 500000 500000 -12400000 500000 -11900000 -1000000 -900000 -600000 -900000 0 12400000 0 12400000 P13M P1M P1M -11800000 600000 1500000 7400000 8100000 7100000 2000000 2000000 500000 1700000 24600000 117300000 17900000 76700000 2900000 1100000 29700000 76100000 100000 400000 42500000 194000000 0.60 0.75 0.80 -0.43 0.60 0.74 0.79 -0.43 7300000 -11500000 0.231 0.294 0.234 1.179 18000000 46900000 P2Y2M19D P2Y0M26D 3400000 6400000 2600000 4700000 20100000 0.4708 0 9500000 9500000 -47400000 0 47400000 0 2800000 0 2800000 78600000 14300000 3400000 60900000 88700000 16400000 4600000 67700000 15000000 10900000 9000000 10400000 12700000 15200000 141400000 33900000 5500000 102000000 161900000 38200000 5700000 118000000 62800000 19600000 2100000 41100000 73200000 21800000 1100000 50300000 -7500000 0 7400000 -11400000 -5000000 -7500000 -16400000 -12200000 222600000 170200000 52400000 236200000 11500000 181700000 54500000 11500000 11500000 0 2100000 0 2100000 275600000 300000 275300000 542600000 -8400000 551000000 318500000 621300000 69600000 77100000 73200000 -39100000 -100000 400000 0 100000 90400000 300000 90100000 109700000 -8400000 118100000 95600000 218100000 69500000 200000 69300000 77500000 -6300000 83800000 73200000 -39000000 0.75 0.83 0.80 -0.43 0.74 0.00 0.74 0.82 -0.07 0.89 0.79 -0.43 -13300000 0 -13300000 -13300000 -6800000 0 -6800000 -6800000 0 0 0 0 100000 100000 0 0 -13300000 -13300000 -6900000 -6900000 0 0 -0.15 -0.08 0.00 0.00 -0.14 -0.08 0.00 0.00 -900000 20900000 100000 20800000 32200000 -2100000 34300000 22400000 257100000 -9900000 900000 14500000 -28400000 29900000 11500000 14300000 10900000 55500000 0 8800000 8800000 150200000 170700000 71600000 82000000 2400000 5300000 2300000 4400000 73500000 73200000 417700000 -22000000 439700000 433800000 296500000 306500000 47700000 54100000 2700000 7500000 3600000 6800000 1772500000 1850900000 3294400000 3307500000 1645100000 1530200000 0 12400000 2800000 15200000 2500000 3700000 2500000 2500000 3700000 3700000 48600000 208100000 0.0025 0.00125 600000000 3000000000 600000000.0 50000000.0 25000000 1800000000.0 0 25000000 0 0 25000000 25000000 25000000 7900000 1000000 19300000 3400000 4300000 4400000 -205000000 -154200000 -53200000 -55100000 114400000 244500000 56300000 200000 -1000000 56100000 70200000 -6300000 -1900000 76500000 73200000 -1500000 -39100000 -1800000 -400000 -100000 0 0 0 3100000 0 44000000 53500000 2000000 7200000 15600000 28700000 112000000 25400000 5000000 25100000 26400000 25300000 42300000 5100000 24600000 3100000 100200000 33800000 0 26200000 2600000 62600000 3000000 105200000 87900000 2 2 185500000 435100000 224200000 405600000 90100000 103100000 122900000 -19800000 -13000000 107500000 168900000 239000000 -70100000 -61400000 94300000 125600000 143100000 -17500000 -31300000 215700000 248600000 281300000 -32700000 -32900000 300800000 282000000 -100000 -200000 -300000 -500000 0 100000 0 100000 0 -10200000 -10200000 0 9700000 -900000 8800000 0 0 300000 0 2900000 -10200000 6600000 9700000 3700000 -8600000 7300000 10400000 -800000 -1600000 -400000 -700000 0 0 -700000 -600000 0 0 -300000 -300000 -900000 -1800000 -700000 -1200000 -200000 -400000 -100000 -300000 300000 0 300000 200000 0 0 200000 0 0 -400000 -600000 0 0 200000 300000 127400000 -2600000 130000000 320700000 700000 0 61700000 61200000 38300000 13100000 100000 300000 200000 400000 -900000 -300000 222300000 92700000 3300000 3300000 10500000 11100000 4300000 1100000 6000000 1600000000 1200000000 29600000 0 29600000 5000000 3100000 11500000 0 32100000 6300000 17800000 1 1 1000000.0 1000000.0 0 0 0 0 0 0 190300000 -9500000 199800000 226400000 0 500000 5200000 90000000 234300000 25400000 44600000 255000000 0 -5300000 700000 0 -107000000 -120000000 8500000 0 8000000 203000000 41900000 36100000 41300000 41100000 23200000 26500000 56200000 200000 56000000 70700000 -6300000 77000000 73200000 -39000000 255300000 247000000 38800000 2000000 -1900000 0 -1900000 -900000 0 -900000 -1800000 1600000 1400000 255000000 100000000 209300000 53300000 103200000 58900000 114800000 2500000 6300000 0 0 3900000 3900000 600000 600000 778600000 22600000 756000000 664200000 1060800000 2089500000 729400000 1276300000 663200000 8200000 631900000 31300000 314600000 284500000 30100000 230200000 229000000 1200000 118400000 118400000 0 0 631900000 332000000 132400000 167500000 309700000 322200000 334800000 297100000 31300000 9600000 3900000 17800000 9600000 21700000 0 31300000 341600000 136300000 185300000 319300000 343900000 655000000 334800000 328400000 1264700000 -2100000 1203100000 61600000 580000000 523100000 56900000 454100000 449400000 4700000 230600000 230600000 0 0 1203100000 622800000 243800000 336500000 584700000 618400000 617200000 585900000 61600000 17000000 11800000 32800000 17000000 44600000 0 61600000 639800000 255600000 369300000 601700000 663000000 1266800000 617200000 647500000 729900000 698000000 31900000 341700000 311600000 30100000 261500000 259700000 1800000 126700000 126700000 0 -1000000 698000000 321200000 135600000 241200000 299600000 398400000 363700000 334300000 31900000 19000000 300000 12600000 19000000 12900000 0 31900000 340200000 135900000 253800000 318600000 411300000 363700000 366200000 1408400000 1347400000 61000000 662100000 604700000 57400000 504500000 500900000 3600000 241800000 241800000 0 -900000 1347400000 658600000 264100000 424700000 625900000 721500000 702000000 645400000 61000000 38300000 600000 22100000 38300000 22700000 0 61000000 696900000 264700000 446800000 664200000 744200000 702000000 706400000 364900000 -21200000 386100000 674100000 -55600000 729700000 393800000 759400000 298300000 29400000 268900000 590600000 53500000 537100000 336100000 649000000 131600000 292700000 134500000 258500000 23600000 2000000 21200000 100000 84.16 300000 111.81 900000 800000 75.37 88.61 300000 76.33 0 0 0 0 0 0 0.218 0.218 0.223 0.192 0.190 0.179 0.017 0.017 0.005 0.024 0.022 0.012 6000000 2500000 7100000 1100000 73.65 0 75.69 600000 16.13 16.13 19.37 21.48 20.73 20.97 89300000 2300000 2400000 74.08 85.00 70.67 111.43 122.65 P3Y11M27D P3Y11M27D P6M P3Y9M29D P3Y9M29D P6M 52000000 P3Y11M16D P5Y1M21D 350000000 350000000 230000000 230000000 500000 8000000.0 4400000 2000000 2500000 300000 800000 172800000 222300000 36000000 92700000 1517600000 1452200000 -63300000 -37500000 -100800000 3700000 -61700000 -47700000 -109400000 4100000 1521900000 -44100000 -24700000 0 -68800000 4300000 1456600000 -43400000 -15000000 0 -58400000 4400000 -334100000 10300000 0 100000 -100000 11600000 700000 700000 1100000 0 93700000 93900000 92600000 91600000 93000000 93200000 91500000 91600000 0 0 13300000 4500000 6400000 0 13800000 4500000 100000000.0 33.60 19300000 34200000 89000000 0 0 2800000 2800000 81300000 81300000 0 -1000000 -1900000 -500000 -900000 P12M 112000000 5 4700000 6200000 0.246 P30Y P1Y P30Y P1Y 25100000.0 3 0.085 0.12 0.135 0.085 0.085 0.080 P6Y6M 5500000 0 5500000 729900000 1408400000 -25500000 125300000 84700000 185000000 7200000 15000000 0 56600000 P24M P18M 35000000 91500000 18500000 73000000 16100000 0.095 0.12 0.095 0.095 25100000 67400000 58900000 53500000 125600000 114100000 5 1 4 0 0 0.075 0.1 4400000 1300000 24500000 21500000 0.01 38700000 200000000 200000000 0 17400000 26300000 1.75 1.75 2.0 2.0 11800000 0 0 0 0 0 0 2200000 2200000 0 0 0 0 11800000 0 0 4100000 4100000 0 0 0 0 0 0 0 0 11800000 11800000 1 1 2.6 5500000 0.4 203000000 P1Y 300000 1700000 86.42 88.93 110.52 109.06 2400000 40200000 3800000 173100000 -10300000 P24M P60D 1300000 6200000 13800000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables summarize the Company's available-for-sale securities:</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APTC securities </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Original CPTC loans </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DRTC securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets because the Company has the ability and intent to sell this security in the next twelve months. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets because the maturity dates are greater than one year and the Company does not have the intent and ability to collect or sell all or a portion of its loans or securities in the next twelve months.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;</font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Annual Report&#8221;). In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company&#8217;s financial position as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, results of operations and statements of comprehensive earnings (loss) for the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, and cash flows for the </font><font style="font-family:inherit;font-size:10pt;">six months ended March 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The results of operations for the </font><font style="font-family:inherit;font-size:10pt;">six months ended March 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the beginning of the Company's fiscal year 2018, the Company early adopted the new revenue recognition Accounting Standard Codification 606 "Revenues from Contracts with Customers" ("ASC 606") by using the full retrospective method. All financial statements and disclosures have been recast to comply with ASC 606. See "Recently Adopted Accounting Pronouncements" below for further information.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The historical financial position and results of operations of the Imaging Components business and costs relating to the Distribution are reported in the condensed consolidated financial statements as discontinued operations for all the periods presented. Information in the accompanying notes to the condensed consolidated financial statements have been recast to reflect the effect of the Distribution. The Condensed Consolidated Statements of Comprehensive Earnings (Loss) and Cash Flows have not been recast to reflect the effect of the Distribution. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BUSINESS COMBINATIONS</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sirtex</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 30, 2018, the Company signed an agreement to acquire Sirtex Medical Limited ("Sirtex"), an Australian company that is listed on the Australian Securities Exchange, for </font><font style="font-family:inherit;font-size:10pt;">A$28</font><font style="font-family:inherit;font-size:10pt;"> per share or approximately </font><font style="font-family:inherit;font-size:10pt;">A$1.6 billion</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">$1.2 billion</font><font style="font-family:inherit;font-size:10pt;"> as of March 30, 2018). Sirtex is an Australian-based global life sciences company focused on interventional oncology therapies. T</font><font style="font-family:inherit;font-size:10pt;color:#2c2c2c;">he Company plans to fund the acquisition primarily using its 2018 Revolving Credit Facility, as well as cash on hand.&#160;</font><font style="font-family:inherit;font-size:10pt;">The transaction has received all necessary regulatory approvals, is subject to the approval of the Sirtex shareholders, the Federal Court of Australia and the satisfaction of other customary closing conditions.</font><font style="font-family:inherit;font-size:10pt;color:#2c2c2c;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#2c2c2c;">On May 4, 2018, Sirtex received </font><font style="font-family:inherit;font-size:10pt;">an unsolicited non-binding, indicative and conditional proposal from CDH Investments ("CDH"), a China-based alternative asset manager, for the acquisition of all of the issued shares in Sirtex for </font><font style="font-family:inherit;font-size:10pt;">A$33.60</font><font style="font-family:inherit;font-size:10pt;"> per share. The Sirtex board of directors has determined to engage with CDH to further understand the conditions associated with the CDH proposal. As a result, the meeting of Sirtex shareholders to approve the acquisition by Varian, which was scheduled to occur on Monday, May 7, 2018 (Sydney time), was adjourned to a time and date to be determined. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Acquisitions </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal year 2018, the Company acquired </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> privately-held software companies for a purchase price of </font><font style="font-family:inherit;font-size:10pt;">$29.6 million</font><font style="font-family:inherit;font-size:10pt;">. The purchase price primarily consisted of </font><font style="font-family:inherit;font-size:10pt;">$20.4 million</font><font style="font-family:inherit;font-size:10pt;"> in finite-lived intangible assets and </font><font style="font-family:inherit;font-size:10pt;">$11.5 million</font><font style="font-family:inherit;font-size:10pt;"> in goodwill. The Company has integrated these two acquisitions into its Oncology Systems reporting unit.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Information</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisitions completed above. The Company believes the factors that contributed to goodwill include synergies that are specific to the Company's acquisitions completed and not available to market participants and the acquisition of a talented workforce. The goodwill for the recent acquisitions mentioned above is deductible for income tax purposes. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of assets acquired and liabilities assumed has been determined on a preliminary basis, and the Company will finalize these amounts as it obtains the information necessary to complete the measurement process. Any changes resulting from facts and circumstances that existed as of the date of the acquisitions may result in adjustments to the amounts of goodwill, intangible assets and deferred revenue balances recorded. The Company expects to finalize these amounts no later than one year from the date of each acquisition.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements include the operating results from the date of acquisition. The impact of the acquisitions completed to the periods presented was not material. Pro forma results of operations for the acquisitions completed have not been presented because the effects of the acquisitions, individually and in the aggregate, were not material to the Company's condensed consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">COMMITMENTS AND CONTINGENCIES</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Warranty</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reflects the changes in the Company&#8217;s accrued product warranty:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.85575048732943%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued product warranty, at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.3</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charged to cost of revenues</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual product warranty expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued product warranty, at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued product warranty was included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Environmental Remediation Liabilities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s operations and facilities, past and present, are subject to environmental laws, including laws that regulate the handling, storage, transport and disposal of hazardous substances. Certain of those laws impose cleanup liabilities on the Company in connection with its past and present operations. Those include facilities sold as part of the Company&#8217;s electron devices business in 1995 and thin film systems business in 1997. As a result, the Company oversees various environmental cleanup projects and receives reimbursements from third parties for a portion of the costs of its cleanup activities. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also reimburses certain third parties for cleanup activities. The Company spent </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> (net of amounts borne by third parties) in the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, on environmental cleanup costs, third-party claim costs, project management costs and legal costs. The Company spent </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> (net of amounts borne by third parties) in the </font><font style="font-family:inherit;font-size:10pt;">six months ended March 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, on such costs.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to some of these facilities, inherent uncertainties make it difficult to estimate the likelihood of the cost of future cleanup, third-party claims, project management and legal services for the cleanup sites (&#8220;Group A Sites&#8221;). Nonetheless, as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company estimated that, net of third parties&#8217; indemnification obligations, future costs associated with the environmental remediation liabilities for the Group A Sites would range in total from </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$7.9 million</font><font style="font-family:inherit;font-size:10pt;">. The time frames over which these cleanup project costs are estimated vary, ranging from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> year to </font><font style="font-family:inherit;font-size:10pt;">thirty</font><font style="font-family:inherit;font-size:10pt;"> years as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. Management believes that no amount in that range is more probable of being incurred than any other amount and therefore accrued </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> for these cleanup projects as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. The accrued amount has not been discounted to present value due to the uncertainties that make it difficult to develop a single best estimate.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the Group A Sites, there are other past and present facilities (&#8220;Group B Sites&#8221;) where the Company believes it has gained sufficient knowledge to better estimate the scope and cost of monitoring, cleanup and management activities. This, in part, is based on agreements with other parties and also cleanup plans approved by or completed in accordance with the requirements of, the governmental agencies having jurisdiction. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company estimated that the Company&#8217;s future exposure on the Group B Sites, net of third parties&#8217; indemnification obligations, for the costs at these facilities, and reimbursements of third-party&#8217;s claims for these facilities, ranged in total from </font><font style="font-family:inherit;font-size:10pt;">$3.4 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$19.3 million</font><font style="font-family:inherit;font-size:10pt;">. The time frames over which these costs are estimated to be incurred vary, ranging from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> year to </font><font style="font-family:inherit;font-size:10pt;">thirty</font><font style="font-family:inherit;font-size:10pt;"> years as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. As to each of these facilities, management determined that a particular amount within the range of estimated costs was a better estimate than any other amount within the range, and that the amount and timing of these future costs were reliably determinable. The best estimate within that range was </font><font style="font-family:inherit;font-size:10pt;">$5.5 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. Accordingly, the Company had accrued </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> for these costs, which represented the best estimate discounted at </font><font style="font-family:inherit;font-size:10pt;">4%</font><font style="font-family:inherit;font-size:10pt;">, net of inflation. This accrual is in addition to the </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> accrued for the Group A Sites.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These amounts are only estimates of anticipated future costs. The amounts the Company will actually spend may be greater than the estimates. The Company believes its reserve is adequate; however, as the scope of the Company&#8217;s obligations becomes more clearly defined, the Company may modify the reserve, and charge or credit future earnings accordingly. Based on information currently known to management, management believes the costs of these environmental-related matters are not reasonably likely to have a material adverse effect on the consolidated financial statements of the Company in any one fiscal year.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates its liability for investigation and cleanup costs in light of the obligations and financial strength of potential third parties and insurance companies the Company believes it has rights to indemnity or reimbursement. The Company has an agreement with an insurance company under which that insurer has agreed to pay a portion of the Company&#8217;s past and future environmental-related expenditures. Receivables, net of the portion due to third parties who reimburse the Company, from that insurer amounted to </font><font style="font-family:inherit;font-size:10pt;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, with the respective current portion included in prepaid expenses and other current assets and the respective noncurrent portion included in other assets. The payable portion to that insurer is included in other long-term liabilities on the Condensed Consolidated Balance Sheets. The Company believes that this receivable is recoverable because it is based on a binding, written settlement agreement with an insurance company who appears to be financially viable and who has paid the Company&#8217;s claims in the past.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Matters</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations and other legal matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise.&#160;The Company accrues amounts, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value). A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision.&#160;</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the above, the Company is involved in other legal matters. However, such matters are subject to many uncertainties and outcomes are not predictable with assurance. The Company is unable to estimate a loss or a range of reasonably possible losses with respect to such matters.&#160;There can be no assurances as to whether the Company will become subject to significant additional claims and liabilities with respect to ongoing or future proceedings.&#160;If actual liabilities significantly exceed the estimates made, the Company&#8217;s consolidated financial position, results of operations or cash flows could be materially adversely affected. Legal expenses relating to legal matters are expensed as incurred.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restructuring Charges</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2017, the Company offered an enhanced retirement program to its qualifying employees and implemented a workforce reduction (collectively, the "2017 Restructuring Plan"), primarily in its Oncology Systems and VPT segments, to improve operational performance. The Company did not incur any restructuring charges during the three and six months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, and incurred </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$6.3 million</font><font style="font-family:inherit;font-size:10pt;"> in restructuring charges during the three and </font><font style="font-family:inherit;font-size:10pt;">six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company plans to complete this plan in fiscal year 2018 and does not expect any additional restructuring charges under this plan. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a summary of changes in the restructuring liability related to the Company's restructuring plans:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Restructuring Charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 Restructuring Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The restructuring charges are included in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings (Loss).</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers: </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unbilled receivables - current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unbilled receivables - long-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenues - current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(766.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(755.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenues - long-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net unbilled receivables (deferred revenues)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(435.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(492.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BORROWINGS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's short-term borrowings and long-term debt:</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except for percentages)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Interest Rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Interest Rate</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Short-term borrowings:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 Revolving Credit Facility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.79</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">350.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.36</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total short-term borrowings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">350.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-term debt:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 Revolving Credit Facility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.88</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company entered into an agreement, dated September 1, 2017, ("Credit Agreement") with certain lenders and Bank of America, N.A. (&#8220;BofA&#8221;) as administrative agent ("Debt Lenders"). The Credit Agreement provides for a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year revolving credit facility (the "2017 Revolving Credit Facility") in an aggregate principal amount of up to </font><font style="font-family:inherit;font-size:10pt;">$600.0 million</font><font style="font-family:inherit;font-size:10pt;">. The Company incurred </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;"> in debt issuance costs for its 2017 Revolving Credit Facility, which will be amortized over the </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year term. Debt issuance costs are recorded in prepaid expenses and other current assets and other assets on the Condensed Consolidated Balance Sheets. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 3, 2018, the Company replaced its 2017 Revolving Credit Facility with a new credit agreement ("2018 Credit Agreement"). See </font><font style="font-family:inherit;font-size:10pt;">Note 18, "Subsequent Events"</font><font style="font-family:inherit;font-size:10pt;"> for more information on the 2018 Revolving Credit Facility.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings under the 2017 Revolving Credit Facility accrue interest based on either (i) the Eurodollar Rate plus a margin of </font><font style="font-family:inherit;font-size:10pt;">1.125%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.875%</font><font style="font-family:inherit;font-size:10pt;"> based on a leverage ratio involving funded indebtedness and EBITDA, or (ii) a base rate of (a) the federal funds rate plus </font><font style="font-family:inherit;font-size:10pt;">0.50%</font><font style="font-family:inherit;font-size:10pt;">, (b) BofA&#8217;s announced prime rate, or (c) the Eurodollar Rate plus </font><font style="font-family:inherit;font-size:10pt;">1.00%</font><font style="font-family:inherit;font-size:10pt;">, whichever is highest, plus a margin of </font><font style="font-family:inherit;font-size:10pt;">0.125%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">0.875%</font><font style="font-family:inherit;font-size:10pt;"> based on the same leverage ratio, depending upon instructions from the Company. Borrowings under the 2017 Revolving Credit Facility have a contract repayment date of </font><font style="font-family:inherit;font-size:10pt;">twelve months</font><font style="font-family:inherit;font-size:10pt;">, or less, and a final maturity of five years if based on the Eurodollar Rate and all overnight borrowings on the base rate would also have a final maturity of five years.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company must pay a commitment fee on the unused portion of the 2017 Revolving Credit Facility at a rate from </font><font style="font-family:inherit;font-size:10pt;">0.125%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">0.25%</font><font style="font-family:inherit;font-size:10pt;"> based on a leverage ratio. The Company may prepay, reduce or terminate the commitments without penalty. Swing line loans under the 2017 Credit Facility will bear interest at the base rate plus the then applicable margin for base rate loans.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement provides that certain material domestic subsidiaries must guarantee the 2017 Revolving Credit Facility, subject to certain limitations on the amount secured. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, no subsidiary guaranties were required to be executed under the Credit Agreement.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement contains provisions that limit the Company's ability to, among other things, incur future indebtedness, contingent obligations or liens, guarantee indebtedness, make certain investments and capital expenditures, sell stock or assets and pay dividends, and consummate certain mergers or acquisitions.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement contains affirmative and negative covenants applicable to the Company and its subsidiaries that are typical for credit facilities of this type, and that are subject to materiality and other qualifications, carve-outs, baskets and exceptions. The Company has also agreed to maintain certain financial covenants including (i) a maximum consolidated leverage ratio, involving funded indebtedness and EBITDA, and (ii) a minimum consolidated interest coverage ratio. The Company was in compliance with all financial covenants under the Credit Agreement for all periods within these condensed consolidated financial statements. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">VMS&#8217;s Japanese subsidiary (&#8220;VMS KK&#8221;) has an unsecured uncommitted credit agreement with Sumitomo that enables VMS KK to borrow and have outstanding at any given time a maximum of </font><font style="font-family:inherit;font-size:10pt;">3.0 billion</font><font style="font-family:inherit;font-size:10pt;"> Japanese Yen (the &#8220;Sumitomo Credit Facility&#8221;). In February 2018, the Sumitomo Credit Facility was extended and will expire in </font><font style="font-family:inherit;font-size:10pt;">February 2019</font><font style="font-family:inherit;font-size:10pt;">. Borrowings under the Sumitomo Credit Facility accrue interest based on the basic loan rate announced by the Bank of Japan plus a margin of </font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company measures all derivatives at fair value on the Condensed Consolidated Balance Sheets. The accounting for gains or losses resulting from changes in the fair value of those derivatives depends upon the use of the derivative and whether it qualifies for hedge accounting. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of derivative instruments reported on the Condensed Consolidated Balance Sheets was as follows:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:51%;" rowspan="1" colspan="1"></td><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Sheet</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange option contract</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange forward contracts</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company did not have any outstanding derivatives designated as hedging instruments. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, the fair value of the Company's derivatives not designated as hedging instruments was not material. See </font><font style="font-family:inherit;font-size:10pt;">Note 5, "Fair Value"</font><font style="font-family:inherit;font-size:10pt;"> for the valuation of the Company&#8217;s derivative instruments. Also, see </font><font style="font-family:inherit;font-size:10pt;">Note 1, "Summary of Significant Accounting Policies"</font><font style="font-family:inherit;font-size:10pt;"> in the Consolidated Financial Statements in the Company&#8217;s </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Annual Report for the credit risk associated with the Company&#8217;s derivative instruments.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Offsetting of Derivatives</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company presents its derivative assets and derivative liabilities on a gross basis on the Condensed Consolidated Balance Sheets. However, under agreements containing provisions on netting with certain counterparties of foreign exchange contracts, subject to applicable requirements, the Company is allowed to net-settle transactions in the same currency, with a single net amount payable by one party to the other. As of&#160;</font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">,&#160;and&#160;</font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, there were no potential effects of rights of setoff associated with derivative instruments. The Company is neither required to pledge nor entitled to receive cash collateral related to these derivative transactions.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash Flow Hedging Activities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has many transactions denominated in foreign currencies and addresses certain of those financial exposures through a risk management program that includes the use of derivative financial instruments. The Company sells products throughout the world, often in the currency of the customer&#8217;s country, and may hedge certain of the larger foreign currency transactions when they are either not denominated in the relevant subsidiary&#8217;s functional currency or the U.S. Dollar. These foreign currency sales transactions are hedged using foreign currency forward contracts. The Company may use other derivative instruments in the future. The Company does not enter into foreign currency forward contracts for speculative or trading purposes. Foreign currency forward contracts are entered into up to several times a quarter and range from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">thirteen</font><font style="font-family:inherit;font-size:10pt;"> months in maturity.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The hedges of foreign currency denominated forecasted revenues are designated and accounted for as cash flow hedges. The designated cash flow hedges de-designate when the anticipated revenues associated with the transactions are recognized and the change in fair value of the derivatives in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets is reclassified to revenues in the Condensed Consolidated Statements of Earnings (Loss). Subsequent changes in fair value of the derivative instrument are recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings (Loss) to offset changes in fair value of the resulting non-functional currency receivables. For derivative instruments that are designated and qualified as cash flow hedges, the Company formally documents for each derivative instrument at the hedge&#8217;s inception, the relationship between the hedging instrument (foreign currency forward contract) and hedged item (forecasted foreign currency revenues), the nature of the risk being hedged and its risk management objective and strategy for undertaking the hedge. The Company records the gain or loss on the derivative instruments that are designated and qualified as cash flow hedges in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets and reclassifies these amounts into revenues in the Condensed Consolidated Statements of Earnings (Loss) in the period in which the hedged transaction is recognized in earnings. The Company assesses hedge effectiveness both at the onset of the hedge and on an ongoing basis using regression analysis. The time value of the derivative and hedged item is included in the assessment of hedge effectiveness. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the inception of the hedge relationship and quarterly thereafter, the Company assesses whether the likelihood of meeting the forecasted cash flow is highly probable. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company did not have any outstanding foreign currency forward contracts designated as cash flow hedges. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company recognized an unrealized loss of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, in other comprehensive earnings (loss) on foreign currency forward contracts designated as cash flow hedges. The Company did not have any foreign currency forward contracts designated as cash flow hedges during the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings (Loss) was as follows: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location and Amount Recognized in Earnings (Loss) on Cash Flow Hedging Relationships</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenues</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings (Loss) in which the effects of fair value and cash flow hedges are recorded</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on cash flow hedge relationships: </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency forward contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of loss reclassified from accumulated other comprehensive loss into earnings (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Balance Sheet Hedging Activities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also hedges balance sheet exposures from its various subsidiaries and business units where the U.S. Dollar is the functional currency. The Company enters into foreign currency forward contracts to minimize the short-term impact of foreign currency fluctuations on monetary assets and liabilities denominated in currencies other than the U.S. Dollar functional currency. The foreign currency forward contracts are short term in nature, typically with a maturity of approximately </font><font style="font-family:inherit;font-size:10pt;">one month</font><font style="font-family:inherit;font-size:10pt;">, and are based on the net forecasted balance sheet exposure. For derivative instruments not designated as hedging instruments, changes in their fair values are recognized in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings (Loss). Changes in the values of these hedging instruments are offset by changes in the values of foreign-currency-denominated assets and liabilities. Variations from the forecasted foreign currency assets or liabilities, coupled with a significant currency rate movement, may result in a material gain or loss if the hedges are not effectively offsetting the change in value of the foreign currency asset or liability. Other than foreign exchange hedging activities, the Company has no other free-standing or embedded derivative instruments. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had the following outstanding foreign currency forward contracts relating to balance sheet hedging activities: </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional<br clear="none"/>Value Sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional<br clear="none"/>Value Purchased</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Australian Dollar</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazilian Real</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">British Pound</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canadian Dollar</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Danish Krone</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hungarian Forint</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indian Rupee</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Japanese Yen</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Polish Zloty</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Singapore Dollar</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Swedish Krona</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South African Rand</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Swiss Franc</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thai Baht</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Totals</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">477.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings (Loss) related to the foreign currency forward contracts that are not designated as hedging instruments.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain (Loss) Recognized in Income on Derivative Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain (Loss) Recognized in Net Earnings (Loss) on Derivative Instruments</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.5</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.2</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gains (losses) on these derivative instruments were significantly offset by the gains (losses) resulting from the re-measurement of monetary assets and liabilities denominated in currencies other than the U.S.&#160;Dollar functional currency.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Forward and Option Contracts related to the Acquisition of Sirtex </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the Company entered into foreign currency forward contracts and a foreign currency option contract to economically hedge its foreign currency exchange rate risk on the consideration to be paid for the Sirtex acquisition. The foreign currency forward contracts allow the Company to purchase a notional amount of </font><font style="font-family:inherit;font-size:10pt;">A$793.0 million</font><font style="font-family:inherit;font-size:10pt;"> for </font><font style="font-family:inherit;font-size:10pt;">$621.0 million</font><font style="font-family:inherit;font-size:10pt;"> on May 25, 2018. The quoted forward exchange rate on </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> would provide that the same amount of Australian Dollars would cost </font><font style="font-family:inherit;font-size:10pt;">$609.6 million</font><font style="font-family:inherit;font-size:10pt;">. The Company paid a premium of </font><font style="font-family:inherit;font-size:10pt;">$5.5 million</font><font style="font-family:inherit;font-size:10pt;"> for a foreign currency option that allows the Company to purchase a notional amount of </font><font style="font-family:inherit;font-size:10pt;">A$792.0 million</font><font style="font-family:inherit;font-size:10pt;"> for </font><font style="font-family:inherit;font-size:10pt;">$641.5 million</font><font style="font-family:inherit;font-size:10pt;"> that will expire on May 23, 2018. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the foreign currency option has a fair value of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foreign currency forward contracts and option contract do not qualify for hedge accounting. As such, changes in the fair value will be recognized in acquisition-related expenses on the Condensed Consolidated Statements of Earnings. In the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded losses of </font><font style="font-family:inherit;font-size:10pt;">$11.4 million</font><font style="font-family:inherit;font-size:10pt;"> on the foreign currency forward contracts and </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> on the foreign currency option contract. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingent Features</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of the Company&#8217;s derivative instruments are subject to master agreements which contain provisions that require the Company, in the event of a default, to settle the outstanding contracts in net liability positions by making settlement payments in cash or by setting off amounts owed to the counterparty against any credit support or collateral held by the counterparty. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company did not have any outstanding derivative instruments with credit-risk-related contingent features that were in a net liability position in the Company&#8217;s outstanding balance sheet hedges.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company disaggregates its revenues from contracts by major product categories and by geographic region for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below. </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Total Revenues by product type</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hardware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">604.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">662.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">261.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">504.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:top;padding-left:24px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;text-indent:-24px;"><font style="font-family:inherit;font-size:9pt;">Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Total Revenues by product type</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hardware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">523.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">580.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">454.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss). </font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Total Revenues by geographical region</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">658.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EMEA</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">253.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">446.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APAC</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">North America</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">625.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">664.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">398.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">721.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">744.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Total Revenues by geographical region</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">622.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">639.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EMEA</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">336.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">369.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APAC</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">243.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">255.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">North America</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">584.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">601.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">618.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Timing of revenue recognition</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products transferred at a point in time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products and Services transferred over time</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products transferred at a point in time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products and Services transferred over time</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">702.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">645.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Varian Particle Therapy</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">702.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">706.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-top:16px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Timing of revenue recognition</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products Transferred at a Point in Time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products and Services Transferred Over Time</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products Transferred at a Point in Time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products and Services Transferred Over Time</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">617.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">585.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Varian Particle Therapy</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">328.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">617.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">647.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EMPLOYEE STOCK PLANS </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues - Product</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues - Service</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit for share-based compensation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted new accounting guidance in the first quarter of 2018 where it elected to change its accounting policy to account for forfeitures as they occur rather than estimating expected forfeitures. Share-based compensation expense for the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> was recorded net of estimated forfeitures. See </font><font style="font-family:inherit;font-size:10pt;">Note 1, "Summary of Significant Accounting Policies"</font><font style="font-family:inherit;font-size:10pt;"> for further information. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions:&#160;</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee Stock Option Plans</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected term (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.83</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.83</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average fair value at grant date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.48</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.73</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions:&#160;</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee Stock Purchase Plan</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected term (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average fair value at grant date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.97</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of share-based awards available for grant is as follows:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares Available for Grant</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Authorized </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">On February 8, 2018, the Company's stockholders approved its Fifth Amended and Restated 2005 Omnibus Stock Plan ("2005 Plan") to increase the number of shares authorized for issuance by </font><font style="font-family:inherit;font-size:9pt;">6.0 million</font><font style="font-family:inherit;font-size:9pt;"> shares.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For purposes of the total number of shares available for grant under the 2005 Plan, any shares subject to awards of stock options and performance stock options are counted against the available-for-grant limit as one share for every </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> share subject to the award. Awards other than stock options and performance stock options are counted against the available-for-grant limit as </font><font style="font-family:inherit;font-size:10pt;">2.6</font><font style="font-family:inherit;font-size:10pt;"> shares for every one share awarded on or after February 9, 2012. The shares available for grant limit is further adjusted to reflect a maximum payout that could be issued for each performance grant. The maximum payouts that could be issued for each performance grant are </font><font style="font-family:inherit;font-size:10pt;">2.0</font><font style="font-family:inherit;font-size:10pt;"> shares beginning in fiscal year 2018, </font><font style="font-family:inherit;font-size:10pt;">1.75</font><font style="font-family:inherit;font-size:10pt;"> shares in fiscal years 2017 and 2016, and </font><font style="font-family:inherit;font-size:10pt;">2.0</font><font style="font-family:inherit;font-size:10pt;"> shares in fiscal year 2015. All awards may be subject to restrictions on transferability and continued employment as determined by the Compensation and Management Development Committee. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Activity under the Company&#8217;s employee stock plans related to stock options is presented below:&#160;</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.05068226120858%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options Outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of<br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Exercise<br clear="none"/>Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Remaining<br clear="none"/>Term (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate<br clear="none"/>Intrinsic<br clear="none"/>Value</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111.43</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.69</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.67</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercisable at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of </font><font style="font-family:inherit;font-size:9pt;">$122.65</font><font style="font-family:inherit;font-size:9pt;"> as of March 29, 2018, the last trading date of the </font><font style="font-family:inherit;font-size:9pt;">second</font><font style="font-family:inherit;font-size:9pt;"> quarter of fiscal year </font><font style="font-family:inherit;font-size:9pt;">2018</font><font style="font-family:inherit;font-size:9pt;">, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The cancelled and expired shares were not material for disclosure.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$18.0 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation expense related to stock options granted under the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">2.2</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of<br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted Average<br clear="none"/>Grant-Date Fair<br clear="none"/>Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.37</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111.81</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.33</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.16</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.61</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, unrecognized compensation expense totaling </font><font style="font-family:inherit;font-size:10pt;">$46.9 million</font><font style="font-family:inherit;font-size:10pt;"> was related to awards of restricted stock units, deferred stock units and performance units granted under the Company's employee stock plans. This unrecognized share-based compensation expense is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">2.1</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DISCONTINUED OPERATIONS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 28, 2017, the Company completed the Distribution of Varex. In connection with the Distribution, the Company and Varex entered into a separation and distribution agreement as well as various other agreements that governs the relationships between the parties, including a transition services agreement, a tax matters agreement, an employee matters agreement, an intellectual property matters agreement, a trademark license agreement and supply/distribution agreements. The separation and distribution agreement and other agreements related to the separation were entered into on January 27, 2017. Services under the transition services agreement were for </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;"> days to </font><font style="font-family:inherit;font-size:10pt;">24</font><font style="font-family:inherit;font-size:10pt;"> months following the Distribution Date, depending on the service provided. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 25, 2017, the Company entered into a term facility ("Varex Term Facility"), and on the same day drew down </font><font style="font-family:inherit;font-size:10pt;">$203.0 million</font><font style="font-family:inherit;font-size:10pt;"> under the facility. In conjunction with the Distribution, the Company used </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;"> of those proceeds to repay a portion of its outstanding 2013 Revolving Credit Facility. At the Distribution Date, the Company contributed </font><font style="font-family:inherit;font-size:10pt;">$81.3 million</font><font style="font-family:inherit;font-size:10pt;"> in cash and cash equivalents to Varex as part of the distribution and transfer of certain legal entities. In fiscal year 2017, the Company received </font><font style="font-family:inherit;font-size:10pt;">$38.7 million</font><font style="font-family:inherit;font-size:10pt;"> from Varex for excess cash and cash equivalents contributed at the Distribution Date. In fiscal year 2017, the Company recorded a </font><font style="font-family:inherit;font-size:10pt;">$334.1 million</font><font style="font-family:inherit;font-size:10pt;"> reduction to retained earnings as a result of the Distribution of Varex, which included assets and liabilities transferred to Varex on the Distribution Date, including </font><font style="font-family:inherit;font-size:10pt;">$203.0 million</font><font style="font-family:inherit;font-size:10pt;"> of debt outstanding under the Varex Term Facility. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following the Distribution, Varex retained a specified amount of cash that would enable Varex to pay the Company consideration for certain net assets outside of the United States that were required to be transferred to Varex but which did not occur on the Distribution Date due to not having received regulatory approvals for such transfers. Once those regulatory approvals are received, the Company will receive a cash payment from Varex in consideration for such net asset transfers. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;"> in assets (net of liabilities) on its Condensed Consolidated Balance Sheet related to Varex net assets to be transferred. The Company expects the remainder of Varex's net assets will be transferred in fiscal year 2018. If the Company does not receive the necessary regulatory approvals during a specified time period, Varex will be required to transfer such cash amounts to Varian. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The financial results of Varex are presented as net earnings from discontinued operations on the Condensed Consolidated Statements of Earnings (Loss), and primarily include the financial results of the Company's former Imaging Components operating segment and costs relating to the Distribution. Corporate costs previously allocated to the Company's Imaging Components operating segment are not included in discontinued operations. See </font><font style="font-family:inherit;font-size:10pt;">Note 17, "Segment Information"</font><font style="font-family:inherit;font-size:10pt;"> for more information related to corporate allocated costs. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the key components of net loss from discontinued operations:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">194.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross margin</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes on earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net earnings from discontinued operations attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">There was </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> activity in net loss from discontinued operations during the three and </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating expenses included separation costs of </font><font style="font-family:inherit;font-size:9pt;">$19.3 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$34.2 million</font><font style="font-family:inherit;font-size:9pt;"> during the three and </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;">, respectively. Separation costs include expenses for transaction advisory services, consulting services, restructuring and other expenses.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in the Company's Condensed Consolidated Balance Sheets:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade accounts receivable, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets of discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets of discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities of discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities of discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents supplemental cash flow information of discontinued operations:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating activities: </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investing activities: </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases of property, plant and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">There was no significant cash flow activity from discontinued operations during the </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;">.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net earnings per share is computed by dividing net earnings attributable to Varian by the weighted average number of shares of VMS common stock outstanding for the period. Diluted net earnings per share is computed by dividing net earnings attributable to Varian by the sum of the weighted average number of common shares outstanding and dilutive common shares under the treasury stock method.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted net earnings per share:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net (loss) earnings from continuing operations attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) from continuing operations attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net earnings from discontinued operations attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares outstanding - basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dilutive effect of potential common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares outstanding - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per share attributable to Varian - basic</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per share - basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.80</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.43</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per share attributable to Varian - diluted</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.79</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.43</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.82</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per share - diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.79</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.43</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive employee share-based awards, excluded</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company excludes potentially dilutive common shares (consisting of shares underlying stock options and the employee stock purchase plan) from the computation of diluted weighted average shares outstanding if the per share value, either the exercise price of the awards or the sum of (a)&#160;the exercise price of the awards and (b)&#160;the amount of the compensation cost attributed to future services and not yet recognized and (c)&#160;the amount of tax benefit or shortfall that would be recorded in additional paid-in capital when the award becomes deductible, is greater than the average market price of the shares, because the inclusion of the shares underlying these stock awards would be anti-dilutive to earnings per share. For the six months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the diluted net loss per share is the same as the basic net loss per share as the effects of all potential common stock equivalents are anti-dilutive.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the reconciliation for all assets and liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Available-for-sale Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent<br clear="none"/>Consideration</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions from business combinations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassification of Original CPTC Loans to Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of derivative instruments reported on the Condensed Consolidated Balance Sheets was as follows:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:51%;" rowspan="1" colspan="1"></td><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Sheet</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange option contract</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange forward contracts</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FAIR VALUE</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Assets/Liabilities Measured at Fair Value on a Recurring Basis</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in<br clear="none"/>Active Markets<br clear="none"/>for Identical<br clear="none"/>Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Type of Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets at March 30, 2018:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APTC securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities at March 30, 2018:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities measured at fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets at September 29, 2017:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Original CPTC loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DRTC securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The Company's Level 2 available-for-sale securities consist of bonds for APTC, GPTC, and DRTC. The observable inputs for these securities are comparable bond issues, broker/dealer quotations for the same or similar investments in active markets and other observable inputs such as yields, credit risks, default rates, and volatility. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, the carrying amount of the Level 2 available-for-sale securities approximated their fair value.</font><font style="font-family:inherit;font-size:11pt;"> See </font><font style="font-family:inherit;font-size:10pt;">Note 16, "VPT Loans and Securities"</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:10pt;">for further information about these bonds. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads. The Company&#8217;s derivative instruments are generally short-term in nature, typically </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> month to </font><font style="font-family:inherit;font-size:10pt;">thirteen</font><font style="font-family:inherit;font-size:10pt;"> months in duration. See </font><font style="font-family:inherit;font-size:10pt;">Note 9, "Derivative Instruments and Hedging Activities"</font><font style="font-family:inherit;font-size:10pt;"> for more information about the Company's derivative instruments. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company measures the fair value of its Level 3 contingent consideration liabilities based on the income approach by using a discounted cash flow model with key assumptions that include estimated sales units or revenues of the acquired business or completion of certain milestone targets during the earn-out period, volatility, and estimated discount rates corresponding to the periods of expected payments. If the estimated sales units, revenues or probability of completing certain milestones were to increase or decrease during the respective earn-out period, the fair value of the contingent consideration would increase or decrease, respectively. If the estimated discount rates were to increase or decrease, the fair value of contingent consideration would decrease or increase, respectively. Changes in volatility may result in an increase or decrease in the fair value of contingent consideration. The Company's contingent consideration are from its business combinations in fiscal year 2018 and is included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2017, the Original CPTC loans were modified and partially satisfied resulting in a Term Loan of </font><font style="font-family:inherit;font-size:10pt;">$53.5 million</font><font style="font-family:inherit;font-size:10pt;">, as defined in </font><font style="font-family:inherit;font-size:10pt;">Note 16, "VPT Loans and Securities"</font><font style="font-family:inherit;font-size:10pt;">. One of the modifications was that the loan agent no longer has the option to purchase these loans from the Company, therefore, the Original CPTC loans are no longer classified as an available-for-sale security. The Company had no unrealized gains or unrealized losses associated with the Original CPTC loans recorded in its other comprehensive income. The modification to the Original CPTC Loans had no impact on the Company's Condensed Consolidated Statements of Earnings (Loss) for the three months ended December 29, 2017. As of September 29, 2017, the Company classified the Original CPTC loans as available-for-sale securities, the fair value of which was based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks associated with the loans as well as underlying cash flow assumptions. However, the Company did not increase the fair value of the Original CPTC loans above their par values as ORIX Capital Markets, LLC (&#8220;ORIX&#8221;), the loan agent, had the option to purchase these loans from the Company under the original terms and conditions at par value. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the reconciliation for all assets and liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Available-for-sale Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contingent<br clear="none"/>Consideration</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions from business combinations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassification of Original CPTC Loans to Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> transfers of assets or liabilities between fair value measurement levels during either the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, or the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Transfers between fair value measurement levels are recognized at the end of the reporting period.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value of Other Financial Instruments</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of certain of the Company&#8217;s financial instruments, including bank deposits included in cash and cash equivalents, trade and unbilled receivables, net of allowance for doubtful accounts,&#160;short-term notes receivable, revolving loan to CPTC, RPTC senior secured debt, accounts payable, and short-term borrowings approximate their carrying amounts due to their short maturities.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the fair value of the Company's long-term debt approximated its carrying value of </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> because it is carried at a market observable interest rate that resets periodically and is categorized as Level 2 in the fair value hierarchy. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the fair value of the Term Loan with CPTC approximated its carrying value of </font><font style="font-family:inherit;font-size:10pt;">$44.0 million</font><font style="font-family:inherit;font-size:10pt;">. See </font><font style="font-family:inherit;font-size:10pt;">Note 16, "VPT Loans and Securities"</font><font style="font-family:inherit;font-size:10pt;"> for further information. The carrying value is based on the present value of expected future cash payments discounted at a rate reflecting the nature and duration of the loans, risks involved with CPTC, and its industry. As a result, the Term Loan is categorized as Level 3 in the fair value hierarchy. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the outstanding long-term notes receivable, including accrued interest, approximated their carrying value of </font><font style="font-family:inherit;font-size:10pt;">$62.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$100.2 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, because they are based on terms of recent comparable transactions and are categorized as Level 3 in the fair value hierarchy. The fair value is based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks as well as underlying cash flow assumptions. See </font><font style="font-family:inherit;font-size:10pt;">Note 6, "Receivables"</font><font style="font-family:inherit;font-size:10pt;"> for information on the long-term notes receivable.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September&#160;30. Fiscal year </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> is the 52-week period ending </font><font style="font-family:inherit;font-size:10pt;">September&#160;28, 2018</font><font style="font-family:inherit;font-size:10pt;">. Fiscal year&#160;</font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> was the 52-week period that ended on </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">. The fiscal quarters ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> were both 13-week periods.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOODWILL AND INTANGIBLE ASSETS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reflects the activity of goodwill by reportable operating segment:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Business combinations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">236.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See </font><font style="font-family:inherit;font-size:10pt;">Note 3, "Business Combinations"</font><font style="font-family:inherit;font-size:10pt;"> for more information on the Company's acquisitions in fiscal year 2018.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets:&#160;</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technologies and patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(60.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer contracts and supplier relationship</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible with finite lives</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">141.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development with indefinite lives</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense for intangible assets was </font><font style="font-family:inherit;font-size:10pt;">$4.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> during the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, and </font><font style="font-family:inherit;font-size:10pt;">$10.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$7.3 million</font><font style="font-family:inherit;font-size:10pt;"> during the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions): </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Years:</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining Amortization Expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total remaining amortization for intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s effective tax rate was </font><font style="font-family:inherit;font-size:10pt;">23.4%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">23.1%</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, and </font><font style="font-family:inherit;font-size:10pt;">117.9%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">29.4%</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively. The </font><font style="font-family:inherit;font-size:10pt;">increase</font><font style="font-family:inherit;font-size:10pt;"> in the Company&#8217;s effective tax rate for the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, compared to the year-ago periods, was primarily due to the tax effect of the Tax Cuts and Jobs Act (the "Act"), which was signed into law on December 22, 2017. The Company&#8217;s effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> was also high due to the impairment of the CPTC loans in December 2016, which were made by one of the Company's Swiss subsidiaries, which has a low tax rate, and a significant portion of the expense associated with the allowance for doubtful accounts recorded in the period being attributable to one of the Company's German subsidiaries which has a full valuation allowance.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Act was signed into law on December 22, 2017. Among other changes, the Act reduces the U.S. corporate tax rate from </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, and imposes a one-time transition tax on the unremitted earnings of the Company's foreign subsidiaries. U.S. GAAP generally requires that the tax effect of a change in tax laws or rates be accounted for in the period of enactment.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reduction in the U.S. corporate tax rate was effective January 1, 2018. As the Company has a September fiscal year end, the lower corporate tax rate will be phased in, resulting in a U.S. corporate rate of approximately </font><font style="font-family:inherit;font-size:10pt;">24.6%</font><font style="font-family:inherit;font-size:10pt;"> for the Company's fiscal year ending September 28, 2018, and </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;"> for subsequent fiscal years. The reduction in the rate requires the Company to re-measure its net deferred tax assets that were originally recorded assuming a future tax benefit at the </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> rate. Because the rate change is phased in, a portion of the tax impact was included in the period of enactment and a portion is included gradually during the year of enactment. During the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended March 30, 2018, the Company recorded a provisional discrete tax expense of </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$40.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to re-measuring its net deferred tax assets as a result of the rate reduction.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the transition to a modified territorial system, the Act imposes a one-time transition tax on the unremitted earnings of the Company's foreign subsidiaries. During the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended March 30, 2018, the Company recorded a provisional discrete tax expense of </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$173.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to the one-time transition tax. The Company intends to elect to pay this tax over the </font><font style="font-family:inherit;font-size:10pt;">eight</font><font style="font-family:inherit;font-size:10pt;">-year period allowed for in the Act. The transition to a modified territorial regime and the one-time transition tax on unremitted earnings has also caused the Company to re-evaluate its intentions with respect to the unremitted earnings of foreign subsidiaries. In the past, the Company did not accrue U.S. taxes on certain undistributed profits of certain foreign subsidiaries because the earnings were considered to be indefinitely reinvested. In light of the changes to the taxation of foreign earnings in the Act, the Company no longer considers the earnings of its foreign subsidiaries to be indefinitely reinvested.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other provisions of the Act include a new minimum tax on certain foreign earnings (the Global Intangibles Low-taxed Income, or "GILTI"), a new tax on certain payments to foreign related parties (the Base Erosion Anti-avoidance Tax, or "BEAT"), a new incentive for Foreign-derived Intangibles Income ("FDII"), changes to the limitation on the deductibility of certain executive compensation, and new limitations on the deductibility of interest expense. Generally, these other provisions take effect for the Company in the fiscal year ending September 27, 2019.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118 (&#8220;SAB 118&#8221;). This guidance allows registrants a &#8220;measurement period,&#8221; not to exceed one year from the date of enactment, to complete their accounting for the tax effects of the Act. SAB 118 further directs that during the measurement period, registrants who are able to make reasonable estimates of the tax effects of the Act should include those amounts in their financial statements as &#8220;provisional&#8221; amounts. Registrants should reflect adjustments over subsequent periods as they are able to refine their estimates and complete their accounting for the tax effects of the Act. The amounts of the tax effects related to the Act described in the paragraphs above represent the Company&#8217;s current reasonable estimates and are provisional amounts within the meaning of SAB 118. Also, it is expected that the U.S. Treasury will issue regulations and other guidance on the application of certain provisions of the Act. In subsequent periods, but within the measurement period, the Company will analyze that guidance and other necessary information, including the amount of foreign earnings and profits, pools of foreign tax, and the Company's foreign cash position, to refine its estimates and complete its accounting for the tax effects of the Act.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company adopted the FASB guidance related to employee share-based payments in the first quarter of fiscal year 2018. Among other changes, this standard changes the treatment of the tax effect of the excess stock deduction. For a share-based compensation instrument, the excess stock deduction is the difference between the amount of the deduction for taxable income and the amount of expense in the financial statements related to that instrument. Under the prior standard, the tax effect of the excess stock deduction related to share-based compensation was recorded to additional paid-in capital in the equity section on the Condensed Consolidated Balance Sheets. Under the new standard, the tax effect of the excess stock deduction related to share-based compensation is recorded as a discrete item to Taxes on Earnings in the Condensed Consolidated Statements of Earnings (Loss). For the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded a discrete tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$6.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to excess stock deduction activity. The Company expects that the new standard may cause its effective tax rate to be less predictable and more volatile going forward.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s effective income tax rate differs from the U.S. federal statutory rate primarily because the Company&#8217;s foreign earnings are taxed at rates that are, on average, lower than the U.S. federal rate, and because the Company&#8217;s domestic earnings are subject to state income taxes. The total amount of unrecognized tax benefits increased by </font><font style="font-family:inherit;font-size:10pt;">$11.6 million</font><font style="font-family:inherit;font-size:10pt;"> during the </font><font style="font-family:inherit;font-size:10pt;">six months ended March 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, primarily due to the impact of the Act on the Company's unrecognized tax benefits. The impact of this increase in tax expense is included in the amount of the provisional discrete expense related to the one-time transition tax above. In addition, the amount of unrecognized tax benefits has increased as a result of positions taken during the current and prior years, and has decreased as the result of the expiration of the statute of limitations in various jurisdictions.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standards or Updates Not Yet Effective</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB amended its guidance that will allow companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2020. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB provided guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The guidance is effective for the Company beginning in the first quarter of fiscal 2019. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, the FASB amended its guidance on the accounting related to defined benefit plans and other post-retirement benefits. This amendment requires the service cost component of net periodic pension and post-retirement benefit cost be presented in the same line item as other employee compensation costs, while the other components be presented separately as non-operating income (expense). The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2016, the FASB amended its guidance on the classification and presentation of restricted cash in the statement of cash flow. The amendment requires entities to include restricted cash and restricted cash equivalents in its cash and cash equivalents in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively. The amendment is not expected to have a material impact to the Company&#8217;s condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB amended its guidance for tax accounting for intra-entity asset transfers. The amendment removes the prohibition against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The amendment is required to be adopted on a modified retrospective basis. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued an amendment to its accounting guidance related to the classification of certain cash receipts and cash payments. The amendment was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively unless it is impracticable. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued an amendment to its accounting guidance related to impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021 with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued a new standard on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company is evaluating the impact of adopting this new standard to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued an amendment to its accounting guidance related to recognition and measurement of financial assets and financial liabilities. The amendment addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's other long-term liabilities:</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term income taxes payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RETIREMENT PLANS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sponsors </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> defined benefit pension plans for regular full-time employees in Germany, Japan, Switzerland and the United Kingdom. The Company also sponsors a post-retirement benefit plan that provides healthcare benefits to certain eligible retirees in the United States. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of net defined benefit costs were as follows:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Defined Benefit Plans</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized actuarial loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amounts reclassified out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings (Loss), with line item location, during each period were as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Comprehensive Earnings Components</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss Before Taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss Before Taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Line Item in Statements of Earnings (Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized loss on defined benefit pension and post-retirement benefit plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues &amp; Operating expenses</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized loss on cash flow hedging instruments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total amounts reclassified out of other comprehensive earnings (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's revenues are derived primarily from the sale of radiotherapy and proton therapy hardware and software products, support, training and maintenance of all those products, installation services and the sale of parts. The Company accounts for a contract with a customer when there is approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's revenues are measured based on consideration specified in the contract with each customer, net of any sales incentives and amounts collected on behalf of third parties such as sales taxes. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The majority of the Company's revenue arrangements consist of multiple performance obligations including hardware, software, and services. Determining the stand-alone selling price ("SSP") and allocation of consideration from an arrangement to the individual performance obligations, and the appropriate timing of revenue recognition are significant judgments with respect to these arrangements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's products are generally not sold with a right of return, and the Company does not provide credits or incentives, which may be required to be accounted for as variable consideration when estimating the amount of revenue to be recognized.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the Company expects the benefit of those costs to be longer than one year. The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less. These costs mainly include the Company's internal sales force compensation program; under the terms of these programs these are generally earned and the costs are recognized at the time the revenue is recognized.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The majority of the Company&#8217;s products and services are sold in bundled arrangements (e.g., hardware, software, and services). For bundled arrangements, the Company accounts for individual products and services separately if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their individual SSP. The SSP is determined based on observable prices at which the Company separately sells the products and services. If an SSP is not directly observable, then the Company will estimate the SSP considering marketing conditions, entity-specific factors, and information about the customer or class of customer that is reasonably available.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a description of the principal activities, separated by reportable segment, from which the Company generates its revenues.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Oncology Systems</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's Oncology Systems linear accelerators are generally sold in a bundled arrangement with hardware and software accessory products that enhance efficiency and enable delivery of advanced radiotherapy and radiosurgery treatments, however, certain products are occasionally sold on a stand-alone basis. The majority of machine and software sales include installation services and training. Delivery of different elements in a revenue arrangement often span more than one reporting period. For example, a linear accelerator and software may be delivered in one reporting period, but the related installation of those products may be completed in a later period. Hardware and software extended maintenance and service contracts are occasionally sold during the initial product sale, but the majority are sold separately near or at the end of the initial warranty period. Revenues related to extended warranty and service contracts are earned after the expiration of the initial warranty period. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment terms and conditions vary by contract type, although terms are generally commensurate with a significant milestone, such as contract signing, shipment, delivery, acceptance or service commencement. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts generally do not include a significant financing component. The primary purpose of the Company's invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company's products and services, not to receive financing from the Company's customers, such as invoicing at the beginning of a contract term with revenue recognized ratably over the contract period for a service contract. Payment terms can also vary based on the type of customer, such as government purchases. There are occasions where the Company provides extended payment terms in which case a portion of the transaction price is allocated to imputed interest income.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, the Company's contracts are modified to account for additional, or change existing, performance obligations. The Company's contract modifications are generally accounted for prospectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hardware Products and Installation </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hardware products may include software that the hardware is dependent on and highly interrelated with and cannot operate without. The Company typically has a standard base configuration for its hardware products, but there are typically multiple options and configuration choices. Revenues from the sale of hardware are recognized when the Company transfers control to the customer.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product installation includes uncrating, moving the machine to the treatment room, connection and validating configuration. In addition, a number of testing protocols are completed to confirm the equipment is performing to the contracted specifications. The Company recognizes revenues for hardware installation over time as the customer receives and consumes benefits provided as the Company performs the installation services.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Software Products and Installation </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software products include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. Software installation includes transferring software to the customer&#8217;s computers, configuration of the software and potentially data migration. The Company recognizes revenues for software and software installation upon the customer's acceptance of the software and installation services.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Service</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenues include revenues from initial and extended software support agreements, extended hardware warranty agreements, training, paid service arrangements when a customer does not have an extended warranty and parts that are sold by the service department.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from hardware and software support agreements are accounted for ratably over the term of the agreement. Services and training revenues are recognized in the period the services and training are performed. Revenues for sales of parts are recognized when the parts are delivered to the customer and control is transferred.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Warranties </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's sale of hardware includes a </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">-year warranty. The Company uses the cost accrual method to account for assurance-type warranties. The standard warranty provision further includes services in addition to an assurance-type warranty (preventative maintenance inspections, help desk support, when and if available operating system upgrades). These service-type warranty features are recorded as a separate performance obligation and recognized ratably over the one-year warranty period.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Varian Particle Therapy ("VPT")</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The manufacturing of the major components of a proton therapy system, installation, and commissioning typically lasts </font><font style="font-family:inherit;font-size:10pt;">18</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">24</font><font style="font-family:inherit;font-size:10pt;"> months. The Company's proton therapy system is highly customized. A proton therapy system typically includes hardware, software that the hardware is dependent upon and highly interrelated with, and without which the hardware cannot operate, and installation. The Company also sells software products that include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software, and software installation.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides operations and maintenance services related to the proton therapy system under a separate arrangement. These contracts are typically executed at or about the same time as the proton therapy system contracts; however, the pricing and performance of the proton therapy system contracts are not typically related to the pricing or performance of the operations and maintenance contracts. Therefore, the Company recognizes operations and maintenance services as a separate performance obligation.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the typical payment terms of the Company's fixed-price contracts, the customer pays the Company an up-front advance payment and then performance-based payments based on quantifiable measures of performance or on the achievement of specified events or milestones. As the revenue is recognized over time relative to the costs incurred and the customer billing milestones are typically event driven, this may result in revenue recognized in excess of billings at some point during the contract which the Company presents as unbilled receivables on the Condensed Consolidated Balance Sheets. Amounts billed and due from the Company's customers are classified as trade accounts receivable on the Condensed Consolidated Balance Sheets. In most contracts, the Company is entitled to receive an advance payment at the beginning of the contract. The Company recognizes a liability for these advance payments in excess of revenue recognized and presents it as deferred revenues on the Condensed Consolidated Balance Sheets. The advance payment typically is not considered a significant financing component because it is used to ensure the customer's commitment to the project. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue for its proton therapy systems over time because the customer controls the work in process, the Company's performance does not create an asset with an alternative use to the Company, and the Company has an enforceable right to payment for performance completed to date.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due to the nature of the work required to be performed on many of the Company's performance obligations, the estimation of total revenues and costs at completion is complex, subject to many variables and requires significant judgment. The Company's contracts generally do not include award fees, incentive fees or other provisions that may be considered variable consideration. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a standard quarterly progress review process in which management reviews the progress and execution of the Company's performance obligations. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and costs to achieve the schedule (e.g., the number and type of milestone events), technical and other contract requirements. Management must make assumptions and estimates regarding the complexity of the work to be performed, the availability of materials and outside services, the length of time to complete the performance obligation and labor and overhead cost rates, among other significant judgments. Based on this analysis, any quarterly adjustments to revenues, cost of revenues, and the related impact to operating earnings are recognized as necessary in the period they become known on a cumulative catch-up basis. When estimates of total costs to be incurred on a performance obligation exceed total estimates of revenues to be earned, a provision for the entire loss on the performance obligation is recognized in the period the loss is determined.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Similar to the Oncology Systems segment, the Company recognizes VPT revenues for software and installation upon completion and acceptance of the software and installation services. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unfulfilled Performance Obligations for Oncology Systems and VPT</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the Company's unfulfilled performance obligations as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and the estimated revenue expected to be recognized in the future related to these unfulfilled performance obligations: </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal years of revenue recognition</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Thereafter</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unfulfilled Performance Obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,060.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,089.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,276.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table above includes both product and service unfulfilled performance obligations, which includes a component of service performance obligations which have not been invoiced. The time bands reflect management&#8217;s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers&#8217; facilities for installation, installation requirements, and availability of products or customer acceptance terms.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the Company's adoption of ASC 606, the Company elected to use the following practical expedients (i) to exclude disclosures of transaction prices allocated to remaining performance obligations when the Company expects to recognize such revenue for all periods prior to the date of initial application of ASC 606 (ii) not to adjust the promised amount of consideration for the effects of a significant financing component when the Company expects, at contract inception, that the period between the Company's transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less (iii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less, which mainly includes the Company's internal sales force compensation program and certain partner sales incentive programs (iv) not to recast revenue for contracts that begin and end in the same fiscal period, and (v) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contract Balances</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The timing of revenue recognition, billings and cash collections results in trade and unbilled receivables, and deferred revenues on the Condensed Consolidated Balance Sheet. In Oncology Systems, the Company often collects an advance payment and the balance is typically billed on a combination of delivery and/or acceptance. In VPT, the Company usually collects an advance payment and additional amounts are billed as work progresses in accordance with agreed-upon contractual terms upon achievement of contractual milestones. Service contracts are usually billed at the beginning of the contract period or at periodic intervals (e.g. monthly or quarterly) during the contract which could result in a contract asset and contract liability. At times, billing occurs subsequent to revenue recognition, resulting in an unbilled receivable which represents a contract asset. However, when the Company receives advances or deposits from customers, which can be higher in the initial stages of the contract, particularly international contracts in the case of Oncology Systems, before revenue is recognized, this results in deferred revenues which represents a contract liability. These contract assets and liabilities are reported as unbilled receivables and deferred revenues, respectively, on the Condensed Consolidated Balance Sheet on a contract-by-contract basis at the end of each reporting period.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the Company's unfulfilled performance obligations as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and the estimated revenue expected to be recognized in the future related to these unfulfilled performance obligations: </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal years of revenue recognition</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Thereafter</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unfulfilled Performance Obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,060.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,089.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,276.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's trade and unbilled receivables, net and notes receivable: </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade and unbilled receivables, gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,008.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,039.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for doubtful accounts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(63.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade and unbilled receivables, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">968.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">976.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">936.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notes receivable</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) (3)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Balances are included in other assets on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balances are included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-top:8px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Unrealized Gains<br clear="none"/>(Losses) Defined<br clear="none"/>Benefit Pension and<br clear="none"/>Post-Retirement<br clear="none"/>Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net<br clear="none"/>Unrealized<br clear="none"/>Gains<br clear="none"/>(Losses)<br clear="none"/>Cash Flow<br clear="none"/>Hedging<br clear="none"/>Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cumulative<br clear="none"/>Translation<br clear="none"/>Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated<br clear="none"/>Other<br clear="none"/>Comprehensive<br clear="none"/>Loss</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44.1</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24.7</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified out of other comprehensive earnings (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(58.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Unrealized Gains<br clear="none"/>(Losses) Defined<br clear="none"/>Benefit Pension and<br clear="none"/>Post-Retirement<br clear="none"/>Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cumulative<br clear="none"/>Translation<br clear="none"/>Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated<br clear="none"/>Other<br clear="none"/>Comprehensive Earnings<br clear="none"/>(Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(63.3</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37.5</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive loss before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified out of other comprehensive earnings (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(109.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings (Loss) was as follows: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location and Amount Recognized in Earnings (Loss) on Cash Flow Hedging Relationships</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenues</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings (Loss) in which the effects of fair value and cash flow hedges are recorded</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on cash flow hedge relationships: </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency forward contracts:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of loss reclassified from accumulated other comprehensive loss into earnings (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the key components of net loss from discontinued operations:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">194.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross margin</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes on earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net earnings from discontinued operations attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">There was </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> activity in net loss from discontinued operations during the three and </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating expenses included separation costs of </font><font style="font-family:inherit;font-size:9pt;">$19.3 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$34.2 million</font><font style="font-family:inherit;font-size:9pt;"> during the three and </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:9pt;">, respectively. Separation costs include expenses for transaction advisory services, consulting services, restructuring and other expenses.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in the Company's Condensed Consolidated Balance Sheets:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade accounts receivable, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets of discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets of discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities of discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities of discontinued operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents supplemental cash flow information of discontinued operations:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating activities: </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investing activities: </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases of property, plant and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">There was no significant cash flow activity from discontinued operations during the </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;">.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the computation of basic and diluted net earnings per share:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) from continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net (loss) earnings from continuing operations attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) from continuing operations attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net earnings from discontinued operations attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares outstanding - basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dilutive effect of potential common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares outstanding - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per share attributable to Varian - basic</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per share - basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.80</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.43</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per share attributable to Varian - diluted</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.79</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.43</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.82</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per share - diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.79</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.43</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive employee share-based awards, excluded</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues - Product</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues - Service</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit for share-based compensation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurement Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in<br clear="none"/>Active Markets<br clear="none"/>for Identical<br clear="none"/>Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Type of Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets at March 30, 2018:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APTC securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities at March 30, 2018:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities measured at fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets at September 29, 2017:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Original CPTC loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DRTC securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets:&#160;</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technologies and patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(60.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer contracts and supplier relationship</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible with finite lives</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">141.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development with indefinite lives</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reflects the activity of goodwill by reportable operating segment:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Business combinations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">236.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets:&#160;</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technologies and patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(60.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer contracts and supplier relationship</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible with finite lives</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">141.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development with indefinite lives</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's inventories:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials and parts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">306.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of net defined benefit costs were as follows:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Defined Benefit Plans</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized actuarial loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic benefit cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recast its condensed consolidated financial statements from amounts previously reported due to the adoption of ASC 606. Select Condensed Consolidated Statements of Earnings (Loss) line items, which reflect the adoption of ASC 606 are as follows: </font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adjusted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adjusted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">386.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">655.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,266.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">254.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">478.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cost of revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">387.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">715.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">722.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross margin</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">551.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from continuing operations before taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes on earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net earnings per share from continuing operations attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.89</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.82</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Select Condensed Consolidated Statements of Balance Sheet line items, which reflect the adoption of ASC 606 are as follows: </font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adjusted</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade and unbilled receivables, net </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">823.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities and Equity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">394.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">374.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">640.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">755.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">756.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">778.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had the following outstanding foreign currency forward contracts relating to balance sheet hedging activities: </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional<br clear="none"/>Value Sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional<br clear="none"/>Value Purchased</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Australian Dollar</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazilian Real</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">British Pound</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canadian Dollar</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Danish Krone</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hungarian Forint</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indian Rupee</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Japanese Yen</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Polish Zloty</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Singapore Dollar</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Swedish Krona</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South African Rand</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Swiss Franc</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thai Baht</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Totals</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">477.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings (Loss) related to the foreign currency forward contracts that are not designated as hedging instruments.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain (Loss) Recognized in Income on Derivative Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain (Loss) Recognized in Net Earnings (Loss) on Derivative Instruments</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.5</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.2</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reflects the changes in the Company&#8217;s accrued product warranty:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.85575048732943%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued product warranty, at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.3</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charged to cost of revenues</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual product warranty expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued product warranty, at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a summary of changes in the restructuring liability related to the Company's restructuring plans:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Restructuring Charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 Restructuring Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes select operating results information for each reportable segment:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Varian Particle Therapy</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Company</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating Earnings </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Varian Particle Therapy</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(70.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total reportable segments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">248.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Company</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Activity under the Company&#8217;s employee stock plans related to stock options is presented below:&#160;</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.05068226120858%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options Outstanding</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of<br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Exercise<br clear="none"/>Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Remaining<br clear="none"/>Term (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate<br clear="none"/>Intrinsic<br clear="none"/>Value</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111.43</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.69</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.67</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exercisable at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of </font><font style="font-family:inherit;font-size:9pt;">$122.65</font><font style="font-family:inherit;font-size:9pt;"> as of March 29, 2018, the last trading date of the </font><font style="font-family:inherit;font-size:9pt;">second</font><font style="font-family:inherit;font-size:9pt;"> quarter of fiscal year </font><font style="font-family:inherit;font-size:9pt;">2018</font><font style="font-family:inherit;font-size:9pt;">, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The cancelled and expired shares were not material for disclosure.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions:&#160;</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee Stock Purchase Plan</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected term (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average fair value at grant date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.97</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions:&#160;</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee Stock Option Plans</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected term (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.83</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.83</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average fair value at grant date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.48</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.73</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of<br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted Average<br clear="none"/>Grant-Date Fair<br clear="none"/>Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.37</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111.81</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.33</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.16</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.61</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's short-term borrowings and long-term debt:</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except for percentages)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Interest Rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Interest Rate</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Short-term borrowings:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 Revolving Credit Facility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.79</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">350.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.36</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total short-term borrowings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">350.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-term debt:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 Revolving Credit Facility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.88</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions): </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Years:</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining Amortization Expense</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total remaining amortization for intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SEGMENT INFORMATION</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable operating segments: Oncology Systems and VPT. The operating segments were determined based on how the Company&#8217;s Chief Executive Officer, its Chief Operating Decision Maker (&#8220;CODM&#8221;), views and evaluates the Company&#8217;s operations. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Description of Segments</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments such as fixed field intensity-modulated radiation therapy (&#8220;IMRT&#8221;), image-guided radiation therapy (&#8220;IGRT&#8221;), VMAT, stereotactic radiosurgery (&#8220;SRS&#8221;), stereotactic body radiotherapy (&#8220;SBRT&#8221;) and brachytherapy. Products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment and accessories; as well as information management, treatment planning and image processing, clinical knowledge exchange, patient care management, decision-making support and practice management software. Oncology Systems&#8217; products enable radiation oncology departments in hospitals and clinics to perform conventional radiotherapy treatments and offer advanced treatments such as IMRT, IGRT, VMAT, SRS and SBRT, as well as to treat patients using brachytherapy techniques, which involve temporarily implanting radioactive sources. The Company&#8217;s Oncology Systems products are also used by neurosurgeons to perform stereotactic radiosurgery. Oncology Systems&#8217; customers worldwide include university research and community hospitals, private and governmental institutions, healthcare agencies, physicians&#8217; offices and cancer care clinics.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The VPT segment develops, designs, manufactures, sells and services products and systems for delivering proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accordingly, the following information is provided for purposes of achieving an understanding of operations, but may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company&#8217;s operations to similar operations of other companies may not be meaningful.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company allocates corporate costs to its operating segments based on the relative revenues of Oncology Systems and VPT. The Company allocates these costs excluding certain corporate related costs, transactions or adjustments that the Company's CODM considers to be non-operational, such as restructuring and impairment charges, significant litigation charges or benefits and legal costs, acquisition-related expenses and benefits. Although the Company excludes these amounts from segment operating earnings and loss, they are included in the consolidated operating earnings and included in the reconciliation below. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes select operating results information for each reportable segment:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Varian Particle Therapy</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Company</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating Earnings </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Varian Particle Therapy</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(70.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total reportable segments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">248.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Company</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Disaggregation of Revenues </font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company disaggregates its revenues from contracts by major product categories and by geographic region for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below. </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Total Revenues by product type</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hardware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">604.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">662.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">261.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">504.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:top;padding-left:24px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;text-indent:-24px;"><font style="font-family:inherit;font-size:9pt;">Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Total Revenues by product type</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hardware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">523.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">580.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">449.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">454.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss). </font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Total Revenues by geographical region</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">658.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EMEA</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">241.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">253.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">446.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APAC</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">264.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">North America</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">625.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">664.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">398.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">721.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">744.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Total Revenues by geographical region</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Varian Particle Therapy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Americas</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">622.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">639.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EMEA</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">336.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">369.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APAC</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">132.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">243.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">255.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">North America</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">584.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">601.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">618.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Timing of revenue recognition</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products transferred at a point in time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products and Services transferred over time</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products transferred at a point in time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products and Services transferred over time</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">702.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">645.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,347.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Varian Particle Therapy</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">702.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">706.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,408.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-top:16px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Timing of revenue recognition</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended<br clear="none"/>March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended<br clear="none"/>March 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products Transferred at a Point in Time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products and Services Transferred Over Time</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products Transferred at a Point in Time</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Products and Services Transferred Over Time</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology Systems</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">297.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">631.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">617.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">585.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,203.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Varian Particle Therapy</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">328.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">617.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">647.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Description of Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Varian Medical Systems, Inc. (&#8220;VMS&#8221;) and subsidiaries (collectively, the &#8220;Company&#8221;) designs, manufactures, sells and services hardware and software products for treating cancer with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Software solutions also include informatics software for information management, clinical knowledge exchange, patient care management, practice management and decision-making support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices. The Company also develops, designs, manufactures, sells and services proton therapy products and systems for cancer treatment.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Distribution</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 28, 2017 (the "Distribution Date"), the Company completed the separation and distribution (the "Distribution") of Varex Imaging Corporation ("Varex"), the Company's former Imaging Components business segment. On the Distribution Date, each of Varian's stockholder of record as of the close of business on January 20, 2017 (the "Record Date") received </font><font style="font-family:inherit;font-size:10pt;">0.4</font><font style="font-family:inherit;font-size:10pt;"> of a share of Varex common stock for every one share of Varian common stock as of the Record Date. Varex is now an independent publicly traded company and is listed on The NASDAQ Global Select Market under the ticker &#8220;VREX.&#8221; Varian continues to trade on the New York Stock Exchange under the ticker &#8220;VAR.&#8221; See </font><font style="font-family:inherit;font-size:10pt;">Note 2, "Discontinued Operations"</font><font style="font-family:inherit;font-size:10pt;"> for additional information.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;</font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> Annual Report&#8221;). In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company&#8217;s financial position as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, results of operations and statements of comprehensive earnings (loss) for the </font><font style="font-family:inherit;font-size:10pt;">three and six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, and cash flows for the </font><font style="font-family:inherit;font-size:10pt;">six months ended March 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The results of operations for the </font><font style="font-family:inherit;font-size:10pt;">six months ended March 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the beginning of the Company's fiscal year 2018, the Company early adopted the new revenue recognition Accounting Standard Codification 606 "Revenues from Contracts with Customers" ("ASC 606") by using the full retrospective method. All financial statements and disclosures have been recast to comply with ASC 606. See "Recently Adopted Accounting Pronouncements" below for further information.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The historical financial position and results of operations of the Imaging Components business and costs relating to the Distribution are reported in the condensed consolidated financial statements as discontinued operations for all the periods presented. Information in the accompanying notes to the condensed consolidated financial statements have been recast to reflect the effect of the Distribution. The Condensed Consolidated Statements of Comprehensive Earnings (Loss) and Cash Flows have not been recast to reflect the effect of the Distribution. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September&#160;30. Fiscal year </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> is the 52-week period ending </font><font style="font-family:inherit;font-size:10pt;">September&#160;28, 2018</font><font style="font-family:inherit;font-size:10pt;">. Fiscal year&#160;</font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> was the 52-week period that ended on </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">. The fiscal quarters ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> were both 13-week periods.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</font></div><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Significant Accounting Policies</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's significant accounting policies are detailed in "Note 1: Summary of Significant Accounting Policies" within Item 8 of the Company's Annual Report on Form 10-K for the year ended September 29, 2017. Significant changes to these accounting policies as a result of adoption of ASC 606 are discussed below:</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's revenues are derived primarily from the sale of radiotherapy and proton therapy hardware and software products, support, training and maintenance of all those products, installation services and the sale of parts. The Company accounts for a contract with a customer when there is approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's revenues are measured based on consideration specified in the contract with each customer, net of any sales incentives and amounts collected on behalf of third parties such as sales taxes. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The majority of the Company's revenue arrangements consist of multiple performance obligations including hardware, software, and services. Determining the stand-alone selling price ("SSP") and allocation of consideration from an arrangement to the individual performance obligations, and the appropriate timing of revenue recognition are significant judgments with respect to these arrangements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's products are generally not sold with a right of return, and the Company does not provide credits or incentives, which may be required to be accounted for as variable consideration when estimating the amount of revenue to be recognized.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the Company expects the benefit of those costs to be longer than one year. The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less. These costs mainly include the Company's internal sales force compensation program; under the terms of these programs these are generally earned and the costs are recognized at the time the revenue is recognized.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The majority of the Company&#8217;s products and services are sold in bundled arrangements (e.g., hardware, software, and services). For bundled arrangements, the Company accounts for individual products and services separately if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their individual SSP. The SSP is determined based on observable prices at which the Company separately sells the products and services. If an SSP is not directly observable, then the Company will estimate the SSP considering marketing conditions, entity-specific factors, and information about the customer or class of customer that is reasonably available.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a description of the principal activities, separated by reportable segment, from which the Company generates its revenues.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Oncology Systems</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's Oncology Systems linear accelerators are generally sold in a bundled arrangement with hardware and software accessory products that enhance efficiency and enable delivery of advanced radiotherapy and radiosurgery treatments, however, certain products are occasionally sold on a stand-alone basis. The majority of machine and software sales include installation services and training. Delivery of different elements in a revenue arrangement often span more than one reporting period. For example, a linear accelerator and software may be delivered in one reporting period, but the related installation of those products may be completed in a later period. Hardware and software extended maintenance and service contracts are occasionally sold during the initial product sale, but the majority are sold separately near or at the end of the initial warranty period. Revenues related to extended warranty and service contracts are earned after the expiration of the initial warranty period. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment terms and conditions vary by contract type, although terms are generally commensurate with a significant milestone, such as contract signing, shipment, delivery, acceptance or service commencement. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts generally do not include a significant financing component. The primary purpose of the Company's invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company's products and services, not to receive financing from the Company's customers, such as invoicing at the beginning of a contract term with revenue recognized ratably over the contract period for a service contract. Payment terms can also vary based on the type of customer, such as government purchases. There are occasions where the Company provides extended payment terms in which case a portion of the transaction price is allocated to imputed interest income.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, the Company's contracts are modified to account for additional, or change existing, performance obligations. The Company's contract modifications are generally accounted for prospectively.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hardware Products and Installation </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hardware products may include software that the hardware is dependent on and highly interrelated with and cannot operate without. The Company typically has a standard base configuration for its hardware products, but there are typically multiple options and configuration choices. Revenues from the sale of hardware are recognized when the Company transfers control to the customer.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product installation includes uncrating, moving the machine to the treatment room, connection and validating configuration. In addition, a number of testing protocols are completed to confirm the equipment is performing to the contracted specifications. The Company recognizes revenues for hardware installation over time as the customer receives and consumes benefits provided as the Company performs the installation services.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Software Products and Installation </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software products include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. Software installation includes transferring software to the customer&#8217;s computers, configuration of the software and potentially data migration. The Company recognizes revenues for software and software installation upon the customer's acceptance of the software and installation services.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Service</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service revenues include revenues from initial and extended software support agreements, extended hardware warranty agreements, training, paid service arrangements when a customer does not have an extended warranty and parts that are sold by the service department.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from hardware and software support agreements are accounted for ratably over the term of the agreement. Services and training revenues are recognized in the period the services and training are performed. Revenues for sales of parts are recognized when the parts are delivered to the customer and control is transferred.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Warranties </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's sale of hardware includes a </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">-year warranty. The Company uses the cost accrual method to account for assurance-type warranties. The standard warranty provision further includes services in addition to an assurance-type warranty (preventative maintenance inspections, help desk support, when and if available operating system upgrades). These service-type warranty features are recorded as a separate performance obligation and recognized ratably over the one-year warranty period.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Varian Particle Therapy ("VPT")</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The manufacturing of the major components of a proton therapy system, installation, and commissioning typically lasts </font><font style="font-family:inherit;font-size:10pt;">18</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">24</font><font style="font-family:inherit;font-size:10pt;"> months. The Company's proton therapy system is highly customized. A proton therapy system typically includes hardware, software that the hardware is dependent upon and highly interrelated with, and without which the hardware cannot operate, and installation. The Company also sells software products that include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software, and software installation.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides operations and maintenance services related to the proton therapy system under a separate arrangement. These contracts are typically executed at or about the same time as the proton therapy system contracts; however, the pricing and performance of the proton therapy system contracts are not typically related to the pricing or performance of the operations and maintenance contracts. Therefore, the Company recognizes operations and maintenance services as a separate performance obligation.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the typical payment terms of the Company's fixed-price contracts, the customer pays the Company an up-front advance payment and then performance-based payments based on quantifiable measures of performance or on the achievement of specified events or milestones. As the revenue is recognized over time relative to the costs incurred and the customer billing milestones are typically event driven, this may result in revenue recognized in excess of billings at some point during the contract which the Company presents as unbilled receivables on the Condensed Consolidated Balance Sheets. Amounts billed and due from the Company's customers are classified as trade accounts receivable on the Condensed Consolidated Balance Sheets. In most contracts, the Company is entitled to receive an advance payment at the beginning of the contract. The Company recognizes a liability for these advance payments in excess of revenue recognized and presents it as deferred revenues on the Condensed Consolidated Balance Sheets. The advance payment typically is not considered a significant financing component because it is used to ensure the customer's commitment to the project. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue for its proton therapy systems over time because the customer controls the work in process, the Company's performance does not create an asset with an alternative use to the Company, and the Company has an enforceable right to payment for performance completed to date.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due to the nature of the work required to be performed on many of the Company's performance obligations, the estimation of total revenues and costs at completion is complex, subject to many variables and requires significant judgment. The Company's contracts generally do not include award fees, incentive fees or other provisions that may be considered variable consideration. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a standard quarterly progress review process in which management reviews the progress and execution of the Company's performance obligations. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and costs to achieve the schedule (e.g., the number and type of milestone events), technical and other contract requirements. Management must make assumptions and estimates regarding the complexity of the work to be performed, the availability of materials and outside services, the length of time to complete the performance obligation and labor and overhead cost rates, among other significant judgments. Based on this analysis, any quarterly adjustments to revenues, cost of revenues, and the related impact to operating earnings are recognized as necessary in the period they become known on a cumulative catch-up basis. When estimates of total costs to be incurred on a performance obligation exceed total estimates of revenues to be earned, a provision for the entire loss on the performance obligation is recognized in the period the loss is determined.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Similar to the Oncology Systems segment, the Company recognizes VPT revenues for software and installation upon completion and acceptance of the software and installation services. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Unfulfilled Performance Obligations for Oncology Systems and VPT</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the Company's unfulfilled performance obligations as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and the estimated revenue expected to be recognized in the future related to these unfulfilled performance obligations: </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal years of revenue recognition</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Thereafter</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unfulfilled Performance Obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,060.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,089.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,276.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table above includes both product and service unfulfilled performance obligations, which includes a component of service performance obligations which have not been invoiced. The time bands reflect management&#8217;s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers&#8217; facilities for installation, installation requirements, and availability of products or customer acceptance terms.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the Company's adoption of ASC 606, the Company elected to use the following practical expedients (i) to exclude disclosures of transaction prices allocated to remaining performance obligations when the Company expects to recognize such revenue for all periods prior to the date of initial application of ASC 606 (ii) not to adjust the promised amount of consideration for the effects of a significant financing component when the Company expects, at contract inception, that the period between the Company's transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less (iii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less, which mainly includes the Company's internal sales force compensation program and certain partner sales incentive programs (iv) not to recast revenue for contracts that begin and end in the same fiscal period, and (v) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contract Balances</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The timing of revenue recognition, billings and cash collections results in trade and unbilled receivables, and deferred revenues on the Condensed Consolidated Balance Sheet. In Oncology Systems, the Company often collects an advance payment and the balance is typically billed on a combination of delivery and/or acceptance. In VPT, the Company usually collects an advance payment and additional amounts are billed as work progresses in accordance with agreed-upon contractual terms upon achievement of contractual milestones. Service contracts are usually billed at the beginning of the contract period or at periodic intervals (e.g. monthly or quarterly) during the contract which could result in a contract asset and contract liability. At times, billing occurs subsequent to revenue recognition, resulting in an unbilled receivable which represents a contract asset. However, when the Company receives advances or deposits from customers, which can be higher in the initial stages of the contract, particularly international contracts in the case of Oncology Systems, before revenue is recognized, this results in deferred revenues which represents a contract liability. These contract assets and liabilities are reported as unbilled receivables and deferred revenues, respectively, on the Condensed Consolidated Balance Sheet on a contract-by-contract basis at the end of each reporting period. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board ("FASB") issued ASC 606. Under the standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration the entity expects to receive in exchange for those goods or services. Effective September 30, 2017, the Company elected to early adopt the requirements of ASC 606 using the full retrospective method, which required the Company to recast the prior reporting periods presented.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The most significant impacts on adoption were in the Oncology Systems segment and are primarily due to the removal of the contingent revenue cap which limited revenue recognition to the amount of cash received from the customer, the elimination of the mandatory revenue deferral for software sold with extended payment terms and the removal of the vendor-specific objective evidence requirement for the separation of bundled software products. The Company also identified additional performance obligations for training and certain elements of warranty that are recognized as separate performance obligations, and identified that certain new performance obligations were previously accounted for as part of hardware products and will result in a change in classification of revenues from product to service. In preparation for adoption of the standard, the Company implemented internal controls and key system functionalities to enable the preparation of financial information. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recast its condensed consolidated financial statements from amounts previously reported due to the adoption of ASC 606. Select Condensed Consolidated Statements of Earnings (Loss) line items, which reflect the adoption of ASC 606 are as follows: </font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adjusted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adjusted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">386.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">655.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,266.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">254.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">478.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cost of revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">387.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">715.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">722.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross margin</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">551.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from continuing operations before taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes on earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net earnings per share from continuing operations attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.89</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.82</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Select Condensed Consolidated Statements of Balance Sheet line items, which reflect the adoption of ASC 606 are as follows: </font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adjusted</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade and unbilled receivables, net </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">823.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities and Equity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">394.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">374.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">640.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">755.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">756.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">778.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the cumulative effect of ASC 606 to the Company's retained earnings at October 2, 2015 was </font><font style="font-family:inherit;font-size:10pt;">$56.7 million</font><font style="font-family:inherit;font-size:10pt;">. Adoption of ASC 606 had no impact to net cash from or used in operating, investing or financing activities in the Company's Condensed Consolidated Statements of Cash Flows.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance which targeted improvements to the accounting for hedging activities. The guidance allows companies to more accurately present the economic effects of risk management activities in the financial statements. This amendment is required to be applied prospectively. The primary impact of the adoption is the required disclosure changes. The adoption of the new guidance did not have a material impact on the Company's condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company adopted the FASB guidance related to employee share-based payments. The amendment simplifies several aspects of the accounting for employee share-based payments including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The Company elected to use the prospective transition method for the presentation of excess tax benefits on the statement of cash flows. Under the new standard, excess tax benefits are now included in taxes on earnings in the Consolidated Statement of Earnings (Loss). The Company elected to recognize forfeitures as they occur, and the impact of this change in accounting policy was recorded as a </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> reduction, net, to its beginning retained earnings balance as of September 30, 2017. See </font><font style="font-family:inherit;font-size:10pt;">Note 12, "Income Taxes"</font><font style="font-family:inherit;font-size:10pt;"> for more information on the impact of this accounting guidance. The remaining provisions of this amendment did not have a material impact on the Company's condensed consolidated financial statements. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company adopted the FASB accounting guidance related to inventory measurement. The amendment requires inventory measured using first-in, first-out (FIFO) or average cost to be subsequently measured at the lower of cost and net realizable value, thereby simplifying the current guidance that requires an entity to measure inventory at the lower of cost or market. This amendment is required to be applied prospectively. The adoption of this new guidance did not have a material impact to the Company&#8217;s condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance on the definition of a business in accounting for transactions when determining whether they represent acquisitions or disposals of assets or of a business. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company&#8217;s condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance simplifying the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company&#8217;s condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standards or Updates Not Yet Effective</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2018, the FASB amended its guidance that will allow companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2020. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB provided guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The guidance is effective for the Company beginning in the first quarter of fiscal 2019. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, the FASB amended its guidance on the accounting related to defined benefit plans and other post-retirement benefits. This amendment requires the service cost component of net periodic pension and post-retirement benefit cost be presented in the same line item as other employee compensation costs, while the other components be presented separately as non-operating income (expense). The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2016, the FASB amended its guidance on the classification and presentation of restricted cash in the statement of cash flow. The amendment requires entities to include restricted cash and restricted cash equivalents in its cash and cash equivalents in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively. The amendment is not expected to have a material impact to the Company&#8217;s condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB amended its guidance for tax accounting for intra-entity asset transfers. The amendment removes the prohibition against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The amendment is required to be adopted on a modified retrospective basis. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued an amendment to its accounting guidance related to the classification of certain cash receipts and cash payments. The amendment was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively unless it is impracticable. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued an amendment to its accounting guidance related to impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021 with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued a new standard on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company is evaluating the impact of adopting this new standard to its condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued an amendment to its accounting guidance related to recognition and measurement of financial assets and financial liabilities. The amendment addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCKHOLDERS&#8217; EQUITY AND NONCONTROLLING INTERESTS</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share Repurchase Program</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2016, the VMS Board of Directors authorized the repurchase of an additional </font><font style="font-family:inherit;font-size:10pt;">8.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of VMS common stock commencing on January 1, 2017. Share repurchases under the Company's authorizations may be made in open market purchases, in privately negotiated transactions (including accelerated share repurchase (&#8220;ASR&#8221;) programs), or under Rule 10b5-1 share repurchase plans, and may be made from time to time in one or more blocks. All shares that were repurchased under the Company's share repurchase programs have been retired. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">4.4 million</font><font style="font-family:inherit;font-size:10pt;"> shares of VMS common stock remained available for repurchase under the November 2016 authorization. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company repurchased shares of VMS common stock under various authorizations during the periods presented as follows:</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average repurchase price per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.42</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109.06</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Comprehensive Earnings</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-top:8px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Unrealized Gains<br clear="none"/>(Losses) Defined<br clear="none"/>Benefit Pension and<br clear="none"/>Post-Retirement<br clear="none"/>Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net<br clear="none"/>Unrealized<br clear="none"/>Gains<br clear="none"/>(Losses)<br clear="none"/>Cash Flow<br clear="none"/>Hedging<br clear="none"/>Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cumulative<br clear="none"/>Translation<br clear="none"/>Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated<br clear="none"/>Other<br clear="none"/>Comprehensive<br clear="none"/>Loss</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44.1</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24.7</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified out of other comprehensive earnings (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(58.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Unrealized Gains<br clear="none"/>(Losses) Defined<br clear="none"/>Benefit Pension and<br clear="none"/>Post-Retirement<br clear="none"/>Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cumulative<br clear="none"/>Translation<br clear="none"/>Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated<br clear="none"/>Other<br clear="none"/>Comprehensive Earnings<br clear="none"/>(Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(63.3</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37.5</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100.8</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive loss before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified out of other comprehensive earnings (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.9</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cff0fc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cff0fc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(109.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cff0fc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amounts reclassified out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings (Loss), with line item location, during each period were as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Comprehensive Earnings Components</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss Before Taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Loss Before Taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Line Item in Statements of Earnings (Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized loss on defined benefit pension and post-retirement benefit plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues &amp; Operating expenses</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized loss on cash flow hedging instruments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total amounts reclassified out of other comprehensive earnings (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Noncontrolling Interests</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Distribution of Varex in January 2017, the Company's redeemable noncontrolling interests relating to MeVis Medical Solutions AG ("MeVis") were transferred to Varex.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in noncontrolling interests and redeemable noncontrolling interests relating to MeVis and other subsidiaries of the Company were as follows:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Noncontrolling Interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Noncontrolling Interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Redeemable Noncontrolling Interests</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Beginning of Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfer of redeemable noncontrolling interests in MeVis to Varex</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">End of Period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUBSEQUENT EVENTS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Sirtex.</font><font style="font-family:inherit;font-size:10pt;"> On January 30, 2018, the Company signed an agreement to acquire Sirtex, an Australian company that is listed on the Australian Securities Exchange, for </font><font style="font-family:inherit;font-size:10pt;">A$28</font><font style="font-family:inherit;font-size:10pt;"> per share or approximately </font><font style="font-family:inherit;font-size:10pt;">A$1.6 billion</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">$1.2 billion</font><font style="font-family:inherit;font-size:10pt;"> as of March 30, 2018). The transaction has received all necessary regulatory approvals, is subject to the approval of the Sirtex shareholders, the Federal Court of Australia and the satisfaction of other customary closing conditions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 4, 2018, Sirtex received an unsolicited non-binding, indicative and conditional proposal from CDH, a China-based alternative asset manager, for the acquisition of all of the issued shares in Sirtex for </font><font style="font-family:inherit;font-size:10pt;">A$33.60</font><font style="font-family:inherit;font-size:10pt;"> per share. The Sirtex board of directors has determined to engage with CDH to further understand the conditions associated with the CDH proposal. As a result, the meeting of Sirtex shareholders to approve the acquisition by Varian, which was scheduled to occur on Monday, May 7, 2018 (Sydney time), was adjourned to a time and date to be determined. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Borrowings.</font><font style="font-family:inherit;font-size:10pt;"> On April 3, 2018, the Company entered into the 2018 Credit Agreement with certain lenders and Bank of America, N.A. as administrative agent. The 2018 Credit Agreement provides for a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year revolving credit facility (the "2018 Revolving Credit Facility") in an aggregate principal amount of up to </font><font style="font-family:inherit;font-size:10pt;">$1.8 billion</font><font style="font-family:inherit;font-size:10pt;">. The 2018 Revolving Credit Facility also includes a </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;"> sub-facility for the issuance of letters of credit and permits swing line loans of up to </font><font style="font-family:inherit;font-size:10pt;">$25 million</font><font style="font-family:inherit;font-size:10pt;">. Under the 2018 Revolving Credit Facility, the Company has the right to make (i) a request to increase the aggregate commitments by an aggregate amount for all such requests of up to </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;"> and (ii) request an additional increase in the commitments or establish one or more term loans, provided that, in each case, the lenders are willing to provide such new or increased commitments and certain other conditions are met. The proceeds of the 2018 Revolving Credit Facility may be used for working capital, capital expenditures, to pay the consideration for the Sirtex acquisition, Company share repurchases, permitted acquisitions and other corporate purposes, as well as to satisfy the outstanding obligation under the 2017 Revolving Credit Facility. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2018 Revolving Credit Facility replaces the 2017 Revolving Credit Facility of </font><font style="font-family:inherit;font-size:10pt;">$600 million</font><font style="font-family:inherit;font-size:10pt;">. The Company borrowed </font><font style="font-family:inherit;font-size:10pt;">$255.0 million</font><font style="font-family:inherit;font-size:10pt;"> under the 2018 Revolving Credit Facility and repaid in full the </font><font style="font-family:inherit;font-size:10pt;">$255.0 million</font><font style="font-family:inherit;font-size:10pt;"> then outstanding principal balance on its 2017 Revolving Credit Facility, plus accrued interest and fees.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BALANCE SHEET COMPONENTS</font><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers: </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unbilled receivables - current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unbilled receivables - long-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenues - current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(766.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(755.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenues - long-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net unbilled receivables (deferred revenues)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(435.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(492.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, unbilled receivables net of deferred revenues </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;"> by </font><font style="font-family:inherit;font-size:10pt;">$56.7 million</font><font style="font-family:inherit;font-size:10pt;"> primarily due to the contractual timing of billings occurring after the revenues were recognized, as well as the timing of milestone payments.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company recognized revenues of </font><font style="font-family:inherit;font-size:10pt;">$108.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$305.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, which was included in the deferred revenues balance at </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">. During the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company recognized revenues of </font><font style="font-family:inherit;font-size:10pt;">$127.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$346.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, which was included in the deferred revenues balance at </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company did not have any impairment losses on its unbilled receivables during the </font><font style="font-family:inherit;font-size:10pt;">six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">. The Company recognized an impairment loss of </font><font style="font-family:inherit;font-size:10pt;">$17.2 million</font><font style="font-family:inherit;font-size:10pt;"> from long-term unbilled receivables during the six months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. See </font><font style="font-family:inherit;font-size:10pt;">Note 16, "VPT Loans and Securities"</font><font style="font-family:inherit;font-size:10pt;"> for further information.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's inventories:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials and parts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">306.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables summarize the Company's available-for-sale securities:</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APTC securities </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Original CPTC loans </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DRTC securities</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets because the Company has the ability and intent to sell this security in the next twelve months. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets because the maturity dates are greater than one year and the Company does not have the intent and ability to collect or sell all or a portion of its loans or securities in the next twelve months.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See </font><font style="font-family:inherit;font-size:10pt;">Note 5, "Fair Value"</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">Note 16, "VPT Loans and Securities"</font><font style="font-family:inherit;font-size:10pt;"> for more information on the Original California Proton Treatment Center, LLC (&#8220;Original CPTC&#8221;) Loans, Alabama Proton Therapy Center ("APTC"), Delray Radiation Therapy Center (&#8220;DRTC&#8221;), and Georgia Proton Treatment Center ("GPTC") Securities. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's other long-term liabilities:</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term income taxes payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board ("FASB") issued ASC 606. Under the standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration the entity expects to receive in exchange for those goods or services. Effective September 30, 2017, the Company elected to early adopt the requirements of ASC 606 using the full retrospective method, which required the Company to recast the prior reporting periods presented.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The most significant impacts on adoption were in the Oncology Systems segment and are primarily due to the removal of the contingent revenue cap which limited revenue recognition to the amount of cash received from the customer, the elimination of the mandatory revenue deferral for software sold with extended payment terms and the removal of the vendor-specific objective evidence requirement for the separation of bundled software products. The Company also identified additional performance obligations for training and certain elements of warranty that are recognized as separate performance obligations, and identified that certain new performance obligations were previously accounted for as part of hardware products and will result in a change in classification of revenues from product to service. In preparation for adoption of the standard, the Company implemented internal controls and key system functionalities to enable the preparation of financial information. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has recast its condensed consolidated financial statements from amounts previously reported due to the adoption of ASC 606. Select Condensed Consolidated Statements of Earnings (Loss) line items, which reflect the adoption of ASC 606 are as follows: </font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adjusted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adjusted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">386.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">729.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">655.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">663.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,266.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">254.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">478.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cost of revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">387.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">715.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">722.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross margin</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">275.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">551.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from continuing operations before taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes on earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings from continuing operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss from discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net earnings per share from continuing operations attributable to Varian</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.89</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.82</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Select Condensed Consolidated Statements of Balance Sheet line items, which reflect the adoption of ASC 606 are as follows: </font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Previously Reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As Adjusted</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade and unbilled receivables, net </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">823.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities and Equity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">394.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">374.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">640.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">755.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">756.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">778.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the cumulative effect of ASC 606 to the Company's retained earnings at October 2, 2015 was </font><font style="font-family:inherit;font-size:10pt;">$56.7 million</font><font style="font-family:inherit;font-size:10pt;">. Adoption of ASC 606 had no impact to net cash from or used in operating, investing or financing activities in the Company's Condensed Consolidated Statements of Cash Flows.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance which targeted improvements to the accounting for hedging activities. The guidance allows companies to more accurately present the economic effects of risk management activities in the financial statements. This amendment is required to be applied prospectively. The primary impact of the adoption is the required disclosure changes. The adoption of the new guidance did not have a material impact on the Company's condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company adopted the FASB guidance related to employee share-based payments. The amendment simplifies several aspects of the accounting for employee share-based payments including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The Company elected to use the prospective transition method for the presentation of excess tax benefits on the statement of cash flows. Under the new standard, excess tax benefits are now included in taxes on earnings in the Consolidated Statement of Earnings (Loss). The Company elected to recognize forfeitures as they occur, and the impact of this change in accounting policy was recorded as a </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> reduction, net, to its beginning retained earnings balance as of September 30, 2017. See </font><font style="font-family:inherit;font-size:10pt;">Note 12, "Income Taxes"</font><font style="font-family:inherit;font-size:10pt;"> for more information on the impact of this accounting guidance. The remaining provisions of this amendment did not have a material impact on the Company's condensed consolidated financial statements. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company adopted the FASB accounting guidance related to inventory measurement. The amendment requires inventory measured using first-in, first-out (FIFO) or average cost to be subsequently measured at the lower of cost and net realizable value, thereby simplifying the current guidance that requires an entity to measure inventory at the lower of cost or market. This amendment is required to be applied prospectively. The adoption of this new guidance did not have a material impact to the Company&#8217;s condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance on the definition of a business in accounting for transactions when determining whether they represent acquisitions or disposals of assets or of a business. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company&#8217;s condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance simplifying the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company&#8217;s condensed consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECEIVABLES </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's trade and unbilled receivables, net and notes receivable: </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade and unbilled receivables, gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,008.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,039.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for doubtful accounts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(63.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade and unbilled receivables, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">968.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">976.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">936.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notes receivable</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) (3)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Balances are included in other assets on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balances are included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A financing receivable represents a financing arrangement with a contractual right to receive money, on demand or on fixed or determinable dates, and that is recognized as an asset on the Company&#8217;s Condensed Consolidated Balance Sheets. The Company&#8217;s financing receivables consist of trade receivables with contractual maturities of more than one year and notes receivable. A small portion of the Company's financing trade receivables are included in short-term trade accounts receivable. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the allowance for doubtful accounts is entirely related to short-term trade and unbilled receivables. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, the allowance for doubtful accounts included </font><font style="font-family:inherit;font-size:10pt;">$45.9 million</font><font style="font-family:inherit;font-size:10pt;"> related to short-term trade and unbilled receivables and </font><font style="font-family:inherit;font-size:10pt;">$17.2 million</font><font style="font-family:inherit;font-size:10pt;"> related to long-term unbilled receivables, which was written off in the first quarter of fiscal year 2018. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See </font><font style="font-family:inherit;font-size:10pt;">Note 16, "VPT Loans and Securities"</font><font style="font-family:inherit;font-size:10pt;"> for more information on the Company's short-term and long-term notes receivable balances.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in noncontrolling interests and redeemable noncontrolling interests relating to MeVis and other subsidiaries of the Company were as follows:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Noncontrolling Interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Noncontrolling Interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Redeemable Noncontrolling Interests</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Beginning of Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfer of redeemable noncontrolling interests in MeVis to Varex</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">End of Period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table lists the Company's outstanding loans and investments, including accrued interest, and commitments for funding development, construction and operations of various proton therapy centers:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Commitment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Commitment</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Notes receivable and secured debt:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MPTC loans</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RPTC senior secured debt</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NYPC loan</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PI loan</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CPTC DIP loan</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Available-for-sale Securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APTC securities </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Original CPTC loans</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DRTC securities</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">CPTC Loans and Investment:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term revolving loan </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loan </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity investment in CPTC</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Includes </font><font style="font-family:inherit;font-size:9pt;">$33.8 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$42.3 million</font><font style="font-family:inherit;font-size:9pt;"> in other assets at </font><font style="font-family:inherit;font-size:9pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:9pt;">, respectively, and </font><font style="font-family:inherit;font-size:9pt;">$25.1 million</font><font style="font-family:inherit;font-size:9pt;"> in prepaid and other current assets at </font><font style="font-family:inherit;font-size:9pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> and other assets at </font><font style="font-family:inherit;font-size:9pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:9pt;"> on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other assets at </font><font style="font-family:inherit;font-size:9pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:9pt;"> on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of share-based awards available for grant is as follows:</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares Available for Grant</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at September 29, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Authorized </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at March 30, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">On February 8, 2018, the Company's stockholders approved its Fifth Amended and Restated 2005 Omnibus Stock Plan ("2005 Plan") to increase the number of shares authorized for issuance by </font><font style="font-family:inherit;font-size:9pt;">6.0 million</font><font style="font-family:inherit;font-size:9pt;"> shares.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company repurchased shares of VMS common stock under various authorizations during the periods presented as follows:</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average repurchase price per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.42</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109.06</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">VPT LOANS AND INVESTMENT</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In limited cases, the Company participates, along with other investors and at market terms, in the financing of proton therapy centers. Over time the Company has divested some of its investments, including investments in CPTC, NYPC and DRTC. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table lists the Company's outstanding loans and investments, including accrued interest, and commitments for funding development, construction and operations of various proton therapy centers:</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March&#160;30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;29, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Commitment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Commitment</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Notes receivable and secured debt:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MPTC loans</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RPTC senior secured debt</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NYPC loan</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PI loan</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CPTC DIP loan</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Available-for-sale Securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">APTC securities </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GPTC securities</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Original CPTC loans</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DRTC securities</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;</sup></font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">CPTC Loans and Investment:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term revolving loan </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loan </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity investment in CPTC</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#160;(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Includes </font><font style="font-family:inherit;font-size:9pt;">$33.8 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$42.3 million</font><font style="font-family:inherit;font-size:9pt;"> in other assets at </font><font style="font-family:inherit;font-size:9pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:9pt;">, respectively, and </font><font style="font-family:inherit;font-size:9pt;">$25.1 million</font><font style="font-family:inherit;font-size:9pt;"> in prepaid and other current assets at </font><font style="font-family:inherit;font-size:9pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:9pt;"> and other assets at </font><font style="font-family:inherit;font-size:9pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:9pt;"> on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Included in other assets at </font><font style="font-family:inherit;font-size:9pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:9pt;"> on the Company's Condensed Consolidated Balance Sheets.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Alabama Proton Therapy Center ("APTC") Securities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2017, the Company purchased </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;"> in Subordinate Revenue Bonds from the Public Finance Authority which is financing the APTC. The Subordinate Revenue Bonds carry an interest rate of </font><font style="font-family:inherit;font-size:10pt;">8.5%</font><font style="font-family:inherit;font-size:10pt;"> and pay interest semi-annually. The Company is scheduled, based upon the terms, to start receiving annual principal payments on the Subordinate Revenue Bonds beginning on November 1, 2022. The Subordinate Revenue Bonds will mature on October 1, 2047. </font></div><div style="line-height:120%;padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Rinecker</font><font style="font-family:inherit;font-size:12pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Proton Therapy Center ("RPTC") Senior Secured Debt</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2017, the Company purchased the outstanding senior secured debt related to the RPTC in Munich, Germany for </font><font style="font-family:inherit;font-size:10pt;">21.5 million</font><font style="font-family:inherit;font-size:10pt;"> Euros or </font><font style="font-family:inherit;font-size:10pt;">$24.5 million</font><font style="font-family:inherit;font-size:10pt;">. By purchasing the senior secured debt, the Company has a right to </font><font style="font-family:inherit;font-size:10pt;">89 million</font><font style="font-family:inherit;font-size:10pt;"> Euros in claims against all of RPTC's assets. In September 2017, the management of RPTC filed for bankruptcy in Germany. In January 2018, the final insolvency proceedings commenced, and the Company expects the insolvency proceedings to be finalized within the next twelve months. Upon finalization of bankruptcy proceedings, the Company believes it is probable it will recover its outstanding senior secured debt balance and trade accounts receivable, net.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At both </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;">, in trade receivables, net for RPTC, which does not include any unbilled receivables.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Georgia Proton Treatment Center ("GPTC") Security</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2017, the Company committed to purchase up to </font><font style="font-family:inherit;font-size:10pt;">$16.1 million</font><font style="font-family:inherit;font-size:10pt;"> in Senior Capital Appreciation Bonds ("Senior Bonds") from the Atlanta Development Authority, which is financing the GPTC. In July 2017, the Company purchased </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;"> of the Senior Bonds that carry an interest rate of </font><font style="font-family:inherit;font-size:10pt;">8.0%</font><font style="font-family:inherit;font-size:10pt;"> per annum with interest accruing up to the principal amount of </font><font style="font-family:inherit;font-size:10pt;">$6.6 million</font><font style="font-family:inherit;font-size:10pt;"> until January 1, 2023 and then will pay cash interest semi-annually. The Company will purchase the remaining commitment in July 2018. The Company is scheduled, based upon the original terms, to start receiving annual principal payments on the Senior Bonds beginning on January 1, 2024. The Senior Bonds will mature on January 1, 2028. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the outstanding loan, the Company had </font><font style="font-family:inherit;font-size:10pt;">$6.4 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> in trade and unbilled receivables, which included </font><font style="font-family:inherit;font-size:10pt;">$6.2 million</font><font style="font-family:inherit;font-size:10pt;"> in unbilled receivables from GPTC. The Company did not have any trade and unbilled receivables as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;"> from GPTC.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Delray Radiation Therapy Center ("DRTC") Securities and Loan</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2017, the Company purchased </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;"> in Subordinate Bonds from the Public Finance Authority, which is financing the DRTC. The Subordinate Bonds carried an interest rate of </font><font style="font-family:inherit;font-size:10pt;">8.5%</font><font style="font-family:inherit;font-size:10pt;"> and paid interest semi-annually. In January 2018, the Company sold all of its Subordinate Bonds for </font><font style="font-family:inherit;font-size:10pt;">$8.5 million</font><font style="font-family:inherit;font-size:10pt;">, which included accrued interest. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the purchase of the Subordinate Bonds, the Company also loaned </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> to Proton International LLC ("PI") to allow PI to purchase </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> in Subordinate Bonds from the Public Finance Authority. The loan to PI carries an interest rate of </font><font style="font-family:inherit;font-size:10pt;">8.5%</font><font style="font-family:inherit;font-size:10pt;"> per annum, paid semi-annually and matures on April 30, 2022, subject to early repayment as proceeds are received by PI from the bonds purchased, and is secured by the related bonds. In the first quarter of fiscal year 2018, the Company received a principal payment of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">New York Proton Center ("NYPC") Loan</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the Company committed to loan up to </font><font style="font-family:inherit;font-size:10pt;">$91.5 million</font><font style="font-family:inherit;font-size:10pt;"> to MM Proton I, LLC in connection with a purchase agreement to supply a proton system to equip the NYPC. In June 2016, the Company assigned </font><font style="font-family:inherit;font-size:10pt;">$73.0 million</font><font style="font-family:inherit;font-size:10pt;"> of this loan to Deutsche Bank AG. The remaining balance is comprised of an </font><font style="font-family:inherit;font-size:10pt;">$18.5 million</font><font style="font-family:inherit;font-size:10pt;"> &#8220;Subordinate Loan&#8221; with a six-and-a-half-year term at up to </font><font style="font-family:inherit;font-size:10pt;">13.5%</font><font style="font-family:inherit;font-size:10pt;"> interest. The principal balance and accrued interest on the Subordinate Loan are due in full at maturity in January 2022. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the outstanding loan, the Company had </font><font style="font-family:inherit;font-size:10pt;">$13.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$13.3 million</font><font style="font-family:inherit;font-size:10pt;">, as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, in trade and unbilled receivables, which included </font><font style="font-family:inherit;font-size:10pt;">$13.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> in unbilled receivables as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, from NYPC. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Maryland Proton Treatment Center ("MPTC") Loans</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2015, the Company committed to loan up to </font><font style="font-family:inherit;font-size:10pt;">$35.0 million</font><font style="font-family:inherit;font-size:10pt;"> to MPTC. The Company completed its funding requirements per the loan agreement in the first quarter of fiscal year 2017. Varian's lending is in the form of a subordinated loan that is due, with accrued interest, in </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> annual payments from 2020 to 2022. The interest on the loan accrues at </font><font style="font-family:inherit;font-size:10pt;">12.0%</font><font style="font-family:inherit;font-size:10pt;">. In the second quarter of fiscal year 2018, the Company recorded an </font><font style="font-family:inherit;font-size:10pt;">$11.1 million</font><font style="font-family:inherit;font-size:10pt;"> impairment charge on its MPTC subordinated loan, which included accrued interest, due to the expected difference in value between the security currently held by the Company and the value of the new security that will be issued to the Company in exchange as part of the refinancing expected in the second half of fiscal year 2018.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Company had previously entered into an agreement with MPTC to supply it with a proton system, which included a deferral of up to </font><font style="font-family:inherit;font-size:10pt;">$25.1 million</font><font style="font-family:inherit;font-size:10pt;"> of equipment payments when triggered by achievement of delivery milestones under the contract. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has recorded </font><font style="font-family:inherit;font-size:10pt;">$25.1 million</font><font style="font-family:inherit;font-size:10pt;"> as a notes receivable related to this deferred payment arrangement. The notes receivable is due September 30, 2018. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;"> net trade and unbilled receivables from MPTC. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Variable Interest Entities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has determined that MM Proton I, LLC, MPTC, and RPTC are variable interest entities and that the Company holds a significant variable interest of each of the entities through its participation in the loan facilities and its agreements to supply and service the proton therapy equipment.&#160;The Company has concluded that it is not the primary beneficiary of any of these entities. The Company has no voting rights, has no approval authority or veto rights for these centers' budget, and does not have the power to direct patient recruitment, clinical operations and management of these Centers, which the Company believes are the matters that most significantly affect their economic performance. The Company&#8217;s exposure to loss as a result of its involvement with MM Proton I, LLC, MPTC, and RPTC is limited to the carrying amounts of the above-mentioned assets on its Condensed Consolidated Balance Sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">California Proton Therapy Center ("CPTC") Loans and Investment</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Between September 2011 and November 2015, the Company, ORIX and J.P. Morgan (&#8220;the Lenders&#8221;) committed to loan up to </font><font style="font-family:inherit;font-size:10pt;">$185.0 million</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;Original CPTC Loans&#8221;), of which the Company's commitment was </font><font style="font-family:inherit;font-size:10pt;">$84.7 million</font><font style="font-family:inherit;font-size:10pt;">, to fund the development, construction, initial operations, and working capital needs of the Scripps Proton Therapy Center in San Diego, California. ORIX is the loan agent. In November 2015, the Lenders and California Proton Treatment Center ("Original CPTC") entered into a forbearance agreement whereby the Lenders agreed not to enforce their rights to principal and interest payments until April 2017, subject to Original CPTC maintaining certain covenants and achieving certain targets, with additional extensions through September 2017 based on hitting additional targets largely around patient volume and cash flow. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December 30, 2016, even though patient volumes continued to increase, Original CPTC was not in compliance with one of the patient volume covenants in the forbearance agreement, which would allow the Lenders to cease funding and terminate the forbearance agreement. In January 2017, the Company was informed of actions taken by Original CPTC and the loan agent, including Original CPTC obtaining shareholder consents for voluntary bankruptcy filing and the loan agent deciding that no additional funding would be available outside of a bankruptcy process. As a result of this information and the Company&#8217;s analysis that these actions would likely lead to insolvency or bankruptcy proceedings of Original CPTC, the Company determined that it was appropriate to record a </font><font style="font-family:inherit;font-size:10pt;">$38.3 million</font><font style="font-family:inherit;font-size:10pt;"> impairment, as determined by the discounted cash flow model using a single best estimate methodology, of its Original CPTC Loans on the Condensed Consolidated Statements of Earnings in the first quarter of fiscal year 2017. As a result of this impairment, the Original CPTC Loans were written down to their estimated fair value of </font><font style="font-family:inherit;font-size:10pt;">$60.0 million</font><font style="font-family:inherit;font-size:10pt;"> and reclassified from short-term investments to other assets on the Company's Condensed Consolidated Balance Sheet because the Company did not expect to collect or sell all or a portion of these loans in the next twelve months.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2017, Original CPTC filed for bankruptcy and concurrently entered into a Debtor-in-Possession facility (the "DIP Facility") with the Lenders for up to </font><font style="font-family:inherit;font-size:10pt;">$16.0 million</font><font style="font-family:inherit;font-size:10pt;"> of additional financing during the bankruptcy process. The Company's pro-rata share of the DIP Facility was </font><font style="font-family:inherit;font-size:10pt;">$7.3 million</font><font style="font-family:inherit;font-size:10pt;">. In December 2017, the Company completed its funding commitment under the DIP Facility. The DIP Facility carried an interest rate at the London Interbank Offer Rate (&#8220;LIBOR&#8221;) plus </font><font style="font-family:inherit;font-size:10pt;">9.0%</font><font style="font-family:inherit;font-size:10pt;"> per annum and had a senior secured position ahead of the Original CPTC Loans. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Between April 2017 and August 2017, the Company did not become aware of any new information that warranted an impairment assessment. In September 2017, the Lenders and Scripps signed a Transition Agreement to transition the operations of the center from Scripps to Proton Doctors Professional Corporation (&#8220;Practice&#8221;). Based on the terms of the Transition Agreement, a slower projected growth in patient volume, an increase in additional projected capital needs and the Company's analysis, the Company determined that an additional </font><font style="font-family:inherit;font-size:10pt;">$13.1 million</font><font style="font-family:inherit;font-size:10pt;"> impairment charge was deemed appropriate on its Original CPTC Loans which was recorded on the Consolidated Statements of Earnings in the fourth quarter of fiscal year 2017. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to an order of the Bankruptcy Court, Original CPTC conducted an auction of the Scripps Proton Therapy Center. On December 6, 2017 (&#8220;Closing Date&#8221;), the Bankruptcy Court approved the sale of Scripps Proton Therapy Center to California Proton Therapy Center, LLC (&#8220;CPTC&#8221;), an entity owned by the Lenders. The Lenders purchased all assets and assumed </font><font style="font-family:inherit;font-size:10pt;">$112.0 million</font><font style="font-family:inherit;font-size:10pt;"> of Original CPTC&#8217;s outstanding liabilities. On December 13, 2017, the Bankruptcy Court dismissed the bankruptcy filing of Original CPTC. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On the Closing Date, the Lenders entered into a Credit Agreement with Original CPTC of which the terms of the Original CPTC Loans, DIP Facility and accrued interest (collectively &#8220;Former Loans&#8221;) have been modified. In addition to the partially satisfied Original CPTC Loans reinstated by the Bankruptcy Court, the Company received a </font><font style="font-family:inherit;font-size:10pt;">47.08%</font><font style="font-family:inherit;font-size:10pt;"> equity ownership in CPTC. Original CPTC has assigned all its Former Loans to CPTC at an amount of </font><font style="font-family:inherit;font-size:10pt;">$112.0 million</font><font style="font-family:inherit;font-size:10pt;">, the partially satisfied loan balance. Per the terms of the Credit Agreement, the Company's portion of the </font><font style="font-family:inherit;font-size:10pt;">$112.0 million</font><font style="font-family:inherit;font-size:10pt;"> is </font><font style="font-family:inherit;font-size:10pt;">$53.5 million</font><font style="font-family:inherit;font-size:10pt;">; the remainder is allocated between ORIX and J.P. Morgan. The </font><font style="font-family:inherit;font-size:10pt;">$53.5 million</font><font style="font-family:inherit;font-size:10pt;"> is composed of </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> Tranches: Tranche A of </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, Tranche B of </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;">, Tranche C of </font><font style="font-family:inherit;font-size:10pt;">$15.6 million</font><font style="font-family:inherit;font-size:10pt;">, and Tranche D of </font><font style="font-family:inherit;font-size:10pt;">$28.7 million</font><font style="font-family:inherit;font-size:10pt;"> (collectively the "Term Loan"). The maturity date of the Term Loan is </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years from the Closing Date. The Term Loan is secured by the assets of CPTC. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Lenders have committed to lend up to </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;"> in a Revolving Loan with a maturity date of </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> year from the Closing Date. The Company's share of the funding commitment from the Revolving Loan is </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;">, and as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has funded </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All of the Tranches accrue paid-in-kind interest at </font><font style="font-family:inherit;font-size:10pt;">7.5%</font><font style="font-family:inherit;font-size:10pt;"> per annum, except the Tranche B and Revolving Loan which accrue paid-in-kind interest at </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> per annum. The seniority of these loans is as follows: Revolving Loan, Tranche A, Tranche B, Tranche C and Tranche D. If CPTC is in default, the interest rate of the Tranche A, C and D will increase to </font><font style="font-family:inherit;font-size:10pt;">9.5%</font><font style="font-family:inherit;font-size:10pt;"> and the interest rate on the Tranche B and the Revolving Loan will increase to </font><font style="font-family:inherit;font-size:10pt;">12.0%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Considering Original CPTC&#8217;s financial difficulties, the modification of the original terms of the Former Loans, and the Lenders agreement to grant a concession on the Original CPTC Loans, the Company classified the transaction above as a troubled debt restructuring (&#8220;TDR&#8221;). The Company does not have any unamortized fees from the Former Loans and any prepayment penalties. As a result, the cost basis and fair value of the Company's outstanding Term Loan as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> is </font><font style="font-family:inherit;font-size:10pt;">$53.5 million</font><font style="font-family:inherit;font-size:10pt;">, which approximates the carrying value of the Former Loans prior to the TDR. </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company, using a discounted cash flow approach, determined that the fair value of CPTC's equity as of Closing Date is </font><font style="font-family:inherit;font-size:10pt;">$20.1 million</font><font style="font-family:inherit;font-size:10pt;">. The Company's </font><font style="font-family:inherit;font-size:10pt;">47.08%</font><font style="font-family:inherit;font-size:10pt;"> ownership percentage amounts to a </font><font style="font-family:inherit;font-size:10pt;">$9.5 million</font><font style="font-family:inherit;font-size:10pt;"> equity interest in CPTC. Since the common stock received were in addition to a loan receivable partially satisfied through the bankruptcy proceedings, in accordance with the TDR accounting guidance, the Company recorded the equity interest at fair value and as an offset to the reinstated loan balance. The equity investment in CPTC is accounted for under the equity method of accounting, and the Company accounts for its equity method share of the income or loss of CPTC on a quarter lag basis. The Company recorded a loss of </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> in the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;30, 2018</font><font style="font-family:inherit;font-size:10pt;"> in selling, general and administrative expenses on the Condensed Consolidated Statement of Earnings.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Per the terms of the Former Loans, as of September&#160;29, 2017, ORIX had the option to purchase the Company's share of the Original CPTC Loans at par, and therefore they were accounted for as available-for-sale securities. Per the terms of the new agreement, ORIX no longer has the option to purchase the Company&#8217;s share of the Term Loan at par. As a result, the Term Loan no longer qualified for available-for-sale classification as of December 29, 2017. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Further, the Company has determined that CPTC is a variable interest entity because of the Company's participation in the loan facilities, equity ownership and its operations and maintenance agreement.&#160;The Company has </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> board seat out of </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">, has no special approval authority or veto rights for CPTC&#8217;s budget, and does not have the power to direct patient recruitment, clinical operations and management of CPTC, which the Company believes are the matters that most significantly affect their economic performance. Therefore, the Company does not have majority voting rights and no power to direct activities at CPTC as a result it is not the primary beneficiary of CPTC.</font></div></div> Tax expense or benefit related to the periods presented are not material. EX-101.SCH 8 var-20180330.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2104100 - Disclosure - BALANCE SHEET COMPONENTS link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - BALANCE SHEET COMPONENTS - Available-for-Sale Securities (Detail) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - BALANCE SHEET COMPONENTS - Components of Inventories (Detail) link:presentationLink link:calculationLink link:definitionLink 2404405 - Disclosure - BALANCE SHEET COMPONENTS - Components of Other Long-Term Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - BALANCE SHEET COMPONENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - BALANCE SHEET COMPONENTS - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - BORROWINGS link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - BORROWINGS - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - BORROWINGS - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - BORROWINGS (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - BUSINESS COMBINATIONS link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - BUSINESS COMBINATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - COMMITMENTS AND CONTINGENCIES - Restructuring (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Fair Value of Derivative Instruments Reported in Condensed Consolidated Balance Sheets (Detail) link:presentationLink link:calculationLink link:definitionLink 2409407 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Foreign Currency Contracts Related to the Acquisition of Sirtex Medical Limited (Details) link:presentationLink link:calculationLink link:definitionLink 2409406 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - DISCONTINUED OPERATIONS link:presentationLink link:calculationLink link:definitionLink 2402404 - Disclosure - DISCONTINUED OPERATIONS - Balance Sheet Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 2402405 - Disclosure - DISCONTINUED OPERATIONS - Cash Flow Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - DISCONTINUED OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - DISCONTINUED OPERATIONS - Income Statement Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - DISCONTINUED OPERATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - EMPLOYEE STOCK PLANS link:presentationLink link:calculationLink link:definitionLink 2414407 - Disclosure - EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail) link:presentationLink link:calculationLink link:definitionLink 2414406 - Disclosure - EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail) link:presentationLink link:calculationLink link:definitionLink 2414405 - Disclosure - EMPLOYEE STOCK PLANS - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail) link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - EMPLOYEE STOCK PLANS - Summary of Share-Based Awards Available for Grant (Detail) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - EMPLOYEE STOCK PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - FAIR VALUE link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - FAIR VALUE - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - FAIR VALUE (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2412401 - Disclosure - INCOME TAXES - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - RECEIVABLES link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - RECEIVABLES (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - RECEIVABLES (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - RECEIVABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - RETIREMENT PLANS link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - RETIREMENT PLANS - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - RETIREMENT PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - SEGMENT INFORMATION - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2419404 - Disclosure - SEGMENT INFORMATION - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2419403 - Disclosure - SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2413406 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Noncontrolling interests (Details) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail) link:presentationLink link:calculationLink link:definitionLink 2413405 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Shares Repurchased During Period (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 2421401 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2401405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - VPT LOANS AND INVESTMENT link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - VPT LOANS AND INVESTMENT - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - VPT LOANS AND INVESTMENT - Loans and Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - VPT LOANS AND INVESTMENT (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 var-20180330_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 var-20180330_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 var-20180330_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of revenues - Product Cost Of Revenues Product [Member] Cost of Revenues - Product [Member] Cost of revenues - Service Cost Of Revenues Service [Member] Cost Of Revenues Service [Member] Research and development Research and Development Expense [Member] Selling, general and administrative General and Administrative Expense [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Total share-based compensation expense Allocated Share-based Compensation Expense Income tax benefit for share-based compensation Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Accounting Policies [Abstract] New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Difference between Revenue Guidance in Effect before and after Topic 606 Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Retained Earnings Retained Earnings [Member] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] As Previously Reported Scenario, Previously Reported [Member] Adjustments Restatement Adjustment [Member] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2014-09 Accounting Standards Update 2014-09 [Member] Accounting Standards Update 2016-09, Forfeiture Rate [Member] Accounting Standards Update 2016-09, Forfeiture Rate [Member] Accounting Standards Update 2016-09, Forfeiture Rate [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Revenues: Revenues [Abstract] Product Sales Revenue, Goods, Net Service Sales Revenue, Services, Net Total revenues Revenues Cost of revenues: Cost of Revenue [Abstract] Product Cost of Goods Sold Service Cost of Services Total cost of revenues Cost of Revenue Gross margin Gross Profit Earnings from continuing operations before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Taxes on earnings Income Tax Expense (Benefit) Net earnings (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net loss from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net (loss) earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net earnings attributable to Varian Net Income (Loss) Attributable to Parent Diluted net earnings per share from continuing operations attributable to Varian (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Assets: Assets [Abstract] Trade and unbilled receivables, net Accounts Receivable, Net, Current Inventories Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Deferred tax assets Deferred Income Tax Assets, Net Liabilities and Equity: Liabilities and Equity [Abstract] Accrued liabilities Accrued Liabilities, Current Deferred revenues Contract with Customer, Liability, Current Other long-term liabilities Other Liabilities, Noncurrent Retained earnings Retained Earnings (Accumulated Deficit) Cumulative effect of ASC 606 to retained earnings Cumulative Effect on Retained Earnings, Net of Tax Reduction to beginning retained earnings due to election to recognize forfeitures as they occur Cumulative Effect of New Accounting Principle in Period of Adoption Deferred finance costs Debt Issuance Costs, Net Balance Sheet Components [Abstract] Balance Sheet Components [Abstract] Raw materials and parts Inventory, Raw Materials and Purchased Parts, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventories Fair Value Disclosures [Abstract] Assets and Liabilities Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Reconciliation for Assets Measured and Recorded at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Table] Derivative [Table] Revenues Sales Revenue, Net [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash Flow Hedging Cash Flow Hedging [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Derivatives designated as hedging instruments: Designated as Hedging Instrument [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign Exchange Contract Foreign Exchange Contract [Member] Derivative [Line Items] Derivative [Line Items] Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings (Loss) in which the effects of fair value and cash flow hedges are recorded Income (Expense), Effects of Hedging Income (Expense), Effects of Hedging Amount of loss reclassified from accumulated other comprehensive loss into earnings (loss) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Position [Axis] Position [Axis] Position [Domain] Position [Domain] Notional Value Sold Short [Member] Notional Value Purchased Long [Member] Derivatives Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Foreign exchange forward contracts Foreign Exchange Forward [Member] Currency Currency [Axis] All Currencies All Currencies [Domain] Australian Dollar Australia, Dollars Brazilian Real Brazil, Brazil Real British Pound United Kingdom, Pounds Canadian Dollar Canada, Dollars Danish Krone Denmark, Kroner Euro Euro Member Countries, Euro Hungarian Forint Hungary, Forint Indian Rupee India, Rupees Japanese Yen Japan, Yen Polish Zloty Poland, Zlotych Singapore Dollar Singapore, Dollars Swedish Krona Sweden, Kronor South African Rand South Africa, Rand Swiss Franc Switzerland, Francs Thai Baht Thailand, Baht Notional Value Derivative Asset, Notional Amount Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Fiscal Year Fiscal Period, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements Accounting Standards Recently Adopted [Policy Text Block] Accounting Standards Recently Adopted [Policy Text Block] Recent Accounting Standards or Updates Not Yet Effective New Accounting Pronouncements, Policy [Policy Text Block] Statement of Comprehensive Income [Abstract] Tax on amortization of prior service cost included in net periodic benefit cost Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax Tax on amortization of net actuarial loss included in net periodic benefit cost Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax Tax on increase (decrease) in unrealized gain on derivative instruments Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax Tax on reclassification adjustments on derivative instruments Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax Retirement Benefits [Abstract] RETIREMENT PLANS Pension and Other Postretirement Benefits Disclosure [Text Block] Debt Disclosure [Abstract] BORROWINGS Debt Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Remainder of 2018 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year Future amortization expense, fiscal year 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Two Future amortization expense, fiscal year 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Three Future amortization expense, fiscal year 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Four Future amortization expense, fiscal year 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Net Carrying Amount Finite-Lived Intangible Assets, Net Unbilled receivables - current Contract with Customer, Asset, Net, Current Unbilled receivables - long-term (1) Contract with Customer, Asset, Net, Noncurrent Deferred revenues - current Deferred revenues - long-term (2) Contract with Customer, Liability, Noncurrent Total net unbilled receivables (deferred revenues) Contract with Customer, Liability Increase in deferred revenues net of unbilled receivables Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination Recognized revenue included in deferred revenue balance Contract with Customer, Liability, Revenue Recognized Impairment loss on non-current unbilled receivable Capitalized Contract Cost, Impairment Loss Receivables [Abstract] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other Assets Other Assets [Member] Prepaid expenses and other current assets [Member] Prepaid Expenses and Other Current Assets [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] MPTC loans (1) Maryland Proton Therapy Center (MPTC) [Member] Maryland Proton Therapy Center (MPTC) [Member] RPTC senior secured debt (2) RPTC Securities [Member] RPTC Securities [Member] NYPC loan (3) MM Proton I, LLC [Member] MM Proton I, LLC [Member] PI loan (3) Proton International [Member] Proton International [Member] CPTC DIP Loan CPTC DIP Loan [Member] CPTC DIP Loan [Member] Original CPTC loans C P T C Loan [Member] CPTC loan. GPTC Securities GPTC Securities [Member] GPTC Securities [Member] Receivable Type [Axis] Receivable Type [Axis] Receivable [Domain] Receivable [Domain] Loans Receivable Loans Receivable [Member] Revolving Loan Revolving Loan [Member] Revolving Loan [Member] Term Loan Term Loan [Member] Term Loan Investment [Axis] Investment [Axis] Investment [Domain] Investment [Domain] APTC Securities APTC Securities [Member] APTC Securities [Member] DRTC securities (4) DRTC Loans [Member] DRTC Loans [Member] C P T C C P T C [Member] CPTC Long-term notes receivable and Available-for-sale Securities [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Notes receivable Notes, Loans and Financing Receivable, Current and Noncurrent, Net Notes, Loans and Financing Receivable, Current and Noncurrent, Net Short-term Notes, Loans and Financing Receivable, Net, Current Long-term Notes, Loans and Financing Receivable, Net, Noncurrent Notes receivable and secured debt Notes, Loans and Financing Receivable, Net Notes, Loans and Financing Receivable, Net Fair Value Available-for-sale Securities Commitment Remaining Obligation to Fund Bond Remaining Obligation to Fund Bond Commitment Remaining Obligation Fund Loan Remaining Obligation Fund Loan Short-term revolving loan Notes, Loans and Financing Receivable, Gross, Current Term loan Notes, Loans and Financing Receivable, Gross, Noncurrent Equity investment in CPTC Equity Method Investments Loans and Investments Loans and Investments Loans and Investments Statement of Financial Position [Abstract] Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, issued (in shares) Preferred Stock, Shares Issued Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Discontinued Operations and Disposal Groups [Abstract] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Discontinued Operations, Disposed of by Means Other than Sale, Spinoff Discontinued Operations, Disposed of by Means Other than Sale, Spinoff [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Revenues Disposal Group, Including Discontinued Operation, Revenue Cost of revenues Disposal Group, Including Discontinued Operation, Costs of Goods Sold Gross margin Disposal Group, Including Discontinued Operation, Gross Profit (Loss) Operating expenses Disposal Group, Including Discontinued Operation, Operating Expense Operating earnings Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax Taxes on earnings Discontinued Operation, Tax Effect of Income (Loss) from Discontinued Operation During Phase-out Period Net loss from discontinued operations Less: Net earnings from discontinued operations attributable to noncontrolling interests Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest Net loss from discontinued operations attributable to Varian Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Separation costs Business Separation Costs Business separation costs Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Measurement Frequency Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value, Measurements, Recurring [Member] Investments by Category [Axis] Investments by Category [Axis] Marketable Securities and Investments Held at Cost [Domain] Marketable Securities and Investments Held at Cost [Domain] Available-for-sale Securities Available-for-sale Securities [Member] Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Contingent Consideration Contingent Consideration [Member] Contingent consideration [member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Available-for-sale Securities, beginning balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Additions from business combinations Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases Reclassification of Original CPTC Loans to Term Loan Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) Available-for-sale Securities, Ending balance Contingent Consideration, beginning balance Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Additions from business combinations Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Contingent Consideration, ending balance Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Foreign exchange option contract Foreign Exchange Option [Member] Accrued liabilities Accrued Liabilities [Member] Derivatives Fair Value [Line Items] Derivatives, Fair Value [Line Items] Derivative asset Derivative Asset, Fair Value, Gross Asset Derivative liability Derivative Liability, Fair Value, Gross Liability Total derivatives Derivative, Fair Value, Net Schedule Of Finite Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Technologies and patents Technology-Based Intangible Assets [Member] Customer contracts and supplier relationship Customer Relationships [Member] Other Other Intangible Assets [Member] Finite Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite lived intangible assets, gross Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Indefinite intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Total intangible assets, net Intangible Assets, Net (Excluding Goodwill) Schedule Of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Forecast Scenario, Forecast [Member] Subordinated Bond Senior Subordinated Notes [Member] Senior First Lien Loan Senior First Lien Loan [Member] Senior First Lien Loan [Member] Senior Subordinated Loans Senior Subordinated Loans [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Varian Medical Systems, Inc. Varian Medical Systems, Inc. [Member] Varian Medical Systems, Inc. [Member] Other Significant Noncash Transaction [Axis] Other Significant Noncash Transaction [Axis] Other Significant Noncash Transaction, Name [Domain] Other Significant Noncash Transaction, Name [Domain] Reclassification From Long-Term Notes Receivable Reclassification From Long-Term Accounts Receivable In June 2016 [Member] Reclassification From Long-Term Accounts Receivable In June 2016 [Member] Proton Center, Munich Proton Center, Munich [Member] Proton Center, Munich [Member] RPTC Securities Georgia Proton Therapy Center Georgia Proton Therapy Center [Member] Georgia Proton Therapy Center [Member] Public Finance Authority Public Finance Authority [Member] Public Finance Authority [Member] New York Proton Center [Member] New York Proton Center [Member] New York Proton Center [Member] Major Types of Debt and Equity Securities Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities Major Types of Debt and Equity Securities [Domain] Tranche A loan Tranche A Loans [Member] Tranche A loans. Tranche B loan Tranche B Loans [Member] Tranche B loans. Tranche C Loans Tranche C Loans [Member] Tranche C Loans [Member] Tranche D Loans Tranche D Loans [Member] Tranche D Loans [Member] DRTC Securities DRTC Securities [Member] DRTC Securities [Member] Long term notes receivable and available for sale securities [Line Items] Schedule of Available-for-sale Securities [Line Items] Commitment Interest rate (as a percent) Financing Receivable, Stated Rate Financing Receivable, Stated Rate Impairment charges Asset Impairment Charges Payments to Acquire Senior Secured Debt Payments to Acquire Senior Secured Debt Payments to Acquire Senior Secured Debt Claims Filed Against Assets of Company in Bankruptcy Claims Filed Against Assets of Company in Bankruptcy Claims Filed Against Assets of Company in Bankruptcy Accounts receivable, includes unbilled accounts receivable Accounts Receivable From Variable Interest Entity Accounts receivable from variable interest entity. Maximum lending commitment Maximum Lending Commitment Maximum Lending Commitment Term (in years) Financing Receivable, Term Financing Receivable, Term Payments to acquire available-for-sale securities Payments to Acquire Available-for-sale Securities, Debt Available-for-sale Securities, Debt Securities Available-for-sale Securities, Debt Securities Unbilled receivables from variable interest entity Unbilled Receivables from Variable Interest Entity Unbilled Receivables from Variable Interest Entity Sale of available-for-sale securities Proceeds from Sale of Available-for-sale Securities, Debt Principal payments on notes receivable Proceeds from Collection of Notes Receivable Number of annual payments Financing Receivable, Number of Annual Payments Financing Receivable, Number of Annual Payments Deferral Financing Receivable, Deferral Financing Receivable, Deferral Maximum lending commitment Loan Facility Maximum Lending Commitment Loan Facility Maximum Lending Commitment Impairment charges Other than Temporary Impairment Losses, Investments, Available-for-sale Securities Liabilities assumed by lenders Debtor in Possession, Financing, Liabilities Assumed by Lenders Debtor in Possession, Financing, Liabilities Assumed by Lenders Available-for-sale securities: Available-for-sale Securities, Amortized Cost Basis Additional financing Debtor-in-Possession Financing, Amount Arranged Interest rate Debtor-in-Possession Financing, Interest Rate on Borrowings Outstanding Ownership interest in dpiX Holding LLC (as a percent) Equity Method Investment, Ownership Percentage Modified former loans receivable Number of Tranches Number of Tranches Number of Tranches Credit facility term (in years) Debt Instrument, Term Loans Paid-in-kind interest receivable (percent) Paid-in-kind Interest Receivable, Percent Paid-in-kind Interest Receivable, Percent Interest receivable, default rate (percent) Note Receivable, Default Interest Rate, Percent Note Receivable, Default Interest Rate, Percent Cost basis of term loan receivable Notes, Loans and Financing Receivable, Gross, Cost Basis Notes, Loans and Financing Receivable, Gross, Cost Basis Fair value of CPTC's equity Equity, Fair Value Disclosure Equity method investment Income (Loss) on equity investment in affiliate Income (Loss) from Equity Method Investments Number of CPTC board seats held by the Company Number of Board Seats Held by the Company Number of Board Seats Held by the Company Number of CPTC board seats Number of Board Seats Number of Board Seats Segment Reporting [Abstract] Operating Results Information for Each Business Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type Award Type [Axis] Equity Award Equity Award [Domain] Employee Stock Option Plans Employee Stock Option [Member] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee stock purchase plan. Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Expected term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected dividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Weighted average fair value at grant date (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Earnings Per Share [Abstract] Less: Net (loss) earnings from continuing operations attributable to noncontrolling interests Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest Net earnings (loss) from continuing operations attributable to Varian Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Net earnings (loss) attributable to Varian Weighted average shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Dilutive effect of potential common shares (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Weighted average shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Net earnings (loss) per share - basic Earnings Per Share, Basic [Abstract] Continuing operations (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Discontinued operations (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Net earnings (loss) per share - basic (in dollars per share) Earnings Per Share, Basic Net earnings (loss) per share - diluted Earnings Per Share, Diluted [Abstract] Continuing operations (in dollars per share) Discontinued operations (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Net earnings (loss) per share - diluted (in dollars per share) Earnings Per Share, Diluted Anti-dilutive employee shared based awards, excluded (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Income Statement [Abstract] Total revenues Total cost of revenues Gross margin Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Acquisition-related expenses Business Combination, Acquisition Related Costs Total operating expenses Operating Expenses Operating earnings Operating Income (Loss) Interest income Investment Income, Interest Interest expense Interest Expense Earnings from continuing operations before taxes Net earnings (loss) from continuing operations Net earnings (loss) Less: Net (loss) earnings attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Continuing operations (in dollars per share) Discontinued operations (in dollars per share) Continuing operations (in dollars per share) Discontinued operations (in dollars per share) Shares used in the calculation of net earnings per share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average shares outstanding - diluted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant [Roll Forward] Balance at beginning of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Authorized (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Granted (in shares) Stock Option And Other Share Based Awards Granted Stock option and other share based awards granted. Cancelled or expired (in shares) Stock Option And Other Share Based Awards Cancelled Stock option and other share-based awards that are cancelled during the period. Balance at end of period (in shares) Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Sirtex Sirtex Medical Limited [Member] Sirtex Medical Limited [Member] Other Acquisitions Other Acquisitions [Member] Other Acquisitions [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Acquisition, share price (in AUD per share) Business Acquisition, Share Price Acquisition price Payments to Acquire Businesses, Gross Competing bid for Sirtex made by CDH Investments (in AUD per share) Business Acquisition, Share Price Offered by Third-party Bidder Business Acquisition, Share Price Offered by Third-party Bidder Number of companies acquired Number of Businesses Acquired Finite-lived intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Goodwill Goodwill Schedule of Trade and Unbilled Receivables, Net and Notes Receivable Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Activity of Goodwill by Reportable Operating Segment Schedule of Goodwill [Table Text Block] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Gross Carrying Amount and Accumulated Amortization of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Document And Entity Information [Abstract] Document Document and Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Revenue from Contract with Customer [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Unfulfilled Performance Obligations Revenue, Remaining Performance Obligation EMPLOYEE STOCK PLANS Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments and Contingencies [Table] Environmental Remediation Contingency [Axis] Environmental Remediation Contingency [Axis] Environmental Remediation Contingency [Domain] Environmental Remediation Contingency [Domain] Group A Sites Group A Sites [Member] Group A Sites Group B Sites Group B Sites [Member] Group B Sites Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and Contingencies [Line Items] Environmental cleanup costs, third-party claim costs, project management costs and legal costs Payments for Environmental Liabilities Estimate of loss Loss Contingency, Estimate of Possible Loss Estimated time frames to resolve contingency related to environmental remediation contingencies, years Estimated Time Frames To Resolve Contingency Related To Environmental Remediation Contingencies Estimated time frames to resolve contingency related to environmental remediation contingencies. Amount accrued for environmental remediation expense Accrual for Environmental Loss Contingencies, Component Amount Estimated environmental remediation costs, best estimate, undiscounted Site Contingency Loss Best Estimate Best estimate of environmental remediation costs, undiscounted. Discount rate for environmental remediation costs, net of inflation (as a percent) Accrual for Environmental Loss Contingencies, Discount Rate Receivables of past and future environmental-related expenditures Recorded Third-Party Environmental Recoveries Receivable Unbilled Accounts Receivable and Deferred Revenues from Contracts with Customers: Contract with Customer, Asset and Liability [Table Text Block] Inventories: Schedule of Inventory, Current [Table Text Block] Available-for-sale Securities: Available-for-sale Securities [Table Text Block] Other long-term liabilities: Other Noncurrent Liabilities [Table Text Block] Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Share-based compensation expense Share-based Compensation Depreciation Depreciation Amortization of intangible assets Amortization of Intangible Assets Deferred taxes Deferred Income Tax Expense (Benefit) Loss on hedges related to the Sirtex acquisition Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Provision for doubtful accounts receivable Provision for Doubtful Accounts Other, net Other Noncash Income (Expense) Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Trade and unbilled receivables Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities and other long-term liabilities Increase (Decrease) In Accrued Liabilities And Other Non-current Liabilities Increase (Decrease) In Accrued Liabilities And Other Non-current Liabilities Deferred revenues Increase (Decrease) in Deferred Revenue Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Issuance of notes receivable Payments to Acquire Notes Receivable Investment in available-for-sale securities Loans to CPTC Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties Purchase of foreign currency option related to the Sirtex acquisition Foreign Currency Option Premium Foreign Currency Option Premium Investment in privately-held companies Payments to Acquire Investments Amounts paid to deferred compensation plan trust account Payments For (Proceeds From) Deferred Compensation Plan Securities, Net Payments For (Proceeds From) Deferred Compensation Plan Securities, Net Other, net Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Repurchases of common stock Payments for Repurchase of Common Stock Proceeds from issuance of common stock to employees Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Excluding Stock Options Employees' taxes withheld and paid for restricted stock and restricted stock units Payments Related to Tax Withholding for Share-based Compensation Cash received from Varex Imaging Corporation Proceeds From Spinoff Proceeds From Spinoff Cash and cash equivalents contributed to Varex Imaging Corporation Contribution Of Cash And Cash Equivalents In Spinoff Contribution Of Cash And Cash Equivalents In Spinoff Borrowings under credit facility agreement Proceeds from Issuance of Long-term Debt Repayments under credit facility agreement Repayments of Long-term Debt Net repayments under the credit facility agreements with maturities less than 90 days Proceeds from (Repayments of) Lines of Credit Other Proceeds from (Payments for) Other Financing Activities Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Effects of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents at beginning of period Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations Cash and cash equivalents at end of period Income Tax Disclosure [Abstract] Income Tax Contingency [Table] Income Tax Contingency [Table] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Effective tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Estimated effective U.S. corporate tax rate (as a percent) Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Blended Rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Blended Rate, Percent Provisional discrete tax expense related to re-measuring deferred tax assets Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit) Provisional discrete tax expense related to the one-time transition tax Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) Discrete income tax benefit, related to excess stock deduction activity Effective Income Tax Rate Reconciliation, Share-based Compensation, Excess Tax Benefit, Amount Effective Income Tax Rate Reconciliation, Share-based Compensation, Excess Tax Benefit, Amount Increase in unrecognized tax benefits Unrecognized Tax Benefits, Period Increase (Decrease) Equity [Abstract] Reclassification Out Of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Unrealized loss on defined benefit pension and post-retirement benefit plans Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Unrealized loss on cash flow hedging instruments Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member] Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Cost of revenues & Operating expenses Cost Of Revenues And Operating Expenses Cost of revenues and operating expenses. Revenues Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] Varex Imaging Varex Imaging [Member] Varex Imaging [Member] Pro rata distribution (shares) Spinoff, Conversion, Number Of New Shares Distributed For Every Existing Share Spinoff, Conversion, Number Of New Shares Distributed For Every Existing Share Warranty period included in sale of hardware Standard Product Warranty, Period Standard Product Warranty, Period Manufacturing, Commissioning and Installation Period Manufacturing, Commissioning and Installation Period Manufacturing, Commissioning and Installation Period Notes Receivable Notes Receivable [Member] Accounts, Notes, Loans and Financing Receivable [Line Items] Trade and unbilled receivables, gross Accounts Receivable, Gross Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable Trade and unbilled receivables, net Accounts Receivable, Net Short-term Long-term Accounts Receivable, Net, Noncurrent Notes receivable Financing Receivable, Net Allowance for doubtful accounts, current Allowance, noncurrent Allowance for Doubtful Accounts Receivable, Noncurrent Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Letter of Credit Letter of Credit [Member] Swing Line Loans Swing Line Loans [Member] Swing line loans. Revolving Credit Facility Revolving Credit Facility [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 2018 Revolving Credit Facility 2018 Revolving Credit Facility [Member] 2018 Revolving Credit Facility [Member] 2017 Revolving Credit Facility 2017 Revolving Credit Facility [Member] 2017 Revolving Credit Facility [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Loan facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Additional maximum commitment amount Additional Loan Facility Maximum Commitment Amount Additional Loan Facility Maximum Commitment Amount Amount borrowed on line of credit Proceeds from Lines of Credit Repayment of line of credit Repayments of Lines of Credit Long-term income taxes payable Liability for Uncertainty in Income Taxes, Noncurrent Deferred income taxes Deferred Income Taxes and Other Tax Liabilities, Noncurrent Long-term debt Long-term Debt Other Other Sundry Liabilities, Noncurrent Total other long-term liabilities Noncontrolling Interest [Table] Noncontrolling Interest [Table] Noncontrolling Interests Noncontrolling Interest [Member] Noncontrolling Interest [Line Items] Noncontrolling Interest [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance at beginning of period Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Transfer of redeemable noncontrolling interests in MeVis to Varex Noncontrolling Interest, Decrease from Deconsolidation Other Other Adjustments To Stockholders Equity Attributable To Noncontrolling Interests Other Adjustments To Stockholders Equity Attributable To Noncontrolling Interests Balance at end of period Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Balance at beginning of period Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Net earnings attributable to noncontrolling interests Temporary Equity, Net Income Transfer of redeemable noncontrolling interests in MeVis to Varex Temporary Equity, Transfer Of Interest Temporary Equity, Transfer Of Interest Other Temporary Equity, Other Changes Balance at end of period DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Derivative Instruments and Hedging Activities Disclosure [Text Block] RECEIVABLES Loans, Notes, Trade and Other Receivables, Including Financing Receivables Disclosure [Text Block] Loans, Notes, Trade and Other Receivables, Including Financing Receivables Disclosure [Text Block] Schedule Of Goodwill [Table] Schedule of Goodwill [Table] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Oncology Systems Oncology Systems [Member] Oncology Systems Varian Particle Therapy Varian Particle Therapy [Member] Varian Particle Therapy [Member] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Balance, beginning Business combinations Goodwill, Acquired During Period Foreign currency translation adjustments Goodwill, Foreign Currency Translation Gain (Loss) Balance, ending Acquisition-related expenses Acquisition-related Costs [Member] Notional amount Derivative, Notional Amount Foreign currency option premium Fair value of foreign currency option Loss on foreign currency contracts that do not qualify for hedge accounting Disposal Groups, Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Balance at beginning of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Cancelled or expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Balance at end of period (in shares) Weighted Average Grant-Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Balance at beginning of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Cancelled or expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Balance at end of period (in dollars per share) Schedule of Share Repurchases Share Repurchases [Table Text Block] Share Repurchases [Table Text Block] Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Loss) Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Schedule of Changes In Noncontrolling Interests Schedule Of Changes In Noncontrolling Interests [Table Text Block] Schedule Of Changes In Noncontrolling Interests [Table Text Block] Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Accrued product warranty, at beginning of period Standard and Extended Product Warranty Accrual Charged to cost of revenues Product Warranty Accrual, Charged To Cost Of Revenues Product Warranty Accrual, Charged To Cost Of Revenues Actual product warranty expenditures Standard and Extended Product Warranty Accrual, Decrease for Payments Accrued product warranty, at end of period BUSINESS COMBINATIONS Business Combination Disclosure [Text Block] Remaining maturity Derivative, Remaining Maturity Gain/loss Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Derivative, term of contract (in months) Derivative, Term of Contract Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Retirement Plan Sponsor Location [Axis] Defined Benefit Plan and Other Postretirement Benefit Plan Retirement Plan Sponsor Location [Domain] Foreign Pension Plan Foreign Plan [Member] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plan, Number of Plans Defined Benefit Plan, Number of Plans Defined Benefit Plan, Number of Plans Share-based compensation expense Depreciation expense Amortization expense Purchases of property, plant and equipment Assets Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Trade and unbilled receivables, net of allowance for doubtful accounts of $40.3 at March 30, 2018 and $45.9 at September 29, 2017 Current assets of discontinued operations Disposal Group, Including Discontinued Operation, Assets, Current Total current assets Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Intangible assets Other assets Other Assets, Noncurrent Total assets Assets Liabilities and Equity Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Short-term borrowings Short-term Debt Current liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Current Total current liabilities Liabilities, Current Total liabilities Liabilities Commitments and contingencies (Note 10) Commitments and Contingencies Equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock of $1 par value: 1.0 shares authorized; none issued and outstanding Preferred Stock, Value, Issued Common stock of $1 par value: 189.0 shares authorized; 91.7 shares issued and outstanding at both March 30, 2018, and at September 29, 2017, respectively Common Stock, Value, Issued Capital in excess of par value Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total Varian stockholders' equity Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Total equity Total liabilities and equity Liabilities and Equity Number of shares (in shares) Stock Repurchased and Retired During Period, Shares Average repurchase price per share (in dollars per share) Stock Repurchased During Period, Average Cost Per Share Stock Repurchased During Period, Per Share Total cost Stock Repurchased During Period, Value Amount of Gain (Loss) Recognized in Net Earnings (Loss) on Derivative Instruments GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Schedule of Short-term Borrowings and Long-term Debt Schedule of Short-term Debt [Table Text Block] Accrued Product Warranty Schedule of Product Warranty Liability [Table Text Block] Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Original CPTC loans Corporate Debt Securities, California Proton Treatment Center, LLC [Member] Corporate Debt Securities, California Proton Treatment Center, LLC [Member] Schedule of Available-for-sale Securities [Line Items] Amortized cost Gross Unrealized Gains Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Losses Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] EARNINGS PER SHARE Earnings Per Share [Text Block] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Balance at beginning of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Cancelled or expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Balance at end of period (in shares) Exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Balance at beginning of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Cancelled or expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Balance at end of period (in dollars per share) Exercisable (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Remaining Term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Balance at end of period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Exercisable (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Balance at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share price (in dollars per share) Share Price DISCONTINUED OPERATIONS Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Short-term borrowings: Debt Instrument [Line Items] Weighted-Average Interest Rate (as a percent) Debt, Weighted Average Interest Rate Total short-term borrowings Debt, Current Total long-term debt Long-term Debt, Excluding Current Maturities Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Hardware Hardware [Member] Hardware [Member] Software Software [Member] Software [Member] Service Service [Member] Service [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Americas Americas [Member] EMEA EMEA [Member] APAC Asia Pacific [Member] North America North America [Member] International International [Member] International. Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Products transferred at a point in time Transferred at Point in Time [Member] Products and Services transferred over time Transferred over Time [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Schedule of Net Defined Benefit Costs Schedule of Net Benefit Costs [Table Text Block] BALANCE SHEET COMPONENTS Supplemental Balance Sheet Disclosures [Text Block] Schedule of Unfulfilled Performance Obligations Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Schedule of Adoption of ASC 606 Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Schedule of Derivative Instruments Reported on the Condensed Consolidated Balance Sheets Fair Value, by Balance Sheet Grouping [Table Text Block] Schedule of Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Earnings (Loss) Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Schedule of Notional Amounts of Outstanding Derivative Positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] INCOME TAXES Income Tax Disclosure [Text Block] Computation of Basic and Diluted Net Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Accumulated Other Comprehensive Income Loss [Table] Accumulated Other Comprehensive Income (Loss) [Table] Net Unrealized Gains (Losses) Defined Benefit Pension and Post-Retirement Benefit Plans Net Unrealized Gains (Losses) Cash Flow Hedging Instruments Cumulative Translation Adjustment Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Other Comprehensive Earnings (Loss) AOCI Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Other Comprehensive Income Loss [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Other comprehensive earnings (loss) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Amounts reclassified out of other comprehensive earnings (loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Tax expense Other Comprehensive Income (Loss), Tax Net earnings (loss) Other comprehensive earnings (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Defined benefit pension and post-retirement benefit plans: Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract] Amortization of prior service cost included in net periodic benefit cost, net of tax benefit of $0.0 and $0.1 for the three and six months ended March 30, 2018, respectively, and $0.0 and $0.1 for the corresponding periods of fiscal year 2017, respectively. Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Amortization of net actuarial loss included in net periodic benefit cost, net of tax expense of ($0.1) and ($0.3) for three and six months ended March 30, 2018, respectively, and ($0.2) and ($0.4) for the corresponding periods of fiscal year 2017, respectively. Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Defined benefit pension and post-retirement benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Derivative instruments: Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax [Abstract] Change in unrealized loss, net of tax benefit of $0.2 and $0.3 for the three and six months ended March 30, 2018. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Reclassification adjustments, net of tax expense of ($0.3) for both the three and six months ended March 30, 2018. Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Derivative instruments Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other comprehensive earnings (loss) Other Comprehensive Income (Loss), Net of Tax Comprehensive earnings (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: Comprehensive (loss) earnings attributable to noncontrolling interests Comprehensive earnings (loss) attributable to Varian Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule Of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Defined Benefit Plans Pension Plan [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amortization of prior service cost Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Recognized actuarial loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Carrying value of long-term debt Line Of Credit Facility [Table] Line of Credit Facility [Table] Sumitomo Credit Facility Sumitomo Credit Facility [Member] Sumitomo credit facility. Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Eurodollar Eurodollar [Member] Eurodollar Rate plus 1% Eurodollar Plus 1% [Member] Eurodollar Plus 1% [Member] Federal Funds Rate Federal Funds Effective Swap Rate [Member] Base Rate Base Rate [Member] Line Of Credit Facility [Line Items] Line of Credit Facility [Line Items] Line of credit, interest rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Debt instrument, contract repayment date Debt Instrument, Contract Repayment Date Debt Instrument, Contract Repayment Date Percentage added to Eurodollar base rate before margin (as a percent) Percentage Added To Eurodollar Base Rate Before Margin Percentage added to Eurodollar base rate before margin. Commitment fee Line of Credit Facility, Commitment Fee Percentage Debt issuance costs Schedule Of Employee Stock Ownership Plan E S O P Disclosures [Table] Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table] Award Date [Axis] Award Date [Axis] Award Date [Domain] Award Date [Domain] Beginning Fiscal Year 2018 Beginning Fiscal Year 2018 [Member] Beginning Fiscal Year 2018 [Member] Beginning Fiscal Year 2017 Beginning Fiscal Year 2017 [Member] Beginning Fiscal Year 2017 [Member] Beginning Fiscal Year 2016 Beginning Fiscal Year 2016 [Member] Beginning Fiscal Year 2016 [Member] Beginning In Fiscal 2015 Beginning In Fiscal 2015 [Member] Beginning In Fiscal 2015 [Member] Fourth Amended 2005 Plan Fourth Amended Two Thousand And Five Plan [Member] Fourth Amended Two Thousand And Five Plan [Member] Stock options Performance stock options Performance Stock Options [Member] Performance Stock Options [Member] Restricted stocks, restricted stock units, deferred stock units and performance units Restricted Stock Restricted Stock Units Deferred Stock Units And Performance Units [Member] Restricted Stock, Restricted Stock Units, Deferred Stock Units And Performance Units [Member] Shares counted against the available for grant (in shares) Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Counted Against Available For Grant Limit For Every One Share Awarded Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Counted Against Available-For-Grant Limit for Every One Share Awarded Ratio of maximum payout (in shares) Ratio Of Maximum Payout For Each Performance Unit The Maximum payout for each performance unit that could be issued. Unrecognized compensation expense related to outstanding stock awards Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted average period unrecognized compensation expense is expected to be recognized, years Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition STOCKHOLDERS’ EQUITY AND NONCONTROLLING INTERESTS Stockholders' Equity Note Disclosure [Text Block] Schedule of Finite-Lived Intangible Assets [Table] Operating Activities [Axis] Operating Activities [Axis] Operating Activities [Domain] Operating Activities [Domain] Continuing Operations Continuing Operations [Member] Finite-Lived Intangible Assets [Line Items] Trade accounts receivable, net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Inventories Disposal Group, Including Discontinued Operation, Inventory, Current Prepaid expenses and other current assets Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Current assets of discontinued operations Total assets of discontinued operations Disposal Group, Including Discontinued Operation, Assets Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable, Current Accrued liabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current Current liabilities of discontinued operations Total liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities VPT LOANS AND INVESTMENT VPT Loans [Text Block] VPT Loans [Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] Varex Term Facility Varex Term Facility [Member] Varex Term Facility [Member] Transition services agreement Transition Services Agreement, Term Transition Services Agreement, Term Proceeds from term facility Proceeds from Short-term Debt Contribution of cash and cash equivalents Receipt of excess cash and cash equivalents Proceeds From Related Party, Discontinued Operations Proceeds From Related Party, Discontinued Operations Distribution of Varex Stockholders' Equity Note, Spinoff Transaction Transfer of debt outstanding Spinoff Transaction, Transfer of Debt Outstanding Spinoff Transaction, Transfer of Debt Outstanding Net assets Net Assets Shareholders Equity [Table] Shareholders Equity [Table] Shareholders Equity [Table] Accelerated Share Repurchases, Date [Axis] Accelerated Share Repurchases, Date [Axis] Accelerated Share Repurchases, Date [Domain] Accelerated Share Repurchases, Date [Domain] November 2016 November 2016 [Member] November 2016 [Member] Stockholders’ equity and noncontrolling interests [Line Items] Shareholders Equity [Line Items] Shareholders Equity [Line Items] Number of shares authorized to be repurchased by VMS Board of Directors (in shares) Stock Repurchase Program, Number of Shares Authorized to be Repurchased Remaining authorization (shares) Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased FAIR VALUE Fair Value Disclosures [Text Block] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] 2017 Restructuring Plan [Member] 2017 Restructuring Plan [Member] 2017 Restructuring Plan [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] September 29, 2017 Restructuring Reserve Restructuring Charges Restructuring Charges Cash Payments Payments for Restructuring March 30, 2018 Schedule Of Segment Reporting Information By Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items Consolidation Items [Axis] Consolidation Items Consolidation Items [Domain] Operating Segments Operating Segments [Member] Unallocated corporate Corporate Segment [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Operating Earnings (Loss) Quoted Prices in Active Markets for Identical Instruments Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs Significant Unobservable Inputs Fair Value, Inputs, Level 3 [Member] Original CPTC loans Corporate Debt Securities [Member] Assets/Liabilities Measured at Fair Value on a Recurring Basis Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract] Available-for-sale securities Derivative assets Derivative Asset Total assets measured at fair value Assets, Fair Value Disclosure Derivative liabilities Derivative Liability Contingent consideration Contingent Consideration Liability, Fair Value Contingent Consideration Liability, Fair Value Total liabilities measured at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Number of segments Number of Reportable Segments Schedule of Loans and Investments to Fund PT Centers Schedule Of Loans and Investments to Fund PT Centers [Table Text Block] Schedule Of Loans and Investments to Fund PT Centers [Table Text Block] Share-Based Compensation Expense Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Fair Value of Employee Stock Option Plans With Weighted Average Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Option Component of ESPP Shares with Weighted Average Assumptions Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Summary of Share-Based Awards Available for Grant Schedule Of Share Based Awards Available For Grant [Table Text Block] Tabular disclosure of the number share based awards available for grant that were outstanding at the beginning and end of year, and the number of shares granted, cancelled or expired during the year. Activity Under Employee Stock Plans Share-based Compensation, Stock Options, Activity [Table Text Block] Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] EX-101.PRE 12 var-20180330_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 13 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document and Entity Information - shares
 6 Months Ended
Mar. 30, 2018
Apr. 27, 2018
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q2  
Trading Symbol VAR  
Entity Registrant Name VARIAN MEDICAL SYSTEMS INC  
Entity Central Index Key 0000203527  
Current Fiscal Year End Date --09-28  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   91,504,711
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Revenues:        
Product $ 393.8 $ 364.9 $ 759.4 $ 674.1
Service 336.1 298.3 649.0 590.6
Total revenues 729.9 663.2 1,408.4 1,264.7
Cost of revenues:        
Product 264.2 246.9 488.1 453.1
Service 147.2 140.7 299.0 269.0
Total cost of revenues 411.4 387.6 787.1 722.1
Gross margin 318.5 275.6 621.3 542.6
Operating expenses:        
Research and development 58.9 53.3 114.8 103.2
Selling, general and administrative 134.5 131.6 258.5 292.7
Impairment charges 11.1 0.0 11.1 38.3
Acquisition-related expenses 19.7 0.6 21.2 0.9
Total operating expenses 224.2 185.5 405.6 435.1
Operating earnings 94.3 90.1 215.7 107.5
Interest income 3.6 2.7 6.8 7.5
Interest expense (2.3) (2.4) (4.4) (5.3)
Earnings from continuing operations before taxes 95.6 90.4 218.1 109.7
Taxes on earnings 22.4 20.9 257.1 32.2
Net earnings (loss) from continuing operations 73.2 69.5 (39.0) 77.5
Net loss from discontinued operations 0.0 (13.3) 0.0 (6.8)
Net earnings (loss) 73.2 56.2 (39.0) 70.7
Less: Net (loss) earnings attributable to noncontrolling interests 0.0 (0.1) 0.1 0.5
Net earnings (loss) attributable to Varian $ 73.2 $ 56.3 $ (39.1) $ 70.2
Net earnings (loss) per share - basic        
Continuing operations (in dollars per share) $ 0.80 $ 0.75 $ (0.43) $ 0.83
Discontinued operations (in dollars per share) 0.00 (0.15) 0.00 (0.08)
Net earnings (loss) per share - basic (in dollars per share) 0.80 0.60 (0.43) 0.75
Net earnings (loss) per share - diluted        
Continuing operations (in dollars per share) 0.79 0.74 (0.43) 0.82
Discontinued operations (in dollars per share) 0.00 (0.14) 0.00 (0.08)
Net earnings (loss) per share - diluted (in dollars per share) $ 0.79 $ 0.60 $ (0.43) $ 0.74
Shares used in the calculation of net earnings per share:        
Weighted average shares outstanding - basic (in shares) 91.5 93.0 91.6 93.2
Weighted average shares outstanding - diluted (in shares) 92.6 93.7 91.6 93.9
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Statement of Comprehensive Income [Abstract]        
Net earnings (loss) $ 73.2 $ 56.2 $ (39.0) $ 70.7
Defined benefit pension and post-retirement benefit plans:        
Amortization of prior service cost included in net periodic benefit cost, net of tax benefit of $0.0 and $0.1 for the three and six months ended March 30, 2018, respectively, and $0.0 and $0.1 for the corresponding periods of fiscal year 2017, respectively. [1] (0.3) (0.1) (0.5) (0.2)
Amortization of net actuarial loss included in net periodic benefit cost, net of tax expense of ($0.1) and ($0.3) for three and six months ended March 30, 2018, respectively, and ($0.2) and ($0.4) for the corresponding periods of fiscal year 2017, respectively. 0.7 0.9 1.2 1.8
Defined benefit pension and post-retirement benefit plans 0.4 0.8 0.7 1.6
Derivative instruments:        
Change in unrealized loss, net of tax benefit of $0.2 and $0.3 for the three and six months ended March 30, 2018. (0.4) 0.0 (0.6) 0.0
Reclassification adjustments, net of tax expense of ($0.3) for both the three and six months ended March 30, 2018. 0.7 0.0 0.6 0.0
Derivative instruments 0.3 0.0 0.0 0.0
Currency translation adjustment 6.6 2.9 9.7 (10.2)
Other comprehensive earnings (loss) 7.3 3.7 10.4 (8.6)
Comprehensive earnings (loss) 80.5 59.9 (28.6) 62.1
Less: Comprehensive (loss) earnings attributable to noncontrolling interests 0.0 (0.1) 0.1 0.5
Comprehensive earnings (loss) attributable to Varian $ 80.5 $ 60.0 $ (28.7) $ 61.6
[1] Tax expense or benefit related to the periods presented are not material.
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Statement of Comprehensive Income [Abstract]        
Tax on amortization of prior service cost included in net periodic benefit cost $ 0.0 $ 0.0 $ 0.1 $ 0.1
Tax on amortization of net actuarial loss included in net periodic benefit cost (0.1) (0.2) (0.3) (0.4)
Tax on increase (decrease) in unrealized gain on derivative instruments 0.2 0.0 0.3 0.0
Tax on reclassification adjustments on derivative instruments $ (0.3) $ 0.0 $ (0.3) $ 0.0
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Current assets:    
Cash and cash equivalents $ 739.9 $ 716.2
Trade and unbilled receivables, net of allowance for doubtful accounts of $40.3 at March 30, 2018 and $45.9 at September 29, 2017 936.7 961.5
Inventories 433.8 417.7
Prepaid expenses and other current assets 226.4 190.3
Current assets of discontinued operations 8.6 11.1
Total current assets 2,345.4 2,296.8
Property, plant and equipment, net 247.0 255.3
Goodwill 236.2 222.6
Intangible assets 82.0 71.6
Deferred tax assets 114.9 147.3
Other assets 282.0 300.8
Total assets 3,307.5 3,294.4
Current liabilities:    
Accounts payable 164.9 162.3
Accrued liabilities 365.1 374.9
Deferred revenues 766.5 755.4
Short-term borrowings 230.0 350.0
Current liabilities of discontinued operations 3.7 2.5
Total current liabilities 1,530.2 1,645.1
Other long-term liabilities 320.7 127.4
Total liabilities 1,850.9 1,772.5
Commitments and contingencies (Note 10)
Equity:    
Preferred stock of $1 par value: 1.0 shares authorized; none issued and outstanding 0.0 0.0
Common stock of $1 par value: 189.0 shares authorized; 91.7 shares issued and outstanding at both March 30, 2018, and at September 29, 2017, respectively 91.7 91.7
Capital in excess of par value 754.7 716.1
Retained earnings 664.2 778.6
Accumulated other comprehensive loss (58.4) (68.8)
Total Varian stockholders' equity 1,452.2 1,517.6
Noncontrolling interests 4.4 4.3
Total equity 1,456.6 1,521.9
Total liabilities and equity $ 3,307.5 $ 3,294.4
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 40.3 $ 45.9
Preferred stock, par value (in dollars per share) $ 1 $ 1
Preferred stock, shares authorized (in shares) 1,000,000.0 1,000,000.0
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 1 $ 1
Common stock, shares authorized (in shares) 189,000,000 189,000,000.0
Common stock, shares issued (in shares) 91,700,000 91,700,000
Common stock, shares outstanding (in shares) 91,700,000 91,700,000
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Sep. 29, 2017
Statement of Cash Flows [Abstract]          
Net (loss) earnings $ 73.2 $ 56.2 $ (39.0) $ 70.7  
Adjustments to reconcile net earnings to net cash provided by operating activities:          
Share-based compensation expense     21.2 23.6  
Depreciation     25.4 31.9  
Amortization of intangible assets     10.4 9.1  
Deferred taxes     41.8 (7.5)  
Loss on hedges related to the Sirtex acquisition     16.4 0.0  
Provision for doubtful accounts receivable     2.0 38.8  
Impairment charges 11.1 0.0 11.1 38.3  
Other, net     0.0 (0.7)  
Changes in assets and liabilities:          
Trade and unbilled receivables     28.4 (14.5)  
Inventories     (10.9) (14.3)  
Prepaid expenses and other assets     0.0 (55.5)  
Accounts payable     0.9 (9.9)  
Accrued liabilities and other long-term liabilities     125.3 (25.5)  
Deferred revenues     11.5 29.9  
Net cash provided by operating activities     244.5 114.4  
Cash flows from investing activities:          
Purchases of property, plant and equipment     (17.8) (32.1)  
Acquisitions, net of cash acquired     (29.6) 0.0  
Issuance of notes receivable     0.0 (11.5)  
Principal payments on notes receivable     5.2 0.0  
Investment in available-for-sale securities     (6.0) (1.1)  
Sale of available-for-sale securities     8.0 0.0  
Loans to CPTC     (5.3) 0.0  
Purchase of foreign currency option related to the Sirtex acquisition     (5.5) 0.0  
Investment in privately-held companies     (3.1) (5.0)  
Amounts paid to deferred compensation plan trust account     (1.3) (4.4)  
Other, net     0.3 0.9  
Net cash used in investing activities     (55.1) (53.2)  
Cash flows from financing activities:          
Repurchases of common stock     (92.7) (222.3)  
Proceeds from issuance of common stock to employees     44.6 25.4  
Employees' taxes withheld and paid for restricted stock and restricted stock units     (11.1) (10.5)  
Cash received from Varex Imaging Corporation     0.0 200.0  
Cash and cash equivalents contributed to Varex Imaging Corporation     0.0 (81.3)  
Borrowings under credit facility agreement     234.3 90.0  
Repayments under credit facility agreement     (209.3) (100.0)  
Net repayments under the credit facility agreements with maturities less than 90 days     (120.0) (107.0)  
Other     0.0 0.7  
Net cash used in financing activities     (154.2) (205.0)  
Effects of exchange rate changes on cash and cash equivalents     (11.5) 7.3  
Net increase (decrease) in cash and cash equivalents     23.7 (136.5)  
Cash and cash equivalents at beginning of period     716.2 843.5 $ 843.5
Cash and cash equivalents at end of period $ 739.9 $ 707.0 $ 739.9 $ 707.0 $ 716.2
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Mar. 30, 2018
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business
Varian Medical Systems, Inc. (“VMS”) and subsidiaries (collectively, the “Company”) designs, manufactures, sells and services hardware and software products for treating cancer with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Software solutions also include informatics software for information management, clinical knowledge exchange, patient care management, practice management and decision-making support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices. The Company also develops, designs, manufactures, sells and services proton therapy products and systems for cancer treatment.
Distribution
On January 28, 2017 (the "Distribution Date"), the Company completed the separation and distribution (the "Distribution") of Varex Imaging Corporation ("Varex"), the Company's former Imaging Components business segment. On the Distribution Date, each of Varian's stockholder of record as of the close of business on January 20, 2017 (the "Record Date") received 0.4 of a share of Varex common stock for every one share of Varian common stock as of the Record Date. Varex is now an independent publicly traded company and is listed on The NASDAQ Global Select Market under the ticker “VREX.” Varian continues to trade on the New York Stock Exchange under the ticker “VAR.” See Note 2, "Discontinued Operations" for additional information.
Basis of Presentation
The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended September 29, 2017 (the “2017 Annual Report”). In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s financial position as of March 30, 2018 and September 29, 2017, results of operations and statements of comprehensive earnings (loss) for the three and six months ended March 30, 2018 and March 31, 2017, and cash flows for the six months ended March 30, 2018 and March 31, 2017. The results of operations for the six months ended March 30, 2018 are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period.
At the beginning of the Company's fiscal year 2018, the Company early adopted the new revenue recognition Accounting Standard Codification 606 "Revenues from Contracts with Customers" ("ASC 606") by using the full retrospective method. All financial statements and disclosures have been recast to comply with ASC 606. See "Recently Adopted Accounting Pronouncements" below for further information.
The historical financial position and results of operations of the Imaging Components business and costs relating to the Distribution are reported in the condensed consolidated financial statements as discontinued operations for all the periods presented. Information in the accompanying notes to the condensed consolidated financial statements have been recast to reflect the effect of the Distribution. The Condensed Consolidated Statements of Comprehensive Earnings (Loss) and Cash Flows have not been recast to reflect the effect of the Distribution.
Fiscal Year
The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September 30. Fiscal year 2018 is the 52-week period ending September 28, 2018. Fiscal year 2017 was the 52-week period that ended on September 29, 2017. The fiscal quarters ended March 30, 2018 and March 31, 2017 were both 13-week periods.
Principles of Consolidation
The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Significant Accounting Policies
The Company's significant accounting policies are detailed in "Note 1: Summary of Significant Accounting Policies" within Item 8 of the Company's Annual Report on Form 10-K for the year ended September 29, 2017. Significant changes to these accounting policies as a result of adoption of ASC 606 are discussed below:
Revenue Recognition
The Company's revenues are derived primarily from the sale of radiotherapy and proton therapy hardware and software products, support, training and maintenance of all those products, installation services and the sale of parts. The Company accounts for a contract with a customer when there is approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
The Company's revenues are measured based on consideration specified in the contract with each customer, net of any sales incentives and amounts collected on behalf of third parties such as sales taxes. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.
The majority of the Company's revenue arrangements consist of multiple performance obligations including hardware, software, and services. Determining the stand-alone selling price ("SSP") and allocation of consideration from an arrangement to the individual performance obligations, and the appropriate timing of revenue recognition are significant judgments with respect to these arrangements.
The Company's products are generally not sold with a right of return, and the Company does not provide credits or incentives, which may be required to be accounted for as variable consideration when estimating the amount of revenue to be recognized.
The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the Company expects the benefit of those costs to be longer than one year. The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less. These costs mainly include the Company's internal sales force compensation program; under the terms of these programs these are generally earned and the costs are recognized at the time the revenue is recognized.
The majority of the Company’s products and services are sold in bundled arrangements (e.g., hardware, software, and services). For bundled arrangements, the Company accounts for individual products and services separately if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their individual SSP. The SSP is determined based on observable prices at which the Company separately sells the products and services. If an SSP is not directly observable, then the Company will estimate the SSP considering marketing conditions, entity-specific factors, and information about the customer or class of customer that is reasonably available.
The following is a description of the principal activities, separated by reportable segment, from which the Company generates its revenues.
Oncology Systems
The Company's Oncology Systems linear accelerators are generally sold in a bundled arrangement with hardware and software accessory products that enhance efficiency and enable delivery of advanced radiotherapy and radiosurgery treatments, however, certain products are occasionally sold on a stand-alone basis. The majority of machine and software sales include installation services and training. Delivery of different elements in a revenue arrangement often span more than one reporting period. For example, a linear accelerator and software may be delivered in one reporting period, but the related installation of those products may be completed in a later period. Hardware and software extended maintenance and service contracts are occasionally sold during the initial product sale, but the majority are sold separately near or at the end of the initial warranty period. Revenues related to extended warranty and service contracts are earned after the expiration of the initial warranty period.
Payment terms and conditions vary by contract type, although terms are generally commensurate with a significant milestone, such as contract signing, shipment, delivery, acceptance or service commencement. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts generally do not include a significant financing component. The primary purpose of the Company's invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company's products and services, not to receive financing from the Company's customers, such as invoicing at the beginning of a contract term with revenue recognized ratably over the contract period for a service contract. Payment terms can also vary based on the type of customer, such as government purchases. There are occasions where the Company provides extended payment terms in which case a portion of the transaction price is allocated to imputed interest income.
From time to time, the Company's contracts are modified to account for additional, or change existing, performance obligations. The Company's contract modifications are generally accounted for prospectively.
Hardware Products and Installation
Hardware products may include software that the hardware is dependent on and highly interrelated with and cannot operate without. The Company typically has a standard base configuration for its hardware products, but there are typically multiple options and configuration choices. Revenues from the sale of hardware are recognized when the Company transfers control to the customer.
Product installation includes uncrating, moving the machine to the treatment room, connection and validating configuration. In addition, a number of testing protocols are completed to confirm the equipment is performing to the contracted specifications. The Company recognizes revenues for hardware installation over time as the customer receives and consumes benefits provided as the Company performs the installation services.
Software Products and Installation
Software products include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. Software installation includes transferring software to the customer’s computers, configuration of the software and potentially data migration. The Company recognizes revenues for software and software installation upon the customer's acceptance of the software and installation services.
Service
Service revenues include revenues from initial and extended software support agreements, extended hardware warranty agreements, training, paid service arrangements when a customer does not have an extended warranty and parts that are sold by the service department.
Revenues from hardware and software support agreements are accounted for ratably over the term of the agreement. Services and training revenues are recognized in the period the services and training are performed. Revenues for sales of parts are recognized when the parts are delivered to the customer and control is transferred.
Warranties
The Company's sale of hardware includes a one-year warranty. The Company uses the cost accrual method to account for assurance-type warranties. The standard warranty provision further includes services in addition to an assurance-type warranty (preventative maintenance inspections, help desk support, when and if available operating system upgrades). These service-type warranty features are recorded as a separate performance obligation and recognized ratably over the one-year warranty period.
Varian Particle Therapy ("VPT")
The manufacturing of the major components of a proton therapy system, installation, and commissioning typically lasts 18 to 24 months. The Company's proton therapy system is highly customized. A proton therapy system typically includes hardware, software that the hardware is dependent upon and highly interrelated with, and without which the hardware cannot operate, and installation. The Company also sells software products that include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software, and software installation.
The Company provides operations and maintenance services related to the proton therapy system under a separate arrangement. These contracts are typically executed at or about the same time as the proton therapy system contracts; however, the pricing and performance of the proton therapy system contracts are not typically related to the pricing or performance of the operations and maintenance contracts. Therefore, the Company recognizes operations and maintenance services as a separate performance obligation.
Under the typical payment terms of the Company's fixed-price contracts, the customer pays the Company an up-front advance payment and then performance-based payments based on quantifiable measures of performance or on the achievement of specified events or milestones. As the revenue is recognized over time relative to the costs incurred and the customer billing milestones are typically event driven, this may result in revenue recognized in excess of billings at some point during the contract which the Company presents as unbilled receivables on the Condensed Consolidated Balance Sheets. Amounts billed and due from the Company's customers are classified as trade accounts receivable on the Condensed Consolidated Balance Sheets. In most contracts, the Company is entitled to receive an advance payment at the beginning of the contract. The Company recognizes a liability for these advance payments in excess of revenue recognized and presents it as deferred revenues on the Condensed Consolidated Balance Sheets. The advance payment typically is not considered a significant financing component because it is used to ensure the customer's commitment to the project.
The Company recognizes revenue for its proton therapy systems over time because the customer controls the work in process, the Company's performance does not create an asset with an alternative use to the Company, and the Company has an enforceable right to payment for performance completed to date.
Due to the nature of the work required to be performed on many of the Company's performance obligations, the estimation of total revenues and costs at completion is complex, subject to many variables and requires significant judgment. The Company's contracts generally do not include award fees, incentive fees or other provisions that may be considered variable consideration.
The Company has a standard quarterly progress review process in which management reviews the progress and execution of the Company's performance obligations. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and costs to achieve the schedule (e.g., the number and type of milestone events), technical and other contract requirements. Management must make assumptions and estimates regarding the complexity of the work to be performed, the availability of materials and outside services, the length of time to complete the performance obligation and labor and overhead cost rates, among other significant judgments. Based on this analysis, any quarterly adjustments to revenues, cost of revenues, and the related impact to operating earnings are recognized as necessary in the period they become known on a cumulative catch-up basis. When estimates of total costs to be incurred on a performance obligation exceed total estimates of revenues to be earned, a provision for the entire loss on the performance obligation is recognized in the period the loss is determined.
Similar to the Oncology Systems segment, the Company recognizes VPT revenues for software and installation upon completion and acceptance of the software and installation services.
Unfulfilled Performance Obligations for Oncology Systems and VPT
The following table represents the Company's unfulfilled performance obligations as of March 30, 2018 and the estimated revenue expected to be recognized in the future related to these unfulfilled performance obligations:
 
Fiscal years of revenue recognition
(In millions)
2018
 
2019
 
2020
 
Thereafter
Unfulfilled Performance Obligations
$
1,060.8

 
$
2,089.5

 
$
729.4

 
$
1,276.3


The table above includes both product and service unfulfilled performance obligations, which includes a component of service performance obligations which have not been invoiced. The time bands reflect management’s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers’ facilities for installation, installation requirements, and availability of products or customer acceptance terms.
As part of the Company's adoption of ASC 606, the Company elected to use the following practical expedients (i) to exclude disclosures of transaction prices allocated to remaining performance obligations when the Company expects to recognize such revenue for all periods prior to the date of initial application of ASC 606 (ii) not to adjust the promised amount of consideration for the effects of a significant financing component when the Company expects, at contract inception, that the period between the Company's transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less (iii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less, which mainly includes the Company's internal sales force compensation program and certain partner sales incentive programs (iv) not to recast revenue for contracts that begin and end in the same fiscal period, and (v) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.
Contract Balances
The timing of revenue recognition, billings and cash collections results in trade and unbilled receivables, and deferred revenues on the Condensed Consolidated Balance Sheet. In Oncology Systems, the Company often collects an advance payment and the balance is typically billed on a combination of delivery and/or acceptance. In VPT, the Company usually collects an advance payment and additional amounts are billed as work progresses in accordance with agreed-upon contractual terms upon achievement of contractual milestones. Service contracts are usually billed at the beginning of the contract period or at periodic intervals (e.g. monthly or quarterly) during the contract which could result in a contract asset and contract liability. At times, billing occurs subsequent to revenue recognition, resulting in an unbilled receivable which represents a contract asset. However, when the Company receives advances or deposits from customers, which can be higher in the initial stages of the contract, particularly international contracts in the case of Oncology Systems, before revenue is recognized, this results in deferred revenues which represents a contract liability. These contract assets and liabilities are reported as unbilled receivables and deferred revenues, respectively, on the Condensed Consolidated Balance Sheet on a contract-by-contract basis at the end of each reporting period.
Recently Adopted Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board ("FASB") issued ASC 606. Under the standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration the entity expects to receive in exchange for those goods or services. Effective September 30, 2017, the Company elected to early adopt the requirements of ASC 606 using the full retrospective method, which required the Company to recast the prior reporting periods presented.
The most significant impacts on adoption were in the Oncology Systems segment and are primarily due to the removal of the contingent revenue cap which limited revenue recognition to the amount of cash received from the customer, the elimination of the mandatory revenue deferral for software sold with extended payment terms and the removal of the vendor-specific objective evidence requirement for the separation of bundled software products. The Company also identified additional performance obligations for training and certain elements of warranty that are recognized as separate performance obligations, and identified that certain new performance obligations were previously accounted for as part of hardware products and will result in a change in classification of revenues from product to service. In preparation for adoption of the standard, the Company implemented internal controls and key system functionalities to enable the preparation of financial information.
The Company has recast its condensed consolidated financial statements from amounts previously reported due to the adoption of ASC 606. Select Condensed Consolidated Statements of Earnings (Loss) line items, which reflect the adoption of ASC 606 are as follows:
 
Three Months Ended
 
Six Months Ended
 
March 31, 2017
 
March 31, 2017
(In millions, except per share amounts)
As Previously Reported
 
Adjustments
 
As Adjusted
 
As Previously Reported
 
Adjustments
 
As Adjusted
Revenues:
 
 
 
 
 
 
 
 
 
 
 
Product
$
386.1

 
$
(21.2
)
 
$
364.9

 
$
729.7

 
$
(55.6
)
 
$
674.1

Service
268.9

 
29.4

 
298.3

 
537.1

 
53.5

 
590.6

Total revenues
655.0

 
8.2

 
663.2

 
1,266.8

 
(2.1
)
 
1,264.7

Cost of revenues:
 
 
 
 
 
 
 
 
 
 
 
Product
254.2

 
(7.3
)
 
246.9

 
478.6

 
(25.5
)
 
453.1

Service
125.5

 
15.2

 
140.7

 
237.2

 
31.8

 
269.0

Total cost of revenues
379.7

 
7.9

 
387.6

 
715.8

 
6.3

 
722.1

Gross margin
275.3

 
0.3

 
275.6

 
551.0

 
(8.4
)
 
542.6

Earnings from continuing operations before taxes
90.1

 
0.3

 
90.4

 
118.1

 
(8.4
)
 
109.7

Taxes on earnings
20.8

 
0.1

 
20.9

 
34.3

 
(2.1
)
 
32.2

Net earnings from continuing operations
69.3

 
0.2

 
69.5

 
83.8

 
(6.3
)
 
77.5

Net loss from discontinued operations
(13.3
)
 
—

 
(13.3
)
 
(6.8
)
 
—

 
(6.8
)
Net earnings
$
56.0

 
$
0.2

 
$
56.2

 
$
77.0

 
$
(6.3
)
 
$
70.7

Net earnings attributable to Varian
$
56.1

 
$
0.2

 
$
56.3

 
$
76.5

 
$
(6.3
)
 
$
70.2

 
 
 
 
 
 
 
 
 
 
 
 
Diluted net earnings per share from continuing operations attributable to Varian
$
0.74

 
$
—

 
$
0.74

 
$
0.89

 
(0.07
)
 
$
0.82

Select Condensed Consolidated Statements of Balance Sheet line items, which reflect the adoption of ASC 606 are as follows:
 
September 29, 2017
(In millions)
As Previously Reported
 
Adjustments
 
As Adjusted
Assets:
 
 
 
 
 
Trade and unbilled receivables, net
$
823.5

 
$
138.0

 
$
961.5

Inventories
439.7

 
(22.0
)
 
417.7

Prepaid expenses and other current assets
199.8

 
(9.5
)
 
190.3

Deferred tax assets
138.8

 
8.5

 
147.3

 
 
 
 
 
 
Liabilities and Equity:
 
 
 
 
 
Accrued liabilities
394.7

 
(19.8
)
 
374.9

Deferred revenues
640.6

 
114.8

 
755.4

Other long-term liabilities
130.0

 
(2.6
)
 
127.4

Retained earnings
756.0

 
22.6

 
778.6


In addition, the cumulative effect of ASC 606 to the Company's retained earnings at October 2, 2015 was $56.7 million. Adoption of ASC 606 had no impact to net cash from or used in operating, investing or financing activities in the Company's Condensed Consolidated Statements of Cash Flows.
In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance which targeted improvements to the accounting for hedging activities. The guidance allows companies to more accurately present the economic effects of risk management activities in the financial statements. This amendment is required to be applied prospectively. The primary impact of the adoption is the required disclosure changes. The adoption of the new guidance did not have a material impact on the Company's condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company adopted the FASB guidance related to employee share-based payments. The amendment simplifies several aspects of the accounting for employee share-based payments including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The Company elected to use the prospective transition method for the presentation of excess tax benefits on the statement of cash flows. Under the new standard, excess tax benefits are now included in taxes on earnings in the Consolidated Statement of Earnings (Loss). The Company elected to recognize forfeitures as they occur, and the impact of this change in accounting policy was recorded as a $0.4 million reduction, net, to its beginning retained earnings balance as of September 30, 2017. See Note 12, "Income Taxes" for more information on the impact of this accounting guidance. The remaining provisions of this amendment did not have a material impact on the Company's condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company adopted the FASB accounting guidance related to inventory measurement. The amendment requires inventory measured using first-in, first-out (FIFO) or average cost to be subsequently measured at the lower of cost and net realizable value, thereby simplifying the current guidance that requires an entity to measure inventory at the lower of cost or market. This amendment is required to be applied prospectively. The adoption of this new guidance did not have a material impact to the Company’s condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance on the definition of a business in accounting for transactions when determining whether they represent acquisitions or disposals of assets or of a business. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company’s condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance simplifying the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company’s condensed consolidated financial statements.
Recent Accounting Standards or Updates Not Yet Effective
In February 2018, the FASB amended its guidance that will allow companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2020. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In May 2017, the FASB provided guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The guidance is effective for the Company beginning in the first quarter of fiscal 2019. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its condensed consolidated financial statements.
In March 2017, the FASB amended its guidance on the accounting related to defined benefit plans and other post-retirement benefits. This amendment requires the service cost component of net periodic pension and post-retirement benefit cost be presented in the same line item as other employee compensation costs, while the other components be presented separately as non-operating income (expense). The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In November 2016, the FASB amended its guidance on the classification and presentation of restricted cash in the statement of cash flow. The amendment requires entities to include restricted cash and restricted cash equivalents in its cash and cash equivalents in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively. The amendment is not expected to have a material impact to the Company’s condensed consolidated financial statements.
In October 2016, the FASB amended its guidance for tax accounting for intra-entity asset transfers. The amendment removes the prohibition against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The amendment is required to be adopted on a modified retrospective basis. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In August 2016, the FASB issued an amendment to its accounting guidance related to the classification of certain cash receipts and cash payments. The amendment was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively unless it is impracticable. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In June 2016, the FASB issued an amendment to its accounting guidance related to impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021 with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In February 2016, the FASB issued a new standard on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company is evaluating the impact of adopting this new standard to its condensed consolidated financial statements.
In January 2016, the FASB issued an amendment to its accounting guidance related to recognition and measurement of financial assets and financial liabilities. The amendment addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS
 6 Months Ended
Mar. 30, 2018
Discontinued Operations and Disposal Groups [Abstract]  
DISCONTINUED OPERATIONS
DISCONTINUED OPERATIONS
On January 28, 2017, the Company completed the Distribution of Varex. In connection with the Distribution, the Company and Varex entered into a separation and distribution agreement as well as various other agreements that governs the relationships between the parties, including a transition services agreement, a tax matters agreement, an employee matters agreement, an intellectual property matters agreement, a trademark license agreement and supply/distribution agreements. The separation and distribution agreement and other agreements related to the separation were entered into on January 27, 2017. Services under the transition services agreement were for 60 days to 24 months following the Distribution Date, depending on the service provided.
On January 25, 2017, the Company entered into a term facility ("Varex Term Facility"), and on the same day drew down $203.0 million under the facility. In conjunction with the Distribution, the Company used $200.0 million of those proceeds to repay a portion of its outstanding 2013 Revolving Credit Facility. At the Distribution Date, the Company contributed $81.3 million in cash and cash equivalents to Varex as part of the distribution and transfer of certain legal entities. In fiscal year 2017, the Company received $38.7 million from Varex for excess cash and cash equivalents contributed at the Distribution Date. In fiscal year 2017, the Company recorded a $334.1 million reduction to retained earnings as a result of the Distribution of Varex, which included assets and liabilities transferred to Varex on the Distribution Date, including $203.0 million of debt outstanding under the Varex Term Facility.
Following the Distribution, Varex retained a specified amount of cash that would enable Varex to pay the Company consideration for certain net assets outside of the United States that were required to be transferred to Varex but which did not occur on the Distribution Date due to not having received regulatory approvals for such transfers. Once those regulatory approvals are received, the Company will receive a cash payment from Varex in consideration for such net asset transfers. At March 30, 2018, the Company had $4.9 million in assets (net of liabilities) on its Condensed Consolidated Balance Sheet related to Varex net assets to be transferred. The Company expects the remainder of Varex's net assets will be transferred in fiscal year 2018. If the Company does not receive the necessary regulatory approvals during a specified time period, Varex will be required to transfer such cash amounts to Varian.
The financial results of Varex are presented as net earnings from discontinued operations on the Condensed Consolidated Statements of Earnings (Loss), and primarily include the financial results of the Company's former Imaging Components operating segment and costs relating to the Distribution. Corporate costs previously allocated to the Company's Imaging Components operating segment are not included in discontinued operations. See Note 17, "Segment Information" for more information related to corporate allocated costs.
The following table summarizes the key components of net loss from discontinued operations:
 
Three Months Ended (1)
 
Six Months Ended
(In millions)
March 31,
2017
 
March 31,
2017
Revenues
$
42.5

 
$
194.0

Cost of revenues
24.6

 
117.3

Gross margin
17.9

 
76.7

Operating expenses (2)
29.7

 
76.1

Operating earnings
(11.8
)
 
0.6

Taxes on earnings
1.5

 
7.4

Net loss from discontinued operations
(13.3
)
 
(6.8
)
Less: Net earnings from discontinued operations attributable to noncontrolling interests
—

 
0.1

Net loss from discontinued operations attributable to Varian
$
(13.3
)
 
$
(6.9
)
(1) 
There was no activity in net loss from discontinued operations during the three and six months ended March 30, 2018.
(2) 
Operating expenses included separation costs of $19.3 million and $34.2 million during the three and six months ended March 31, 2017, respectively. Separation costs include expenses for transaction advisory services, consulting services, restructuring and other expenses.
The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in the Company's Condensed Consolidated Balance Sheets:
(In millions)
March 30,
2018
 
September 29,
2017
Assets:
 
 
 
Trade accounts receivable, net
$
7.1

 
$
8.1

Inventories
1.1

 
2.9

Prepaid expenses and other current assets
0.4

 
0.1

Current assets of discontinued operations
8.6

 
11.1

Total assets of discontinued operations
$
8.6

 
$
11.1

Liabilities:
 
 
 
Accounts payable
$
2.0

 
$
2.0

Accrued liabilities
1.7

 
0.5

Current liabilities of discontinued operations
3.7

 
2.5

Total liabilities of discontinued operations
$
3.7

 
$
2.5


The following table presents supplemental cash flow information of discontinued operations:
 
Six Months Ended (1)
(In millions)
March 31,
2017
Operating activities:
 
Share-based compensation expense
$
2.0

Depreciation expense
4.4

Amortization expense
1.8

Investing activities:
 
Purchases of property, plant and equipment
$
(6.3
)

(1) 
There was no significant cash flow activity from discontinued operations during the six months ended March 30, 2018.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
BUSINESS COMBINATIONS
 6 Months Ended
Mar. 30, 2018
Business Combinations [Abstract]  
BUSINESS COMBINATIONS
BUSINESS COMBINATIONS
Sirtex
On January 30, 2018, the Company signed an agreement to acquire Sirtex Medical Limited ("Sirtex"), an Australian company that is listed on the Australian Securities Exchange, for A$28 per share or approximately A$1.6 billion ($1.2 billion as of March 30, 2018). Sirtex is an Australian-based global life sciences company focused on interventional oncology therapies. The Company plans to fund the acquisition primarily using its 2018 Revolving Credit Facility, as well as cash on hand. The transaction has received all necessary regulatory approvals, is subject to the approval of the Sirtex shareholders, the Federal Court of Australia and the satisfaction of other customary closing conditions.

On May 4, 2018, Sirtex received an unsolicited non-binding, indicative and conditional proposal from CDH Investments ("CDH"), a China-based alternative asset manager, for the acquisition of all of the issued shares in Sirtex for A$33.60 per share. The Sirtex board of directors has determined to engage with CDH to further understand the conditions associated with the CDH proposal. As a result, the meeting of Sirtex shareholders to approve the acquisition by Varian, which was scheduled to occur on Monday, May 7, 2018 (Sydney time), was adjourned to a time and date to be determined.
Other Acquisitions
In fiscal year 2018, the Company acquired two privately-held software companies for a purchase price of $29.6 million. The purchase price primarily consisted of $20.4 million in finite-lived intangible assets and $11.5 million in goodwill. The Company has integrated these two acquisitions into its Oncology Systems reporting unit.
Other Information
The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisitions completed above. The Company believes the factors that contributed to goodwill include synergies that are specific to the Company's acquisitions completed and not available to market participants and the acquisition of a talented workforce. The goodwill for the recent acquisitions mentioned above is deductible for income tax purposes.

The fair value of assets acquired and liabilities assumed has been determined on a preliminary basis, and the Company will finalize these amounts as it obtains the information necessary to complete the measurement process. Any changes resulting from facts and circumstances that existed as of the date of the acquisitions may result in adjustments to the amounts of goodwill, intangible assets and deferred revenue balances recorded. The Company expects to finalize these amounts no later than one year from the date of each acquisition.
The condensed consolidated financial statements include the operating results from the date of acquisition. The impact of the acquisitions completed to the periods presented was not material. Pro forma results of operations for the acquisitions completed have not been presented because the effects of the acquisitions, individually and in the aggregate, were not material to the Company's condensed consolidated financial statements.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEET COMPONENTS
 6 Months Ended
Mar. 30, 2018
Balance Sheet Components [Abstract]  
BALANCE SHEET COMPONENTS
BALANCE SHEET COMPONENTS 
The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers:
(In millions)
March 30,
2018
 
September 29,
2017
Unbilled receivables - current
$
311.5

 
$
259.1

Unbilled receivables - long-term (1)
28.2

 
10.9

Deferred revenues - current
(766.5
)
 
(755.4
)
Deferred revenues - long-term (2)
(9.1
)
 
(7.2
)
Total net unbilled receivables (deferred revenues)
$
(435.9
)
 
$
(492.6
)
(1) 
Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2) 
Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.
During the six months ended March 30, 2018, unbilled receivables net of deferred revenues increased by $56.7 million primarily due to the contractual timing of billings occurring after the revenues were recognized, as well as the timing of milestone payments.
During the three and six months ended March 30, 2018, the Company recognized revenues of $108.8 million and $305.2 million, respectively, which was included in the deferred revenues balance at September 29, 2017. During the three and six months ended March 31, 2017, the Company recognized revenues of $127.2 million and $346.0 million, respectively, which was included in the deferred revenues balance at September 30, 2016.
The Company did not have any impairment losses on its unbilled receivables during the six months ended March 30, 2018. The Company recognized an impairment loss of $17.2 million from long-term unbilled receivables during the six months ended March 31, 2017. See Note 16, "VPT Loans and Securities" for further information.
The following table summarizes the Company's inventories:
(In millions)
March 30,
2018
 
September 29,
2017
Raw materials and parts
$
306.5

 
$
296.5

Work-in-process
54.1

 
47.7

Finished goods
73.2

 
73.5

Total inventories
$
433.8

 
$
417.7


The following tables summarize the Company's available-for-sale securities:
 
March 30, 2018
(In millions)
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
APTC securities (1)
$
6.1

 
$
—

 
$
—

 
$
6.1

GPTC securities (2)
4.6

 
—

 
—

 
4.6

   Total available-for-sale securities
$
10.7

 
$
—

 
$
—

 
$
10.7

 
September 29, 2017
(In millions)
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Original CPTC loans (2)
$
47.4

 
$
—

 
$
—

 
$
47.4

DRTC securities (2)
8.3

 
—

 
—

 
8.3

GPTC securities (2)
4.4

 
—

 
—

 
4.4

   Total available-for-sale securities
$
60.1

 
$
—

 
$
—

 
$
60.1

(1) 
Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets because the Company has the ability and intent to sell this security in the next twelve months.
(2) 
Included in other assets on the Company's Condensed Consolidated Balance Sheets because the maturity dates are greater than one year and the Company does not have the intent and ability to collect or sell all or a portion of its loans or securities in the next twelve months.
See Note 5, "Fair Value" and Note 16, "VPT Loans and Securities" for more information on the Original California Proton Treatment Center, LLC (“Original CPTC”) Loans, Alabama Proton Therapy Center ("APTC"), Delray Radiation Therapy Center (“DRTC”), and Georgia Proton Treatment Center ("GPTC") Securities.
The following table summarizes the Company's other long-term liabilities:
(In millions)
March 30,
2018
 
September 29,
2017
Long-term income taxes payable
$
208.1

 
$
48.6

Deferred income taxes
26.4

 
17.1

Long-term debt
25.0

 
—

Other
61.2

 
61.7

Total other long-term liabilities
$
320.7

 
$
127.4
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE
 6 Months Ended
Mar. 30, 2018
Fair Value Disclosures [Abstract]  
FAIR VALUE
FAIR VALUE
Assets/Liabilities Measured at Fair Value on a Recurring Basis
In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
 
 
Fair Value Measurement Using
 
 
Quoted Prices in
Active Markets
for Identical
Instruments
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
Total
Type of Instruments
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Balance
(In millions)
 
 
 
 
 
 
 
 
Assets at March 30, 2018:
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
APTC securities
 
$
—

 
$
6.1

 
$
—

 
$
6.1

GPTC securities
 
—

 
4.6

 
—

 
4.6

Derivative assets
 
—

 
0.5

 
—

 
0.5

Total assets measured at fair value
 
$
—

 
$
11.2

 
$
—

 
$
11.2

 
 
 
 
 
 
 
 
 
Liabilities at March 30, 2018:
 
 
 
 
 
 
 
 
Derivative liabilities
 
$
—

 
$
(12.4
)
 
$
—

 
$
(12.4
)
Contingent consideration
 
—

 
—

 
(2.8
)
 
(2.8
)
Total liabilities measured at fair value
 
$
—

 
$
(12.4
)
 
$
(2.8
)
 
$
(15.2
)
 
 
 
 
 
 
 
 
 
Assets at September 29, 2017:
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
Original CPTC loans
 
$
—

 
$
—

 
$
47.4

 
$
47.4

DRTC securities
 
—

 
8.3

 
—

 
8.3

GPTC securities
 
—

 
4.4

 
—

 
4.4

Total assets measured at fair value
 
$
—

 
$
12.7

 
$
47.4

 
$
60.1


The Company's Level 2 available-for-sale securities consist of bonds for APTC, GPTC, and DRTC. The observable inputs for these securities are comparable bond issues, broker/dealer quotations for the same or similar investments in active markets and other observable inputs such as yields, credit risks, default rates, and volatility. As of March 30, 2018 and September 29, 2017, the carrying amount of the Level 2 available-for-sale securities approximated their fair value. See Note 16, "VPT Loans and Securities" for further information about these bonds.
The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads. The Company’s derivative instruments are generally short-term in nature, typically one month to thirteen months in duration. See Note 9, "Derivative Instruments and Hedging Activities" for more information about the Company's derivative instruments.
The Company measures the fair value of its Level 3 contingent consideration liabilities based on the income approach by using a discounted cash flow model with key assumptions that include estimated sales units or revenues of the acquired business or completion of certain milestone targets during the earn-out period, volatility, and estimated discount rates corresponding to the periods of expected payments. If the estimated sales units, revenues or probability of completing certain milestones were to increase or decrease during the respective earn-out period, the fair value of the contingent consideration would increase or decrease, respectively. If the estimated discount rates were to increase or decrease, the fair value of contingent consideration would decrease or increase, respectively. Changes in volatility may result in an increase or decrease in the fair value of contingent consideration. The Company's contingent consideration are from its business combinations in fiscal year 2018 and is included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets.
In December 2017, the Original CPTC loans were modified and partially satisfied resulting in a Term Loan of $53.5 million, as defined in Note 16, "VPT Loans and Securities". One of the modifications was that the loan agent no longer has the option to purchase these loans from the Company, therefore, the Original CPTC loans are no longer classified as an available-for-sale security. The Company had no unrealized gains or unrealized losses associated with the Original CPTC loans recorded in its other comprehensive income. The modification to the Original CPTC Loans had no impact on the Company's Condensed Consolidated Statements of Earnings (Loss) for the three months ended December 29, 2017. As of September 29, 2017, the Company classified the Original CPTC loans as available-for-sale securities, the fair value of which was based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks associated with the loans as well as underlying cash flow assumptions. However, the Company did not increase the fair value of the Original CPTC loans above their par values as ORIX Capital Markets, LLC (“ORIX”), the loan agent, had the option to purchase these loans from the Company under the original terms and conditions at par value.
The following table presents the reconciliation for all assets and liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):
(In millions)
Available-for-sale Securities
 
Contingent
Consideration
Balance at September 29, 2017
$
47.4

 
$
—

Additions from business combinations
—

 
(2.8
)
Reclassification of Original CPTC Loans to Term Loan
(47.4
)
 
—

Balance at March 30, 2018
$
—

 
$
(2.8
)
There were no transfers of assets or liabilities between fair value measurement levels during either the three and six months ended March 30, 2018, or the three and six months ended March 31, 2017. Transfers between fair value measurement levels are recognized at the end of the reporting period.
Fair Value of Other Financial Instruments
The fair values of certain of the Company’s financial instruments, including bank deposits included in cash and cash equivalents, trade and unbilled receivables, net of allowance for doubtful accounts, short-term notes receivable, revolving loan to CPTC, RPTC senior secured debt, accounts payable, and short-term borrowings approximate their carrying amounts due to their short maturities.
As of March 30, 2018, the fair value of the Company's long-term debt approximated its carrying value of $25.0 million because it is carried at a market observable interest rate that resets periodically and is categorized as Level 2 in the fair value hierarchy.
As of March 30, 2018, the fair value of the Term Loan with CPTC approximated its carrying value of $44.0 million. See Note 16, "VPT Loans and Securities" for further information. The carrying value is based on the present value of expected future cash payments discounted at a rate reflecting the nature and duration of the loans, risks involved with CPTC, and its industry. As a result, the Term Loan is categorized as Level 3 in the fair value hierarchy.
The fair value of the outstanding long-term notes receivable, including accrued interest, approximated their carrying value of $62.6 million and $100.2 million at March 30, 2018 and September 29, 2017, respectively, because they are based on terms of recent comparable transactions and are categorized as Level 3 in the fair value hierarchy. The fair value is based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks as well as underlying cash flow assumptions. See Note 6, "Receivables" for information on the long-term notes receivable.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
RECEIVABLES
 6 Months Ended
Mar. 30, 2018
Receivables [Abstract]  
RECEIVABLES
RECEIVABLES
The following table summarizes the Company's trade and unbilled receivables, net and notes receivable:
(In millions)
March 30,
2018
 
September 29,
2017
Trade and unbilled receivables, gross
$
1,008.8

 
$
1,039.2

Allowance for doubtful accounts
(40.3
)
 
(63.1
)
Trade and unbilled receivables, net
$
968.5

 
$
976.1

Short-term
$
936.7

 
$
961.5

Long-term (1) 
$
31.8

 
$
14.6

 
 
 
 
Notes receivable
$
87.9

 
$
105.2

Short-term (2) 
$
25.3

 
$
5.0

Long-term (1) (3)
$
62.6

 
$
100.2

(1) 
Balances are included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2) 
Balances are included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets.
(3) 
Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.
A financing receivable represents a financing arrangement with a contractual right to receive money, on demand or on fixed or determinable dates, and that is recognized as an asset on the Company’s Condensed Consolidated Balance Sheets. The Company’s financing receivables consist of trade receivables with contractual maturities of more than one year and notes receivable. A small portion of the Company's financing trade receivables are included in short-term trade accounts receivable.
As of March 30, 2018, the allowance for doubtful accounts is entirely related to short-term trade and unbilled receivables. As of September 29, 2017, the allowance for doubtful accounts included $45.9 million related to short-term trade and unbilled receivables and $17.2 million related to long-term unbilled receivables, which was written off in the first quarter of fiscal year 2018.
See Note 16, "VPT Loans and Securities" for more information on the Company's short-term and long-term notes receivable balances.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
GOODWILL AND INTANGIBLE ASSETS
 6 Months Ended
Mar. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS
GOODWILL AND INTANGIBLE ASSETS
The following table reflects the activity of goodwill by reportable operating segment: 
(In millions)
Oncology
Systems
 
Varian Particle Therapy
 
Total
Balance at September 29, 2017
$
170.2

 
$
52.4

 
$
222.6

Business combinations
11.5

 
—

 
11.5

Foreign currency translation adjustments
—

 
2.1

 
2.1

Balance at March 30, 2018
$
181.7

 
$
54.5

 
$
236.2


See Note 3, "Business Combinations" for more information on the Company's acquisitions in fiscal year 2018.
The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets: 
 
March 30, 2018
 
September 29, 2017
(In millions)
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Technologies and patents
$
118.0

 
$
(67.7
)
 
$
50.3

 
$
102.0

 
$
(60.9
)
 
$
41.1

Customer contracts and supplier relationship
38.2

 
(16.4
)
 
21.8

 
33.9

 
(14.3
)
 
19.6

Other
5.7

 
(4.6
)
 
1.1

 
5.5

 
(3.4
)
 
2.1

Total intangible with finite lives
161.9

 
(88.7
)
 
73.2

 
141.4

 
(78.6
)
 
62.8

In-process research and development with indefinite lives
8.8

 
—

 
8.8

 
8.8

 
—

 
8.8

Total intangible assets
$
170.7

 
$
(88.7
)
 
$
82.0

 
$
150.2

 
$
(78.6
)
 
$
71.6


Amortization expense for intangible assets was $4.1 million and $3.5 million during the three months ended March 30, 2018 and March 31, 2017, respectively, and $10.4 million and $7.3 million during the six months ended March 30, 2018 and March 31, 2017, respectively.
As of March 30, 2018, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions):
Fiscal Years:
Remaining Amortization Expense
Remainder of 2018
$
10.9

2019
15.2

2020
12.7

2021
10.4

2022
9.0

Thereafter
15.0

Total remaining amortization for intangible assets
$
73.2
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
BORROWINGS
 6 Months Ended
Mar. 30, 2018
Debt Disclosure [Abstract]  
BORROWINGS
BORROWINGS
The following table summarizes the Company's short-term borrowings and long-term debt:
 
March 30, 2018
 
September 29, 2017
(In millions, except for percentages)
Amount
 
Weighted-Average Interest Rate
 
Amount
 
Weighted-Average Interest Rate
Short-term borrowings:
 
 
 
 
 
 
 
2017 Revolving Credit Facility
$
230.0

 
2.79
%
 
$
350.0

 
2.36
%
Total short-term borrowings
$
230.0

 
 
 
$
350.0

 
 
 
 
 
 
 
 
 
 
Long-term debt:
 
 
 
 
 
 
 
2017 Revolving Credit Facility
$
25.0

 
4.88
%
 
$
—

 
—
%
Total long-term debt
$
25.0

 
 
 
$
—

 
 

The Company entered into an agreement, dated September 1, 2017, ("Credit Agreement") with certain lenders and Bank of America, N.A. (“BofA”) as administrative agent ("Debt Lenders"). The Credit Agreement provides for a five-year revolving credit facility (the "2017 Revolving Credit Facility") in an aggregate principal amount of up to $600.0 million. The Company incurred $1.8 million in debt issuance costs for its 2017 Revolving Credit Facility, which will be amortized over the five-year term. Debt issuance costs are recorded in prepaid expenses and other current assets and other assets on the Condensed Consolidated Balance Sheets.
On April 3, 2018, the Company replaced its 2017 Revolving Credit Facility with a new credit agreement ("2018 Credit Agreement"). See Note 18, "Subsequent Events" for more information on the 2018 Revolving Credit Facility.
Borrowings under the 2017 Revolving Credit Facility accrue interest based on either (i) the Eurodollar Rate plus a margin of 1.125% to 1.875% based on a leverage ratio involving funded indebtedness and EBITDA, or (ii) a base rate of (a) the federal funds rate plus 0.50%, (b) BofA’s announced prime rate, or (c) the Eurodollar Rate plus 1.00%, whichever is highest, plus a margin of 0.125% to 0.875% based on the same leverage ratio, depending upon instructions from the Company. Borrowings under the 2017 Revolving Credit Facility have a contract repayment date of twelve months, or less, and a final maturity of five years if based on the Eurodollar Rate and all overnight borrowings on the base rate would also have a final maturity of five years.
The Company must pay a commitment fee on the unused portion of the 2017 Revolving Credit Facility at a rate from 0.125% to 0.25% based on a leverage ratio. The Company may prepay, reduce or terminate the commitments without penalty. Swing line loans under the 2017 Credit Facility will bear interest at the base rate plus the then applicable margin for base rate loans.
The Credit Agreement provides that certain material domestic subsidiaries must guarantee the 2017 Revolving Credit Facility, subject to certain limitations on the amount secured. As of March 30, 2018, no subsidiary guaranties were required to be executed under the Credit Agreement.
The Credit Agreement contains provisions that limit the Company's ability to, among other things, incur future indebtedness, contingent obligations or liens, guarantee indebtedness, make certain investments and capital expenditures, sell stock or assets and pay dividends, and consummate certain mergers or acquisitions.
The Credit Agreement contains affirmative and negative covenants applicable to the Company and its subsidiaries that are typical for credit facilities of this type, and that are subject to materiality and other qualifications, carve-outs, baskets and exceptions. The Company has also agreed to maintain certain financial covenants including (i) a maximum consolidated leverage ratio, involving funded indebtedness and EBITDA, and (ii) a minimum consolidated interest coverage ratio. The Company was in compliance with all financial covenants under the Credit Agreement for all periods within these condensed consolidated financial statements.
VMS’s Japanese subsidiary (“VMS KK”) has an unsecured uncommitted credit agreement with Sumitomo that enables VMS KK to borrow and have outstanding at any given time a maximum of 3.0 billion Japanese Yen (the “Sumitomo Credit Facility”). In February 2018, the Sumitomo Credit Facility was extended and will expire in February 2019. Borrowings under the Sumitomo Credit Facility accrue interest based on the basic loan rate announced by the Bank of Japan plus a margin of 0.5%.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 6 Months Ended
Mar. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company measures all derivatives at fair value on the Condensed Consolidated Balance Sheets. The accounting for gains or losses resulting from changes in the fair value of those derivatives depends upon the use of the derivative and whether it qualifies for hedge accounting.
The fair value of derivative instruments reported on the Condensed Consolidated Balance Sheets was as follows:
 
Balance Sheet
 
March 30, 2018
(In millions)
Location
 
Fair Value
Derivatives not designated as hedging instruments:
 
 
 
Foreign exchange option contract
Prepaid expenses and other current assets
 
$
0.5

Foreign exchange forward contracts
Accrued liabilities
 
(12.4
)
Total derivatives
 
 
$
(11.9
)

At March 30, 2018, and September 29, 2017, the Company did not have any outstanding derivatives designated as hedging instruments. As of September 29, 2017, the fair value of the Company's derivatives not designated as hedging instruments was not material. See Note 5, "Fair Value" for the valuation of the Company’s derivative instruments. Also, see Note 1, "Summary of Significant Accounting Policies" in the Consolidated Financial Statements in the Company’s 2017 Annual Report for the credit risk associated with the Company’s derivative instruments.
Offsetting of Derivatives
The Company presents its derivative assets and derivative liabilities on a gross basis on the Condensed Consolidated Balance Sheets. However, under agreements containing provisions on netting with certain counterparties of foreign exchange contracts, subject to applicable requirements, the Company is allowed to net-settle transactions in the same currency, with a single net amount payable by one party to the other. As of March 30, 2018, and September 29, 2017, there were no potential effects of rights of setoff associated with derivative instruments. The Company is neither required to pledge nor entitled to receive cash collateral related to these derivative transactions.
Cash Flow Hedging Activities
The Company has many transactions denominated in foreign currencies and addresses certain of those financial exposures through a risk management program that includes the use of derivative financial instruments. The Company sells products throughout the world, often in the currency of the customer’s country, and may hedge certain of the larger foreign currency transactions when they are either not denominated in the relevant subsidiary’s functional currency or the U.S. Dollar. These foreign currency sales transactions are hedged using foreign currency forward contracts. The Company may use other derivative instruments in the future. The Company does not enter into foreign currency forward contracts for speculative or trading purposes. Foreign currency forward contracts are entered into up to several times a quarter and range from one to thirteen months in maturity.
The hedges of foreign currency denominated forecasted revenues are designated and accounted for as cash flow hedges. The designated cash flow hedges de-designate when the anticipated revenues associated with the transactions are recognized and the change in fair value of the derivatives in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets is reclassified to revenues in the Condensed Consolidated Statements of Earnings (Loss). Subsequent changes in fair value of the derivative instrument are recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings (Loss) to offset changes in fair value of the resulting non-functional currency receivables. For derivative instruments that are designated and qualified as cash flow hedges, the Company formally documents for each derivative instrument at the hedge’s inception, the relationship between the hedging instrument (foreign currency forward contract) and hedged item (forecasted foreign currency revenues), the nature of the risk being hedged and its risk management objective and strategy for undertaking the hedge. The Company records the gain or loss on the derivative instruments that are designated and qualified as cash flow hedges in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets and reclassifies these amounts into revenues in the Condensed Consolidated Statements of Earnings (Loss) in the period in which the hedged transaction is recognized in earnings. The Company assesses hedge effectiveness both at the onset of the hedge and on an ongoing basis using regression analysis. The time value of the derivative and hedged item is included in the assessment of hedge effectiveness.
At the inception of the hedge relationship and quarterly thereafter, the Company assesses whether the likelihood of meeting the forecasted cash flow is highly probable. As of March 30, 2018, the Company did not have any outstanding foreign currency forward contracts designated as cash flow hedges.
During the three and six months ended March 30, 2018, the Company recognized an unrealized loss of $0.6 million and $0.9 million, respectively, in other comprehensive earnings (loss) on foreign currency forward contracts designated as cash flow hedges. The Company did not have any foreign currency forward contracts designated as cash flow hedges during the three and six months ended March 31, 2017.
The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings (Loss) was as follows:
 
Location and Amount Recognized in Earnings (Loss) on Cash Flow Hedging Relationships
 
Three Months Ended
 
Six Months Ended
 
March 30, 2018
 
March 30, 2018
(In millions)
Revenues
 
Revenues
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings (Loss) in which the effects of fair value and cash flow hedges are recorded
$
729.9

 
$
1,408.4

 
 
 
 
Loss on cash flow hedge relationships:
 
 
 
Foreign currency forward contracts:
 
 
 
Amount of loss reclassified from accumulated other comprehensive loss into earnings (loss)
$
(1.0
)
 
$
(0.9
)

Balance Sheet Hedging Activities
The Company also hedges balance sheet exposures from its various subsidiaries and business units where the U.S. Dollar is the functional currency. The Company enters into foreign currency forward contracts to minimize the short-term impact of foreign currency fluctuations on monetary assets and liabilities denominated in currencies other than the U.S. Dollar functional currency. The foreign currency forward contracts are short term in nature, typically with a maturity of approximately one month, and are based on the net forecasted balance sheet exposure. For derivative instruments not designated as hedging instruments, changes in their fair values are recognized in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings (Loss). Changes in the values of these hedging instruments are offset by changes in the values of foreign-currency-denominated assets and liabilities. Variations from the forecasted foreign currency assets or liabilities, coupled with a significant currency rate movement, may result in a material gain or loss if the hedges are not effectively offsetting the change in value of the foreign currency asset or liability. Other than foreign exchange hedging activities, the Company has no other free-standing or embedded derivative instruments.
The Company had the following outstanding foreign currency forward contracts relating to balance sheet hedging activities:
 
March 30, 2018
(In millions)
Notional
Value Sold
 
Notional
Value Purchased
Australian Dollar
$
35.1

 
$
—

Brazilian Real
7.7

 
—

British Pound
33.0

 
—

Canadian Dollar
12.3

 
—

Danish Krone
9.9

 
0.5

Euro
246.6

 
—

Hungarian Forint
1.9

 
—

Indian Rupee
17.8

 
—

Japanese Yen
69.5

 
—

Polish Zloty
18.6

 
—

Singapore Dollar
—

 
5.1

Swedish Krona
12.1

 
—

South African Rand

8.9

 
—

Swiss Franc
—

 
36.2

Thai Baht
3.9

 
—

Totals
$
477.3

 
$
41.8


The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings (Loss) related to the foreign currency forward contracts that are not designated as hedging instruments.
Location of Gain (Loss) Recognized in Income on Derivative Instruments
 
Amount of Gain (Loss) Recognized in Net Earnings (Loss) on Derivative Instruments
 
 
Three Months Ended
 
Six Months Ended
(In millions)
 
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Selling, general and administrative expenses
 
$
(7.5
)
 
$
(7.5
)
 
$
(12.2
)
 
$
7.4


The gains (losses) on these derivative instruments were significantly offset by the gains (losses) resulting from the re-measurement of monetary assets and liabilities denominated in currencies other than the U.S. Dollar functional currency.
Foreign Currency Forward and Option Contracts related to the Acquisition of Sirtex
In February 2018, the Company entered into foreign currency forward contracts and a foreign currency option contract to economically hedge its foreign currency exchange rate risk on the consideration to be paid for the Sirtex acquisition. The foreign currency forward contracts allow the Company to purchase a notional amount of A$793.0 million for $621.0 million on May 25, 2018. The quoted forward exchange rate on March 30, 2018 would provide that the same amount of Australian Dollars would cost $609.6 million. The Company paid a premium of $5.5 million for a foreign currency option that allows the Company to purchase a notional amount of A$792.0 million for $641.5 million that will expire on May 23, 2018. As of March 30, 2018, the foreign currency option has a fair value of $0.5 million.
The foreign currency forward contracts and option contract do not qualify for hedge accounting. As such, changes in the fair value will be recognized in acquisition-related expenses on the Condensed Consolidated Statements of Earnings. In the three months ended March 30, 2018, the Company recorded losses of $11.4 million on the foreign currency forward contracts and $5.0 million on the foreign currency option contract.
Contingent Features
Certain of the Company’s derivative instruments are subject to master agreements which contain provisions that require the Company, in the event of a default, to settle the outstanding contracts in net liability positions by making settlement payments in cash or by setting off amounts owed to the counterparty against any credit support or collateral held by the counterparty. As of March 30, 2018, and September 29, 2017, the Company did not have any outstanding derivative instruments with credit-risk-related contingent features that were in a net liability position in the Company’s outstanding balance sheet hedges.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
COMMITMENTS AND CONTINGENCIES
 6 Months Ended
Mar. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES
Product Warranty
The following table reflects the changes in the Company’s accrued product warranty:
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
Accrued product warranty, at beginning of period
$
41.3

 
$
41.9

Charged to cost of revenues
26.3

 
17.4

Actual product warranty expenditures
(26.5
)
 
(23.2
)
Accrued product warranty, at end of period
$
41.1

 
$
36.1


Accrued product warranty was included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets.
Contingencies
Environmental Remediation Liabilities
The Company’s operations and facilities, past and present, are subject to environmental laws, including laws that regulate the handling, storage, transport and disposal of hazardous substances. Certain of those laws impose cleanup liabilities on the Company in connection with its past and present operations. Those include facilities sold as part of the Company’s electron devices business in 1995 and thin film systems business in 1997. As a result, the Company oversees various environmental cleanup projects and receives reimbursements from third parties for a portion of the costs of its cleanup activities.
The Company also reimburses certain third parties for cleanup activities. The Company spent $0.2 million and $0.1 million (net of amounts borne by third parties) in the three months ended March 30, 2018 and March 31, 2017, respectively, on environmental cleanup costs, third-party claim costs, project management costs and legal costs. The Company spent $0.4 million and $0.3 million (net of amounts borne by third parties) in the six months ended March 30, 2018 and March 31, 2017, respectively, on such costs.
With respect to some of these facilities, inherent uncertainties make it difficult to estimate the likelihood of the cost of future cleanup, third-party claims, project management and legal services for the cleanup sites (“Group A Sites”). Nonetheless, as of March 30, 2018, the Company estimated that, net of third parties’ indemnification obligations, future costs associated with the environmental remediation liabilities for the Group A Sites would range in total from $1.0 million to $7.9 million. The time frames over which these cleanup project costs are estimated vary, ranging from one year to thirty years as of March 30, 2018. Management believes that no amount in that range is more probable of being incurred than any other amount and therefore accrued $1.0 million for these cleanup projects as of March 30, 2018. The accrued amount has not been discounted to present value due to the uncertainties that make it difficult to develop a single best estimate.
In addition to the Group A Sites, there are other past and present facilities (“Group B Sites”) where the Company believes it has gained sufficient knowledge to better estimate the scope and cost of monitoring, cleanup and management activities. This, in part, is based on agreements with other parties and also cleanup plans approved by or completed in accordance with the requirements of, the governmental agencies having jurisdiction. As of March 30, 2018, the Company estimated that the Company’s future exposure on the Group B Sites, net of third parties’ indemnification obligations, for the costs at these facilities, and reimbursements of third-party’s claims for these facilities, ranged in total from $3.4 million to $19.3 million. The time frames over which these costs are estimated to be incurred vary, ranging from one year to thirty years as of March 30, 2018. As to each of these facilities, management determined that a particular amount within the range of estimated costs was a better estimate than any other amount within the range, and that the amount and timing of these future costs were reliably determinable. The best estimate within that range was $5.5 million at March 30, 2018. Accordingly, the Company had accrued $4.7 million as of March 30, 2018 for these costs, which represented the best estimate discounted at 4%, net of inflation. This accrual is in addition to the $1.0 million accrued for the Group A Sites.
These amounts are only estimates of anticipated future costs. The amounts the Company will actually spend may be greater than the estimates. The Company believes its reserve is adequate; however, as the scope of the Company’s obligations becomes more clearly defined, the Company may modify the reserve, and charge or credit future earnings accordingly. Based on information currently known to management, management believes the costs of these environmental-related matters are not reasonably likely to have a material adverse effect on the consolidated financial statements of the Company in any one fiscal year.
The Company evaluates its liability for investigation and cleanup costs in light of the obligations and financial strength of potential third parties and insurance companies the Company believes it has rights to indemnity or reimbursement. The Company has an agreement with an insurance company under which that insurer has agreed to pay a portion of the Company’s past and future environmental-related expenditures. Receivables, net of the portion due to third parties who reimburse the Company, from that insurer amounted to $1.4 million and $1.6 million at March 30, 2018 and September 29, 2017, respectively, with the respective current portion included in prepaid expenses and other current assets and the respective noncurrent portion included in other assets. The payable portion to that insurer is included in other long-term liabilities on the Condensed Consolidated Balance Sheets. The Company believes that this receivable is recoverable because it is based on a binding, written settlement agreement with an insurance company who appears to be financially viable and who has paid the Company’s claims in the past.
Other Matters
From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations and other legal matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value). A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. 
In addition to the above, the Company is involved in other legal matters. However, such matters are subject to many uncertainties and outcomes are not predictable with assurance. The Company is unable to estimate a loss or a range of reasonably possible losses with respect to such matters. There can be no assurances as to whether the Company will become subject to significant additional claims and liabilities with respect to ongoing or future proceedings. If actual liabilities significantly exceed the estimates made, the Company’s consolidated financial position, results of operations or cash flows could be materially adversely affected. Legal expenses relating to legal matters are expensed as incurred.
Restructuring Charges
In the first quarter of fiscal year 2017, the Company offered an enhanced retirement program to its qualifying employees and implemented a workforce reduction (collectively, the "2017 Restructuring Plan"), primarily in its Oncology Systems and VPT segments, to improve operational performance. The Company did not incur any restructuring charges during the three and six months ended March 30, 2018, respectively, and incurred $2.5 million and $6.3 million in restructuring charges during the three and six months ended March 31, 2017, respectively. As of March 30, 2018, the Company plans to complete this plan in fiscal year 2018 and does not expect any additional restructuring charges under this plan.
The following table provides a summary of changes in the restructuring liability related to the Company's restructuring plans:
(In millions)
September 29,
2017
 
Restructuring Charges
 
Cash Payments
 
March 30,
2018
2017 Restructuring Plan
$
3.9

 
$
—

 
$
(3.3
)
 
$
0.6

Total
$
3.9

 
$
—

 
$
(3.3
)
 
$
0.6


The restructuring charges are included in selling, general and administrative expenses in the Condensed Consolidated Statements of Earnings (Loss).
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
RETIREMENT PLANS
 6 Months Ended
Mar. 30, 2018
Retirement Benefits [Abstract]  
RETIREMENT PLANS
RETIREMENT PLANS
The Company sponsors five defined benefit pension plans for regular full-time employees in Germany, Japan, Switzerland and the United Kingdom. The Company also sponsors a post-retirement benefit plan that provides healthcare benefits to certain eligible retirees in the United States.
The components of net defined benefit costs were as follows:
 
Three Months Ended
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Defined Benefit Plans
 
 
 
 
 
 
 
Service cost
$
1.7

 
$
1.8

 
$
3.3

 
$
3.5

Interest cost
0.8

 
0.6

 
1.6

 
1.2

Expected return on plan assets
(2.0
)
 
(1.8
)
 
(4.0
)
 
(3.5
)
Amortization of prior service cost
(0.2
)
 
—

 
(0.3
)
 
(0.1
)
Recognized actuarial loss
0.7

 
1.1

 
1.4

 
2.2

Net periodic benefit cost
$
1.0

 
$
1.7

 
$
2.0

 
$
3.3
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
INCOME TAXES
 6 Months Ended
Mar. 30, 2018
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES
The Company’s effective tax rate was 23.4% and 23.1% for the three months ended March 30, 2018 and March 31, 2017, respectively, and 117.9% and 29.4% for the six months ended March 30, 2018 and March 31, 2017, respectively. The increase in the Company’s effective tax rate for the three and six months ended March 30, 2018, compared to the year-ago periods, was primarily due to the tax effect of the Tax Cuts and Jobs Act (the "Act"), which was signed into law on December 22, 2017. The Company’s effective tax rate for the six months ended March 31, 2017 was also high due to the impairment of the CPTC loans in December 2016, which were made by one of the Company's Swiss subsidiaries, which has a low tax rate, and a significant portion of the expense associated with the allowance for doubtful accounts recorded in the period being attributable to one of the Company's German subsidiaries which has a full valuation allowance.
The Act was signed into law on December 22, 2017. Among other changes, the Act reduces the U.S. corporate tax rate from 35% to 21%, and imposes a one-time transition tax on the unremitted earnings of the Company's foreign subsidiaries. U.S. GAAP generally requires that the tax effect of a change in tax laws or rates be accounted for in the period of enactment.
The reduction in the U.S. corporate tax rate was effective January 1, 2018. As the Company has a September fiscal year end, the lower corporate tax rate will be phased in, resulting in a U.S. corporate rate of approximately 24.6% for the Company's fiscal year ending September 28, 2018, and 21% for subsequent fiscal years. The reduction in the rate requires the Company to re-measure its net deferred tax assets that were originally recorded assuming a future tax benefit at the 35% rate. Because the rate change is phased in, a portion of the tax impact was included in the period of enactment and a portion is included gradually during the year of enactment. During the three and six months ended March 30, 2018, the Company recorded a provisional discrete tax expense of $2.4 million and $40.2 million, respectively, related to re-measuring its net deferred tax assets as a result of the rate reduction.
As part of the transition to a modified territorial system, the Act imposes a one-time transition tax on the unremitted earnings of the Company's foreign subsidiaries. During the three and six months ended March 30, 2018, the Company recorded a provisional discrete tax expense of $3.8 million and $173.1 million, respectively, related to the one-time transition tax. The Company intends to elect to pay this tax over the eight-year period allowed for in the Act. The transition to a modified territorial regime and the one-time transition tax on unremitted earnings has also caused the Company to re-evaluate its intentions with respect to the unremitted earnings of foreign subsidiaries. In the past, the Company did not accrue U.S. taxes on certain undistributed profits of certain foreign subsidiaries because the earnings were considered to be indefinitely reinvested. In light of the changes to the taxation of foreign earnings in the Act, the Company no longer considers the earnings of its foreign subsidiaries to be indefinitely reinvested.
Other provisions of the Act include a new minimum tax on certain foreign earnings (the Global Intangibles Low-taxed Income, or "GILTI"), a new tax on certain payments to foreign related parties (the Base Erosion Anti-avoidance Tax, or "BEAT"), a new incentive for Foreign-derived Intangibles Income ("FDII"), changes to the limitation on the deductibility of certain executive compensation, and new limitations on the deductibility of interest expense. Generally, these other provisions take effect for the Company in the fiscal year ending September 27, 2019.
On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”). This guidance allows registrants a “measurement period,” not to exceed one year from the date of enactment, to complete their accounting for the tax effects of the Act. SAB 118 further directs that during the measurement period, registrants who are able to make reasonable estimates of the tax effects of the Act should include those amounts in their financial statements as “provisional” amounts. Registrants should reflect adjustments over subsequent periods as they are able to refine their estimates and complete their accounting for the tax effects of the Act. The amounts of the tax effects related to the Act described in the paragraphs above represent the Company’s current reasonable estimates and are provisional amounts within the meaning of SAB 118. Also, it is expected that the U.S. Treasury will issue regulations and other guidance on the application of certain provisions of the Act. In subsequent periods, but within the measurement period, the Company will analyze that guidance and other necessary information, including the amount of foreign earnings and profits, pools of foreign tax, and the Company's foreign cash position, to refine its estimates and complete its accounting for the tax effects of the Act.
The Company adopted the FASB guidance related to employee share-based payments in the first quarter of fiscal year 2018. Among other changes, this standard changes the treatment of the tax effect of the excess stock deduction. For a share-based compensation instrument, the excess stock deduction is the difference between the amount of the deduction for taxable income and the amount of expense in the financial statements related to that instrument. Under the prior standard, the tax effect of the excess stock deduction related to share-based compensation was recorded to additional paid-in capital in the equity section on the Condensed Consolidated Balance Sheets. Under the new standard, the tax effect of the excess stock deduction related to share-based compensation is recorded as a discrete item to Taxes on Earnings in the Condensed Consolidated Statements of Earnings (Loss). For the three and six months ended March 30, 2018, the Company recorded a discrete tax benefit of $4.7 million and $6.2 million, respectively, related to excess stock deduction activity. The Company expects that the new standard may cause its effective tax rate to be less predictable and more volatile going forward.
The Company’s effective income tax rate differs from the U.S. federal statutory rate primarily because the Company’s foreign earnings are taxed at rates that are, on average, lower than the U.S. federal rate, and because the Company’s domestic earnings are subject to state income taxes. The total amount of unrecognized tax benefits increased by $11.6 million during the six months ended March 30, 2018, primarily due to the impact of the Act on the Company's unrecognized tax benefits. The impact of this increase in tax expense is included in the amount of the provisional discrete expense related to the one-time transition tax above. In addition, the amount of unrecognized tax benefits has increased as a result of positions taken during the current and prior years, and has decreased as the result of the expiration of the statute of limitations in various jurisdictions.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS
 6 Months Ended
Mar. 30, 2018
Equity [Abstract]  
STOCKHOLDERS’ EQUITY AND NONCONTROLLING INTERESTS
STOCKHOLDERS’ EQUITY AND NONCONTROLLING INTERESTS
Share Repurchase Program
In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. Share repurchases under the Company's authorizations may be made in open market purchases, in privately negotiated transactions (including accelerated share repurchase (“ASR”) programs), or under Rule 10b5-1 share repurchase plans, and may be made from time to time in one or more blocks. All shares that were repurchased under the Company's share repurchase programs have been retired. As of March 30, 2018, approximately 4.4 million shares of VMS common stock remained available for repurchase under the November 2016 authorization.
The Company repurchased shares of VMS common stock under various authorizations during the periods presented as follows:
 
Three Months Ended
 
Six Months Ended
(In millions, except per share amounts)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Number of shares
0.3

 
2.0

 
0.8

 
2.5

Average repurchase price per share
$
110.52

 
$
86.42

 
$
109.06

 
$
88.93

Total cost
$
36.0

 
$
172.8

 
$
92.7

 
$
222.3


Other Comprehensive Earnings
The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:
(In millions)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans
 
Net
Unrealized
Gains
(Losses)
Cash Flow
Hedging
Instruments
 
Cumulative
Translation
Adjustment
 
Accumulated
Other
Comprehensive
Loss
Balance at September 29, 2017
$
(44.1
)
 
$
—

 
$
(24.7
)
 
$
(68.8
)
Other comprehensive earnings (loss) before reclassifications
—

 
(0.9
)
 
9.7

 
8.8

Amounts reclassified out of other comprehensive earnings (loss)
0.9

 
0.9

 
—

 
1.8

Tax expense
(0.2
)
 
—

 
—

 
(0.2
)
Balance at March 30, 2018
$
(43.4
)
 
$
—

 
$
(15.0
)
 
$
(58.4
)
(In millions)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans
 
Cumulative
Translation
Adjustment
 
Accumulated
Other
Comprehensive Earnings
(Loss)
Balance at September 30, 2016
$
(63.3
)
 
$
(37.5
)
 
$
(100.8
)
Other comprehensive loss before reclassifications
—

 
(10.2
)
 
(10.2
)
Amounts reclassified out of other comprehensive earnings (loss)
1.9

 
—

 
1.9

Tax expense
(0.3
)
 
—

 
(0.3
)
Balance at March 31, 2017
$
(61.7
)
 
$
(47.7
)
 
$
(109.4
)

The amounts reclassified out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings (Loss), with line item location, during each period were as follows: 
 
Three Months Ended
 
Six Months Ended
 
 
 (In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
 
 
Comprehensive Earnings Components
Loss Before Taxes
 
Loss Before Taxes
 
Line Item in Statements of Earnings (Loss)
Unrealized loss on defined benefit pension and post-retirement benefit plans
$
(0.5
)
 
$
(1.0
)
 
$
(0.9
)
 
$
(1.9
)
 
Cost of revenues & Operating expenses
Unrealized loss on cash flow hedging instruments
(1.0
)
 
—

 
(0.9
)
 
—

 
Revenues
Total amounts reclassified out of other comprehensive earnings (loss)
$
(1.5
)
 
$
(1.0
)
 
$
(1.8
)
 
$
(1.9
)
 
 
 
Noncontrolling Interests
In connection with the Distribution of Varex in January 2017, the Company's redeemable noncontrolling interests relating to MeVis Medical Solutions AG ("MeVis") were transferred to Varex.
Changes in noncontrolling interests and redeemable noncontrolling interests relating to MeVis and other subsidiaries of the Company were as follows:
 
Six Months Ended
 
March 30, 2018
 
March 31, 2017
 (In millions)
Noncontrolling Interests
 
Noncontrolling Interests
 
Redeemable Noncontrolling Interests
Beginning of Period
$
4.3

 
$
3.7

 
$
10.3

Net earnings attributable to noncontrolling interests
0.1

 
0.4

 
0.1

Transfer of redeemable noncontrolling interests in MeVis to Varex
—

 
—

 
(10.3
)
Other
—

 
—

 
(0.1
)
End of Period
$
4.4

 
$
4.1

 
$
—
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE STOCK PLANS
 6 Months Ended
Mar. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
EMPLOYEE STOCK PLANS
EMPLOYEE STOCK PLANS
The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:
 
Three Months Ended
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Cost of revenues - Product
$
0.8

 
$
0.8

 
$
1.5

 
$
1.6

Cost of revenues - Service
1.0

 
1.1

 
2.0

 
2.1

Research and development
1.2

 
1.4

 
2.4

 
2.6

Selling, general and administrative
7.5

 
8.1

 
15.3

 
15.3

Total share-based compensation expense
$
10.5

 
$
11.4

 
$
21.2

 
$
21.6

Income tax benefit for share-based compensation
$
(2.6
)
 
$
(3.4
)
 
$
(4.7
)
 
$
(6.4
)

The Company adopted new accounting guidance in the first quarter of 2018 where it elected to change its accounting policy to account for forfeitures as they occur rather than estimating expected forfeitures. Share-based compensation expense for the three and six months ended March 31, 2017 was recorded net of estimated forfeitures. See Note 1, "Summary of Significant Accounting Policies" for further information.
The fair value of options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Three Months Ended
 
Six Months Ended
 
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Employee Stock Option Plans
 
 
 
 
 
 
 
Expected term (in years)
3.83

 
3.99

 
3.83

 
3.99

Risk-free interest rate
2.4
%
 
1.7
%
 
2.2
%
 
1.7
%
Expected volatility
19.2
%
 
21.8
%
 
19.0
%
 
21.8
%
Expected dividend
—
%
 
—
%
 
—
%
 
—
%
Weighted average fair value at grant date
$
21.48

 
$
16.13

 
$
20.73

 
$
16.13


The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Six Months Ended
 
March 30,
2018
 
March 31,
2017
Employee Stock Purchase Plan
 
 
 
Expected term (in years)
0.50

 
0.50

Risk-free interest rate
1.2
%
 
0.5
%
Expected volatility
17.9
%
 
22.3
%
Expected dividend
—
%
 
—
%
Weighted average fair value at grant date
$
20.97

 
$
19.37


A summary of share-based awards available for grant is as follows:
(In millions)
Shares Available for Grant
Balance at September 29, 2017
2.5

Authorized (1)
6.0

Granted
(1.7
)
Cancelled or expired
0.3

Balance at March 30, 2018
7.1


(1) 
On February 8, 2018, the Company's stockholders approved its Fifth Amended and Restated 2005 Omnibus Stock Plan ("2005 Plan") to increase the number of shares authorized for issuance by 6.0 million shares.
For purposes of the total number of shares available for grant under the 2005 Plan, any shares subject to awards of stock options and performance stock options are counted against the available-for-grant limit as one share for every one share subject to the award. Awards other than stock options and performance stock options are counted against the available-for-grant limit as 2.6 shares for every one share awarded on or after February 9, 2012. The shares available for grant limit is further adjusted to reflect a maximum payout that could be issued for each performance grant. The maximum payouts that could be issued for each performance grant are 2.0 shares beginning in fiscal year 2018, 1.75 shares in fiscal years 2017 and 2016, and 2.0 shares in fiscal year 2015. All awards may be subject to restrictions on transferability and continued employment as determined by the Compensation and Management Development Committee.
Activity under the Company’s employee stock plans related to stock options is presented below: 
 
Options Outstanding
(In millions, except per share amounts)
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term (in years)
 
Aggregate
Intrinsic
Value (1)
Balance at September 29, 2017
2.3

 
$
74.08

 
 
 
 
Granted
0.6

 
111.43

 
 
 
 
Cancelled or expired (2)
—

 
75.69

 
 
 
 
Exercised
(0.5
)
 
70.67

 
 
 
 
Balance at March 30, 2018
2.4

 
$
85.00

 
5.1
 
$
89.3

 
 
 
 
 
 
 
 
Exercisable at March 30, 2018
1.1

 
$
73.65

 
4.0
 
$
52.0


(1) 
The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of $122.65 as of March 29, 2018, the last trading date of the second quarter of fiscal year 2018, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.
(2) 
The cancelled and expired shares were not material for disclosure.
As of March 30, 2018, there was $18.0 million of total unrecognized compensation expense related to stock options granted under the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of 2.2 years.
The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:
(In millions, except per share amounts)
Number of
Shares
 
Weighted Average
Grant-Date Fair
Value
Balance at September 29, 2017
0.9

 
$
75.37

Granted
0.3

 
111.81

Vested
(0.3
)
 
76.33

Cancelled or expired
(0.1
)
 
84.16

Balance at March 30, 2018
0.8

 
$
88.61


As of March 30, 2018, unrecognized compensation expense totaling $46.9 million was related to awards of restricted stock units, deferred stock units and performance units granted under the Company's employee stock plans. This unrecognized share-based compensation expense is expected to be recognized over a weighted average period of 2.1 years.
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
EARNINGS PER SHARE
 6 Months Ended
Mar. 30, 2018
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
EARNINGS PER SHARE
Basic net earnings per share is computed by dividing net earnings attributable to Varian by the weighted average number of shares of VMS common stock outstanding for the period. Diluted net earnings per share is computed by dividing net earnings attributable to Varian by the sum of the weighted average number of common shares outstanding and dilutive common shares under the treasury stock method.
The following table sets forth the computation of basic and diluted net earnings per share:
 
Three Months Ended
 
Six Months Ended
(In millions, except per share amounts)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Net earnings (loss) from continuing operations
$
73.2

 
$
69.5

 
$
(39.0
)
 
$
77.5

Less: Net (loss) earnings from continuing operations attributable to noncontrolling interests
—

 
(0.1
)
 
0.1

 
0.4

Net earnings (loss) from continuing operations attributable to Varian
$
73.2

 
$
69.6

 
$
(39.1
)
 
$
77.1

 
 
 
 
 
 
 
 
Net loss from discontinued operations
$
—

 
$
(13.3
)
 
$
—

 
$
(6.8
)
Less: Net earnings from discontinued operations attributable to noncontrolling interests
—

 
—

 
—

 
0.1

Net loss from discontinued operations attributable to Varian
$
—

 
$
(13.3
)
 
$
—

 
$
(6.9
)
Net earnings (loss) attributable to Varian
$
73.2

 
$
56.3

 
$
(39.1
)
 
$
70.2

 
 
 
 
 
 
 
 
Weighted average shares outstanding - basic
91.5

 
93.0

 
91.6

 
93.2

Dilutive effect of potential common shares
1.1

 
0.7

 
—

 
0.7

Weighted average shares outstanding - diluted
92.6

 
93.7

 
91.6

 
93.9

 
 
 
 
 
 
 
 
Net earnings (loss) per share attributable to Varian - basic
 
 
 
 
 
 
 
Continuing operations
$
0.80

 
$
0.75

 
$
(0.43
)
 
$
0.83

Discontinued operations
—

 
(0.15
)
 
—

 
(0.08
)
Net earnings (loss) per share - basic
$
0.80

 
$
0.60

 
$
(0.43
)
 
$
0.75

 
 
 
 
 
 
 
 
Net earnings (loss) per share attributable to Varian - diluted
 
 
 
 
 
 
 
Continuing operations
$
0.79

 
$
0.74

 
$
(0.43
)
 
$
0.82

Discontinued operations
—

 
(0.14
)
 
—

 
(0.08
)
Net earnings (loss) per share - diluted
$
0.79

 
$
0.60

 
$
(0.43
)
 
$
0.74

Anti-dilutive employee share-based awards, excluded
0.6

 
0.6

 
3.2

 
0.6


The Company excludes potentially dilutive common shares (consisting of shares underlying stock options and the employee stock purchase plan) from the computation of diluted weighted average shares outstanding if the per share value, either the exercise price of the awards or the sum of (a) the exercise price of the awards and (b) the amount of the compensation cost attributed to future services and not yet recognized and (c) the amount of tax benefit or shortfall that would be recorded in additional paid-in capital when the award becomes deductible, is greater than the average market price of the shares, because the inclusion of the shares underlying these stock awards would be anti-dilutive to earnings per share. For the six months ended March 30, 2018, the diluted net loss per share is the same as the basic net loss per share as the effects of all potential common stock equivalents are anti-dilutive.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
VPT LOANS AND INVESTMENT
 6 Months Ended
Mar. 30, 2018
Receivables [Abstract]  
VPT LOANS AND INVESTMENT
VPT LOANS AND INVESTMENT
In limited cases, the Company participates, along with other investors and at market terms, in the financing of proton therapy centers. Over time the Company has divested some of its investments, including investments in CPTC, NYPC and DRTC.
The following table lists the Company's outstanding loans and investments, including accrued interest, and commitments for funding development, construction and operations of various proton therapy centers:
 
 
March 30, 2018
 
September 29, 2017
(In millions)
 
Balance
 
Commitment
 
 Balance
 
Commitment
Notes receivable and secured debt:
 
 
 
 
 
 
 
 
MPTC loans (1)
 
$
58.9

 
$
—

 
$
67.4

 
$
—

RPTC senior secured debt (2)
 
26.4

 
—

 
25.4

 
—

NYPC loan (3)
 
26.2

 
—

 
24.6

 
—

PI loan (3)
 
2.6

 
—

 
3.1

 
—

CPTC DIP loan (3)
 
—

 
—

 
5.1

 
2.2

 
 
$
114.1

 
$
—

 
$
125.6

 
$
2.2

Available-for-sale Securities:
 
 
 
 
 
 
 
 
APTC securities (2)
 
$
6.1

 
$
—

 
$
—

 
$
—

GPTC securities (3)
 
4.6

 
11.8

 
4.4

 
11.8

Original CPTC loans (3)
 
—

 
—

 
47.4

 
—

DRTC securities (4)
 
—

 
—

 
8.3

 
—

 
 
$
10.7

 
$
11.8

 
$
60.1

 
$
11.8

 
 
 
 
 
 
 
 
 
CPTC Loans and Investment:
 
 
 
 
 
 
 
 
Short-term revolving loan (2)
 
$
3.1

 
$
4.1

 
$
—

 
$
—

Term loan (3)

 
44.0

 
—

 
—

 
—

Equity investment in CPTC (3)
 
9.5

 
—

 
—

 
—

 
 
$
56.6

 
$
4.1

 
$
—

 
$
—

(1) 
Includes $33.8 million and $42.3 million in other assets at March 30, 2018 and September 29, 2017, respectively, and $25.1 million in prepaid and other current assets at March 30, 2018 and other assets at September 29, 2017 on the Company's Condensed Consolidated Balance Sheets.
(2) 
Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets.
(3) 
Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(4) 
Included in other assets at September 29, 2017 on the Company's Condensed Consolidated Balance Sheets.
Alabama Proton Therapy Center ("APTC") Securities
In December 2017, the Company purchased $6.0 million in Subordinate Revenue Bonds from the Public Finance Authority which is financing the APTC. The Subordinate Revenue Bonds carry an interest rate of 8.5% and pay interest semi-annually. The Company is scheduled, based upon the terms, to start receiving annual principal payments on the Subordinate Revenue Bonds beginning on November 1, 2022. The Subordinate Revenue Bonds will mature on October 1, 2047.
Rinecker Proton Therapy Center ("RPTC") Senior Secured Debt
In July 2017, the Company purchased the outstanding senior secured debt related to the RPTC in Munich, Germany for 21.5 million Euros or $24.5 million. By purchasing the senior secured debt, the Company has a right to 89 million Euros in claims against all of RPTC's assets. In September 2017, the management of RPTC filed for bankruptcy in Germany. In January 2018, the final insolvency proceedings commenced, and the Company expects the insolvency proceedings to be finalized within the next twelve months. Upon finalization of bankruptcy proceedings, the Company believes it is probable it will recover its outstanding senior secured debt balance and trade accounts receivable, net.
At both March 30, 2018, and September 29, 2017, the Company had $4.5 million, in trade receivables, net for RPTC, which does not include any unbilled receivables.
Georgia Proton Treatment Center ("GPTC") Security
In July 2017, the Company committed to purchase up to $16.1 million in Senior Capital Appreciation Bonds ("Senior Bonds") from the Atlanta Development Authority, which is financing the GPTC. In July 2017, the Company purchased $4.3 million of the Senior Bonds that carry an interest rate of 8.0% per annum with interest accruing up to the principal amount of $6.6 million until January 1, 2023 and then will pay cash interest semi-annually. The Company will purchase the remaining commitment in July 2018. The Company is scheduled, based upon the original terms, to start receiving annual principal payments on the Senior Bonds beginning on January 1, 2024. The Senior Bonds will mature on January 1, 2028.
In addition to the outstanding loan, the Company had $6.4 million as of March 30, 2018 in trade and unbilled receivables, which included $6.2 million in unbilled receivables from GPTC. The Company did not have any trade and unbilled receivables as of September 29, 2017 from GPTC.
Delray Radiation Therapy Center ("DRTC") Securities and Loan
In April 2017, the Company purchased $8.0 million in Subordinate Bonds from the Public Finance Authority, which is financing the DRTC. The Subordinate Bonds carried an interest rate of 8.5% and paid interest semi-annually. In January 2018, the Company sold all of its Subordinate Bonds for $8.5 million, which included accrued interest.
In addition to the purchase of the Subordinate Bonds, the Company also loaned $3.0 million to Proton International LLC ("PI") to allow PI to purchase $3.0 million in Subordinate Bonds from the Public Finance Authority. The loan to PI carries an interest rate of 8.5% per annum, paid semi-annually and matures on April 30, 2022, subject to early repayment as proceeds are received by PI from the bonds purchased, and is secured by the related bonds. In the first quarter of fiscal year 2018, the Company received a principal payment of $0.5 million.
New York Proton Center ("NYPC") Loan
In July 2015, the Company committed to loan up to $91.5 million to MM Proton I, LLC in connection with a purchase agreement to supply a proton system to equip the NYPC. In June 2016, the Company assigned $73.0 million of this loan to Deutsche Bank AG. The remaining balance is comprised of an $18.5 million “Subordinate Loan” with a six-and-a-half-year term at up to 13.5% interest. The principal balance and accrued interest on the Subordinate Loan are due in full at maturity in January 2022.
In addition to the outstanding loan, the Company had $13.8 million and $13.3 million, as of March 30, 2018, and September 29, 2017, respectively, in trade and unbilled receivables, which included $13.8 million and $1.3 million in unbilled receivables as of March 30, 2018 and September 29, 2017, respectively, from NYPC.
Maryland Proton Treatment Center ("MPTC") Loans
In May 2015, the Company committed to loan up to $35.0 million to MPTC. The Company completed its funding requirements per the loan agreement in the first quarter of fiscal year 2017. Varian's lending is in the form of a subordinated loan that is due, with accrued interest, in three annual payments from 2020 to 2022. The interest on the loan accrues at 12.0%. In the second quarter of fiscal year 2018, the Company recorded an $11.1 million impairment charge on its MPTC subordinated loan, which included accrued interest, due to the expected difference in value between the security currently held by the Company and the value of the new security that will be issued to the Company in exchange as part of the refinancing expected in the second half of fiscal year 2018.
In addition, the Company had previously entered into an agreement with MPTC to supply it with a proton system, which included a deferral of up to $25.1 million of equipment payments when triggered by achievement of delivery milestones under the contract. As of March 30, 2018, the Company has recorded $25.1 million as a notes receivable related to this deferred payment arrangement. The notes receivable is due September 30, 2018.
As of March 30, 2018, and September 29, 2017, the Company had zero net trade and unbilled receivables from MPTC.
Variable Interest Entities
The Company has determined that MM Proton I, LLC, MPTC, and RPTC are variable interest entities and that the Company holds a significant variable interest of each of the entities through its participation in the loan facilities and its agreements to supply and service the proton therapy equipment. The Company has concluded that it is not the primary beneficiary of any of these entities. The Company has no voting rights, has no approval authority or veto rights for these centers' budget, and does not have the power to direct patient recruitment, clinical operations and management of these Centers, which the Company believes are the matters that most significantly affect their economic performance. The Company’s exposure to loss as a result of its involvement with MM Proton I, LLC, MPTC, and RPTC is limited to the carrying amounts of the above-mentioned assets on its Condensed Consolidated Balance Sheets.
California Proton Therapy Center ("CPTC") Loans and Investment
Between September 2011 and November 2015, the Company, ORIX and J.P. Morgan (“the Lenders”) committed to loan up to $185.0 million (the “Original CPTC Loans”), of which the Company's commitment was $84.7 million, to fund the development, construction, initial operations, and working capital needs of the Scripps Proton Therapy Center in San Diego, California. ORIX is the loan agent. In November 2015, the Lenders and California Proton Treatment Center ("Original CPTC") entered into a forbearance agreement whereby the Lenders agreed not to enforce their rights to principal and interest payments until April 2017, subject to Original CPTC maintaining certain covenants and achieving certain targets, with additional extensions through September 2017 based on hitting additional targets largely around patient volume and cash flow.
As of December 30, 2016, even though patient volumes continued to increase, Original CPTC was not in compliance with one of the patient volume covenants in the forbearance agreement, which would allow the Lenders to cease funding and terminate the forbearance agreement. In January 2017, the Company was informed of actions taken by Original CPTC and the loan agent, including Original CPTC obtaining shareholder consents for voluntary bankruptcy filing and the loan agent deciding that no additional funding would be available outside of a bankruptcy process. As a result of this information and the Company’s analysis that these actions would likely lead to insolvency or bankruptcy proceedings of Original CPTC, the Company determined that it was appropriate to record a $38.3 million impairment, as determined by the discounted cash flow model using a single best estimate methodology, of its Original CPTC Loans on the Condensed Consolidated Statements of Earnings in the first quarter of fiscal year 2017. As a result of this impairment, the Original CPTC Loans were written down to their estimated fair value of $60.0 million and reclassified from short-term investments to other assets on the Company's Condensed Consolidated Balance Sheet because the Company did not expect to collect or sell all or a portion of these loans in the next twelve months.
In March 2017, Original CPTC filed for bankruptcy and concurrently entered into a Debtor-in-Possession facility (the "DIP Facility") with the Lenders for up to $16.0 million of additional financing during the bankruptcy process. The Company's pro-rata share of the DIP Facility was $7.3 million. In December 2017, the Company completed its funding commitment under the DIP Facility. The DIP Facility carried an interest rate at the London Interbank Offer Rate (“LIBOR”) plus 9.0% per annum and had a senior secured position ahead of the Original CPTC Loans.
Between April 2017 and August 2017, the Company did not become aware of any new information that warranted an impairment assessment. In September 2017, the Lenders and Scripps signed a Transition Agreement to transition the operations of the center from Scripps to Proton Doctors Professional Corporation (“Practice”). Based on the terms of the Transition Agreement, a slower projected growth in patient volume, an increase in additional projected capital needs and the Company's analysis, the Company determined that an additional $13.1 million impairment charge was deemed appropriate on its Original CPTC Loans which was recorded on the Consolidated Statements of Earnings in the fourth quarter of fiscal year 2017.
Pursuant to an order of the Bankruptcy Court, Original CPTC conducted an auction of the Scripps Proton Therapy Center. On December 6, 2017 (“Closing Date”), the Bankruptcy Court approved the sale of Scripps Proton Therapy Center to California Proton Therapy Center, LLC (“CPTC”), an entity owned by the Lenders. The Lenders purchased all assets and assumed $112.0 million of Original CPTC’s outstanding liabilities. On December 13, 2017, the Bankruptcy Court dismissed the bankruptcy filing of Original CPTC.
On the Closing Date, the Lenders entered into a Credit Agreement with Original CPTC of which the terms of the Original CPTC Loans, DIP Facility and accrued interest (collectively “Former Loans”) have been modified. In addition to the partially satisfied Original CPTC Loans reinstated by the Bankruptcy Court, the Company received a 47.08% equity ownership in CPTC. Original CPTC has assigned all its Former Loans to CPTC at an amount of $112.0 million, the partially satisfied loan balance. Per the terms of the Credit Agreement, the Company's portion of the $112.0 million is $53.5 million; the remainder is allocated between ORIX and J.P. Morgan. The $53.5 million is composed of four Tranches: Tranche A of $2.0 million, Tranche B of $7.2 million, Tranche C of $15.6 million, and Tranche D of $28.7 million (collectively the "Term Loan"). The maturity date of the Term Loan is three years from the Closing Date. The Term Loan is secured by the assets of CPTC.
In addition, the Lenders have committed to lend up to $15.0 million in a Revolving Loan with a maturity date of one year from the Closing Date. The Company's share of the funding commitment from the Revolving Loan is $7.2 million, and as of March 30, 2018, the Company has funded $3.1 million.
All of the Tranches accrue paid-in-kind interest at 7.5% per annum, except the Tranche B and Revolving Loan which accrue paid-in-kind interest at 10% per annum. The seniority of these loans is as follows: Revolving Loan, Tranche A, Tranche B, Tranche C and Tranche D. If CPTC is in default, the interest rate of the Tranche A, C and D will increase to 9.5% and the interest rate on the Tranche B and the Revolving Loan will increase to 12.0%.
Considering Original CPTC’s financial difficulties, the modification of the original terms of the Former Loans, and the Lenders agreement to grant a concession on the Original CPTC Loans, the Company classified the transaction above as a troubled debt restructuring (“TDR”). The Company does not have any unamortized fees from the Former Loans and any prepayment penalties. As a result, the cost basis and fair value of the Company's outstanding Term Loan as of March 30, 2018 is $53.5 million, which approximates the carrying value of the Former Loans prior to the TDR.
The Company, using a discounted cash flow approach, determined that the fair value of CPTC's equity as of Closing Date is $20.1 million. The Company's 47.08% ownership percentage amounts to a $9.5 million equity interest in CPTC. Since the common stock received were in addition to a loan receivable partially satisfied through the bankruptcy proceedings, in accordance with the TDR accounting guidance, the Company recorded the equity interest at fair value and as an offset to the reinstated loan balance. The equity investment in CPTC is accounted for under the equity method of accounting, and the Company accounts for its equity method share of the income or loss of CPTC on a quarter lag basis. The Company recorded a loss of $0.9 million in the three months ended March 30, 2018 in selling, general and administrative expenses on the Condensed Consolidated Statement of Earnings.
Per the terms of the Former Loans, as of September 29, 2017, ORIX had the option to purchase the Company's share of the Original CPTC Loans at par, and therefore they were accounted for as available-for-sale securities. Per the terms of the new agreement, ORIX no longer has the option to purchase the Company’s share of the Term Loan at par. As a result, the Term Loan no longer qualified for available-for-sale classification as of December 29, 2017.
Further, the Company has determined that CPTC is a variable interest entity because of the Company's participation in the loan facilities, equity ownership and its operations and maintenance agreement. The Company has one board seat out of five, has no special approval authority or veto rights for CPTC’s budget, and does not have the power to direct patient recruitment, clinical operations and management of CPTC, which the Company believes are the matters that most significantly affect their economic performance. Therefore, the Company does not have majority voting rights and no power to direct activities at CPTC as a result it is not the primary beneficiary of CPTC.
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION
 6 Months Ended
Mar. 30, 2018
Segment Reporting [Abstract]  
SEGMENT INFORMATION
SEGMENT INFORMATION
The Company has two reportable operating segments: Oncology Systems and VPT. The operating segments were determined based on how the Company’s Chief Executive Officer, its Chief Operating Decision Maker (“CODM”), views and evaluates the Company’s operations. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings.
Description of Segments
The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments such as fixed field intensity-modulated radiation therapy (“IMRT”), image-guided radiation therapy (“IGRT”), VMAT, stereotactic radiosurgery (“SRS”), stereotactic body radiotherapy (“SBRT”) and brachytherapy. Products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment and accessories; as well as information management, treatment planning and image processing, clinical knowledge exchange, patient care management, decision-making support and practice management software. Oncology Systems’ products enable radiation oncology departments in hospitals and clinics to perform conventional radiotherapy treatments and offer advanced treatments such as IMRT, IGRT, VMAT, SRS and SBRT, as well as to treat patients using brachytherapy techniques, which involve temporarily implanting radioactive sources. The Company’s Oncology Systems products are also used by neurosurgeons to perform stereotactic radiosurgery. Oncology Systems’ customers worldwide include university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices and cancer care clinics.
The VPT segment develops, designs, manufactures, sells and services products and systems for delivering proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer.
Accordingly, the following information is provided for purposes of achieving an understanding of operations, but may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.
The Company allocates corporate costs to its operating segments based on the relative revenues of Oncology Systems and VPT. The Company allocates these costs excluding certain corporate related costs, transactions or adjustments that the Company's CODM considers to be non-operational, such as restructuring and impairment charges, significant litigation charges or benefits and legal costs, acquisition-related expenses and benefits. Although the Company excludes these amounts from segment operating earnings and loss, they are included in the consolidated operating earnings and included in the reconciliation below.
The following table summarizes select operating results information for each reportable segment:
 
Three Months Ended
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Revenues
 
 
 
 
 
 
 
Oncology Systems
$
698.0

 
$
631.9

 
$
1,347.4

 
$
1,203.1

Varian Particle Therapy
31.9

 
31.3

 
61.0

 
61.6

Total Company
$
729.9

 
$
663.2

 
$
1,408.4

 
$
1,264.7

Operating Earnings
 
 
 
 
 
 
 
Oncology Systems
$
143.1

 
$
122.9

 
$
281.3

 
$
239.0

Varian Particle Therapy
(17.5
)
 
(19.8
)
 
(32.7
)
 
(70.1
)
Total reportable segments
125.6

 
103.1

 
248.6

 
168.9

Unallocated corporate
(31.3
)
 
(13.0
)
 
(32.9
)
 
(61.4
)
Total Company
$
94.3

 
$
90.1

 
$
215.7

 
$
107.5


Disaggregation of Revenues
The Company disaggregates its revenues from contracts by major product categories and by geographic region for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.
Total Revenues by product type
Three Months Ended
March 30, 2018
 
Six Months Ended
March 30, 2018
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Hardware
$
311.6

 
$
30.1

 
$
341.7

 
$
604.7

 
$
57.4

 
$
662.1

Software (1)
126.7

 
—

 
126.7

 
241.8

 
—

 
241.8

Service
259.7

 
1.8

 
261.5

 
500.9

 
3.6

 
504.5

Total Revenues
$
698.0

 
$
31.9

 
$
729.9

 
$
1,347.4

 
$
61.0

 
$
1,408.4

(1)
Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).
Total Revenues by product type
Three Months Ended
March 31, 2017
 
Six Months Ended
March 31, 2017
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Hardware
$
284.5

 
$
30.1

 
$
314.6

 
$
523.1

 
$
56.9

 
$
580.0

Software (1)
118.4

 
—

 
118.4

 
230.6

 
—

 
230.6

Service
229.0

 
1.2

 
230.2

 
449.4

 
4.7

 
454.1

Total Revenues
$
631.9

 
$
31.3

 
$
663.2

 
$
1,203.1

 
$
61.6

 
$
1,264.7

(1) 
Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).
Total Revenues by geographical region
Three Months Ended
March 30, 2018
 
Six Months Ended
March 30, 2018
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Americas
$
321.2

 
$
19.0

 
$
340.2

 
$
658.6

 
$
38.3

 
$
696.9

EMEA
241.2

 
12.6

 
253.8

 
424.7

 
22.1

 
446.8

APAC
135.6

 
0.3

 
135.9

 
264.1

 
0.6

 
264.7

Total Revenues
$
698.0

 
$
31.9

 
$
729.9

 
$
1,347.4

 
$
61.0

 
$
1,408.4

 
 
 
 
 
 
 
 
 
 
 
 
North America
$
299.6

 
$
19.0

 
$
318.6

 
$
625.9

 
$
38.3

 
$
664.2

International
398.4

 
12.9

 
411.3

 
721.5

 
22.7

 
744.2

Total Revenues
$
698.0

 
$
31.9

 
$
729.9

 
$
1,347.4

 
$
61.0

 
$
1,408.4

Total Revenues by geographical region
Three Months Ended
March 31, 2017
 
Six Months Ended
March 31, 2017
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Americas
$
332.0

 
$
9.6

 
$
341.6

 
$
622.8

 
$
17.0

 
$
639.8

EMEA
167.5

 
17.8

 
185.3

 
336.5

 
32.8

 
369.3

APAC
132.4

 
3.9

 
136.3

 
243.8

 
11.8

 
255.6

Total Revenues
$
631.9

 
$
31.3

 
$
663.2

 
$
1,203.1

 
$
61.6

 
$
1,264.7

 
 
 
 
 
 
 
 
 
 
 
 
North America
$
309.7

 
$
9.6

 
319.3

 
$
584.7

 
$
17.0

 
601.7

International
322.2

 
21.7

 
343.9

 
618.4

 
44.6

 
663.0

Total Revenues
$
631.9

 
$
31.3

 
$
663.2

 
$
1,203.1

 
$
61.6

 
$
1,264.7

Timing of revenue recognition
Three Months Ended
March 30, 2018
 
Six Months Ended
March 30, 2018
(In millions)
Products transferred at a point in time
 
Products and Services transferred over time

 
Total
 
Products transferred at a point in time
 
Products and Services transferred over time

 
Total
Oncology Systems
$
363.7

 
$
334.3

 
$
698.0

 
$
702.0

 
$
645.4

 
$
1,347.4

Varian Particle Therapy
—

 
31.9

 
31.9

 
—

 
61.0

 
61.0

Total Revenues
$
363.7

 
$
366.2

 
$
729.9

 
$
702.0

 
$
706.4

 
$
1,408.4

Timing of revenue recognition
Three Months Ended
March 31, 2017
 
Six Months Ended
March 31, 2017
(In millions)
Products Transferred at a Point in Time
 
Products and Services Transferred Over Time

 
Total
 
Products Transferred at a Point in Time
 
Products and Services Transferred Over Time

 
Total
Oncology Systems
$
334.8

 
$
297.1

 
$
631.9

 
$
617.2

 
$
585.9

 
$
1,203.1

Varian Particle Therapy
—

 
31.3

 
31.3

 
—

 
61.6

 
61.6

Total Revenues
$
334.8

 
$
328.4

 
$
663.2

 
$
617.2

 
$
647.5

 
$
1,264.7
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUBSEQUENT EVENTS
 6 Months Ended
Mar. 30, 2018
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS

Sirtex. On January 30, 2018, the Company signed an agreement to acquire Sirtex, an Australian company that is listed on the Australian Securities Exchange, for A$28 per share or approximately A$1.6 billion ($1.2 billion as of March 30, 2018). The transaction has received all necessary regulatory approvals, is subject to the approval of the Sirtex shareholders, the Federal Court of Australia and the satisfaction of other customary closing conditions.

On May 4, 2018, Sirtex received an unsolicited non-binding, indicative and conditional proposal from CDH, a China-based alternative asset manager, for the acquisition of all of the issued shares in Sirtex for A$33.60 per share. The Sirtex board of directors has determined to engage with CDH to further understand the conditions associated with the CDH proposal. As a result, the meeting of Sirtex shareholders to approve the acquisition by Varian, which was scheduled to occur on Monday, May 7, 2018 (Sydney time), was adjourned to a time and date to be determined.

Borrowings. On April 3, 2018, the Company entered into the 2018 Credit Agreement with certain lenders and Bank of America, N.A. as administrative agent. The 2018 Credit Agreement provides for a five-year revolving credit facility (the "2018 Revolving Credit Facility") in an aggregate principal amount of up to $1.8 billion. The 2018 Revolving Credit Facility also includes a $50.0 million sub-facility for the issuance of letters of credit and permits swing line loans of up to $25 million. Under the 2018 Revolving Credit Facility, the Company has the right to make (i) a request to increase the aggregate commitments by an aggregate amount for all such requests of up to $100.0 million and (ii) request an additional increase in the commitments or establish one or more term loans, provided that, in each case, the lenders are willing to provide such new or increased commitments and certain other conditions are met. The proceeds of the 2018 Revolving Credit Facility may be used for working capital, capital expenditures, to pay the consideration for the Sirtex acquisition, Company share repurchases, permitted acquisitions and other corporate purposes, as well as to satisfy the outstanding obligation under the 2017 Revolving Credit Facility.
The 2018 Revolving Credit Facility replaces the 2017 Revolving Credit Facility of $600 million. The Company borrowed $255.0 million under the 2018 Revolving Credit Facility and repaid in full the $255.0 million then outstanding principal balance on its 2017 Revolving Credit Facility, plus accrued interest and fees.
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 6 Months Ended
Mar. 30, 2018
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended September 29, 2017 (the “2017 Annual Report”). In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s financial position as of March 30, 2018 and September 29, 2017, results of operations and statements of comprehensive earnings (loss) for the three and six months ended March 30, 2018 and March 31, 2017, and cash flows for the six months ended March 30, 2018 and March 31, 2017. The results of operations for the six months ended March 30, 2018 are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period.
At the beginning of the Company's fiscal year 2018, the Company early adopted the new revenue recognition Accounting Standard Codification 606 "Revenues from Contracts with Customers" ("ASC 606") by using the full retrospective method. All financial statements and disclosures have been recast to comply with ASC 606. See "Recently Adopted Accounting Pronouncements" below for further information.
The historical financial position and results of operations of the Imaging Components business and costs relating to the Distribution are reported in the condensed consolidated financial statements as discontinued operations for all the periods presented. Information in the accompanying notes to the condensed consolidated financial statements have been recast to reflect the effect of the Distribution. The Condensed Consolidated Statements of Comprehensive Earnings (Loss) and Cash Flows have not been recast to reflect the effect of the Distribution.
Fiscal Year
Fiscal Year
The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September 30. Fiscal year 2018 is the 52-week period ending September 28, 2018. Fiscal year 2017 was the 52-week period that ended on September 29, 2017. The fiscal quarters ended March 30, 2018 and March 31, 2017 were both 13-week periods.
Principles of Consolidation
Principles of Consolidation
The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Revenue Recognition
Revenue Recognition
The Company's revenues are derived primarily from the sale of radiotherapy and proton therapy hardware and software products, support, training and maintenance of all those products, installation services and the sale of parts. The Company accounts for a contract with a customer when there is approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
The Company's revenues are measured based on consideration specified in the contract with each customer, net of any sales incentives and amounts collected on behalf of third parties such as sales taxes. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.
The majority of the Company's revenue arrangements consist of multiple performance obligations including hardware, software, and services. Determining the stand-alone selling price ("SSP") and allocation of consideration from an arrangement to the individual performance obligations, and the appropriate timing of revenue recognition are significant judgments with respect to these arrangements.
The Company's products are generally not sold with a right of return, and the Company does not provide credits or incentives, which may be required to be accounted for as variable consideration when estimating the amount of revenue to be recognized.
The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the Company expects the benefit of those costs to be longer than one year. The Company applies a practical expedient to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less. These costs mainly include the Company's internal sales force compensation program; under the terms of these programs these are generally earned and the costs are recognized at the time the revenue is recognized.
The majority of the Company’s products and services are sold in bundled arrangements (e.g., hardware, software, and services). For bundled arrangements, the Company accounts for individual products and services separately if they are distinct, that is, if a product or service is separately identifiable from other items in the bundled package and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The consideration (including any discounts) is allocated between separate products and services in a bundle based on their individual SSP. The SSP is determined based on observable prices at which the Company separately sells the products and services. If an SSP is not directly observable, then the Company will estimate the SSP considering marketing conditions, entity-specific factors, and information about the customer or class of customer that is reasonably available.
The following is a description of the principal activities, separated by reportable segment, from which the Company generates its revenues.
Oncology Systems
The Company's Oncology Systems linear accelerators are generally sold in a bundled arrangement with hardware and software accessory products that enhance efficiency and enable delivery of advanced radiotherapy and radiosurgery treatments, however, certain products are occasionally sold on a stand-alone basis. The majority of machine and software sales include installation services and training. Delivery of different elements in a revenue arrangement often span more than one reporting period. For example, a linear accelerator and software may be delivered in one reporting period, but the related installation of those products may be completed in a later period. Hardware and software extended maintenance and service contracts are occasionally sold during the initial product sale, but the majority are sold separately near or at the end of the initial warranty period. Revenues related to extended warranty and service contracts are earned after the expiration of the initial warranty period.
Payment terms and conditions vary by contract type, although terms are generally commensurate with a significant milestone, such as contract signing, shipment, delivery, acceptance or service commencement. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts generally do not include a significant financing component. The primary purpose of the Company's invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company's products and services, not to receive financing from the Company's customers, such as invoicing at the beginning of a contract term with revenue recognized ratably over the contract period for a service contract. Payment terms can also vary based on the type of customer, such as government purchases. There are occasions where the Company provides extended payment terms in which case a portion of the transaction price is allocated to imputed interest income.
From time to time, the Company's contracts are modified to account for additional, or change existing, performance obligations. The Company's contract modifications are generally accounted for prospectively.
Hardware Products and Installation
Hardware products may include software that the hardware is dependent on and highly interrelated with and cannot operate without. The Company typically has a standard base configuration for its hardware products, but there are typically multiple options and configuration choices. Revenues from the sale of hardware are recognized when the Company transfers control to the customer.
Product installation includes uncrating, moving the machine to the treatment room, connection and validating configuration. In addition, a number of testing protocols are completed to confirm the equipment is performing to the contracted specifications. The Company recognizes revenues for hardware installation over time as the customer receives and consumes benefits provided as the Company performs the installation services.
Software Products and Installation
Software products include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. Software installation includes transferring software to the customer’s computers, configuration of the software and potentially data migration. The Company recognizes revenues for software and software installation upon the customer's acceptance of the software and installation services.
Service
Service revenues include revenues from initial and extended software support agreements, extended hardware warranty agreements, training, paid service arrangements when a customer does not have an extended warranty and parts that are sold by the service department.
Revenues from hardware and software support agreements are accounted for ratably over the term of the agreement. Services and training revenues are recognized in the period the services and training are performed. Revenues for sales of parts are recognized when the parts are delivered to the customer and control is transferred.
Warranties
The Company's sale of hardware includes a one-year warranty. The Company uses the cost accrual method to account for assurance-type warranties. The standard warranty provision further includes services in addition to an assurance-type warranty (preventative maintenance inspections, help desk support, when and if available operating system upgrades). These service-type warranty features are recorded as a separate performance obligation and recognized ratably over the one-year warranty period.
Varian Particle Therapy ("VPT")
The manufacturing of the major components of a proton therapy system, installation, and commissioning typically lasts 18 to 24 months. The Company's proton therapy system is highly customized. A proton therapy system typically includes hardware, software that the hardware is dependent upon and highly interrelated with, and without which the hardware cannot operate, and installation. The Company also sells software products that include information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software, and software installation.
The Company provides operations and maintenance services related to the proton therapy system under a separate arrangement. These contracts are typically executed at or about the same time as the proton therapy system contracts; however, the pricing and performance of the proton therapy system contracts are not typically related to the pricing or performance of the operations and maintenance contracts. Therefore, the Company recognizes operations and maintenance services as a separate performance obligation.
Under the typical payment terms of the Company's fixed-price contracts, the customer pays the Company an up-front advance payment and then performance-based payments based on quantifiable measures of performance or on the achievement of specified events or milestones. As the revenue is recognized over time relative to the costs incurred and the customer billing milestones are typically event driven, this may result in revenue recognized in excess of billings at some point during the contract which the Company presents as unbilled receivables on the Condensed Consolidated Balance Sheets. Amounts billed and due from the Company's customers are classified as trade accounts receivable on the Condensed Consolidated Balance Sheets. In most contracts, the Company is entitled to receive an advance payment at the beginning of the contract. The Company recognizes a liability for these advance payments in excess of revenue recognized and presents it as deferred revenues on the Condensed Consolidated Balance Sheets. The advance payment typically is not considered a significant financing component because it is used to ensure the customer's commitment to the project.
The Company recognizes revenue for its proton therapy systems over time because the customer controls the work in process, the Company's performance does not create an asset with an alternative use to the Company, and the Company has an enforceable right to payment for performance completed to date.
Due to the nature of the work required to be performed on many of the Company's performance obligations, the estimation of total revenues and costs at completion is complex, subject to many variables and requires significant judgment. The Company's contracts generally do not include award fees, incentive fees or other provisions that may be considered variable consideration.
The Company has a standard quarterly progress review process in which management reviews the progress and execution of the Company's performance obligations. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and costs to achieve the schedule (e.g., the number and type of milestone events), technical and other contract requirements. Management must make assumptions and estimates regarding the complexity of the work to be performed, the availability of materials and outside services, the length of time to complete the performance obligation and labor and overhead cost rates, among other significant judgments. Based on this analysis, any quarterly adjustments to revenues, cost of revenues, and the related impact to operating earnings are recognized as necessary in the period they become known on a cumulative catch-up basis. When estimates of total costs to be incurred on a performance obligation exceed total estimates of revenues to be earned, a provision for the entire loss on the performance obligation is recognized in the period the loss is determined.
Similar to the Oncology Systems segment, the Company recognizes VPT revenues for software and installation upon completion and acceptance of the software and installation services.
Unfulfilled Performance Obligations for Oncology Systems and VPT
The following table represents the Company's unfulfilled performance obligations as of March 30, 2018 and the estimated revenue expected to be recognized in the future related to these unfulfilled performance obligations:
 
Fiscal years of revenue recognition
(In millions)
2018
 
2019
 
2020
 
Thereafter
Unfulfilled Performance Obligations
$
1,060.8

 
$
2,089.5

 
$
729.4

 
$
1,276.3


The table above includes both product and service unfulfilled performance obligations, which includes a component of service performance obligations which have not been invoiced. The time bands reflect management’s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers’ facilities for installation, installation requirements, and availability of products or customer acceptance terms.
As part of the Company's adoption of ASC 606, the Company elected to use the following practical expedients (i) to exclude disclosures of transaction prices allocated to remaining performance obligations when the Company expects to recognize such revenue for all periods prior to the date of initial application of ASC 606 (ii) not to adjust the promised amount of consideration for the effects of a significant financing component when the Company expects, at contract inception, that the period between the Company's transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less (iii) to expense costs as incurred for costs to obtain a contract when the amortization period would have been one year or less, which mainly includes the Company's internal sales force compensation program and certain partner sales incentive programs (iv) not to recast revenue for contracts that begin and end in the same fiscal period, and (v) not to assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.
Contract Balances
The timing of revenue recognition, billings and cash collections results in trade and unbilled receivables, and deferred revenues on the Condensed Consolidated Balance Sheet. In Oncology Systems, the Company often collects an advance payment and the balance is typically billed on a combination of delivery and/or acceptance. In VPT, the Company usually collects an advance payment and additional amounts are billed as work progresses in accordance with agreed-upon contractual terms upon achievement of contractual milestones. Service contracts are usually billed at the beginning of the contract period or at periodic intervals (e.g. monthly or quarterly) during the contract which could result in a contract asset and contract liability. At times, billing occurs subsequent to revenue recognition, resulting in an unbilled receivable which represents a contract asset. However, when the Company receives advances or deposits from customers, which can be higher in the initial stages of the contract, particularly international contracts in the case of Oncology Systems, before revenue is recognized, this results in deferred revenues which represents a contract liability. These contract assets and liabilities are reported as unbilled receivables and deferred revenues, respectively, on the Condensed Consolidated Balance Sheet on a contract-by-contract basis at the end of each reporting period.
Recently Adopted Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board ("FASB") issued ASC 606. Under the standard, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration the entity expects to receive in exchange for those goods or services. Effective September 30, 2017, the Company elected to early adopt the requirements of ASC 606 using the full retrospective method, which required the Company to recast the prior reporting periods presented.
The most significant impacts on adoption were in the Oncology Systems segment and are primarily due to the removal of the contingent revenue cap which limited revenue recognition to the amount of cash received from the customer, the elimination of the mandatory revenue deferral for software sold with extended payment terms and the removal of the vendor-specific objective evidence requirement for the separation of bundled software products. The Company also identified additional performance obligations for training and certain elements of warranty that are recognized as separate performance obligations, and identified that certain new performance obligations were previously accounted for as part of hardware products and will result in a change in classification of revenues from product to service. In preparation for adoption of the standard, the Company implemented internal controls and key system functionalities to enable the preparation of financial information.
The Company has recast its condensed consolidated financial statements from amounts previously reported due to the adoption of ASC 606. Select Condensed Consolidated Statements of Earnings (Loss) line items, which reflect the adoption of ASC 606 are as follows:
 
Three Months Ended
 
Six Months Ended
 
March 31, 2017
 
March 31, 2017
(In millions, except per share amounts)
As Previously Reported
 
Adjustments
 
As Adjusted
 
As Previously Reported
 
Adjustments
 
As Adjusted
Revenues:
 
 
 
 
 
 
 
 
 
 
 
Product
$
386.1

 
$
(21.2
)
 
$
364.9

 
$
729.7

 
$
(55.6
)
 
$
674.1

Service
268.9

 
29.4

 
298.3

 
537.1

 
53.5

 
590.6

Total revenues
655.0

 
8.2

 
663.2

 
1,266.8

 
(2.1
)
 
1,264.7

Cost of revenues:
 
 
 
 
 
 
 
 
 
 
 
Product
254.2

 
(7.3
)
 
246.9

 
478.6

 
(25.5
)
 
453.1

Service
125.5

 
15.2

 
140.7

 
237.2

 
31.8

 
269.0

Total cost of revenues
379.7

 
7.9

 
387.6

 
715.8

 
6.3

 
722.1

Gross margin
275.3

 
0.3

 
275.6

 
551.0

 
(8.4
)
 
542.6

Earnings from continuing operations before taxes
90.1

 
0.3

 
90.4

 
118.1

 
(8.4
)
 
109.7

Taxes on earnings
20.8

 
0.1

 
20.9

 
34.3

 
(2.1
)
 
32.2

Net earnings from continuing operations
69.3

 
0.2

 
69.5

 
83.8

 
(6.3
)
 
77.5

Net loss from discontinued operations
(13.3
)
 
—

 
(13.3
)
 
(6.8
)
 
—

 
(6.8
)
Net earnings
$
56.0

 
$
0.2

 
$
56.2

 
$
77.0

 
$
(6.3
)
 
$
70.7

Net earnings attributable to Varian
$
56.1

 
$
0.2

 
$
56.3

 
$
76.5

 
$
(6.3
)
 
$
70.2

 
 
 
 
 
 
 
 
 
 
 
 
Diluted net earnings per share from continuing operations attributable to Varian
$
0.74

 
$
—

 
$
0.74

 
$
0.89

 
(0.07
)
 
$
0.82

Select Condensed Consolidated Statements of Balance Sheet line items, which reflect the adoption of ASC 606 are as follows:
 
September 29, 2017
(In millions)
As Previously Reported
 
Adjustments
 
As Adjusted
Assets:
 
 
 
 
 
Trade and unbilled receivables, net
$
823.5

 
$
138.0

 
$
961.5

Inventories
439.7

 
(22.0
)
 
417.7

Prepaid expenses and other current assets
199.8

 
(9.5
)
 
190.3

Deferred tax assets
138.8

 
8.5

 
147.3

 
 
 
 
 
 
Liabilities and Equity:
 
 
 
 
 
Accrued liabilities
394.7

 
(19.8
)
 
374.9

Deferred revenues
640.6

 
114.8

 
755.4

Other long-term liabilities
130.0

 
(2.6
)
 
127.4

Retained earnings
756.0

 
22.6

 
778.6


In addition, the cumulative effect of ASC 606 to the Company's retained earnings at October 2, 2015 was $56.7 million. Adoption of ASC 606 had no impact to net cash from or used in operating, investing or financing activities in the Company's Condensed Consolidated Statements of Cash Flows.
In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance which targeted improvements to the accounting for hedging activities. The guidance allows companies to more accurately present the economic effects of risk management activities in the financial statements. This amendment is required to be applied prospectively. The primary impact of the adoption is the required disclosure changes. The adoption of the new guidance did not have a material impact on the Company's condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company adopted the FASB guidance related to employee share-based payments. The amendment simplifies several aspects of the accounting for employee share-based payments including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The Company elected to use the prospective transition method for the presentation of excess tax benefits on the statement of cash flows. Under the new standard, excess tax benefits are now included in taxes on earnings in the Consolidated Statement of Earnings (Loss). The Company elected to recognize forfeitures as they occur, and the impact of this change in accounting policy was recorded as a $0.4 million reduction, net, to its beginning retained earnings balance as of September 30, 2017. See Note 12, "Income Taxes" for more information on the impact of this accounting guidance. The remaining provisions of this amendment did not have a material impact on the Company's condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company adopted the FASB accounting guidance related to inventory measurement. The amendment requires inventory measured using first-in, first-out (FIFO) or average cost to be subsequently measured at the lower of cost and net realizable value, thereby simplifying the current guidance that requires an entity to measure inventory at the lower of cost or market. This amendment is required to be applied prospectively. The adoption of this new guidance did not have a material impact to the Company’s condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance on the definition of a business in accounting for transactions when determining whether they represent acquisitions or disposals of assets or of a business. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company’s condensed consolidated financial statements.
In the first quarter of fiscal year 2018, the Company elected to early adopt the FASB guidance simplifying the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Company adopted this amendment prospectively. The adoption of this new guidance did not have an impact to the Company’s condensed consolidated financial statements.
Recent Accounting Standards or Updates Not Yet Effective
Recent Accounting Standards or Updates Not Yet Effective
In February 2018, the FASB amended its guidance that will allow companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2020. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In May 2017, the FASB provided guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The guidance is effective for the Company beginning in the first quarter of fiscal 2019. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its condensed consolidated financial statements.
In March 2017, the FASB amended its guidance on the accounting related to defined benefit plans and other post-retirement benefits. This amendment requires the service cost component of net periodic pension and post-retirement benefit cost be presented in the same line item as other employee compensation costs, while the other components be presented separately as non-operating income (expense). The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In November 2016, the FASB amended its guidance on the classification and presentation of restricted cash in the statement of cash flow. The amendment requires entities to include restricted cash and restricted cash equivalents in its cash and cash equivalents in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively. The amendment is not expected to have a material impact to the Company’s condensed consolidated financial statements.
In October 2016, the FASB amended its guidance for tax accounting for intra-entity asset transfers. The amendment removes the prohibition against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. Early adoption is permitted. The amendment is required to be adopted on a modified retrospective basis. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In August 2016, the FASB issued an amendment to its accounting guidance related to the classification of certain cash receipts and cash payments. The amendment was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019 with early adoption permitted. The amendment is required to be adopted retrospectively unless it is impracticable. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In June 2016, the FASB issued an amendment to its accounting guidance related to impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021 with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
In February 2016, the FASB issued a new standard on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company is evaluating the impact of adopting this new standard to its condensed consolidated financial statements.
In January 2016, the FASB issued an amendment to its accounting guidance related to recognition and measurement of financial assets and financial liabilities. The amendment addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2019. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 6 Months Ended
Mar. 30, 2018
Accounting Policies [Abstract]  
Schedule of Unfulfilled Performance Obligations
The following table represents the Company's unfulfilled performance obligations as of March 30, 2018 and the estimated revenue expected to be recognized in the future related to these unfulfilled performance obligations:
 
Fiscal years of revenue recognition
(In millions)
2018
 
2019
 
2020
 
Thereafter
Unfulfilled Performance Obligations
$
1,060.8

 
$
2,089.5

 
$
729.4

 
$
1,276.3
Schedule of Adoption of ASC 606
The Company has recast its condensed consolidated financial statements from amounts previously reported due to the adoption of ASC 606. Select Condensed Consolidated Statements of Earnings (Loss) line items, which reflect the adoption of ASC 606 are as follows:
 
Three Months Ended
 
Six Months Ended
 
March 31, 2017
 
March 31, 2017
(In millions, except per share amounts)
As Previously Reported
 
Adjustments
 
As Adjusted
 
As Previously Reported
 
Adjustments
 
As Adjusted
Revenues:
 
 
 
 
 
 
 
 
 
 
 
Product
$
386.1

 
$
(21.2
)
 
$
364.9

 
$
729.7

 
$
(55.6
)
 
$
674.1

Service
268.9

 
29.4

 
298.3

 
537.1

 
53.5

 
590.6

Total revenues
655.0

 
8.2

 
663.2

 
1,266.8

 
(2.1
)
 
1,264.7

Cost of revenues:
 
 
 
 
 
 
 
 
 
 
 
Product
254.2

 
(7.3
)
 
246.9

 
478.6

 
(25.5
)
 
453.1

Service
125.5

 
15.2

 
140.7

 
237.2

 
31.8

 
269.0

Total cost of revenues
379.7

 
7.9

 
387.6

 
715.8

 
6.3

 
722.1

Gross margin
275.3

 
0.3

 
275.6

 
551.0

 
(8.4
)
 
542.6

Earnings from continuing operations before taxes
90.1

 
0.3

 
90.4

 
118.1

 
(8.4
)
 
109.7

Taxes on earnings
20.8

 
0.1

 
20.9

 
34.3

 
(2.1
)
 
32.2

Net earnings from continuing operations
69.3

 
0.2

 
69.5

 
83.8

 
(6.3
)
 
77.5

Net loss from discontinued operations
(13.3
)
 
—

 
(13.3
)
 
(6.8
)
 
—

 
(6.8
)
Net earnings
$
56.0

 
$
0.2

 
$
56.2

 
$
77.0

 
$
(6.3
)
 
$
70.7

Net earnings attributable to Varian
$
56.1

 
$
0.2

 
$
56.3

 
$
76.5

 
$
(6.3
)
 
$
70.2

 
 
 
 
 
 
 
 
 
 
 
 
Diluted net earnings per share from continuing operations attributable to Varian
$
0.74

 
$
—

 
$
0.74

 
$
0.89

 
(0.07
)
 
$
0.82

Select Condensed Consolidated Statements of Balance Sheet line items, which reflect the adoption of ASC 606 are as follows:
 
September 29, 2017
(In millions)
As Previously Reported
 
Adjustments
 
As Adjusted
Assets:
 
 
 
 
 
Trade and unbilled receivables, net
$
823.5

 
$
138.0

 
$
961.5

Inventories
439.7

 
(22.0
)
 
417.7

Prepaid expenses and other current assets
199.8

 
(9.5
)
 
190.3

Deferred tax assets
138.8

 
8.5

 
147.3

 
 
 
 
 
 
Liabilities and Equity:
 
 
 
 
 
Accrued liabilities
394.7

 
(19.8
)
 
374.9

Deferred revenues
640.6

 
114.8

 
755.4

Other long-term liabilities
130.0

 
(2.6
)
 
127.4

Retained earnings
756.0

 
22.6

 
778.6
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS (Tables)
 6 Months Ended
Mar. 30, 2018
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations
The following table summarizes the key components of net loss from discontinued operations:
 
Three Months Ended (1)
 
Six Months Ended
(In millions)
March 31,
2017
 
March 31,
2017
Revenues
$
42.5

 
$
194.0

Cost of revenues
24.6

 
117.3

Gross margin
17.9

 
76.7

Operating expenses (2)
29.7

 
76.1

Operating earnings
(11.8
)
 
0.6

Taxes on earnings
1.5

 
7.4

Net loss from discontinued operations
(13.3
)
 
(6.8
)
Less: Net earnings from discontinued operations attributable to noncontrolling interests
—

 
0.1

Net loss from discontinued operations attributable to Varian
$
(13.3
)
 
$
(6.9
)
(1) 
There was no activity in net loss from discontinued operations during the three and six months ended March 30, 2018.
(2) 
Operating expenses included separation costs of $19.3 million and $34.2 million during the three and six months ended March 31, 2017, respectively. Separation costs include expenses for transaction advisory services, consulting services, restructuring and other expenses.
The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in the Company's Condensed Consolidated Balance Sheets:
(In millions)
March 30,
2018
 
September 29,
2017
Assets:
 
 
 
Trade accounts receivable, net
$
7.1

 
$
8.1

Inventories
1.1

 
2.9

Prepaid expenses and other current assets
0.4

 
0.1

Current assets of discontinued operations
8.6

 
11.1

Total assets of discontinued operations
$
8.6

 
$
11.1

Liabilities:
 
 
 
Accounts payable
$
2.0

 
$
2.0

Accrued liabilities
1.7

 
0.5

Current liabilities of discontinued operations
3.7

 
2.5

Total liabilities of discontinued operations
$
3.7

 
$
2.5


The following table presents supplemental cash flow information of discontinued operations:
 
Six Months Ended (1)
(In millions)
March 31,
2017
Operating activities:
 
Share-based compensation expense
$
2.0

Depreciation expense
4.4

Amortization expense
1.8

Investing activities:
 
Purchases of property, plant and equipment
$
(6.3
)

(1) 
There was no significant cash flow activity from discontinued operations during the six months ended March 30, 2018.
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEET COMPONENTS (Tables)
 6 Months Ended
Mar. 30, 2018
Balance Sheet Components [Abstract]  
Unbilled Accounts Receivable and Deferred Revenues from Contracts with Customers:
The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers:
(In millions)
March 30,
2018
 
September 29,
2017
Unbilled receivables - current
$
311.5

 
$
259.1

Unbilled receivables - long-term (1)
28.2

 
10.9

Deferred revenues - current
(766.5
)
 
(755.4
)
Deferred revenues - long-term (2)
(9.1
)
 
(7.2
)
Total net unbilled receivables (deferred revenues)
$
(435.9
)
 
$
(492.6
)
(1) 
Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2) 
Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.
Inventories:
The following table summarizes the Company's inventories:
(In millions)
March 30,
2018
 
September 29,
2017
Raw materials and parts
$
306.5

 
$
296.5

Work-in-process
54.1

 
47.7

Finished goods
73.2

 
73.5

Total inventories
$
433.8

 
$
417.7
Available-for-sale Securities:
The following tables summarize the Company's available-for-sale securities:
 
March 30, 2018
(In millions)
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
APTC securities (1)
$
6.1

 
$
—

 
$
—

 
$
6.1

GPTC securities (2)
4.6

 
—

 
—

 
4.6

   Total available-for-sale securities
$
10.7

 
$
—

 
$
—

 
$
10.7

 
September 29, 2017
(In millions)
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Fair Value
Original CPTC loans (2)
$
47.4

 
$
—

 
$
—

 
$
47.4

DRTC securities (2)
8.3

 
—

 
—

 
8.3

GPTC securities (2)
4.4

 
—

 
—

 
4.4

   Total available-for-sale securities
$
60.1

 
$
—

 
$
—

 
$
60.1

(1) 
Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets because the Company has the ability and intent to sell this security in the next twelve months.
(2) 
Included in other assets on the Company's Condensed Consolidated Balance Sheets because the maturity dates are greater than one year and the Company does not have the intent and ability to collect or sell all or a portion of its loans or securities in the next twelve months.
Other long-term liabilities:
The following table summarizes the Company's other long-term liabilities:
(In millions)
March 30,
2018
 
September 29,
2017
Long-term income taxes payable
$
208.1

 
$
48.6

Deferred income taxes
26.4

 
17.1

Long-term debt
25.0

 
—

Other
61.2

 
61.7

Total other long-term liabilities
$
320.7

 
$
127.4
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE (Tables)
 6 Months Ended
Mar. 30, 2018
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis
In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
 
 
Fair Value Measurement Using
 
 
Quoted Prices in
Active Markets
for Identical
Instruments
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
Total
Type of Instruments
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Balance
(In millions)
 
 
 
 
 
 
 
 
Assets at March 30, 2018:
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
APTC securities
 
$
—

 
$
6.1

 
$
—

 
$
6.1

GPTC securities
 
—

 
4.6

 
—

 
4.6

Derivative assets
 
—

 
0.5

 
—

 
0.5

Total assets measured at fair value
 
$
—

 
$
11.2

 
$
—

 
$
11.2

 
 
 
 
 
 
 
 
 
Liabilities at March 30, 2018:
 
 
 
 
 
 
 
 
Derivative liabilities
 
$
—

 
$
(12.4
)
 
$
—

 
$
(12.4
)
Contingent consideration
 
—

 
—

 
(2.8
)
 
(2.8
)
Total liabilities measured at fair value
 
$
—

 
$
(12.4
)
 
$
(2.8
)
 
$
(15.2
)
 
 
 
 
 
 
 
 
 
Assets at September 29, 2017:
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
Original CPTC loans
 
$
—

 
$
—

 
$
47.4

 
$
47.4

DRTC securities
 
—

 
8.3

 
—

 
8.3

GPTC securities
 
—

 
4.4

 
—

 
4.4

Total assets measured at fair value
 
$
—

 
$
12.7

 
$
47.4

 
$
60.1
Reconciliation for Assets Measured and Recorded at Fair Value on Recurring Basis
The following table presents the reconciliation for all assets and liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):
(In millions)
Available-for-sale Securities
 
Contingent
Consideration
Balance at September 29, 2017
$
47.4

 
$
—

Additions from business combinations
—

 
(2.8
)
Reclassification of Original CPTC Loans to Term Loan
(47.4
)
 
—

Balance at March 30, 2018
$
—

 
$
(2.8
)
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
RECEIVABLES (Tables)
 6 Months Ended
Mar. 30, 2018
Receivables [Abstract]  
Schedule of Trade and Unbilled Receivables, Net and Notes Receivable
The following table summarizes the Company's trade and unbilled receivables, net and notes receivable:
(In millions)
March 30,
2018
 
September 29,
2017
Trade and unbilled receivables, gross
$
1,008.8

 
$
1,039.2

Allowance for doubtful accounts
(40.3
)
 
(63.1
)
Trade and unbilled receivables, net
$
968.5

 
$
976.1

Short-term
$
936.7

 
$
961.5

Long-term (1) 
$
31.8

 
$
14.6

 
 
 
 
Notes receivable
$
87.9

 
$
105.2

Short-term (2) 
$
25.3

 
$
5.0

Long-term (1) (3)
$
62.6

 
$
100.2

(1) 
Balances are included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2) 
Balances are included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets.
(3) 
Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
 6 Months Ended
Mar. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Activity of Goodwill by Reportable Operating Segment
The following table reflects the activity of goodwill by reportable operating segment: 
(In millions)
Oncology
Systems
 
Varian Particle Therapy
 
Total
Balance at September 29, 2017
$
170.2

 
$
52.4

 
$
222.6

Business combinations
11.5

 
—

 
11.5

Foreign currency translation adjustments
—

 
2.1

 
2.1

Balance at March 30, 2018
$
181.7

 
$
54.5

 
$
236.2
Schedule of Indefinite-Lived Intangible Assets
The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets: 
 
March 30, 2018
 
September 29, 2017
(In millions)
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Technologies and patents
$
118.0

 
$
(67.7
)
 
$
50.3

 
$
102.0

 
$
(60.9
)
 
$
41.1

Customer contracts and supplier relationship
38.2

 
(16.4
)
 
21.8

 
33.9

 
(14.3
)
 
19.6

Other
5.7

 
(4.6
)
 
1.1

 
5.5

 
(3.4
)
 
2.1

Total intangible with finite lives
161.9

 
(88.7
)
 
73.2

 
141.4

 
(78.6
)
 
62.8

In-process research and development with indefinite lives
8.8

 
—

 
8.8

 
8.8

 
—

 
8.8

Total intangible assets
$
170.7

 
$
(88.7
)
 
$
82.0

 
$
150.2

 
$
(78.6
)
 
$
71.6
Gross Carrying Amount and Accumulated Amortization of Intangible Assets
The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets: 
 
March 30, 2018
 
September 29, 2017
(In millions)
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Technologies and patents
$
118.0

 
$
(67.7
)
 
$
50.3

 
$
102.0

 
$
(60.9
)
 
$
41.1

Customer contracts and supplier relationship
38.2

 
(16.4
)
 
21.8

 
33.9

 
(14.3
)
 
19.6

Other
5.7

 
(4.6
)
 
1.1

 
5.5

 
(3.4
)
 
2.1

Total intangible with finite lives
161.9

 
(88.7
)
 
73.2

 
141.4

 
(78.6
)
 
62.8

In-process research and development with indefinite lives
8.8

 
—

 
8.8

 
8.8

 
—

 
8.8

Total intangible assets
$
170.7

 
$
(88.7
)
 
$
82.0

 
$
150.2

 
$
(78.6
)
 
$
71.6
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
As of March 30, 2018, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions):
Fiscal Years:
Remaining Amortization Expense
Remainder of 2018
$
10.9

2019
15.2

2020
12.7

2021
10.4

2022
9.0

Thereafter
15.0

Total remaining amortization for intangible assets
$
73.2
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
BORROWINGS (Tables)
 6 Months Ended
Mar. 30, 2018
Debt Disclosure [Abstract]  
Schedule of Short-term Borrowings and Long-term Debt
The following table summarizes the Company's short-term borrowings and long-term debt:
 
March 30, 2018
 
September 29, 2017
(In millions, except for percentages)
Amount
 
Weighted-Average Interest Rate
 
Amount
 
Weighted-Average Interest Rate
Short-term borrowings:
 
 
 
 
 
 
 
2017 Revolving Credit Facility
$
230.0

 
2.79
%
 
$
350.0

 
2.36
%
Total short-term borrowings
$
230.0

 
 
 
$
350.0

 
 
 
 
 
 
 
 
 
 
Long-term debt:
 
 
 
 
 
 
 
2017 Revolving Credit Facility
$
25.0

 
4.88
%
 
$
—

 
—
%
Total long-term debt
$
25.0

 
 
 
$
—

 
 
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 6 Months Ended
Mar. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments Reported on the Condensed Consolidated Balance Sheets
The fair value of derivative instruments reported on the Condensed Consolidated Balance Sheets was as follows:
 
Balance Sheet
 
March 30, 2018
(In millions)
Location
 
Fair Value
Derivatives not designated as hedging instruments:
 
 
 
Foreign exchange option contract
Prepaid expenses and other current assets
 
$
0.5

Foreign exchange forward contracts
Accrued liabilities
 
(12.4
)
Total derivatives
 
 
$
(11.9
)
Schedule of Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Earnings (Loss)
The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings (Loss) was as follows:
 
Location and Amount Recognized in Earnings (Loss) on Cash Flow Hedging Relationships
 
Three Months Ended
 
Six Months Ended
 
March 30, 2018
 
March 30, 2018
(In millions)
Revenues
 
Revenues
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings (Loss) in which the effects of fair value and cash flow hedges are recorded
$
729.9

 
$
1,408.4

 
 
 
 
Loss on cash flow hedge relationships:
 
 
 
Foreign currency forward contracts:
 
 
 
Amount of loss reclassified from accumulated other comprehensive loss into earnings (loss)
$
(1.0
)
 
$
(0.9
)
Schedule of Notional Amounts of Outstanding Derivative Positions
The Company had the following outstanding foreign currency forward contracts relating to balance sheet hedging activities:
 
March 30, 2018
(In millions)
Notional
Value Sold
 
Notional
Value Purchased
Australian Dollar
$
35.1

 
$
—

Brazilian Real
7.7

 
—

British Pound
33.0

 
—

Canadian Dollar
12.3

 
—

Danish Krone
9.9

 
0.5

Euro
246.6

 
—

Hungarian Forint
1.9

 
—

Indian Rupee
17.8

 
—

Japanese Yen
69.5

 
—

Polish Zloty
18.6

 
—

Singapore Dollar
—

 
5.1

Swedish Krona
12.1

 
—

South African Rand

8.9

 
—

Swiss Franc
—

 
36.2

Thai Baht
3.9

 
—

Totals
$
477.3

 
$
41.8
Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments
The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings (Loss) related to the foreign currency forward contracts that are not designated as hedging instruments.
Location of Gain (Loss) Recognized in Income on Derivative Instruments
 
Amount of Gain (Loss) Recognized in Net Earnings (Loss) on Derivative Instruments
 
 
Three Months Ended
 
Six Months Ended
(In millions)
 
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Selling, general and administrative expenses
 
$
(7.5
)
 
$
(7.5
)
 
$
(12.2
)
 
$
7.4
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
COMMITMENTS AND CONTINGENCIES (Tables)
 6 Months Ended
Mar. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Accrued Product Warranty
The following table reflects the changes in the Company’s accrued product warranty:
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
Accrued product warranty, at beginning of period
$
41.3

 
$
41.9

Charged to cost of revenues
26.3

 
17.4

Actual product warranty expenditures
(26.5
)
 
(23.2
)
Accrued product warranty, at end of period
$
41.1

 
$
36.1
Restructuring and Related Costs
The following table provides a summary of changes in the restructuring liability related to the Company's restructuring plans:
(In millions)
September 29,
2017
 
Restructuring Charges
 
Cash Payments
 
March 30,
2018
2017 Restructuring Plan
$
3.9

 
$
—

 
$
(3.3
)
 
$
0.6

Total
$
3.9

 
$
—

 
$
(3.3
)
 
$
0.6
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
RETIREMENT PLANS (Tables)
 6 Months Ended
Mar. 30, 2018
Retirement Benefits [Abstract]  
Schedule of Net Defined Benefit Costs
The components of net defined benefit costs were as follows:
 
Three Months Ended
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Defined Benefit Plans
 
 
 
 
 
 
 
Service cost
$
1.7

 
$
1.8

 
$
3.3

 
$
3.5

Interest cost
0.8

 
0.6

 
1.6

 
1.2

Expected return on plan assets
(2.0
)
 
(1.8
)
 
(4.0
)
 
(3.5
)
Amortization of prior service cost
(0.2
)
 
—

 
(0.3
)
 
(0.1
)
Recognized actuarial loss
0.7

 
1.1

 
1.4

 
2.2

Net periodic benefit cost
$
1.0

 
$
1.7

 
$
2.0

 
$
3.3
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS (Tables)
 6 Months Ended
Mar. 30, 2018
Equity [Abstract]  
Schedule of Share Repurchases
The Company repurchased shares of VMS common stock under various authorizations during the periods presented as follows:
 
Three Months Ended
 
Six Months Ended
(In millions, except per share amounts)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Number of shares
0.3

 
2.0

 
0.8

 
2.5

Average repurchase price per share
$
110.52

 
$
86.42

 
$
109.06

 
$
88.93

Total cost
$
36.0

 
$
172.8

 
$
92.7

 
$
222.3
Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects
The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:
(In millions)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans
 
Net
Unrealized
Gains
(Losses)
Cash Flow
Hedging
Instruments
 
Cumulative
Translation
Adjustment
 
Accumulated
Other
Comprehensive
Loss
Balance at September 29, 2017
$
(44.1
)
 
$
—

 
$
(24.7
)
 
$
(68.8
)
Other comprehensive earnings (loss) before reclassifications
—

 
(0.9
)
 
9.7

 
8.8

Amounts reclassified out of other comprehensive earnings (loss)
0.9

 
0.9

 
—

 
1.8

Tax expense
(0.2
)
 
—

 
—

 
(0.2
)
Balance at March 30, 2018
$
(43.4
)
 
$
—

 
$
(15.0
)
 
$
(58.4
)
(In millions)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans
 
Cumulative
Translation
Adjustment
 
Accumulated
Other
Comprehensive Earnings
(Loss)
Balance at September 30, 2016
$
(63.3
)
 
$
(37.5
)
 
$
(100.8
)
Other comprehensive loss before reclassifications
—

 
(10.2
)
 
(10.2
)
Amounts reclassified out of other comprehensive earnings (loss)
1.9

 
—

 
1.9

Tax expense
(0.3
)
 
—

 
(0.3
)
Balance at March 31, 2017
$
(61.7
)
 
$
(47.7
)
 
$
(109.4
)
Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Loss)
The amounts reclassified out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings (Loss), with line item location, during each period were as follows: 
 
Three Months Ended
 
Six Months Ended
 
 
 (In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
 
 
Comprehensive Earnings Components
Loss Before Taxes
 
Loss Before Taxes
 
Line Item in Statements of Earnings (Loss)
Unrealized loss on defined benefit pension and post-retirement benefit plans
$
(0.5
)
 
$
(1.0
)
 
$
(0.9
)
 
$
(1.9
)
 
Cost of revenues & Operating expenses
Unrealized loss on cash flow hedging instruments
(1.0
)
 
—

 
(0.9
)
 
—

 
Revenues
Total amounts reclassified out of other comprehensive earnings (loss)
$
(1.5
)
 
$
(1.0
)
 
$
(1.8
)
 
$
(1.9
)
 
 
Schedule of Changes In Noncontrolling Interests
Changes in noncontrolling interests and redeemable noncontrolling interests relating to MeVis and other subsidiaries of the Company were as follows:
 
Six Months Ended
 
March 30, 2018
 
March 31, 2017
 (In millions)
Noncontrolling Interests
 
Noncontrolling Interests
 
Redeemable Noncontrolling Interests
Beginning of Period
$
4.3

 
$
3.7

 
$
10.3

Net earnings attributable to noncontrolling interests
0.1

 
0.4

 
0.1

Transfer of redeemable noncontrolling interests in MeVis to Varex
—

 
—

 
(10.3
)
Other
—

 
—

 
(0.1
)
End of Period
$
4.4

 
$
4.1

 
$
—
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE STOCK PLANS (Tables)
 6 Months Ended
Mar. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation Expense
The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:
 
Three Months Ended
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Cost of revenues - Product
$
0.8

 
$
0.8

 
$
1.5

 
$
1.6

Cost of revenues - Service
1.0

 
1.1

 
2.0

 
2.1

Research and development
1.2

 
1.4

 
2.4

 
2.6

Selling, general and administrative
7.5

 
8.1

 
15.3

 
15.3

Total share-based compensation expense
$
10.5

 
$
11.4

 
$
21.2

 
$
21.6

Income tax benefit for share-based compensation
$
(2.6
)
 
$
(3.4
)
 
$
(4.7
)
 
$
(6.4
)
Fair Value of Employee Stock Option Plans With Weighted Average Assumptions
The fair value of options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Three Months Ended
 
Six Months Ended
 
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Employee Stock Option Plans
 
 
 
 
 
 
 
Expected term (in years)
3.83

 
3.99

 
3.83

 
3.99

Risk-free interest rate
2.4
%
 
1.7
%
 
2.2
%
 
1.7
%
Expected volatility
19.2
%
 
21.8
%
 
19.0
%
 
21.8
%
Expected dividend
—
%
 
—
%
 
—
%
 
—
%
Weighted average fair value at grant date
$
21.48

 
$
16.13

 
$
20.73

 
$
16.13
Option Component of ESPP Shares with Weighted Average Assumptions
The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 
Six Months Ended
 
March 30,
2018
 
March 31,
2017
Employee Stock Purchase Plan
 
 
 
Expected term (in years)
0.50

 
0.50

Risk-free interest rate
1.2
%
 
0.5
%
Expected volatility
17.9
%
 
22.3
%
Expected dividend
—
%
 
—
%
Weighted average fair value at grant date
$
20.97

 
$
19.37
Summary of Share-Based Awards Available for Grant
A summary of share-based awards available for grant is as follows:
(In millions)
Shares Available for Grant
Balance at September 29, 2017
2.5

Authorized (1)
6.0

Granted
(1.7
)
Cancelled or expired
0.3

Balance at March 30, 2018
7.1


(1) 
On February 8, 2018, the Company's stockholders approved its Fifth Amended and Restated 2005 Omnibus Stock Plan ("2005 Plan") to increase the number of shares authorized for issuance by 6.0 million shares.
Activity Under Employee Stock Plans
Activity under the Company’s employee stock plans related to stock options is presented below: 
 
Options Outstanding
(In millions, except per share amounts)
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term (in years)
 
Aggregate
Intrinsic
Value (1)
Balance at September 29, 2017
2.3

 
$
74.08

 
 
 
 
Granted
0.6

 
111.43

 
 
 
 
Cancelled or expired (2)
—

 
75.69

 
 
 
 
Exercised
(0.5
)
 
70.67

 
 
 
 
Balance at March 30, 2018
2.4

 
$
85.00

 
5.1
 
$
89.3

 
 
 
 
 
 
 
 
Exercisable at March 30, 2018
1.1

 
$
73.65

 
4.0
 
$
52.0


(1) 
The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of $122.65 as of March 29, 2018, the last trading date of the second quarter of fiscal year 2018, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.
(2) 
The cancelled and expired shares were not material for disclosure.
Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units
The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:
(In millions, except per share amounts)
Number of
Shares
 
Weighted Average
Grant-Date Fair
Value
Balance at September 29, 2017
0.9

 
$
75.37

Granted
0.3

 
111.81

Vested
(0.3
)
 
76.33

Cancelled or expired
(0.1
)
 
84.16

Balance at March 30, 2018
0.8

 
$
88.61
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
EARNINGS PER SHARE (Tables)
 6 Months Ended
Mar. 30, 2018
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Net Earnings Per Share
The following table sets forth the computation of basic and diluted net earnings per share:
 
Three Months Ended
 
Six Months Ended
(In millions, except per share amounts)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Net earnings (loss) from continuing operations
$
73.2

 
$
69.5

 
$
(39.0
)
 
$
77.5

Less: Net (loss) earnings from continuing operations attributable to noncontrolling interests
—

 
(0.1
)
 
0.1

 
0.4

Net earnings (loss) from continuing operations attributable to Varian
$
73.2

 
$
69.6

 
$
(39.1
)
 
$
77.1

 
 
 
 
 
 
 
 
Net loss from discontinued operations
$
—

 
$
(13.3
)
 
$
—

 
$
(6.8
)
Less: Net earnings from discontinued operations attributable to noncontrolling interests
—

 
—

 
—

 
0.1

Net loss from discontinued operations attributable to Varian
$
—

 
$
(13.3
)
 
$
—

 
$
(6.9
)
Net earnings (loss) attributable to Varian
$
73.2

 
$
56.3

 
$
(39.1
)
 
$
70.2

 
 
 
 
 
 
 
 
Weighted average shares outstanding - basic
91.5

 
93.0

 
91.6

 
93.2

Dilutive effect of potential common shares
1.1

 
0.7

 
—

 
0.7

Weighted average shares outstanding - diluted
92.6

 
93.7

 
91.6

 
93.9

 
 
 
 
 
 
 
 
Net earnings (loss) per share attributable to Varian - basic
 
 
 
 
 
 
 
Continuing operations
$
0.80

 
$
0.75

 
$
(0.43
)
 
$
0.83

Discontinued operations
—

 
(0.15
)
 
—

 
(0.08
)
Net earnings (loss) per share - basic
$
0.80

 
$
0.60

 
$
(0.43
)
 
$
0.75

 
 
 
 
 
 
 
 
Net earnings (loss) per share attributable to Varian - diluted
 
 
 
 
 
 
 
Continuing operations
$
0.79

 
$
0.74

 
$
(0.43
)
 
$
0.82

Discontinued operations
—

 
(0.14
)
 
—

 
(0.08
)
Net earnings (loss) per share - diluted
$
0.79

 
$
0.60

 
$
(0.43
)
 
$
0.74

Anti-dilutive employee share-based awards, excluded
0.6

 
0.6

 
3.2

 
0.6
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
VPT LOANS AND INVESTMENT (Tables)
 6 Months Ended
Mar. 30, 2018
Receivables [Abstract]  
Schedule of Loans and Investments to Fund PT Centers
The following table lists the Company's outstanding loans and investments, including accrued interest, and commitments for funding development, construction and operations of various proton therapy centers:
 
 
March 30, 2018
 
September 29, 2017
(In millions)
 
Balance
 
Commitment
 
 Balance
 
Commitment
Notes receivable and secured debt:
 
 
 
 
 
 
 
 
MPTC loans (1)
 
$
58.9

 
$
—

 
$
67.4

 
$
—

RPTC senior secured debt (2)
 
26.4

 
—

 
25.4

 
—

NYPC loan (3)
 
26.2

 
—

 
24.6

 
—

PI loan (3)
 
2.6

 
—

 
3.1

 
—

CPTC DIP loan (3)
 
—

 
—

 
5.1

 
2.2

 
 
$
114.1

 
$
—

 
$
125.6

 
$
2.2

Available-for-sale Securities:
 
 
 
 
 
 
 
 
APTC securities (2)
 
$
6.1

 
$
—

 
$
—

 
$
—

GPTC securities (3)
 
4.6

 
11.8

 
4.4

 
11.8

Original CPTC loans (3)
 
—

 
—

 
47.4

 
—

DRTC securities (4)
 
—

 
—

 
8.3

 
—

 
 
$
10.7

 
$
11.8

 
$
60.1

 
$
11.8

 
 
 
 
 
 
 
 
 
CPTC Loans and Investment:
 
 
 
 
 
 
 
 
Short-term revolving loan (2)
 
$
3.1

 
$
4.1

 
$
—

 
$
—

Term loan (3)

 
44.0

 
—

 
—

 
—

Equity investment in CPTC (3)
 
9.5

 
—

 
—

 
—

 
 
$
56.6

 
$
4.1

 
$
—

 
$
—

(1) 
Includes $33.8 million and $42.3 million in other assets at March 30, 2018 and September 29, 2017, respectively, and $25.1 million in prepaid and other current assets at March 30, 2018 and other assets at September 29, 2017 on the Company's Condensed Consolidated Balance Sheets.
(2) 
Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets.
(3) 
Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(4) 
Included in other assets at September 29, 2017 on the Company's Condensed Consolidated Balance Sheets.
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION (Tables)
 6 Months Ended
Mar. 30, 2018
Segment Reporting [Abstract]  
Operating Results Information for Each Business Segment
The following table summarizes select operating results information for each reportable segment:
 
Three Months Ended
 
Six Months Ended
(In millions)
March 30,
2018
 
March 31,
2017
 
March 30,
2018
 
March 31,
2017
Revenues
 
 
 
 
 
 
 
Oncology Systems
$
698.0

 
$
631.9

 
$
1,347.4

 
$
1,203.1

Varian Particle Therapy
31.9

 
31.3

 
61.0

 
61.6

Total Company
$
729.9

 
$
663.2

 
$
1,408.4

 
$
1,264.7

Operating Earnings
 
 
 
 
 
 
 
Oncology Systems
$
143.1

 
$
122.9

 
$
281.3

 
$
239.0

Varian Particle Therapy
(17.5
)
 
(19.8
)
 
(32.7
)
 
(70.1
)
Total reportable segments
125.6

 
103.1

 
248.6

 
168.9

Unallocated corporate
(31.3
)
 
(13.0
)
 
(32.9
)
 
(61.4
)
Total Company
$
94.3

 
$
90.1

 
$
215.7

 
$
107.5
Schedule of Disaggregation of Revenue
The Company disaggregates its revenues from contracts by major product categories and by geographic region for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.
Total Revenues by product type
Three Months Ended
March 30, 2018
 
Six Months Ended
March 30, 2018
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Hardware
$
311.6

 
$
30.1

 
$
341.7

 
$
604.7

 
$
57.4

 
$
662.1

Software (1)
126.7

 
—

 
126.7

 
241.8

 
—

 
241.8

Service
259.7

 
1.8

 
261.5

 
500.9

 
3.6

 
504.5

Total Revenues
$
698.0

 
$
31.9

 
$
729.9

 
$
1,347.4

 
$
61.0

 
$
1,408.4

(1)
Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).
Total Revenues by product type
Three Months Ended
March 31, 2017
 
Six Months Ended
March 31, 2017
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Hardware
$
284.5

 
$
30.1

 
$
314.6

 
$
523.1

 
$
56.9

 
$
580.0

Software (1)
118.4

 
—

 
118.4

 
230.6

 
—

 
230.6

Service
229.0

 
1.2

 
230.2

 
449.4

 
4.7

 
454.1

Total Revenues
$
631.9

 
$
31.3

 
$
663.2

 
$
1,203.1

 
$
61.6

 
$
1,264.7

(1) 
Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).
Total Revenues by geographical region
Three Months Ended
March 30, 2018
 
Six Months Ended
March 30, 2018
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Americas
$
321.2

 
$
19.0

 
$
340.2

 
$
658.6

 
$
38.3

 
$
696.9

EMEA
241.2

 
12.6

 
253.8

 
424.7

 
22.1

 
446.8

APAC
135.6

 
0.3

 
135.9

 
264.1

 
0.6

 
264.7

Total Revenues
$
698.0

 
$
31.9

 
$
729.9

 
$
1,347.4

 
$
61.0

 
$
1,408.4

 
 
 
 
 
 
 
 
 
 
 
 
North America
$
299.6

 
$
19.0

 
$
318.6

 
$
625.9

 
$
38.3

 
$
664.2

International
398.4

 
12.9

 
411.3

 
721.5

 
22.7

 
744.2

Total Revenues
$
698.0

 
$
31.9

 
$
729.9

 
$
1,347.4

 
$
61.0

 
$
1,408.4

Total Revenues by geographical region
Three Months Ended
March 31, 2017
 
Six Months Ended
March 31, 2017
(In millions)
Oncology Systems
 
Varian Particle Therapy
 
Total
 
Oncology Systems
 
Varian Particle Therapy
 
Total
Americas
$
332.0

 
$
9.6

 
$
341.6

 
$
622.8

 
$
17.0

 
$
639.8

EMEA
167.5

 
17.8

 
185.3

 
336.5

 
32.8

 
369.3

APAC
132.4

 
3.9

 
136.3

 
243.8

 
11.8

 
255.6

Total Revenues
$
631.9

 
$
31.3

 
$
663.2

 
$
1,203.1

 
$
61.6

 
$
1,264.7

 
 
 
 
 
 
 
 
 
 
 
 
North America
$
309.7

 
$
9.6

 
319.3

 
$
584.7

 
$
17.0

 
601.7

International
322.2

 
21.7

 
343.9

 
618.4

 
44.6

 
663.0

Total Revenues
$
631.9

 
$
31.3

 
$
663.2

 
$
1,203.1

 
$
61.6

 
$
1,264.7

Timing of revenue recognition
Three Months Ended
March 30, 2018
 
Six Months Ended
March 30, 2018
(In millions)
Products transferred at a point in time
 
Products and Services transferred over time

 
Total
 
Products transferred at a point in time
 
Products and Services transferred over time

 
Total
Oncology Systems
$
363.7

 
$
334.3

 
$
698.0

 
$
702.0

 
$
645.4

 
$
1,347.4

Varian Particle Therapy
—

 
31.9

 
31.9

 
—

 
61.0

 
61.0

Total Revenues
$
363.7

 
$
366.2

 
$
729.9

 
$
702.0

 
$
706.4

 
$
1,408.4

Timing of revenue recognition
Three Months Ended
March 31, 2017
 
Six Months Ended
March 31, 2017
(In millions)
Products Transferred at a Point in Time
 
Products and Services Transferred Over Time

 
Total
 
Products Transferred at a Point in Time
 
Products and Services Transferred Over Time

 
Total
Oncology Systems
$
334.8

 
$
297.1

 
$
631.9

 
$
617.2

 
$
585.9

 
$
1,203.1

Varian Particle Therapy
—

 
31.3

 
31.3

 
—

 
61.6

 
61.6

Total Revenues
$
334.8

 
$
328.4

 
$
663.2

 
$
617.2

 
$
647.5

 
$
1,264.7
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)
 6 Months Ended
Jan. 28, 2017
Mar. 30, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Warranty period included in sale of hardware   1 year
Discontinued Operations, Disposed of by Means Other than Sale, Spinoff | Varex Imaging    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Pro rata distribution (shares) 0.4  
Minimum    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Manufacturing, Commissioning and Installation Period   18 months
Maximum    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Manufacturing, Commissioning and Installation Period   24 months
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Remaining Performance Obligations (Details)
$ in Millions
Mar. 30, 2018
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-03-31  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Unfulfilled Performance Obligations $ 1,060.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-09-29  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Unfulfilled Performance Obligations 2,089.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-09-28  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Unfulfilled Performance Obligations 729.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-03  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Unfulfilled Performance Obligations $ 1,276.3
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Oct. 02, 2015
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Sep. 30, 2017
Sep. 29, 2017
Revenues:              
Product   $ 393.8 $ 364.9 $ 759.4 $ 674.1    
Service   336.1 298.3 649.0 590.6    
Total revenues   729.9 663.2 1,408.4 1,264.7    
Cost of revenues:              
Product   264.2 246.9 488.1 453.1    
Service   147.2 140.7 299.0 269.0    
Total cost of revenues   411.4 387.6 787.1 722.1    
Gross margin   318.5 275.6 621.3 542.6    
Earnings from continuing operations before taxes   95.6 90.4 218.1 109.7    
Taxes on earnings   22.4 20.9 257.1 32.2    
Net earnings (loss) from continuing operations   73.2 69.5 (39.0) 77.5    
Net loss from discontinued operations   0.0 (13.3) 0.0 (6.8)    
Net (loss) earnings   73.2 56.2 (39.0) 70.7    
Net earnings attributable to Varian   $ 73.2 $ 56.3 $ (39.1) $ 70.2    
Diluted net earnings per share from continuing operations attributable to Varian (in dollars per share)   $ 0.79 $ 0.74 $ (0.43) $ 0.82    
Assets:              
Trade and unbilled receivables, net   $ 936.7   $ 936.7     $ 961.5
Inventories   433.8   433.8     417.7
Prepaid expenses and other current assets   226.4   226.4     190.3
Deferred tax assets   114.9   114.9     147.3
Liabilities and Equity:              
Accrued liabilities   365.1   365.1     374.9
Deferred revenues   766.5   766.5     755.4
Other long-term liabilities   320.7   320.7     127.4
Retained earnings   $ 664.2   $ 664.2     778.6
As Previously Reported              
Revenues:              
Product     $ 386.1   $ 729.7    
Service     268.9   537.1    
Total revenues     655.0   1,266.8    
Cost of revenues:              
Product     254.2   478.6    
Service     125.5   237.2    
Total cost of revenues     379.7   715.8    
Gross margin     275.3   551.0    
Earnings from continuing operations before taxes     90.1   118.1    
Taxes on earnings     20.8   34.3    
Net earnings (loss) from continuing operations     69.3   83.8    
Net loss from discontinued operations     (13.3)   (6.8)    
Net (loss) earnings     56.0   77.0    
Net earnings attributable to Varian     $ 56.1   $ 76.5    
Diluted net earnings per share from continuing operations attributable to Varian (in dollars per share)     $ 0.74   $ 0.89    
Assets:              
Trade and unbilled receivables, net             823.5
Inventories             439.7
Prepaid expenses and other current assets             199.8
Deferred tax assets             138.8
Liabilities and Equity:              
Accrued liabilities             394.7
Deferred revenues             640.6
Other long-term liabilities             130.0
Retained earnings             756.0
Adjustments | Accounting Standards Update 2014-09              
Revenues:              
Product     $ (21.2)   $ (55.6)    
Service     29.4   53.5    
Total revenues     8.2   (2.1)    
Cost of revenues:              
Product     (7.3)   (25.5)    
Service     15.2   31.8    
Total cost of revenues     7.9   6.3    
Gross margin     0.3   (8.4)    
Earnings from continuing operations before taxes     0.3   (8.4)    
Taxes on earnings     0.1   (2.1)    
Net earnings (loss) from continuing operations     0.2   (6.3)    
Net loss from discontinued operations     0.0   0.0    
Net (loss) earnings     0.2   (6.3)    
Net earnings attributable to Varian     $ 0.2   $ (6.3)    
Diluted net earnings per share from continuing operations attributable to Varian (in dollars per share)     $ 0.00   $ (0.07)    
Assets:              
Trade and unbilled receivables, net             138.0
Inventories             (22.0)
Prepaid expenses and other current assets             (9.5)
Deferred tax assets             8.5
Liabilities and Equity:              
Accrued liabilities             (19.8)
Deferred revenues             114.8
Other long-term liabilities             (2.6)
Retained earnings             $ 22.6
Retained Earnings | Accounting Standards Update 2016-09, Forfeiture Rate [Member]              
Liabilities and Equity:              
Reduction to beginning retained earnings due to election to recognize forfeitures as they occur           $ 0.4  
Difference between Revenue Guidance in Effect before and after Topic 606              
Liabilities and Equity:              
Cumulative effect of ASC 606 to retained earnings $ 56.7            
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS (Details) - USD ($)
$ in Millions
 6 Months Ended 12 Months Ended
Jan. 28, 2017
Jan. 25, 2017
Mar. 30, 2018
Mar. 31, 2017
Sep. 29, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Cash received from Varex Imaging Corporation     $ 0.0 $ 200.0  
Contribution of cash and cash equivalents $ 81.3   0.0 $ 81.3  
Varex Imaging | Discontinued Operations, Disposed of by Means Other than Sale, Spinoff          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Cash received from Varex Imaging Corporation         $ 200.0
Net assets     $ 4.9    
Varex Imaging          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Receipt of excess cash and cash equivalents         38.7
Varex Term Facility          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from term facility   $ 203.0      
Transfer of debt outstanding         203.0
Retained Earnings | Varex Imaging          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Distribution of Varex         $ 334.1
Minimum | Varex Imaging          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Transition services agreement 60 days        
Maximum | Varex Imaging          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Transition services agreement 24 months        
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS - Income Statement Disclosures (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Net loss from discontinued operations $ 0.0 $ (13.3) $ 0.0 $ (6.8)
Less: Net earnings from discontinued operations attributable to noncontrolling interests 0.0 0.0 0.0 0.1
Net loss from discontinued operations attributable to Varian $ 0.0 (13.3) $ 0.0 (6.9)
Separation costs   19.3   34.2
Discontinued Operations, Disposed of by Means Other than Sale, Spinoff        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenues   42.5   194.0
Cost of revenues   24.6   117.3
Gross margin   17.9   76.7
Operating expenses   29.7   76.1
Operating earnings   (11.8)   0.6
Taxes on earnings   1.5   7.4
Net loss from discontinued operations   (13.3)   (6.8)
Less: Net earnings from discontinued operations attributable to noncontrolling interests   0.0   0.1
Net loss from discontinued operations attributable to Varian   $ (13.3)   $ (6.9)
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS - Balance Sheet Disclosures (Details) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Current assets of discontinued operations $ 8.6 $ 11.1
Current liabilities of discontinued operations 3.7 2.5
Discontinued Operations, Disposed of by Means Other than Sale, Spinoff    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Trade accounts receivable, net 7.1 8.1
Inventories 1.1 2.9
Prepaid expenses and other current assets 0.4 0.1
Current assets of discontinued operations 8.6 11.1
Total assets of discontinued operations 8.6 11.1
Accounts payable 2.0 2.0
Accrued liabilities 1.7 0.5
Current liabilities of discontinued operations 3.7 2.5
Total liabilities of discontinued operations $ 3.7 $ 2.5
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCONTINUED OPERATIONS - Cash Flow Disclosures (Details) - USD ($)
$ in Millions
 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Share-based compensation expense $ 21.2 $ 23.6
Depreciation expense 25.4 31.9
Amortization expense 10.4 9.1
Purchases of property, plant and equipment $ (17.8) (32.1)
Discontinued Operations, Disposed of by Means Other than Sale, Spinoff    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Share-based compensation expense   2.0
Depreciation expense   4.4
Amortization expense   1.8
Purchases of property, plant and equipment   $ (6.3)
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1
BUSINESS COMBINATIONS (Details)
$ / shares in Units, $ in Millions, $ in Billions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
USD ($)
Jan. 30, 2018
AUD ($)
$ / shares
Mar. 30, 2018
USD ($)
Mar. 31, 2017
USD ($)
Mar. 30, 2018
USD ($)
company
Mar. 31, 2017
USD ($)
May 04, 2018
$ / shares
Sep. 29, 2017
USD ($)
Business Acquisition [Line Items]                
Goodwill $ 236.2   $ 236.2   $ 236.2     $ 222.6
Acquisition-related expenses     19.7 $ 0.6 21.2 $ 0.9    
Sirtex                
Business Acquisition [Line Items]                
Acquisition, share price (in AUD per share) | $ / shares   $ 28            
Acquisition price 1,200.0 $ 1.6            
Other Acquisitions                
Business Acquisition [Line Items]                
Acquisition price         $ 29.6      
Number of companies acquired | company         2      
Finite-lived intangible assets 20.4   20.4   $ 20.4      
Goodwill $ 11.5   $ 11.5   $ 11.5      
Subsequent Event | Sirtex                
Business Acquisition [Line Items]                
Competing bid for Sirtex made by CDH Investments (in AUD per share) | $ / shares             $ 33.60  
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEET COMPONENTS - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Sep. 29, 2017
Balance Sheet Components [Abstract]          
Unbilled receivables - current $ 311.5   $ 311.5   $ 259.1
Unbilled receivables - long-term (1) 28.2   28.2   10.9
Deferred revenues - current (766.5)   (766.5)   (755.4)
Deferred revenues - long-term (2) (9.1)   (9.1)   (7.2)
Total net unbilled receivables (deferred revenues) (435.9)   (435.9)   $ (492.6)
Increase in deferred revenues net of unbilled receivables     56.7    
Recognized revenue included in deferred revenue balance 108.8 $ 127.2 305.2 $ 346.0  
Impairment loss on non-current unbilled receivable $ 0.0 $ 0.0 $ 0.0 $ 17.2  
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEET COMPONENTS - Components of Inventories (Detail) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Balance Sheet Components [Abstract]    
Raw materials and parts $ 306.5 $ 296.5
Work-in-process 54.1 47.7
Finished goods 73.2 73.5
Total inventories $ 433.8 $ 417.7
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEET COMPONENTS - Available-for-Sale Securities (Detail) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Schedule of Available-for-sale Securities [Line Items]    
Amortized cost $ 10.7 $ 60.1
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 10.7 60.1
Original CPTC loans    
Schedule of Available-for-sale Securities [Line Items]    
Amortized cost   47.4
Gross Unrealized Gains   0.0
Gross Unrealized Losses   0.0
Fair Value   47.4
DRTC Securities    
Schedule of Available-for-sale Securities [Line Items]    
Amortized cost   8.3
Gross Unrealized Gains   0.0
Gross Unrealized Losses   0.0
Fair Value   8.3
APTC Securities    
Schedule of Available-for-sale Securities [Line Items]    
Amortized cost 6.1  
Gross Unrealized Gains 0.0  
Gross Unrealized Losses 0.0  
Fair Value 6.1  
GPTC Securities    
Schedule of Available-for-sale Securities [Line Items]    
Amortized cost 4.6 4.4
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value $ 4.6 $ 4.4
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEET COMPONENTS - Components of Other Long-Term Liabilities (Detail) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Balance Sheet Components [Abstract]    
Long-term income taxes payable $ 208.1 $ 48.6
Deferred income taxes 26.4 17.1
Long-term debt 25.0 0.0
Other 61.2 61.7
Total other long-term liabilities $ 320.7 $ 127.4
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities $ 10.7 $ 60.1
DRTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities   8.3
APTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 6.1  
GPTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 4.6 4.4
Fair Value, Measurements, Recurring    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Derivative assets 0.5  
Total assets measured at fair value 11.2 60.1
Derivative liabilities (12.4)  
Contingent consideration (2.8)  
Total liabilities measured at fair value (15.2)  
Fair Value, Measurements, Recurring | Original CPTC loans    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities   47.4
Fair Value, Measurements, Recurring | DRTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities   8.3
Fair Value, Measurements, Recurring | APTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 6.1  
Fair Value, Measurements, Recurring | GPTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 4.6 4.4
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Derivative assets 0.0  
Total assets measured at fair value 0.0 0.0
Derivative liabilities 0.0  
Contingent consideration 0.0  
Total liabilities measured at fair value 0.0  
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments | Original CPTC loans    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities   0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments | DRTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities   0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments | APTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 0.0  
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments | GPTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Derivative assets 0.5  
Total assets measured at fair value 11.2 12.7
Derivative liabilities (12.4)  
Contingent consideration 0.0  
Total liabilities measured at fair value (12.4)  
Fair Value, Measurements, Recurring | Significant Other Observable Inputs | Original CPTC loans    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities   0.0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs | DRTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities   8.3
Fair Value, Measurements, Recurring | Significant Other Observable Inputs | APTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 6.1  
Fair Value, Measurements, Recurring | Significant Other Observable Inputs | GPTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 4.6 4.4
Fair Value, Measurements, Recurring | Significant Unobservable Inputs    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Derivative assets 0.0  
Total assets measured at fair value 0.0 47.4
Derivative liabilities 0.0  
Contingent consideration (2.8)  
Total liabilities measured at fair value (2.8)  
Fair Value, Measurements, Recurring | Significant Unobservable Inputs | Original CPTC loans    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities   47.4
Fair Value, Measurements, Recurring | Significant Unobservable Inputs | DRTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities   0.0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs | APTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 0.0  
Fair Value, Measurements, Recurring | Significant Unobservable Inputs | GPTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities $ 0.0 $ 0.0
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail) - Fair Value, Measurements, Recurring
$ in Millions
 6 Months Ended
Mar. 30, 2018
USD ($)
Contingent Consideration  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Contingent Consideration, beginning balance $ 0.0
Additions from business combinations (2.8)
Contingent Consideration, ending balance (2.8)
Available-for-sale Securities  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Available-for-sale Securities, beginning balance 47.4
Additions from business combinations 0.0
Reclassification of Original CPTC Loans to Term Loan (47.4)
Available-for-sale Securities, Ending balance $ 0.0
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.8.0.1
FAIR VALUE - Additional Information (Detail) - USD ($)
$ in Millions
 6 Months Ended
Mar. 30, 2018
Dec. 06, 2017
Sep. 29, 2017
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Carrying value of long-term debt $ 25.0   $ 0.0
Fair Value 10.7   60.1
Notes Receivable      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Long-term $ 62.6   100.2
Minimum      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Remaining maturity 1 month    
Maximum      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Remaining maturity 13 months    
Level 2      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Carrying value of long-term debt $ 25.0    
C P T C | Term Loan      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Modified former loans receivable $ 44.0   $ 0.0
Varian Medical Systems, Inc. | C P T C | Term Loan      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Modified former loans receivable   $ 53.5  
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.8.0.1
RECEIVABLES (Details) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Trade and unbilled receivables, gross $ 1,008.8 $ 1,039.2
Allowance for doubtful accounts (40.3) (63.1)
Trade and unbilled receivables, net 968.5 976.1
Short-term 936.7 961.5
Long-term 31.8 14.6
Allowance for doubtful accounts, current 40.3 45.9
Allowance, noncurrent   17.2
Notes Receivable    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Notes receivable 87.9 105.2
Short-term 25.3 5.0
Long-term $ 62.6 $ 100.2
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.8.0.1
GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail)
$ in Millions
 6 Months Ended
Mar. 30, 2018
USD ($)
Goodwill [Roll Forward]  
Balance, beginning $ 222.6
Business combinations 11.5
Foreign currency translation adjustments 2.1
Balance, ending 236.2
Oncology Systems  
Goodwill [Roll Forward]  
Balance, beginning 170.2
Business combinations 11.5
Foreign currency translation adjustments 0.0
Balance, ending 181.7
Varian Particle Therapy  
Goodwill [Roll Forward]  
Balance, beginning 52.4
Business combinations 0.0
Foreign currency translation adjustments 2.1
Balance, ending $ 54.5
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.8.0.1
GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Finite Lived Intangible Assets [Line Items]    
Finite lived intangible assets, gross $ 161.9 $ 141.4
Accumulated Amortization (88.7) (78.6)
Net Carrying Amount 73.2 62.8
Indefinite intangible assets 8.8 8.8
Total intangible assets 170.7 150.2
Total intangible assets, net 82.0 71.6
Technologies and patents    
Finite Lived Intangible Assets [Line Items]    
Finite lived intangible assets, gross 118.0 102.0
Accumulated Amortization (67.7) (60.9)
Net Carrying Amount 50.3 41.1
Customer contracts and supplier relationship    
Finite Lived Intangible Assets [Line Items]    
Finite lived intangible assets, gross 38.2 33.9
Accumulated Amortization (16.4) (14.3)
Net Carrying Amount 21.8 19.6
Other    
Finite Lived Intangible Assets [Line Items]    
Finite lived intangible assets, gross 5.7 5.5
Accumulated Amortization (4.6) (3.4)
Net Carrying Amount $ 1.1 $ 2.1
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.8.0.1
GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Finite-Lived Intangible Assets [Line Items]        
Amortization expense     $ 10.4 $ 9.1
Continuing Operations        
Finite-Lived Intangible Assets [Line Items]        
Amortization expense $ 4.1 $ 3.5 $ 10.4 $ 7.3
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.8.0.1
GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Goodwill and Intangible Assets Disclosure [Abstract]    
Remainder of 2018 $ 10.9  
Future amortization expense, fiscal year 2019 15.2  
Future amortization expense, fiscal year 2020 12.7  
Future amortization expense, fiscal year 2021 10.4  
Future amortization expense, fiscal year 2022 9.0  
Thereafter 15.0  
Net Carrying Amount $ 73.2 $ 62.8
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.8.0.1
BORROWINGS - Schedule of Debt (Details) - USD ($)
$ in Millions
Mar. 30, 2018
Sep. 29, 2017
Short-term borrowings:    
Short-term borrowings $ 230.0 $ 350.0
Total short-term borrowings 230.0 350.0
Total long-term debt $ 25.0 $ 0.0
2017 Revolving Credit Facility    
Short-term borrowings:    
Weighted-Average Interest Rate (as a percent) 2.79% 2.36%
Short-term borrowings $ 230.0 $ 350.0
2017 Revolving Credit Facility    
Short-term borrowings:    
Weighted-Average Interest Rate (as a percent) 4.88% 0.00%
Total long-term debt $ 25.0 $ 0.0
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.8.0.1
BORROWINGS - Additional Information (Detail)
 6 Months Ended
Sep. 01, 2017
USD ($)
Mar. 30, 2018
JPY (¥)
Mar. 30, 2018
USD ($)
2017 Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Loan facility, maximum borrowing capacity     $ 600,000,000
2017 Revolving Credit Facility | Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Credit facility term (in years)   5 years  
Debt issuance costs $ 1,800,000    
2017 Revolving Credit Facility | Revolving Credit Facility | Minimum      
Line Of Credit Facility [Line Items]      
Commitment fee   0.125%  
2017 Revolving Credit Facility | Revolving Credit Facility | Maximum      
Line Of Credit Facility [Line Items]      
Commitment fee   0.25%  
2017 Revolving Credit Facility | Eurodollar | Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Percentage added to Eurodollar base rate before margin (as a percent)   1.00%  
2017 Revolving Credit Facility | Eurodollar | Revolving Credit Facility | Minimum      
Line Of Credit Facility [Line Items]      
Line of credit, interest rate (as a percent)   1.125%  
2017 Revolving Credit Facility | Eurodollar | Revolving Credit Facility | Maximum      
Line Of Credit Facility [Line Items]      
Line of credit, interest rate (as a percent)   1.875%  
2017 Revolving Credit Facility | Eurodollar Rate plus 1% | Revolving Credit Facility | Minimum      
Line Of Credit Facility [Line Items]      
Line of credit, interest rate (as a percent)   0.125%  
2017 Revolving Credit Facility | Eurodollar Rate plus 1% | Revolving Credit Facility | Maximum      
Line Of Credit Facility [Line Items]      
Line of credit, interest rate (as a percent)   0.875%  
2017 Revolving Credit Facility | Federal Funds Rate | Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Line of credit, interest rate (as a percent)   0.50%  
Sumitomo Credit Facility      
Line Of Credit Facility [Line Items]      
Loan facility, maximum borrowing capacity | ¥   ¥ 3,000,000,000  
Sumitomo Credit Facility | Base Rate      
Line Of Credit Facility [Line Items]      
Line of credit, interest rate (as a percent)   0.50%  
2017 Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Credit facility term (in years) 5 years    
Loan facility, maximum borrowing capacity $ 600,000,000.0    
Debt instrument, contract repayment date 12 months    
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.8.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Fair Value of Derivative Instruments Reported in Condensed Consolidated Balance Sheets (Detail) - Derivatives Not Designated as Hedging Instrument
$ in Millions
Mar. 30, 2018
USD ($)
Foreign exchange option contract | Prepaid expenses and other current assets [Member]  
Derivatives Fair Value [Line Items]  
Derivative asset $ 0.5
Foreign exchange forward contracts | Accrued liabilities  
Derivatives Fair Value [Line Items]  
Derivative liability (12.4)
Foreign Exchange Contract  
Derivatives Fair Value [Line Items]  
Total derivatives $ (11.9)
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.8.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 30, 2018
Derivative [Line Items]    
Derivative, term of contract (in months)   1 month
Derivatives designated as hedging instruments: | Foreign Exchange Contract    
Derivative [Line Items]    
Gain/loss $ (0.6) $ (0.9)
Minimum    
Derivative [Line Items]    
Remaining maturity   1 month
Maximum    
Derivative [Line Items]    
Remaining maturity   13 months
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.8.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 30, 2018
Cash Flow Hedging | Derivatives designated as hedging instruments: | Foreign Exchange Contract    
Derivative [Line Items]    
Amount of loss reclassified from accumulated other comprehensive loss into earnings (loss) $ (1.0) $ (0.9)
Revenues    
Derivative [Line Items]    
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings (Loss) in which the effects of fair value and cash flow hedges are recorded $ 729.9 $ 1,408.4
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.8.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail) - Derivatives Not Designated as Hedging Instrument - Foreign exchange forward contracts
$ in Millions
Mar. 30, 2018
USD ($)
Notional Value Sold  
Derivative [Line Items]  
Notional Value $ 477.3
Notional Value Sold | Australian Dollar  
Derivative [Line Items]  
Notional Value 35.1
Notional Value Sold | Brazilian Real  
Derivative [Line Items]  
Notional Value 7.7
Notional Value Sold | British Pound  
Derivative [Line Items]  
Notional Value 33.0
Notional Value Sold | Canadian Dollar  
Derivative [Line Items]  
Notional Value 12.3
Notional Value Sold | Danish Krone  
Derivative [Line Items]  
Notional Value 9.9
Notional Value Sold | Euro  
Derivative [Line Items]  
Notional Value 246.6
Notional Value Sold | Hungarian Forint  
Derivative [Line Items]  
Notional Value 1.9
Notional Value Sold | Indian Rupee  
Derivative [Line Items]  
Notional Value 17.8
Notional Value Sold | Japanese Yen  
Derivative [Line Items]  
Notional Value 69.5
Notional Value Sold | Polish Zloty  
Derivative [Line Items]  
Notional Value 18.6
Notional Value Sold | Singapore Dollar  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Sold | Swedish Krona  
Derivative [Line Items]  
Notional Value 12.1
Notional Value Sold | South African Rand  
Derivative [Line Items]  
Notional Value 8.9
Notional Value Sold | Swiss Franc  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Sold | Thai Baht  
Derivative [Line Items]  
Notional Value 3.9
Notional Value Purchased  
Derivative [Line Items]  
Notional Value 41.8
Notional Value Purchased | Australian Dollar  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | Brazilian Real  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | British Pound  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | Canadian Dollar  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | Danish Krone  
Derivative [Line Items]  
Notional Value 0.5
Notional Value Purchased | Euro  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | Hungarian Forint  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | Indian Rupee  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | Japanese Yen  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | Polish Zloty  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | Singapore Dollar  
Derivative [Line Items]  
Notional Value 5.1
Notional Value Purchased | Swedish Krona  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | South African Rand  
Derivative [Line Items]  
Notional Value 0.0
Notional Value Purchased | Swiss Franc  
Derivative [Line Items]  
Notional Value 36.2
Notional Value Purchased | Thai Baht  
Derivative [Line Items]  
Notional Value $ 0.0
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.8.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Derivative [Line Items]        
Amount of Gain (Loss) Recognized in Net Earnings (Loss) on Derivative Instruments     $ (16.4) $ 0.0
Derivatives Not Designated as Hedging Instrument | Foreign exchange forward contracts | Selling, general and administrative expenses        
Derivative [Line Items]        
Amount of Gain (Loss) Recognized in Net Earnings (Loss) on Derivative Instruments $ (7.5) $ (7.5) $ (12.2) $ 7.4
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.8.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Foreign Currency Contracts Related to the Acquisition of Sirtex Medical Limited (Details)
$ in Millions, $ in Millions
 1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2018
USD ($)
Mar. 30, 2018
USD ($)
Mar. 30, 2018
USD ($)
Mar. 31, 2017
USD ($)
Feb. 28, 2018
AUD ($)
Derivative [Line Items]          
Foreign currency option premium     $ 5.5 $ 0.0  
Loss on foreign currency contracts that do not qualify for hedge accounting     16.4 $ 0.0  
Sirtex | Foreign exchange forward contracts          
Derivative [Line Items]          
Notional amount $ 621.0 $ 609.6 609.6   $ 793.0
Sirtex | Foreign exchange option contract          
Derivative [Line Items]          
Notional amount 641.5       $ 792.0
Foreign currency option premium $ 5.5        
Fair value of foreign currency option   0.5 $ 0.5    
Acquisition-related expenses | Sirtex | Foreign exchange forward contracts          
Derivative [Line Items]          
Loss on foreign currency contracts that do not qualify for hedge accounting   11.4      
Acquisition-related expenses | Sirtex | Foreign exchange option contract          
Derivative [Line Items]          
Loss on foreign currency contracts that do not qualify for hedge accounting   $ 5.0      
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.8.0.1
COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail) - USD ($)
$ in Millions
 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]    
Accrued product warranty, at beginning of period $ 41.3 $ 41.9
Charged to cost of revenues 26.3 17.4
Actual product warranty expenditures (26.5) (23.2)
Accrued product warranty, at end of period $ 41.1 $ 36.1
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.8.0.1
COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Sep. 29, 2017
Commitments And Contingencies [Line Items]          
Environmental cleanup costs, third-party claim costs, project management costs and legal costs $ 0.2 $ 0.1 $ 0.4 $ 0.3  
Receivables of past and future environmental-related expenditures 1.4   1.4   $ 1.6
Group A Sites          
Commitments And Contingencies [Line Items]          
Amount accrued for environmental remediation expense 1.0   1.0    
Group A Sites | Minimum          
Commitments And Contingencies [Line Items]          
Estimate of loss 1.0   $ 1.0    
Estimated time frames to resolve contingency related to environmental remediation contingencies, years     1 year    
Group A Sites | Maximum          
Commitments And Contingencies [Line Items]          
Estimate of loss 7.9   $ 7.9    
Estimated time frames to resolve contingency related to environmental remediation contingencies, years     30 years    
Group B Sites          
Commitments And Contingencies [Line Items]          
Amount accrued for environmental remediation expense 4.7   $ 4.7    
Estimated environmental remediation costs, best estimate, undiscounted $ 5.5   $ 5.5    
Discount rate for environmental remediation costs, net of inflation (as a percent) 4.00%   4.00%    
Group B Sites | Minimum          
Commitments And Contingencies [Line Items]          
Estimate of loss $ 3.4   $ 3.4    
Estimated time frames to resolve contingency related to environmental remediation contingencies, years     1 year    
Group B Sites | Maximum          
Commitments And Contingencies [Line Items]          
Estimate of loss $ 19.3   $ 19.3    
Estimated time frames to resolve contingency related to environmental remediation contingencies, years     30 years    
XML 84 R72.htm IDEA: XBRL DOCUMENT v3.8.0.1
COMMITMENTS AND CONTINGENCIES - Restructuring (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Restructuring Reserve [Roll Forward]      
September 29, 2017   $ 3.9  
Restructuring Charges   0.0  
Cash Payments   (3.3)  
March 30, 2018   0.6  
2017 Restructuring Plan [Member]      
Restructuring Reserve [Roll Forward]      
September 29, 2017   3.9  
Restructuring Charges $ 2.5 0.0 $ 6.3
Cash Payments   (3.3)  
March 30, 2018   $ 0.6  
XML 85 R73.htm IDEA: XBRL DOCUMENT v3.8.0.1
RETIREMENT PLANS - Additional Information (Detail)
Mar. 30, 2018
plan
Foreign Pension Plan  
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]  
Defined Benefit Plan, Number of Plans 5
XML 86 R74.htm IDEA: XBRL DOCUMENT v3.8.0.1
RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail) - Defined Benefit Plans - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Defined Benefit Plan Disclosure [Line Items]        
Service cost $ 1.7 $ 1.8 $ 3.3 $ 3.5
Interest cost 0.8 0.6 1.6 1.2
Expected return on plan assets (2.0) (1.8) (4.0) (3.5)
Amortization of prior service cost (0.2) 0.0 (0.3) (0.1)
Recognized actuarial loss 0.7 1.1 1.4 2.2
Net periodic benefit cost $ 1.0 $ 1.7 $ 2.0 $ 3.3
XML 87 R75.htm IDEA: XBRL DOCUMENT v3.8.0.1
INCOME TAXES - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Sep. 28, 2018
Income Tax Contingency [Line Items]          
Effective tax rate (as a percent) 23.40% 23.10% 117.90% 29.40%  
Provisional discrete tax expense related to re-measuring deferred tax assets $ 2.4   $ 40.2    
Provisional discrete tax expense related to the one-time transition tax 3.8   173.1    
Discrete income tax benefit, related to excess stock deduction activity $ 4.7   6.2    
Increase in unrecognized tax benefits     $ 11.6    
Forecast          
Income Tax Contingency [Line Items]          
Estimated effective U.S. corporate tax rate (as a percent)         24.60%
XML 88 R76.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Additional Information (Detail) - November 2016 - shares
Mar. 30, 2018
Nov. 30, 2016
Stockholders’ equity and noncontrolling interests [Line Items]    
Number of shares authorized to be repurchased by VMS Board of Directors (in shares)   8,000,000.0
Remaining authorization (shares) 4,400,000  
XML 89 R77.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Shares Repurchased During Period (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Equity [Abstract]        
Number of shares (in shares) 0.3 2.0 0.8 2.5
Average repurchase price per share (in dollars per share) $ 110.52 $ 86.42 $ 109.06 $ 88.93
Total cost $ 36.0 $ 172.8 $ 92.7 $ 222.3
XML 90 R78.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail) - USD ($)
$ in Millions
 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period $ 1,521.9  
Balance at end of period 1,456.6  
Net Unrealized Gains (Losses) Defined Benefit Pension and Post-Retirement Benefit Plans    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period (44.1) $ (63.3)
Other comprehensive earnings (loss) before reclassifications 0.0 0.0
Amounts reclassified out of other comprehensive earnings (loss) 0.9 1.9
Tax expense (0.2) (0.3)
Balance at end of period (43.4) (61.7)
Net Unrealized Gains (Losses) Cash Flow Hedging Instruments    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period 0.0  
Other comprehensive earnings (loss) before reclassifications (0.9)  
Amounts reclassified out of other comprehensive earnings (loss) 0.9  
Tax expense 0.0  
Balance at end of period 0.0  
Cumulative Translation Adjustment    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period (24.7) (37.5)
Other comprehensive earnings (loss) before reclassifications 9.7 (10.2)
Amounts reclassified out of other comprehensive earnings (loss) 0.0 0.0
Tax expense 0.0 0.0
Balance at end of period (15.0) (47.7)
Accumulated Other Comprehensive Earnings (Loss)    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period (68.8) (100.8)
Other comprehensive earnings (loss) before reclassifications 8.8 (10.2)
Amounts reclassified out of other comprehensive earnings (loss) 1.8 1.9
Tax expense (0.2) (0.3)
Balance at end of period $ (58.4) $ (109.4)
XML 91 R79.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items]        
Revenues $ 729.9 $ 663.2 $ 1,408.4 $ 1,264.7
Net earnings (loss) attributable to Varian 73.2 56.3 (39.1) 70.2
Unrealized loss on defined benefit pension and post-retirement benefit plans        
Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items]        
Cost of revenues & Operating expenses (0.5) (1.0) (0.9) (1.9)
Reclassification out of Accumulated Other Comprehensive Income        
Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items]        
Net earnings (loss) attributable to Varian (1.5) (1.0) (1.8) (1.9)
Reclassification out of Accumulated Other Comprehensive Income | Unrealized loss on cash flow hedging instruments        
Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items]        
Revenues $ (1.0) $ 0.0 $ (0.9) $ 0.0
XML 92 R80.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Noncontrolling interests (Details) - USD ($)
$ in Millions
 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period $ 1,521.9  
Balance at end of period 1,456.6  
Increase (Decrease) in Temporary Equity [Roll Forward]    
Balance at beginning of period   $ 10.3
Net earnings attributable to noncontrolling interests   0.1
Transfer of redeemable noncontrolling interests in MeVis to Varex   (10.3)
Other   (0.1)
Balance at end of period   0.0
Noncontrolling Interests    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period 4.3 3.7
Net earnings attributable to noncontrolling interests 0.1 0.4
Transfer of redeemable noncontrolling interests in MeVis to Varex 0.0 0.0
Other 0.0 0.0
Balance at end of period $ 4.4 $ 4.1
XML 93 R81.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense $ 10.5 $ 11.4 $ 21.2 $ 21.6
Income tax benefit for share-based compensation (2.6) (3.4) (4.7) (6.4)
Cost of revenues - Product        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 0.8 0.8 1.5 1.6
Cost of revenues - Service        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 1.0 1.1 2.0 2.1
Research and development        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 1.2 1.4 2.4 2.6
Selling, general and administrative        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense $ 7.5 $ 8.1 $ 15.3 $ 15.3
XML 94 R82.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail) - $ / shares
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Employee Stock Purchase Plan        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Expected term (in years)     6 months 6 months
Risk-free interest rate     1.20% 0.50%
Expected volatility     17.90% 22.30%
Expected dividend     0.00% 0.00%
Weighted average fair value at grant date (dollars per share)     $ 20.97 $ 19.37
Employee Stock Option Plans        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Expected term (in years) 3 years 9 months 29 days 3 years 11 months 27 days 3 years 9 months 29 days 3 years 11 months 27 days
Risk-free interest rate 2.40% 1.70% 2.20% 1.70%
Expected volatility 19.20% 21.80% 19.00% 21.80%
Expected dividend 0.00% 0.00% 0.00% 0.00%
Weighted average fair value at grant date (dollars per share) $ 21.48 $ 16.13 $ 20.73 $ 16.13
XML 95 R83.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE STOCK PLANS - Summary of Share-Based Awards Available for Grant (Detail)
shares in Millions
 6 Months Ended
Mar. 30, 2018
shares
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant [Roll Forward]  
Balance at beginning of period (in shares) 2.5
Authorized (in shares) 6.0
Granted (in shares) (1.7)
Cancelled or expired (in shares) 0.3
Balance at end of period (in shares) 7.1
XML 96 R84.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE STOCK PLANS - Additional Information (Detail)
$ in Millions
 6 Months Ended
Mar. 30, 2018
USD ($)
shares
Stock options  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Unrecognized compensation expense related to outstanding stock awards | $ $ 18.0
Weighted average period unrecognized compensation expense is expected to be recognized, years 2 years 2 months 19 days
Restricted stocks, restricted stock units, deferred stock units and performance units  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Unrecognized compensation expense related to outstanding stock awards | $ $ 46.9
Weighted average period unrecognized compensation expense is expected to be recognized, years 2 years 26 days
Fourth Amended 2005 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Shares counted against the available for grant (in shares) 2.6
Fourth Amended 2005 Plan | Stock options  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Shares counted against the available for grant (in shares) 1
Fourth Amended 2005 Plan | Performance stock options  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Shares counted against the available for grant (in shares) 1
Beginning Fiscal Year 2018 | Fourth Amended 2005 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Ratio of maximum payout (in shares) 2.0
Beginning Fiscal Year 2017 | Fourth Amended 2005 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Ratio of maximum payout (in shares) 1.75
Beginning Fiscal Year 2016 | Fourth Amended 2005 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Ratio of maximum payout (in shares) 1.75
Beginning In Fiscal 2015 | Fourth Amended 2005 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Ratio of maximum payout (in shares) 2.0
XML 97 R85.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail)
$ / shares in Units, shares in Millions, $ in Millions
 6 Months Ended
Mar. 30, 2018
USD ($)
$ / shares
shares
Number of Shares  
Balance at beginning of period (in shares) | shares 2.3
Granted (in shares) | shares 0.6
Cancelled or expired (in shares) | shares 0.0
Exercised (in shares) | shares (0.5)
Balance at end of period (in shares) | shares 2.4
Exercisable (in shares) | shares 1.1
Weighted Average Exercise Price  
Balance at beginning of period (in dollars per share) $ 74.08
Granted (in dollars per share) 111.43
Cancelled or expired (in dollars per share) 75.69
Exercised (in dollars per share) 70.67
Balance at end of period (in dollars per share) 85.00
Exercisable (in dollars per share) $ 73.65
Weighted Average Remaining Term (in years)  
Balance at end of period (in years) 5 years 1 month 21 days
Exercisable (in years) 3 years 11 months 16 days
Aggregate Intrinsic Value  
Balance at end of period | $ $ 89.3
Exercisable | $ $ 52.0
Share price (in dollars per share) $ 122.65
XML 98 R86.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail)
shares in Millions
 6 Months Ended
Mar. 30, 2018
$ / shares
shares
Number of Shares  
Balance at beginning of period (in shares) | shares 0.9
Granted (in shares) | shares 0.3
Vested (in shares) | shares (0.3)
Cancelled or expired (in shares) | shares (0.1)
Balance at end of period (in shares) | shares 0.8
Weighted Average Grant-Date Fair Value  
Balance at beginning of period (in dollars per share) | $ / shares $ 75.37
Granted (in dollars per share) | $ / shares 111.81
Vested (in dollars per share) | $ / shares 76.33
Cancelled or expired (in dollars per share) | $ / shares 84.16
Balance at end of period (in dollars per share) | $ / shares $ 88.61
XML 99 R87.htm IDEA: XBRL DOCUMENT v3.8.0.1
EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Earnings Per Share [Abstract]        
Net earnings (loss) from continuing operations $ 73.2 $ 69.5 $ (39.0) $ 77.5
Less: Net (loss) earnings from continuing operations attributable to noncontrolling interests 0.0 (0.1) 0.1 0.4
Net earnings (loss) from continuing operations attributable to Varian 73.2 69.6 (39.1) 77.1
Net loss from discontinued operations 0.0 (13.3) 0.0 (6.8)
Less: Net earnings from discontinued operations attributable to noncontrolling interests 0.0 0.0 0.0 0.1
Net loss from discontinued operations attributable to Varian 0.0 (13.3) 0.0 (6.9)
Net earnings (loss) attributable to Varian $ 73.2 $ 56.3 $ (39.1) $ 70.2
Weighted average shares outstanding - basic (in shares) 91.5 93.0 91.6 93.2
Dilutive effect of potential common shares (in shares) 1.1 0.7 0.0 0.7
Weighted average shares outstanding - diluted (in shares) 92.6 93.7 91.6 93.9
Net earnings (loss) per share - basic        
Continuing operations (in dollars per share) $ 0.80 $ 0.75 $ (0.43) $ 0.83
Discontinued operations (in dollars per share) 0.00 (0.15) 0.00 (0.08)
Net earnings (loss) per share - basic (in dollars per share) 0.80 0.60 (0.43) 0.75
Net earnings (loss) per share - diluted        
Continuing operations (in dollars per share) 0.79 0.74 (0.43) 0.82
Discontinued operations (in dollars per share) 0.00 (0.14) 0.00 (0.08)
Net earnings (loss) per share - diluted (in dollars per share) $ 0.79 $ 0.60 $ (0.43) $ 0.74
Anti-dilutive employee shared based awards, excluded (in shares) 0.6 0.6 3.2 0.6
XML 100 R88.htm IDEA: XBRL DOCUMENT v3.8.0.1
VPT LOANS AND INVESTMENT - Loans and Commitments (Details) - USD ($)
$ in Millions
Mar. 30, 2018
Dec. 03, 2017
Sep. 29, 2017
Apr. 30, 2017
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Fair Value $ 10.7   $ 60.1  
Commitment 11.8   11.8  
APTC Securities        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Fair Value 6.1 $ 6.0 0.0  
Commitment 0.0   0.0  
Original CPTC loans        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Fair Value 0.0   47.4  
Commitment 0.0   0.0  
DRTC securities (4)        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Fair Value 0.0   8.3 $ 8.0
Commitment 0.0   0.0  
C P T C        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Commitment 4.1   0.0  
Equity investment in CPTC 9.5   0.0  
Loans and Investments 56.6   0.0  
Loans Receivable        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Notes receivable and secured debt 114.1   125.6  
Commitment 0.0   2.2  
Revolving Loan | C P T C        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Commitment 4.1   0.0  
Short-term revolving loan 3.1   0.0  
Term Loan | C P T C        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Commitment 0.0   0.0  
Term loan 44.0   0.0  
MPTC loans (1) | Loans Receivable        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Notes receivable 58.9   67.4  
Commitment 0.0   0.0  
RPTC senior secured debt (2) | Loans Receivable        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Short-term 26.4   25.4  
Commitment 0.0   0.0  
NYPC loan (3) | Loans Receivable        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Long-term 26.2   24.6  
Commitment 0.0   0.0  
PI loan (3) | Loans Receivable        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Long-term 2.6   3.1  
Commitment 0.0   0.0  
CPTC DIP Loan | Loans Receivable        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Long-term 0.0   5.1  
Commitment 0.0   2.2  
GPTC Securities        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Fair Value 4.6   4.4  
Commitment 11.8   11.8  
Other Assets | MPTC loans (1) | Loans Receivable        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Long-term 33.8   42.3  
Prepaid expenses and other current assets [Member] | MPTC loans (1) | Loans Receivable        
Long-term notes receivable and Available-for-sale Securities [Line Items]        
Notes receivable     $ 25.1  
Short-term $ 25.1      
XML 101 R89.htm IDEA: XBRL DOCUMENT v3.8.0.1
VPT LOANS AND INVESTMENT - Additional Information (Detail)
€ in Millions
 1 Months Ended 3 Months Ended 6 Months Ended 51 Months Ended
Dec. 06, 2017
USD ($)
tranche
Jul. 31, 2015
USD ($)
Jan. 31, 2018
USD ($)
Jul. 31, 2017
USD ($)
Jul. 31, 2017
EUR (€)
Mar. 30, 2018
USD ($)
board_seat
Sep. 29, 2017
USD ($)
Mar. 31, 2017
USD ($)
Mar. 30, 2018
USD ($)
board_seat
Mar. 31, 2017
USD ($)
Nov. 30, 2015
USD ($)
Jan. 01, 2023
USD ($)
Dec. 03, 2017
USD ($)
Jul. 31, 2017
EUR (€)
Apr. 30, 2017
USD ($)
Dec. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
May 31, 2015
USD ($)
installment
Long term notes receivable and available for sale securities [Line Items]                                    
Commitment           $ 10,700,000 $ 60,100,000   $ 10,700,000                  
Impairment charges           11,100,000   $ 0 11,100,000 $ 38,300,000                
Payments to acquire available-for-sale securities                 6,000,000 1,100,000                
Sale of available-for-sale securities                 8,000,000 0                
Principal payments on notes receivable                 5,200,000 $ 0                
Available-for-sale securities:           10,700,000 60,100,000   10,700,000                  
APTC Securities                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Commitment           $ 6,100,000 0   $ 6,100,000       $ 6,000,000          
Interest rate (as a percent)           8.50%     8.50%                  
DRTC securities (4)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Commitment           $ 0 8,300,000   $ 0           $ 8,000,000      
Sale of available-for-sale securities     $ 8,500,000                              
DRTC Securities                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Interest rate (as a percent)                             8.50%      
Original CPTC loans                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Commitment           0 47,400,000   0                  
Impairment charges               $ 38,300,000                    
Available-for-sale securities:                               $ 60,000,000    
C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Equity method investment           $ 9,500,000 0   $ 9,500,000                  
Number of CPTC board seats held by the Company | board_seat           1     1                  
Number of CPTC board seats | board_seat           5     5                  
RPTC Securities                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Claims Filed Against Assets of Company in Bankruptcy | €                           € 89.0        
Accounts receivable, includes unbilled accounts receivable           $ 4,500,000 4,500,000   $ 4,500,000                  
Georgia Proton Therapy Center                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Accounts receivable, includes unbilled accounts receivable           6,400,000 0   6,400,000                  
Unbilled receivables from variable interest entity           6,200,000     6,200,000                  
New York Proton Center [Member]                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Accounts receivable, includes unbilled accounts receivable           13,800,000 13,300,000   13,800,000                  
Unbilled receivables from variable interest entity           13,800,000 1,300,000   13,800,000                  
MPTC loans (1)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Accounts receivable, includes unbilled accounts receivable           $ 0 0   $ 0                  
C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Impairment charges             13,100,000                      
Liabilities assumed by lenders $ 112,000,000                                  
Additional financing             16,000,000.0                      
Interest rate           9.00%     9.00%                  
Varian Medical Systems, Inc. | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Ownership interest in dpiX Holding LLC (as a percent)           47.08%     47.08%                  
Fair value of CPTC's equity           $ 20,100,000     $ 20,100,000                  
Equity method investment           9,500,000     9,500,000                  
Varian Medical Systems, Inc. | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Additional financing             7,300,000                      
Subordinated Bond | PI loan (3) | DRTC securities (4)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Interest rate (as a percent)                             8.50%      
Long-term                             $ 3,000,000      
Principal payments on notes receivable           500,000                        
Subordinated Bond | PI loan (3) | Public Finance Authority | DRTC securities (4)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Commitment                             $ 3,000,000      
Loans Receivable | Proton Center, Munich                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Payments to Acquire Senior Secured Debt       $ 24,500,000 € 21.5                          
Loans Receivable | RPTC Securities                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Short-term           26,400,000 25,400,000   26,400,000                  
Loans Receivable | PI loan (3)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Long-term           2,600,000 3,100,000   2,600,000                  
Loans Receivable | NYPC loan (3)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Maximum lending commitment   $ 91,500,000                                
Long-term           $ 26,200,000 24,600,000   $ 26,200,000                  
Loans Receivable | MPTC loans (1)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Interest rate (as a percent)           12.00%     12.00%                  
Impairment charges           $ 11,100,000                        
Maximum lending commitment                                   $ 35,000,000
Number of annual payments | installment                                   3
Notes receivable           58,900,000 67,400,000   $ 58,900,000                  
Loans Receivable | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Modified former loans receivable $ 112,000,000                                  
Loans Receivable | Reclassification From Long-Term Notes Receivable | MPTC loans (1)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Deferral           25,100,000.0     25,100,000.0                  
Loans Receivable | Other Assets | MPTC loans (1)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Long-term           33,800,000 42,300,000   33,800,000                  
Loans Receivable | Prepaid expenses and other current assets [Member] | MPTC loans (1)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Short-term           25,100,000     25,100,000                  
Notes receivable             25,100,000                      
Revolving Loan | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Loans           3,100,000 0   3,100,000                  
Senior First Lien Loan | NYPC loan (3)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Maximum lending commitment                                 $ 73,000,000  
Senior Subordinated Loans | NYPC loan (3)                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Interest rate (as a percent)   13.50%                                
Maximum lending commitment   $ 18,500,000                                
Term (in years)   6 years 6 months                                
Term Loan | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Modified former loans receivable           44,000,000 $ 0   44,000,000                  
Cost basis of term loan receivable           $ 53,500,000     $ 53,500,000                  
Term Loan | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Credit facility term (in years) 3 years                                  
Term Loan | Varian Medical Systems, Inc. | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Modified former loans receivable $ 53,500,000                                  
Number of Tranches | tranche 4                                  
Paid-in-kind interest receivable (percent)           7.50%     7.50%                  
Term Loan | Varian Medical Systems, Inc. | C P T C | Tranche A loan                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Modified former loans receivable $ 2,000,000                                  
Interest receivable, default rate (percent)                 9.50%                  
Term Loan | Varian Medical Systems, Inc. | C P T C | Tranche B loan                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Modified former loans receivable 7,200,000                                  
Paid-in-kind interest receivable (percent)           10.00%     10.00%                  
Interest receivable, default rate (percent)                 12.00%                  
Term Loan | Varian Medical Systems, Inc. | C P T C | Tranche C Loans                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Modified former loans receivable 15,600,000                                  
Interest receivable, default rate (percent)                 9.50%                  
Term Loan | Varian Medical Systems, Inc. | C P T C | Tranche D Loans                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Modified former loans receivable $ 28,700,000                                  
Interest receivable, default rate (percent)                 9.50%                  
Available-for-sale Securities | Georgia Proton Therapy Center                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Interest rate (as a percent)       8.00%                   8.00%        
Maximum lending commitment       $ 16,100,000                            
Payments to acquire available-for-sale securities       $ 4,300,000                            
Available-for-sale Securities | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Maximum lending commitment                     $ 185,000,000              
Available-for-sale Securities | Varian Medical Systems, Inc. | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Maximum lending commitment                     $ 84,700,000              
Forecast | Available-for-sale Securities | Georgia Proton Therapy Center                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Available-for-sale Securities, Debt Securities                       $ 6,600,000            
Revolving Loan | Loans Receivable | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Maximum lending commitment                 $ 15,000,000                  
Credit facility term (in years)                 1 year                  
Revolving Loan | Loans Receivable | Varian Medical Systems, Inc. | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Maximum lending commitment                 $ 7,200,000                  
Selling, general and administrative expenses | Varian Medical Systems, Inc. | C P T C                                    
Long term notes receivable and available for sale securities [Line Items]                                    
Income (Loss) on equity investment in affiliate           $ (900,000)                        
XML 102 R90.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION - Additional Information (Detail)
 6 Months Ended
Mar. 30, 2018
segment
Segment Reporting [Abstract]  
Number of segments 2
XML 103 R91.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Segment Reporting Information [Line Items]        
Revenues $ 729.9 $ 663.2 $ 1,408.4 $ 1,264.7
Operating Earnings (Loss) 94.3 90.1 215.7 107.5
Oncology Systems        
Segment Reporting Information [Line Items]        
Revenues 698.0 631.9 1,347.4 1,203.1
Varian Particle Therapy        
Segment Reporting Information [Line Items]        
Revenues 31.9 31.3 61.0 61.6
Unallocated corporate        
Segment Reporting Information [Line Items]        
Operating Earnings (Loss) (31.3) (13.0) (32.9) (61.4)
Operating Segments        
Segment Reporting Information [Line Items]        
Operating Earnings (Loss) 125.6 103.1 248.6 168.9
Operating Segments | Oncology Systems        
Segment Reporting Information [Line Items]        
Revenues 698.0 631.9 1,347.4 1,203.1
Operating Earnings (Loss) 143.1 122.9 281.3 239.0
Operating Segments | Varian Particle Therapy        
Segment Reporting Information [Line Items]        
Revenues 31.9 31.3 61.0 61.6
Operating Earnings (Loss) $ (17.5) $ (19.8) $ (32.7) $ (70.1)
XML 104 R92.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 30, 2018
Mar. 31, 2017
Mar. 30, 2018
Mar. 31, 2017
Disaggregation of Revenue [Line Items]        
Revenues $ 729.9 $ 663.2 $ 1,408.4 $ 1,264.7
Products transferred at a point in time        
Disaggregation of Revenue [Line Items]        
Revenues 363.7 334.8 702.0 617.2
Products and Services transferred over time        
Disaggregation of Revenue [Line Items]        
Revenues 366.2 328.4 706.4 647.5
Americas        
Disaggregation of Revenue [Line Items]        
Revenues 340.2 341.6 696.9 639.8
EMEA        
Disaggregation of Revenue [Line Items]        
Revenues 253.8 185.3 446.8 369.3
APAC        
Disaggregation of Revenue [Line Items]        
Revenues 135.9 136.3 264.7 255.6
North America        
Disaggregation of Revenue [Line Items]        
Revenues 318.6 319.3 664.2 601.7
International        
Disaggregation of Revenue [Line Items]        
Revenues 411.3 343.9 744.2 663.0
Hardware        
Disaggregation of Revenue [Line Items]        
Revenues 341.7 314.6 662.1 580.0
Software        
Disaggregation of Revenue [Line Items]        
Revenues 126.7 118.4 241.8 230.6
Service        
Disaggregation of Revenue [Line Items]        
Revenues 261.5 230.2 504.5 454.1
Oncology Systems        
Disaggregation of Revenue [Line Items]        
Revenues 698.0 631.9 1,347.4 1,203.1
Oncology Systems | Products transferred at a point in time        
Disaggregation of Revenue [Line Items]        
Revenues 363.7 334.8 702.0 617.2
Oncology Systems | Products and Services transferred over time        
Disaggregation of Revenue [Line Items]        
Revenues 334.3 297.1 645.4 585.9
Oncology Systems | Americas        
Disaggregation of Revenue [Line Items]        
Revenues 321.2 332.0 658.6 622.8
Oncology Systems | EMEA        
Disaggregation of Revenue [Line Items]        
Revenues 241.2 167.5 424.7 336.5
Oncology Systems | APAC        
Disaggregation of Revenue [Line Items]        
Revenues 135.6 132.4 264.1 243.8
Oncology Systems | North America        
Disaggregation of Revenue [Line Items]        
Revenues 299.6 309.7 625.9 584.7
Oncology Systems | International        
Disaggregation of Revenue [Line Items]        
Revenues 398.4 322.2 721.5 618.4
Oncology Systems | Hardware        
Disaggregation of Revenue [Line Items]        
Revenues 311.6 284.5 604.7 523.1
Oncology Systems | Software        
Disaggregation of Revenue [Line Items]        
Revenues 126.7 118.4 241.8 230.6
Oncology Systems | Service        
Disaggregation of Revenue [Line Items]        
Revenues 259.7 229.0 500.9 449.4
Varian Particle Therapy        
Disaggregation of Revenue [Line Items]        
Revenues 31.9 31.3 61.0 61.6
Varian Particle Therapy | Products transferred at a point in time        
Disaggregation of Revenue [Line Items]        
Revenues 0.0 0.0 0.0 0.0
Varian Particle Therapy | Products and Services transferred over time        
Disaggregation of Revenue [Line Items]        
Revenues 31.9 31.3 61.0 61.6
Varian Particle Therapy | Americas        
Disaggregation of Revenue [Line Items]        
Revenues 19.0 9.6 38.3 17.0
Varian Particle Therapy | EMEA        
Disaggregation of Revenue [Line Items]        
Revenues 12.6 17.8 22.1 32.8
Varian Particle Therapy | APAC        
Disaggregation of Revenue [Line Items]        
Revenues 0.3 3.9 0.6 11.8
Varian Particle Therapy | North America        
Disaggregation of Revenue [Line Items]        
Revenues 19.0 9.6 38.3 17.0
Varian Particle Therapy | International        
Disaggregation of Revenue [Line Items]        
Revenues 12.9 21.7 22.7 44.6
Varian Particle Therapy | Hardware        
Disaggregation of Revenue [Line Items]        
Revenues 30.1 30.1 57.4 56.9
Varian Particle Therapy | Software        
Disaggregation of Revenue [Line Items]        
Revenues 0.0 0.0 0.0 0.0
Varian Particle Therapy | Service        
Disaggregation of Revenue [Line Items]        
Revenues $ 1.8 $ 1.2 $ 3.6 $ 4.7
XML 105 R93.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUBSEQUENT EVENTS (Details)
$ / shares in Units, $ in Billions
 6 Months Ended
Apr. 03, 2018
USD ($)
Mar. 30, 2018
USD ($)
Jan. 30, 2018
AUD ($)
$ / shares
Mar. 30, 2018
USD ($)
May 04, 2018
$ / shares
2018 Revolving Credit Facility          
Subsequent Event [Line Items]          
Amount borrowed on line of credit   $ 255,000,000      
2018 Revolving Credit Facility | Subsequent Event          
Subsequent Event [Line Items]          
Credit facility term (in years) 5 years        
Loan facility, maximum borrowing capacity $ 1,800,000,000.0        
2017 Revolving Credit Facility          
Subsequent Event [Line Items]          
Loan facility, maximum borrowing capacity   600,000,000   $ 600,000,000  
Repayment of line of credit   255,000,000      
Revolving Credit Facility | 2018 Revolving Credit Facility | Subsequent Event          
Subsequent Event [Line Items]          
Additional maximum commitment amount 100,000,000.0        
Revolving Credit Facility | 2017 Revolving Credit Facility          
Subsequent Event [Line Items]          
Credit facility term (in years)       5 years  
Letter of Credit | Revolving Credit Facility | 2018 Revolving Credit Facility | Subsequent Event          
Subsequent Event [Line Items]          
Loan facility, maximum borrowing capacity 50,000,000.0        
Swing Line Loans | Revolving Credit Facility | 2018 Revolving Credit Facility | Subsequent Event          
Subsequent Event [Line Items]          
Loan facility, maximum borrowing capacity $ 25,000,000        
Sirtex          
Subsequent Event [Line Items]          
Acquisition, share price (in AUD per share) | $ / shares     $ 28    
Acquisition price   $ 1,200,000,000 $ 1.6    
Sirtex | Subsequent Event          
Subsequent Event [Line Items]          
Competing bid for Sirtex made by CDH Investments (in AUD per share) | $ / shares         $ 33.60
XML 106 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; EXCEL 107 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 108 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 110 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 495 416 1 true 142 0 false 14 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.varian.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) Sheet http://www.varian.com/role/CondensedConsolidatedStatementsOfEarningsLoss CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) Statements 2 false false R3.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Sheet http://www.varian.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsLoss CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Statements 3 false false R4.htm 1003501 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) (Parenthetical) Sheet http://www.varian.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsLossParenthetical CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) (Parenthetical) Statements 4 false false R5.htm 1004000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.varian.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 5 false false R6.htm 1004501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.varian.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 6 false false R7.htm 1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.varian.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 2101100 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.varian.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 2102100 - Disclosure - DISCONTINUED OPERATIONS Sheet http://www.varian.com/role/DiscontinuedOperations DISCONTINUED OPERATIONS Notes 9 false false R10.htm 2103100 - Disclosure - BUSINESS COMBINATIONS Sheet http://www.varian.com/role/BusinessCombinations BUSINESS COMBINATIONS Notes 10 false false R11.htm 2104100 - Disclosure - BALANCE SHEET COMPONENTS Sheet http://www.varian.com/role/BalanceSheetComponents BALANCE SHEET COMPONENTS Notes 11 false false R12.htm 2105100 - Disclosure - FAIR VALUE Sheet http://www.varian.com/role/FairValue FAIR VALUE Notes 12 false false R13.htm 2106100 - Disclosure - RECEIVABLES Sheet http://www.varian.com/role/Receivables RECEIVABLES Notes 13 false false R14.htm 2107100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://www.varian.com/role/GoodwillAndIntangibleAssets GOODWILL AND INTANGIBLE ASSETS Notes 14 false false R15.htm 2108100 - Disclosure - BORROWINGS Sheet http://www.varian.com/role/Borrowings BORROWINGS Notes 15 false false R16.htm 2109100 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Sheet http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivities DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Notes 16 false false R17.htm 2110100 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.varian.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 17 false false R18.htm 2111100 - Disclosure - RETIREMENT PLANS Sheet http://www.varian.com/role/RetirementPlans RETIREMENT PLANS Notes 18 false false R19.htm 2112100 - Disclosure - INCOME TAXES Sheet http://www.varian.com/role/IncomeTaxes INCOME TAXES Notes 19 false false R20.htm 2113100 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS Sheet http://www.varian.com/role/StockholdersEquityAndNoncontrollingInterests STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS Notes 20 false false R21.htm 2114100 - Disclosure - EMPLOYEE STOCK PLANS Sheet http://www.varian.com/role/EmployeeStockPlans EMPLOYEE STOCK PLANS Notes 21 false false R22.htm 2116100 - Disclosure - EARNINGS PER SHARE Sheet http://www.varian.com/role/EarningsPerShare EARNINGS PER SHARE Notes 22 false false R23.htm 2117100 - Disclosure - VPT LOANS AND INVESTMENT Sheet http://www.varian.com/role/VptLoansAndInvestment VPT LOANS AND INVESTMENT Notes 23 false false R24.htm 2119100 - Disclosure - SEGMENT INFORMATION Sheet http://www.varian.com/role/SegmentInformation SEGMENT INFORMATION Notes 24 false false R25.htm 2121100 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.varian.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 25 false false R26.htm 2201201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.varian.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 26 false false R27.htm 2301302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.varian.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.varian.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 2302301 - Disclosure - DISCONTINUED OPERATIONS (Tables) Sheet http://www.varian.com/role/DiscontinuedOperationsTables DISCONTINUED OPERATIONS (Tables) Tables http://www.varian.com/role/DiscontinuedOperations 28 false false R29.htm 2304301 - Disclosure - BALANCE SHEET COMPONENTS (Tables) Sheet http://www.varian.com/role/BalanceSheetComponentsTables BALANCE SHEET COMPONENTS (Tables) Tables http://www.varian.com/role/BalanceSheetComponents 29 false false R30.htm 2305301 - Disclosure - FAIR VALUE (Tables) Sheet http://www.varian.com/role/FairValueTables FAIR VALUE (Tables) Tables http://www.varian.com/role/FairValue 30 false false R31.htm 2306301 - Disclosure - RECEIVABLES (Tables) Sheet http://www.varian.com/role/ReceivablesTables RECEIVABLES (Tables) Tables http://www.varian.com/role/Receivables 31 false false R32.htm 2307301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://www.varian.com/role/GoodwillAndIntangibleAssetsTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://www.varian.com/role/GoodwillAndIntangibleAssets 32 false false R33.htm 2308301 - Disclosure - BORROWINGS (Tables) Sheet http://www.varian.com/role/BorrowingsTables BORROWINGS (Tables) Tables http://www.varian.com/role/Borrowings 33 false false R34.htm 2309301 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Sheet http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivitiesTables DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Tables http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivities 34 false false R35.htm 2310301 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://www.varian.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://www.varian.com/role/CommitmentsAndContingencies 35 false false R36.htm 2311301 - Disclosure - RETIREMENT PLANS (Tables) Sheet http://www.varian.com/role/RetirementPlansTables RETIREMENT PLANS (Tables) Tables http://www.varian.com/role/RetirementPlans 36 false false R37.htm 2313301 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS (Tables) Sheet http://www.varian.com/role/StockholdersEquityAndNoncontrollingInterestsTables STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS (Tables) Tables http://www.varian.com/role/StockholdersEquityAndNoncontrollingInterests 37 false false R38.htm 2314301 - Disclosure - EMPLOYEE STOCK PLANS (Tables) Sheet http://www.varian.com/role/EmployeeStockPlansTables EMPLOYEE STOCK PLANS (Tables) Tables http://www.varian.com/role/EmployeeStockPlans 38 false false R39.htm 2316301 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.varian.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://www.varian.com/role/EarningsPerShare 39 false false R40.htm 2317301 - Disclosure - VPT LOANS AND INVESTMENT (Tables) Sheet http://www.varian.com/role/VptLoansAndInvestmentTables VPT LOANS AND INVESTMENT (Tables) Tables http://www.varian.com/role/VptLoansAndInvestment 40 false false R41.htm 2319301 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.varian.com/role/SegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://www.varian.com/role/SegmentInformation 41 false false R42.htm 2401403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Sheet http://www.varian.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) Details 42 false false R43.htm 2401404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Remaining Performance Obligations (Details) Sheet http://www.varian.com/role/SummaryOfSignificantAccountingPoliciesRemainingPerformanceObligationsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Remaining Performance Obligations (Details) Details 43 false false R44.htm 2401405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details) Sheet http://www.varian.com/role/SummaryOfSignificantAccountingPoliciesAdjustmentsFromAmountsPreviouslyReportedDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details) Details 44 false false R45.htm 2402402 - Disclosure - DISCONTINUED OPERATIONS (Details) Sheet http://www.varian.com/role/DiscontinuedOperationsDetails DISCONTINUED OPERATIONS (Details) Details http://www.varian.com/role/DiscontinuedOperationsTables 45 false false R46.htm 2402403 - Disclosure - DISCONTINUED OPERATIONS - Income Statement Disclosures (Details) Sheet http://www.varian.com/role/DiscontinuedOperationsIncomeStatementDisclosuresDetails DISCONTINUED OPERATIONS - Income Statement Disclosures (Details) Details 46 false false R47.htm 2402404 - Disclosure - DISCONTINUED OPERATIONS - Balance Sheet Disclosures (Details) Sheet http://www.varian.com/role/DiscontinuedOperationsBalanceSheetDisclosuresDetails DISCONTINUED OPERATIONS - Balance Sheet Disclosures (Details) Details 47 false false R48.htm 2402405 - Disclosure - DISCONTINUED OPERATIONS - Cash Flow Disclosures (Details) Sheet http://www.varian.com/role/DiscontinuedOperationsCashFlowDisclosuresDetails DISCONTINUED OPERATIONS - Cash Flow Disclosures (Details) Details 48 false false R49.htm 2403401 - Disclosure - BUSINESS COMBINATIONS (Details) Sheet http://www.varian.com/role/BusinessCombinationsDetails BUSINESS COMBINATIONS (Details) Details http://www.varian.com/role/BusinessCombinations 49 false false R50.htm 2404402 - Disclosure - BALANCE SHEET COMPONENTS - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details) Sheet http://www.varian.com/role/BalanceSheetComponentsUnbilledReceivablesAndDeferredRevenuesFromContractsWithCustomersDetails BALANCE SHEET COMPONENTS - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details) Details 50 false false R51.htm 2404403 - Disclosure - BALANCE SHEET COMPONENTS - Components of Inventories (Detail) Sheet http://www.varian.com/role/BalanceSheetComponentsComponentsOfInventoriesDetail BALANCE SHEET COMPONENTS - Components of Inventories (Detail) Details 51 false false R52.htm 2404404 - Disclosure - BALANCE SHEET COMPONENTS - Available-for-Sale Securities (Detail) Sheet http://www.varian.com/role/BalanceSheetComponentsAvailableForSaleSecuritiesDetail BALANCE SHEET COMPONENTS - Available-for-Sale Securities (Detail) Details 52 false false R53.htm 2404405 - Disclosure - BALANCE SHEET COMPONENTS - Components of Other Long-Term Liabilities (Detail) Sheet http://www.varian.com/role/BalanceSheetComponentsComponentsOfOtherLongTermLiabilitiesDetail BALANCE SHEET COMPONENTS - Components of Other Long-Term Liabilities (Detail) Details 53 false false R54.htm 2405402 - Disclosure - FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.varian.com/role/FairValueAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 54 false false R55.htm 2405403 - Disclosure - FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail) Sheet http://www.varian.com/role/FairValueReconciliationForAssetsAndLiabilitiesMeasuredAndRecordedAtFairValueOnRecurringBasisDetail FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail) Details 55 false false R56.htm 2405404 - Disclosure - FAIR VALUE - Additional Information (Detail) Sheet http://www.varian.com/role/FairValueAdditionalInformationDetail FAIR VALUE - Additional Information (Detail) Details 56 false false R57.htm 2406402 - Disclosure - RECEIVABLES (Details) Sheet http://www.varian.com/role/ReceivablesDetails RECEIVABLES (Details) Details http://www.varian.com/role/ReceivablesTables 57 false false R58.htm 2407402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail) Sheet http://www.varian.com/role/GoodwillAndIntangibleAssetsActivityOfGoodwillByReportableOperatingSegmentDetail GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail) Details 58 false false R59.htm 2407403 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail) Sheet http://www.varian.com/role/GoodwillAndIntangibleAssetsGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetail GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail) Details 59 false false R60.htm 2407404 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail) Sheet http://www.varian.com/role/GoodwillAndIntangibleAssetsAdditionalInformationDetail GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail) Details 60 false false R61.htm 2407405 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details) Sheet http://www.varian.com/role/GoodwillAndIntangibleAssetsFutureAmortizationExpenseDetails GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details) Details 61 false false R62.htm 2408402 - Disclosure - BORROWINGS - Schedule of Debt (Details) Sheet http://www.varian.com/role/BorrowingsScheduleOfDebtDetails BORROWINGS - Schedule of Debt (Details) Details 62 false false R63.htm 2408403 - Disclosure - BORROWINGS - Additional Information (Detail) Sheet http://www.varian.com/role/BorrowingsAdditionalInformationDetail BORROWINGS - Additional Information (Detail) Details 63 false false R64.htm 2409402 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Fair Value of Derivative Instruments Reported in Condensed Consolidated Balance Sheets (Detail) Sheet http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivitiesFairValueOfDerivativeInstrumentsReportedInCondensedConsolidatedBalanceSheetsDetail DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Fair Value of Derivative Instruments Reported in Condensed Consolidated Balance Sheets (Detail) Details 64 false false R65.htm 2409403 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Detail) Sheet http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Detail) Details 65 false false R66.htm 2409404 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail) Sheet http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectivePortionOfForeignCurrencyForwardContractsDesignatedAsCashFlowHedgesDetail DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail) Details 66 false false R67.htm 2409405 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail) Sheet http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivitiesOutstandingForeignCurrencyForwardContractsThatWereEnteredIntoToHedgeBalanceSheetExposuresDetail DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail) Details 67 false false R68.htm 2409406 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail) Sheet http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivitiesGainsLossesRelatedToForeignCurrencyForwardExchangeContractsThatAreNotDesignatedAsHedgingInstrumentsDetail DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail) Details http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivitiesTables 68 false false R69.htm 2409407 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Foreign Currency Contracts Related to the Acquisition of Sirtex Medical Limited (Details) Sheet http://www.varian.com/role/DerivativeInstrumentsAndHedgingActivitiesForeignCurrencyContractsRelatedToAcquisitionOfSirtexMedicalLimitedDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Foreign Currency Contracts Related to the Acquisition of Sirtex Medical Limited (Details) Details 69 false false R70.htm 2410402 - Disclosure - COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail) Sheet http://www.varian.com/role/CommitmentsAndContingenciesAccruedProductWarrantyDetail COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail) Details 70 false false R71.htm 2410403 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Sheet http://www.varian.com/role/CommitmentsAndContingenciesAdditionalInformationDetail COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Details 71 false false R72.htm 2410404 - Disclosure - COMMITMENTS AND CONTINGENCIES - Restructuring (Details) Sheet http://www.varian.com/role/CommitmentsAndContingenciesRestructuringDetails COMMITMENTS AND CONTINGENCIES - Restructuring (Details) Details 72 false false R73.htm 2411402 - Disclosure - RETIREMENT PLANS - Additional Information (Detail) Sheet http://www.varian.com/role/RetirementPlansAdditionalInformationDetail RETIREMENT PLANS - Additional Information (Detail) Details 73 false false R74.htm 2411403 - Disclosure - RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail) Sheet http://www.varian.com/role/RetirementPlansScheduleOfNetPeriodicBenefitCostsDetail RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail) Details 74 false false R75.htm 2412401 - Disclosure - INCOME TAXES - Additional Information (Detail) Sheet http://www.varian.com/role/IncomeTaxesAdditionalInformationDetail INCOME TAXES - Additional Information (Detail) Details 75 false false R76.htm 2413402 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Additional Information (Detail) Sheet http://www.varian.com/role/StockholdersEquityAndNoncontrollingInterestsAdditionalInformationDetail STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Additional Information (Detail) Details 76 false false R77.htm 2413403 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Shares Repurchased During Period (Details) Sheet http://www.varian.com/role/StockholdersEquityAndNoncontrollingInterestsSharesRepurchasedDuringPeriodDetails STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Shares Repurchased During Period (Details) Details 77 false false R78.htm 2413404 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail) Sheet http://www.varian.com/role/StockholdersEquityAndNoncontrollingInterestsScheduleOfAccumulatedOtherComprehensiveEarningsLossAndRelatedTaxEffectsDetail STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail) Details 78 false false R79.htm 2413405 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail) Sheet http://www.varian.com/role/StockholdersEquityAndNoncontrollingInterestsScheduleOfAmountsReclassifiedOutOfOtherComprehensiveEarningsDetail STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail) Details 79 false false R80.htm 2413406 - Disclosure - STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Noncontrolling interests (Details) Sheet http://www.varian.com/role/StockholdersEquityAndNoncontrollingInterestsNoncontrollingInterestsDetails STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Noncontrolling interests (Details) Details 80 false false R81.htm 2414402 - Disclosure - EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail) Sheet http://www.varian.com/role/EmployeeStockPlansNetShareBasedCompensationExpenseDetail EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail) Details 81 false false R82.htm 2414403 - Disclosure - EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail) Sheet http://www.varian.com/role/EmployeeStockPlansFairValueWithWeightedAverageAssumptionsDetail EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail) Details 82 false false R83.htm 2414404 - Disclosure - EMPLOYEE STOCK PLANS - Summary of Share-Based Awards Available for Grant (Detail) Sheet http://www.varian.com/role/EmployeeStockPlansSummaryOfShareBasedAwardsAvailableForGrantDetail EMPLOYEE STOCK PLANS - Summary of Share-Based Awards Available for Grant (Detail) Details 83 false false R84.htm 2414405 - Disclosure - EMPLOYEE STOCK PLANS - Additional Information (Detail) Sheet http://www.varian.com/role/EmployeeStockPlansAdditionalInformationDetail EMPLOYEE STOCK PLANS - Additional Information (Detail) Details 84 false false R85.htm 2414406 - Disclosure - EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail) Sheet http://www.varian.com/role/EmployeeStockPlansActivityUnderEmployeeStockPlansDetail EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail) Details 85 false false R86.htm 2414407 - Disclosure - EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail) Sheet http://www.varian.com/role/EmployeeStockPlansActivityForRestrictedStockRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsDetail EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail) Details 86 false false R87.htm 2416402 - Disclosure - EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail) Sheet http://www.varian.com/role/EarningsPerShareComputationOfNetBasicAndDilutedEarningsPerShareDetail EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail) Details 87 false false R88.htm 2417402 - Disclosure - VPT LOANS AND INVESTMENT - Loans and Commitments (Details) Sheet http://www.varian.com/role/VptLoansAndInvestmentLoansAndCommitmentsDetails VPT LOANS AND INVESTMENT - Loans and Commitments (Details) Details 88 false false R89.htm 2417403 - Disclosure - VPT LOANS AND INVESTMENT - Additional Information (Detail) Sheet http://www.varian.com/role/VptLoansAndInvestmentAdditionalInformationDetail VPT LOANS AND INVESTMENT - Additional Information (Detail) Details 89 false false R90.htm 2419402 - Disclosure - SEGMENT INFORMATION - Additional Information (Detail) Sheet http://www.varian.com/role/SegmentInformationAdditionalInformationDetail SEGMENT INFORMATION - Additional Information (Detail) Details 90 false false R91.htm 2419403 - Disclosure - SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail) Sheet http://www.varian.com/role/SegmentInformationOperatingResultsInformationForEachReportableSegmentDetail SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail) Details 91 false false R92.htm 2419404 - Disclosure - SEGMENT INFORMATION - Disaggregation of Revenue (Details) Sheet http://www.varian.com/role/SegmentInformationDisaggregationOfRevenueDetails SEGMENT INFORMATION - Disaggregation of Revenue (Details) Details 92 false false R93.htm 2421401 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.varian.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://www.varian.com/role/SubsequentEvents 93 false false All Reports Book All Reports var-20180330.xml var-20180330.xsd var-20180330_cal.xml var-20180330_def.xml var-20180330_lab.xml var-20180330_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/currency/2017-01-31 true true ZIP 112 0001628280-18-006282-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-18-006282-xbrl.zip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

  •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�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

      'M(^3XRGY1)ON/>* M0.S"D %"$2GS@1)3PCZGK1*C 9@UC0U3RR%KT]>Z,1H]K% M8%J, []S(:@"3<[)Q_KJ>"<61D> ]WV!T6>K;^ST)X'YI\Z!SM=.C.06,.J$ MI9P'MXP8ZG.Y)="#I=,;CF@U.''D7F-[N/?%M]=9C+LN'#^WWLSO)YOTSHGD@($A BB ^S#*DZ0UKGLW#;:_1W1U=G.:=8%V#67P_S; MLP_S^]2O)O=AOL[>I>ML\3E]TL5]\/Z'[/RFP^&9K;-O)49KP0"WDG-.H/+2 M45>8DT0UR==WH0MN?8*.14M]S9K[H_P7T_TWXS-T/X#]*5N&OZG[;'ORS8F: M+2:.<^DEU,&.CIG88[X\E..#J"Z5%[R+N[Z7R.)^=5$[J=?FZ7"*G=+I>I./ MOB-3Z)E:"<'!9;(6"T!,L+,!,N&K.50.-[G%UNC2[272J'V\QS:MQ:")R/@S M3[G5:2XA,946BY?JE:?84:.+,P=E4;G;'EWST,&T89S.#-:CO=;%?A5T._7#%,_"07V!@CN:;88A)<4Z?R[8_X MK.2 #]@\)N?[1DU!IJ=7S\L_:W&VE<0H"Q&6+AB*6'.)XG-*.1:"@BM[T:(C MGAQ]XJ)M_/M;VI[T^^UB*!@_$A&F8,H@H)30_)6.47=MK*9UH M_<7BU!SGP3AT-J;R2(U$&2PE%40I%D!C1CA8C$-$<9, J1'RJ*&.SS&F%J8U M-PCVK\P_Z\')\+A351+'$3<2("N=H! ;P%3P V*?M0=<7=F[:XU5EW4"ZR#S M1YP[=S/I.EU]3D^=IGG@K"(",4@F (Q02QO.]#Z:HN9+#H,%6J'9@'X1P M^SZ72XUQIF:B.]GII[F7VBAZHU$3;)5A4$>!AEL%=%H/RR]Y#\00Y(SW$ M2B$#@; ^7A[.)0-(-[F"-,)EKA?2U(-V@-"M;WI=+E[KFRHQ#SI6#@L#G36, M:V!,(:$,*/82G/!MSH@/%\NAEE"^I'7+>TFUY-YR3ID,@X0581.,2][$^&F< M^>&RR-,"O,.>/>Q*8-]!!H:1#RI>+KNSYM>)8> M)(\5_;I36)ETI%6;2@#EQ BD8L([BI556A+BB.!*4*W -5]'Z8@^1P\A.M%( M7RM0R3V+2A0MU5)B#)/2:\41UE19*Z7@5C.%G1#DZAZ7ZYN47>B@E\4MK%7+ M=>SH+'9KYL8$ M\^IK6,O^,5EL3_G(I>HGV!JF@/:&(H.)!@PPFLMN$+_&FW$MD>%Y7OX.X.XQ M!CJ&P#Z)-/PMW>R!.1WK?+1: D"\XBR@X8* 8+A9Y0H;&SM??\K6D\4N2=>KY72QG<6 ]'CM(^X];-/9FT_IZN$: MYODEKW:C"1#"0 PIXHP):H'1O$!)&-XDN'"$;SRVO ;V!?L@#F%91S!AC.K@ M'6ON1'R&U6#%12X+0[C)XUK5[XEE\3;5AOU'>> >A17C[(E*5MV*%7AC*^1\V;#I#MBU-VKY!@D&7WZ8?)ET*"$TPZ7BGA MS@A/B?-*60X%-%3F)IN1C#29A$9K*3?F3VMX]L6:)X[D;]ER>M84/E@^44(2 MA3BEF$.H<3#HO2MD(Z3)MM%84R>T3)PV<.W7;3KK+R702 HLLF&2A!!HK@%4 M>>\UX4WBD*OG*QC"46KII*PBD+TE\'M,,1A,\/>;;/K/NVP1U+..YOCF:XD3 MUK)-)"HXE8Y@##%DF"#M)2T&@E+EHNHNU&7J]-R^(P4,0,'RQ_K'*R7&*:PE M F&>Y1@JBJW&N90,-YJQQGX.VSX3CE.M&>Q]G\>^G7R-YWWE3V*_K9#$_2L3 M1(PIH87S2*E'P""53?8++XA4M75^Y""V$UZ$_S+51'@N_OLM7F M0[JZU]EJE?TY7]Z> [O.6C_H8M)\((*J#B!+* O HC#19X\6;OX(QP%[,#$O:K@.$=\N?]+;\EOG!2HG7%#)@&+5. M@3 NI""BF,TA:6)O79!%W\U^0VNP#S GE9N,$J,<111J@2,DV&E#\L-M0Q1H MXA!6CQ,8;!;J?+NJ(L[].81'[W">] ./UDJ,@0[(^*"9@\X3AVT1+&$TX$UR M#EV0^=X-G]K#O3=WL,Z)S@GDD$"80QM/P8(-&/.!D6);1:!&3V"/]:6'WMC5 M&NP]7CYX4->NY^=NT1THG3!O":!&*\\#,HAS38HH',EEDV<+Q[ZMWH:V7]XP M:(APG\M>MBQ%F^=%$X&=#$Z*Q080;XT$EN?#RP)'FL3$C=W>[H S#>'M[1!F M-ML=ED\6;R?SV:NEF7R:!UOUU!',X1H)]M *8C""TCIHE)0B#W2WB)!K?"FU M0_JT@W)_N=$VD_DRG;G):AEW8M5TNKW?[K*8V/1F/IV?LHK.5TXW#::W,9NGG,,1\\G2O>)N^ 4XT![HLVO\Z7.WA?+<- 3M>G5L;G M11-JJ6064<:<=8*"($HQ$!R2@SUR=C$L:8CH<%-+<9[X-EOM-+?9K.8?MYM= MWL(L;M_'T(IL$;IR6X)9[7P@41(&&Y0;8)RUSC!''\T$C6R3D ;19 J[&#X. MHH>QQ, WB'U/'"(4 :X9(YY(8!AAHC ).&FR&S_VQ;//TYTVP'^DVX"I*-_N MH+U+-_/IX^[&5>:E5%X)P9T5W'BJ,)6:6* !5P0[JDRI"_0=N6^+1?9G5(G/ M5C;;?MS<;!5" *NTDZ"+)94.D,U@A0@(1T "F,!//>8L";;FN/?"F^3 M+\^=N ZU,,Q!2Y@CWJQVF,UV6[9OT]7[NP!TZ;.78PTD2-GHV3E=,* _K, ((18?& M*AU$A9Q##QEWP4KM-4[]>LG6$/8A2?9JO=Y6)MA#I0 >BA<]-(044HQ]&$9$ M2"Z-<(!"W81^U]TRQ^K@/$-%0PSXK43M1Q@)I")24$6H"GL9"KA44 MF(-@F38)%!U[?HY.^=8^]@-PKH)9=J)6/$\UEF-BP\BBA& 9AA465 @41YWL M-]O'=7*L(>:#<>NL-7:D1L*\J+Y0HQSERD#K "2,:"!/D>)#$PR#:4#O?G8_CGYWD8<_KK[^N88'%_TWAYJZ:;^>>'H[SSXZ)Z8PFPE"AO M(91"2N>4!Y8]H"*8-XTB,R]H9[L]PG6N@OX"R_]KNWZXTO4A>Y=.L["4[MZ% M>8SO^Y"U1]TN/IOLAGTZ#8X,^6ZQ(4KGDB!*F\0HCWUY'Q71&BBE MMP7_/@8L_GO7Q3?WKX3I=)G>G+R5=J9FX@%2!D@HB&7&$*D-*^35[JJSN8V* MENWJJ2]>_C*9+R-.;Y8^6Z7SVWU&L.E7FZ[FGP-&\1Y4?!5^A_)OV<:FZU J M[L"I]7^FL]M=]'=1X 2/6_Y2X@T",0\C8QG]V^?3$FL@^KS/Y"2P*2Z\"- Y&EIW<^CU9+!$3..,DHXQ0"; &3NZD MA [17#H$51-?:H27]T;%NE8TTFL>Q7C1*X#S -;>I#E!N:-U8GHV;"1CP>KQ M&F@*: $9-ZK1,\/EHP0.KM??V]37EH[ZXF'HXRJ=K%.;/OS["2K[;"0E]N7+ M-Y(0@S%BA#@CA9+&:>0*%*QH=+EY[%$'H^)I9RH;CK@O[R55HNS+ZD%R(I07 MRGE!&->$0"J*I0/C)B$RY7?@AYI6NV#(61(V5L)P]'NU_!Q0#5HY:3:>K)=X M!PW$ 3_#N512.0EA+BM$LLE^4_F=^.^*K"*1!, 8[&@4?G&X M&\_>J\K'PF-F^],IY%MI-X%(.Z69<1B *4"V!?K!-&@2.\M<8CZT!Q]BDHX/WL-'X[,WZX*EYVJH\A)LC8Z31IM1%X^-;O5Q!#BGD[69W9G:S57J*(4P0)+;F7)-@VR@"38Q/,ZR8'AB.,RAV(I5VIH^;Y MX;/+$V\^1<6]7:7W\^W]D:/!4U7"^*)04VL)\)@#K1S:;?D[*#QC1C>)?V@8 M8WNQ+&H9\\'LP0=,SEW2.E4MT=Y8BZ#E "# */+AYWQ(>"*:L*M\7.SW9.G5 M![_F?/1D>GPZ:^8GBT]S"\1MRL?5/:!T9+YJTF1B %&>!LO JS /$Z^Y>A0: MDT;!K>![IES/FNE[UGLFTBXPXP!\)2;"DBTEG 2Q.??,:D>D-93!PK)UD#29 M&^%?YR:]*69\Q\VM'#,G2@7IL0E#U3J!XC,4-#_7%Z#9^VCP0L,@NB!G9QH9 MF)?[#*3MA$&<:"RQC%&O* )&6X !TQ#I8H, HR;3Z-BC9OL,@VA/!0.L[._2 M3]O5]&ZR3@-2CXELRRWF1RHGW"IM%41!8HZAB4^E%+NFEJ$F\3<7NWRWPI+C MRW<[JAABDS#FX8X/CKVY>_/MR%HV/:1!L_CE>?CB/N]T4_9!\F7_Z8;^[B"YP! MR+C!7S6)9-TF$ZN9X"*828(X;3C4B-#"6)*TGY?$OJ/9N6,%U=V=>GK<]&F^ MS&YNCFTZO2R9"&DH14Q)YYP%@"A0Q!T+31I-BI<3.-$F:=H!NB873'Q\.CY' MO8O1V 6G+6?Q7S%L\O-D$5G\:GF:)97:2# 2@=A8!F]-!Z.;$.'R7*KA#[Z) MA3C*?&,],:A+)0QK&^8'C!7"&0Y7#E(CA8TFW@#)C2,".)Y+36RC' ^7$\#0 MGPG7 /N^&!=\I_U279IGQZHDP%HA'?6">,A4G&0>):1A\NXE\& D9RQ=D*PE MX(>8S+[I>HP&#S-T4.7)?+6EZB?&&^:L1E@;&E\_)LRAPLD'KDFT2Z,WPRZ> M;5W /W @UNYLYP!6U4.PCK64,(NP4DX1( .X*+YQ6PQ%V>PUX48IOZZ*CNTK M8GS'(JTC=9WJ;O@O'T9GG8B3K!S"K-))P1)"$5"K$P(IT(3ECNWDLEV&"9 M12[UB*Y#\/NBX>'.ODV#1F;/\U2L)S&/@"+%@*1(])M= MI-\9LA,:=@C^L#1488Y?K;Z&Z7SWXG>09;&-F]EVOIYFR\U\N4UG^SP5VWF^'A97$T7CRP>\/7F[#ZT?1?* MS#^G;K):!N'63Q\7'O(UYX>\UU$K3WNY_VVE!Y[+M)1(K15$R,:T_YQ:!@0B M"#G)O,"6E[M,V]G>3*4WGXEVS%@A%&;Q47+%A;![28@ M)^ JOV<\#E=?_6Y74T??PBZ&L1]+5B[K9T#DL"0X MH-8)#7+4H%%-WJ$8>W!47QSM74M#<]NF-_-E.ML_];:+ZGI\2:$STK?PU818 MAZV#UF(I/#0:<@ESG UOMM,X\M'0)TM+#I#^-3KTR(E@/WW0\U'<>&*@WIA7 M;V/Q\(=]?MVW69 SW.78UEY8> M>Y@8CCV&5$JH+"8 !T;I7'_ ZB;'\9Q_]$RJ4-XK'180Q# MM[3$+S580$Z[VPYIX:L) 3K,3PR0'K MV/=)1ND9]JW1H4?.[\O0^\7\W^GL\;'Q)RBHU7P=3T&VJ_#/!\$;+$'U/Y8P M@)CDU"ELJ984 T1],3^*1N_:7JZ_UB-92PZ@WC0\]+@I9]-^(WSG#M7!KR7! MEB!2,^:1%X)A33PI+ MA&^7,J>LF=7_QX)+&3'_*'<.@*:6!FD.D5-N)#4ZB MLY!!"CDADF$/53'1F$975*L_ C,6#V:G#6 M=C\MGDT##4=&_0\F6#!'D;9<4:\-%A;J_'B2.*GZ>9-A7);7@!Y*K\HXR(Z M\&T\F0I-T^6X0^W;Y:ADDK79_:7VKY2XD*EJ P <\ M+#">"*4*93$*^GWE[@G5+SO<9E@MC8#UW;&\%%[.ZF#641G<')H1EA9ID1L+H#K8R Q?48FF@N#1*(&\^]TA#AL CF_C#781 M:B@J5H1_U/'V;W>@WZ6;^72R^+;?WT7PO??* \\P8![!AP' F)JA(0< ^?P M<,'W P]?04. M[$Z4?9BP+' QCHEZ1(GU!9::\B8>X]AWKH<>)WTH;&CRUSBW[>WT/Z(I-5(! M1P*44 @APY4HT*1.-#'7KF##9)B5H:&2QN#8CN+N^ /F1;=*N*E':B2""DZ M( QJ "VUE"B+E=4.:6.A+V5,=2/CN_1SNMR6>@/F>=&$J$#IF!':>ADW8#CA M<"^5)](T"2L=NZO66-$O$HLVPK:O52J^ [S>]_67+)L=>2SP5/%$!4BHA=P# M2J%&2%J#'R0S0&K:Q+$8.VOJ:SEK'=@A*+/?"JC FBRA,%RL'PPAK&DRBCH"8' $!>MX+ULE AZQ=-( MVU9+&P#W2Y[=8OD^>P3I*&V*DHEPGAFDI$1&"^\ "2#E\@AN&[UY 638&\IX"W%VKAX11@[ ?;2( ?)-9LG7="D)JZ#K$5E MUZ#$8$&54UIQ9X" U&KNU#W MMG&7[H)P?TF7 8U%Z+F:W<^7\XA$/%@ZSZ]R#22"& D(E$Q 8@SSA,MB=L9, M7_,+Q^T3K1/,^V*<6J_3S:O[3Y/Y*@X/KN-S:&N3W7^<+Q_T-?W7=KZ>Q__Q0$1;S)NCC"@(?VR=49U(/9[57L]41R M)PU5.+B[5DD'+0XS[EXF!$BIP/0+O>+1/I>:PML[91ZC>,J0YK%TXDV\D0*U M@Q S*SDR.)=+.H>OF3:=N7>UX>V+-J^6G].'R*Z'KI:X_WBL2H*($XY*@@@G MA!+'V*.$0>8F6TN-WIV^0 *UA'%_+'KHWGF'[5G)A%GKC<5A<'B"D25<49O+ M$V_(->!,W=>D+YDU3<#MCRQ%_H^ B'EXE"C,E8^O$NGT)EOMPU$_3+ZD:_,4SXU(B2GH]4&K[O,4M,_: ML6BFWQ$0)-D/U/U-FK/L?5$CT99J%P1CGGCLH0&*Y$$TT@O3)"=>HX>H+W+R M; /B\4RB+>=VZ>:#"<7>2@U9],R8)AY(P(L!ZMQP3U=?$FD'ULHPG#_\H&&) M[!A5FDF(=\1+AU70CPO>OCT6P_UKA/!?1%V"!"J3WA;\HEWEG*+5%"8XJ9]A)H7)B] MO%&P#QQ[GLFV>=4$V;Y8DM^&?9NNWM\%E/1D/9^6"!<[62\AF!I*K#"* 6X0 MV#U'EB_I4C0Y4X#5#Q4NSGQJ$]SQ>*9!FIT@.Y$:N9S?M)1HK['A0$JIC%>( M,LWR&*?P"]AH_1OC\M<2.RJ[E$U0'Z.O6(^/%=I,)/2(!%?:(R<)"9H&+I_R M50S,ZS/^[%J8V1W^@RZY59?:)$9S"F TA89@S'!8:E@NF^7ZFN][=$.S-F > MBD)VOMANTED-N^U9S20,%@V19O$52N(9I:KP990QKI']W^@T_S(MMV;PCLIV MVXO2BO7VM*V$ Z$DA#T.[U,' "W'U!3A!3%O$,/;: "Z M4\[I E-BKOE5KZ[HU@[4?5'ICW1^>Q?%#B-\W.QZOGZSW:PW MDV4\T"UAY%5M*@'4,D6T]?=[RI2= Z&AF8G4\MAJ>B5.?GL982 M1K#6RGBF)''86LQQ83,STNAQJK'?*1V:H2WIY)&CG26A?4R2^VH9L-CN4L^J MY2P^_!D!FH8_S3?S=+@$M*5[&*WT1;;>KLJD16O0:F*4%Q9Y0:&)A^9,(6N) M4L'B)UQ9I_+-=L(IF$\X-XW&CDQ!(B8?!)K%0 *\U\A W M2@DU]H6R%Y)E@^EJ3-.3FLUV=V3^7 O/XUOY@HD4D0" MZ;E $@/E #:[Q[V"P8XD@0$\GKIBN-%):XN*VV( MN= O[ZXL+>0;+J>W^Y3[IPV%@Y72#PE8=:$:'=OG<:C&6ASZ03%@VVKC=MR M: 7,X:ABL_O)?%F)+ ]5$AM6UC A LZ$=4@ Q!^'E$'#;7]T0Y>F:C[+FEJH M]L6;O)_I3*WW77_TTLXN0B5J)\H%!XY1[KF#D@OC)49[N8VSMM<(\B'85%7] M+SS9MB'NCUHO_?YW\_4_SZQAIZJ%N=Q"YHV)#\B[@!\)LWDNJ;+/GWKO.)#C M8E:R%B'MGSPQUB[N!7T(WS^[IIVJEC!-8XHZQ@F4&%NBN2LDU5X/EAJYOVVW MZDH_RJ3&^/;%))^MTC"#NB_3N^@VY/T^N[:=K)=0 0RE@E*GG4. ,@19+BNS MJM$EO#%&+;:C^*P[B/N?F%[/E^DN3U*I^:@HG7@?A"&.$82HCZEY'9>Y7$C8 MP5+^7\H:5A?)_AGR+HW#(UALOTXVVWAP"TM1Y66UA#@AF>6<8$DYXPRH8G_" MD*K^S4UN M )0[2O^F2J*E5#08LPH!B2B'*AX0[R7T$#4Y#1FU9]@FX1I!.J;0FN=#X,W- MWM0TVZ#$Y?1K^/'/R6J6B[I^NLMB)NL[O\C^C*VFZ[\"+=+U_ M,#58\F>W+0^6CY?1H49*$A@F9@TP1D[GLA'H&B70O!CN5-7S\S?:6D!V%%L( M^NM^<=^]VA3OA=_-/]4XE3O?8&*,##AHQ!70(LS^# F8HV.P;L*[46\#-%OQ M>@&[Y\B4I[TM&YKRLDZ")!'.0R*LA\PA*:@QN8S>DR;)^4H*F2S'%UG@$H3'3_/\-L"JI<6 M4S+CK5$3 %(@**8&&H"C ZJ8HM- MDE[S5@T>:UE:\95B+:M!?#FQEB T3+!Q2A.A&-=0\$(N"AHE%VWT5,9%KFYU M83U/E\^35>2 !B#'0/"+_:[^/N7(Q\B.M;9S=YB.\"#LW42KHW2'FGID><^ MT%RA8J_>HT9!:2,TG!LI+NL&TU&CV_F:>SF"M73:?;^^TB>@1O MS*M7RTW611AEW4\FAD)AG5 P^"%<4&F\TQ#G2& V7"&7DT7NE"?K1-.\0UHX1#[(,/B+P+(W\O MJ0,2DBL[2VA'Z57VZ:KA.] ^W9M/4755=^F>UDJ""RAT,,0E(!SKL*@(Y7(Y M@0=7RZ,F*C^]0]< WH%HM+]44Y5'WU1+7'RK7AO!$8*8&N$AD(6DIM:-\ M#J@/*C5!^+*/#CQQP",0I*4(,Q7<=,!S62E630(O1OEZ>Q]L:@3QI05Z$60= MDA(KSY 7$C%H2"Z=H:A)O.G8-]]&:+2WHJ1+#""30" M=R?&&#$%?1C+N80" MZ"8/F(U]BZ.ISLM&DU6#N"\2_18W7O-XI;.+X8'2B8-4.6\A)RJ@)+4Q><*5 M,#]S<&6'7LW5F[4-:5]4.30UGUGTCE5)(/&,<^V%538F8*)4X%Q"W^RN8:/X MYN]SV6M)34,2\>S2=[Q2(IP7F@ *O5;A?U!;55B8'#1*;CWVQ:^YYDM0J1;, M?9'I[2K]-)G/]N$'\6SC(>_-+I''1JW7Z69]=ETLWTB"+1*"A@'*M'9<":5@ MX20A-MPCB?WQJRH=LIZP[HMQ:CI=;8.&YI./\\7N\.PLOXY522BE&%A@, * M,V84P*(8IAXV64='>/^U S:UA&S_1S2/P16O*\4N'JB7&(4MTTASX81RPC&/ MBAT[26@3[V_L,?HCM,;:U%7_O#P8\[.;E4O1\WCU)#[]IQ$60BLGB;!4"=W*QNH>JYP(X*Q22E+AK/20. %,85_PGG= LLUD<7T4JP[S MJ()GO\TH6:22W&562&RT0L1==J%G6H_3/I)*LA/G!2P ;I))71 A/+G6&2.$NY=P5>@.DK.]FI MK>4*Z22K(3HP:.J+,:A!H_L0H_;HFZUE[: Y M)%OB?Z[2\Y<8SM9-M&:$4\"YD](KCZWDAFTQ420(AVBEAE!?72"@Z9R#OL.+JVD]SV%)AU .\EW]730G-.H83*J+"4 M4Z]D(:G@LDF*K M(]EAW;6H1TDN^8!_A>WUS63J7%@$(-:(<.,#U: A,X6F1H(EU/SO* M?IC,WJ[2^_GV_HC??:I*HIPS#BL%/0!>!=>2>%4,E;#$7NOZ4I\&+4-Z+4$X M' 8$/452,8HM,,G):_E,0QZ9"0@A&F,7&<TN#.DBIK]Q*&1, MT641B76$(GT,*#O\AO'SM SK#W>3C5JE9]'Y*V/CL_@CC&/V3D$X9&%)13$K MWC[0U9@P,9;R;\86?4:<)M)B*!!V%CJ&.?*Y3$:SP2SRD>=&+$V%,Z%HU>"_ MM.0HW@KIO"%8".F--M9[DTLG)+BR9XUJZ[9<$I-J8%YB$A.&G52>,T(9$11# M#5 QJ*@;[I7U;NC25,UE\Y940_5R\I;$9PJ8%%1)I+ASFC-= *4H'BRK;U]L MJ:K>$GE+JD%ZR4?V'%OJF2&:*XTQ$X)*D4L:G( F=Q%'O0/5;&5J$=)+/K+7 MB'//B<868*2I0.1QBM;PVB+)VE%ZE2/[:OA>\I&])D09KA2C0$@AN,2>Y))Z MAGJ]$CWXD7UIM5]>&4"6(D#9:CY!I C(G,Y72PT>7ZL2?D:FMU M:P_>R[[XXSU'"I$ G/)44."Q4'M9K0R#\HJWA%JA0*5;0-7 [HM8[]-%://V MEW29KB8+M9RIV?U\.8^;7W&Y$MD23K#_X+"DN*-_1$'B% M;<#2 $.I0HSGF2Z,12]>J[^JV:\1O3H^(JZFEC$=$;_9;M:;R7(6?GGX9/B; M$^$_TE7JED'Q\3F_3?8AB^VE3S.IA>5B=PCVU\'P\]- Z2E&%!O%L .,*P:, MQS2LS=1(K]Q%'@P++RU1,E@#4 BI55@V;"Y3,$.:7&JZG.FH0RJ<.1BN!G]? MJ^O;K-0E[J?%$H61B0_:&^4(5T0CH5PN"9/PRD[U:NOQ>9;<^A#V38:SVPW? M%DP(U%0Y[JF% 'BI#2,PEX9R=67W;NLI\@@;:B'8VZ;!7;8Z_Q[3DU()B]G= M*(SAI<0Z![0(X.SE !1?V=105XG/G?K: /9%A-?9\O8L#QX+)<)ASIE'!ED# M("/2B&)4 -0H[F.$A[$MT: V?I<61$8DET1 %H0C&'+%@41[Z90D7E\7.]JR M'UH!\Q*#R&! 2%)&D84,(ZB"?(6$!,LK2Z?85,UE@\BJH7HY0624,,X=LY!K MP*AAP6?+W37E!1C,R^TYB*RT>DL$D56#])*#R(A$U DDL1=<(40 %R27E$HS M6-Z7 0X6ZBY3+>)[R1%EQ NK$:$8!*]0QD#.F*E_/U\#=\U'[NTPH$IX636P M+SJ\3 F%M!->(X6!XI0(5DSKVO/O*KRLM-HKA9=50K@O+N7G/&<6MZ?%$AH, M1BV, 80!![G 0!:2!%N@R11T::?D=1>S!GC62^$QW7_P@1GY3\]9D?\^48O% MOHOQ[.+8@G6J>")AW+!T5H=!)+VG4.-"*@#,8(E\>V!)/>UFK8/:#U5^MR>I M\;M-& 6020DY!*'C1 $BB_G4A7Y?(17:T>(+2E0&LQ<*Z'>O3U$@_#E17 #J MPB# PD!"+,:D$)E;KX]:+U7_3;4UH/?TZ@\X810S57G@2?WNE' MH]QC?B7I3KO1>G7\>M&Z42>G^_#GA'G"M 7060.T,MX@GQM%"EIVC6],=D.! MZF#V0@'[O__W*0J$/R>8.1W$5M03%+@+L40%<3D63=)"TFL?^-7QZT7K[O=W MI[0>_IQ #SFUA"$#,5- (%:<+BI-=9,#%?9=#?SJ8/9"@?_\W9^B0/AS C"" M ('J.7&Q@?D(7PD+F]" ?Y=4: ZF+U0X-5O)V>!\.<$2L(=PAH*Q8F 4%@M M\UYCC9J\!B6^*PI4![,7"OS?;__?4Q0(?P[+EX(:>@\9A(9A*(4H#@DU%TWL M?OE=4: ZF+U0X.WKWTY1(/PY"<8J !H'C\5BP5%P7L.4E<]=7C<*V /7;@)6 M![ 7M;__Y:3O%_Z<*&4!#OZ*M1 A1CP,KFO>:R54([6/*$RB&[57![ ?M;N3 M_E[XU_W_JI*D7_IP8!HU@ M!F #(&%4"V&+IHW^*H#V,\&WW^>=/+"GY/ 4^D\I9 ;J3ETP0X1 MAU?_A/?4KMX<^)$H(:8ZTBBC&#..12[WNMF2EW M=_&8VJ]^5Z\Z@!>4-@&*X)5:K16B44!!BWT*S0AH,T!9;O9J(_J]0_QM_-E020W**O\HD9K#/*84 M!;OAM?ZV?]]U)@'CK+(V<(%*I(#PCL8$+4HKBQ07Y6Y$=A2?FC\2HK\^30KQ MRRK;?@I2?0AJT^'+_SP5JUJRB00SZSA3.OC)#& (J1/D 04L:?C34*%%74\4 M'?+E>5!K-ZKH[:KQ]"Z=;1?IFQLS6=_Y1?;GR\PM13*M]9L;/U\&&>>3Q=MT M=9.M[J/ >''7^_O9+[>Y]W:S4ME*-UO1Q*#O'!0&:XYMU@83KPKM,&DNHZ MJR$'QJ@5VO_P^M;2"/(^22KTJ)Y;NW3U*,;YS& ]KR\#]B]ACB#GD61AMO).0V:T MS74'!6QR^#_6V+]Q#+G+47H?7F5 .%MNYLMM.GOS*5WM&AC0>3S8G0!P^,/_ MS]Z7=;F1X^C^H[G]Z9D-!#AF- (/ ,'3DK. MD6,4-.4@?2UQ;(TFCR;\;CJ^N5WM#EL7^" Q=31AZ:NC!9*(%(+@#@'#2H9 M& W&86JE,SC[WDAV7<6[7 OIK/MD=KUNEU4;H_H;] ^%>9R=!CQ=B;T:+Q>1Z4NMZD@,C M(R%(@J76\Y V&%!& =5,:4F(K>TV:UI-^LVU^?VW M:C1=K'SRK]]'TR^CF^K+S\ET=GU]L$U+\;LC5SP7BR+.!08*^>YT!(H&3Y$& MB3N]*JQ7;!Z+H9?H[)037:&W_?WF?8U$H@YG$0%3(!:"E1H#DEX)X87*+9:# M=D24:.L!'H8-W9X8+N=[L4WVKT6/QZLSE ^S994]F/>SI'(^5^-J\BLSX4-U MP%-O[CM)CS)G1:*H(!(0 2,P-@Q98Y/3Y&E1_N=KE*(34+K/?NJ8OP.4E7?3 M7XE3L_GON[3=AB3C^5NC=(A*CW! 7@/#PG BLL&;S J3#.$+:S-]87)0R,T! MHO[3O/HYFEPE9JPLT57:YZ)1"=CWA4A\4A#)". 28X! #//,<?7X[XR9 X9\LUB/2>HI$2%Y=YPF6Y!I2P0)4B*FN<6HVWY. M;R#OA(L#-'763LRGT>_LM#1JY&Q_=\P7;QD-R1AT#"P3AAJO$K^09(0)5&+> M%/6T>KW([YJGPY2#>?KS^\GHS\G-*J>P:5'8_OJ8&&:-P<9I:4$D F(?/& + M5J0-$I=T\BUJ[_4F#1VRM2N!>#31ALW]PC='"DH*B3 (*Q/+G*2*4>=14BJ4 M)8^I0 R.;W'V9@YUSM&A2T +T(^<<,Z(<4X( %:\-\=ZSL+9%V75;WED0[7D:$'4T\"TA;#C;D0@M* A$."2X,[O'B^->31$M# M<$H1IA+EP25W 8@7PEH1O$?ATBXA;@VA/271'L>] :0I%B?1:DDPQ2H9\X"1 M2?^U7GMA*5!'BF)V T3KX%!T=!+M,=P: #H;2*)EGG-K'3&<9\.;&>R$3W8( MM=8RIBX,H8TAX.@DVN/H_)9$FU,W/782.#+>20-4.>4)"@99[AVH4'1US7EA M\U@,-9Y$>QPGWI)HVW)3A1(>I;T.!9\V/0Y&4:LP0X(YR324''2_RK2G,GMB MN)SOK"'']\1(,TI:Q,Y^_*RFBT.AK^T#HB8B),_%@/<"B*7*L^3)*!& 6ZQI MR=5T@[SZ=I#(>=[7H@E6==<1,S%Y/#D$O\>/10HD;5Z>:&L#:"IE($&BM+T" M#\+P3N]#? -=,8,ZRP3Z,9LO)_^[FN+'ZW>)^=-OD[2-W&6#[$OZV3LP.LI5 MH.FCE"@@3FJ'/..::\(L-MTF<;[!L066=0703Z/?JYY"7V=Z_*_;R;SZ-)\E MFBQ_?TH4SK3UZ;<_?^P_GJW_D@A2$SN.>KUG3[D&2&N"=')-L&-$:ZL(\8J'A( 0WAJX M=. G8N/!&XN5"8%S9S!"?L,#!I?6Z+@MA/9T]G0<][K:K#\GBZ(Z<,JT>28B MZA0-FJ0%:)K^[?(2[M>@.-#+0N#@D#%KAB^=8NM@G/[14]%+1+!54H-" 4 K M1>QZ'<+9"VOZ4, MK]>B;5&BV5!Q<"P79\W1KS,LC/ZJAX7'SR79L))J'"P I\AP[1%?KX5[4[+G M#/#,H1$L%-"OL\C]>E?-/N#R=P[QSJ;963Q@B^P=%R4/1%I@@8$'L#(M%]9K ME8Z7A (&B)6AVR=-\JHK7#Z;ZL$,EZW/1T>XLX1BS106U@ 6C*[79BGK]#RI M?1PVQ.=9\Y3MS-+-<:%I=>5'\VD2IL5AHW?K@&B4EUXAA, ICI/"![FQ PEA M%Y9=6LCAY[9P$R3M[KSPS^5#(_Y#69XO'HZ"8:HA_6,1$4SAU#8EH)1U(&1<$2X33C?$,L3.2EM9,N8/%>M)Q, MT<.8^36:9R!(1"E:P2#](OXC+?>OK]7\1QB-<^70[YU[U9ZGHQ=8I=G*$)33 MP+7R06R<"J(O+11=S+%9TR3M2F/87#Q?S1.=EK_SP@]L5=L>CU(X))5!00M& MA-'"#C?*8/#"]FZ'R"5[W+L?HWS=U>'M[2M.16J^-[>+WZG7B03.^EK/#0.NIYJJ>],28?3K-L? >*)17@F]$Y($2KWS7B.,G.5. MKLDF/"TI4'Z5S?\*(ZV-$] *K-RLF5-Z8?M78P@X MNH3^.#J_E=#GW<)*#@H92/^GD%24<(PWFXX(KZ>]P[$8:KR$_CA.7([C_7Y@ M)?0:"QYX[BFNG<!&H"2S1>3UTA=F%!T4&"8M86MSHK"YW/ MQE5UM0B)WE^^S^:KN>:3U3V*>>>8"#I?-ZJM"\AHBAC6>)T;FU2![K1X_G4C MLFE>G:CXGGS^SO+9H>RV/!D9)8Q92;362 2-2,XY6T^1D?"63]6E@BOGT(D@ MLFDE\\F?MW?U]KGY;*)'_D].5?R5;.KI,JU\/[R.>D>4F'DA-9;,Z$" "$HW MNEJ[HFM)7V5N1!GPVN1= WKMSVY=?0^4=?DE,[B!6RG(P6A!@ M7(!>IR(9*VD)*%_E,6%SVK!QYG57[S,;__/[[":!8'&7]YUO(;V7I)5!.QH? MZMU5\Q7129>,7@C4^<"IB4GWYW=6/ MB:^SZVRR?KQ=+I:C:2;(#HUZQ!NB *.TIXK:P"UV%CA=!R<,(T75K*\RY%.F M3MOC7&<=P%;=G_9?^[UY)I+UEQU]4\ZK15\J; MWMH>/2/J(]J]WH9(VE%DM3:)Y1ZXQ+D:A$BD);%&*EFK N)VJ(=!SW!I"K49A)I"0VG"E'&4)< M&QFD#NOU!@X7AM;!H>C(3*+CN#4 =#:0280#DSHI#1NL3JK#)MJZ]9J3$KFP MMCN-(>#H3*+CZ/R6293S5[A$V"@1$/$L6!XH96;##4$NK#58@QAJ/)/H.$Z\ M91*UY7YZ<$Q0&R#YGU2 ,4QO^$"">SL"[]2>&"[G>[%-]J_E<_6K2K^H:ZS4 M>EF$I(@$-81BPR@PKCSQ:ZIPHRZLZ=(@\7;ZQ>2G,7& T+:SQ7+Q\?J/V>QJ M\67VP,$RC#]_:V1,2IJ,4N A"!9X^H]>T\EX]W83TY#!7LC- :(^/;)8?)K/ MKB?+]^FG9D#_[*412&#"!B,4I3)HB0(2&]W 2?[6R+0B!@?I>([:"D'RE.49; 52,Q!N]RI5:;K^^KH:+_-U7B;C]?X-YYC7 M1.$LMXYJ;1S-=^DAIMF:$EX6)>8?G[0W6XYN7CWF6V3?$(&LEW>E"#DJ_77V M83;-SR:6IDE]>Y<[M%6+??E,37\JYM,E+Z54Q :1ME@9T$8U*%%D4KWR/,(N M!*(%%@]?:#Y7/_/]J@PMHE M,8-BU;6HQO_Q;?;K_UQ5 MDZRU6/XAKY(]4E;I5YO)?DW?V;*>YX]$+80#*X0B*$#01'FGG-">>6NPI+V) M]<_Y9#9/M%XE2#0KX\WS=-8(<8_S\.H"0J?97.49A9O1MO+:%\]$;O+=WL Y MQQP$I88ISZTS0F&-J2JY%JTHV>5<(5%"W78PL5[J71C:IUTM;20'M,639R-B M@>;KDY%)&XG01&,4DG7-A S<.5E2]%^4''*N&&F"RNUB)2138G3SW]5H'M)O MMCG(>YZ.1%AEO>18))?-.:,1DT88&5C2A\[W=BG1N>.EC,Y=(.8.T?4Q\^CY MZ)VDV$J*-.(0D%%>4)PTI_5I6]6NM[R"RT#-Z91N!S=?YZ/L\7SY_>//V]S]6V2 MEW5W&^ .:&Q[-#I- 6&"&+,$ B9*!61M,L&5MA2*[)2B9C#GBI &B-PF4&Q: M\WQT\VYZ5?WU_ZIM1U [GXW)SM).DYP7JX SISD0JY&00&F@16DW12>NYPV5 M,BJW@Q5[.Y\_L9WV>T"['H]6$8,(=3[9Y\"Q53*I3$L1$LH( :0 ,<C(YC)(SF4M #ALI3! ^^?L:"T]"R3Y4 M=D!XKE@I)W*K^]#LQX_9=-6%[\OW1*3%_A9W]09&)S5"P4NO P:*B+:6<>9M MD@HN,2XQ=_&K#-8V3O,.#DO\:#Y-$ULD[VTUV]Z.B9]/I,9Y\*XAR?W$B&-C M'2 "RE =1 "-*6OV[LP]K>')H?O=F?RGG*:6 MA*_)E.&F/A@UQ\%[Y A13!O&%4B]IK#Q116, \S3* ?:WO3%GKC23Z[OML7N M6]R1:;ZGO3X&0SP3W((PBC,0!&.VIAQ+UEA?I]$7@^?&>3 <]!9A,P8A'/*( M$HD=L5KGO-'[5*WA;X,7R$]U%9IFP *\!++B77028UL=$2S!3Y4@DHYVF(YP?J$J(V14P_JN:?/N^K*[T MKP3S;]6'V]S%]^/UBY.%5D\4(A^-$BV$5BQ15@AO-AH_T$M,7F@- M96U2OE<4WH>77RQ$7_W/[6*93]B.Q>/A-T8J7-+9 ;!U#CFMO=5X31^J64DG M\:$F272+S,9YT+.FW+6>XW7EKC?%H(GP07/BL4CFA&52NC4]E))%%ZP?GXWQ M:!^^&% V1ORNP/B<+'='?=#T9%XE6U!-@3" 1!Z,VTH>AQ+DH.J+KP8YK!F9-D+DO"-U;G"<8;<]& MIO4Z;QA'/ALM25@,=VQCHEI7Y!^<@<9JW&PKH^^@#+?';DVIZ?;X71%Q+IQ+ MSA%)]@/E5CA!US1!O*C\Z R,MY,1R2+$J&Q<90I:0DT^_< MC+FFX-8,J;N"DDZB<)5G./E5?:G&MXGHDVKA_\KYMM75G4)_E#C_PFSY,;O= M>X31R/NC% Q1@JFR0*QB0:SN++Q/'W)09!P.M?=-:Y9B'RSIH>"CYXZ>359P M""6Y"SQX9)#C'!EF)3&""HJ(D:06_-M9Y4,OQ>V^\::^9L6-X_IL'O7&J"4$ M$QPGS.N@TXXMO;FG$56!O=*$3?OR\F?VNJE6AZ:>;T;3? M#K]W;4$_7F?]6DT7J^5\KFY&B9*K9LDK$O\Y6E17GT:_\RERW8:_I[\X2AV MLX2'8"DPAE1BG.02<^,E4%TKG-6DI5=%^M-Q=?]0KT6L0U5YG'M%M)(61.*_D\[1=7:K=X;V M6!#[ .''R]+S^6CZ[:[K].\7*-?_'LVO_+]N5ST:T@I7;1L6'Y??J_G7[Z/I MQY]W 8[9]%>"477U>79SDR"6!^VSPCJ=2+0\&0B4(R4=L& 4UX2L.:+]I5UL MWA5\GUMU0^9I5_&.#HAPEXW5KW#=S2&BP/)1I 27$V25TL:9#50LU5W*U<]5 MZ\LOR]%\V9VY,E3,=R^:)R'B_*7RC]PQG^3QB:@Q,'(O AX<+DLEGI7;8N5PT!^9)K7P:8:GBY$=@6F?Z:A'C@DANQ9T(H1Q48 M;9A%0NAU]E6P3I6(ZUM@MU51&J!*.!)-YZ\'GH;AAJD,CIQC)(P%1,'D/OG( M,FJD,1LGB>N22-9;6/G<=4&[8#I_A? T$#A,A7#D'*/@@7F:>_LSSR5U@FJ_ MB69*59(0._24^3>%T"^8SE\AW F"1*\#7W MJ#0EML%0;P)^4P4#0-+YZX'+B1A0">"U\0H\.)Q\O6#LQL=CIM-[G2\S@'_F M>J U+/6:3?_W:8+HR[]^RXS?&MC6R;*S@4ED' $1B"(A4,\"MLAH2VMU,QN8 MBK]']Z-NB"T?T.S]8!28XIQ;PIDS $H:'R1XAQC.9G2]6_=>9^E0;6PVI3&; M9.3@+:&7BVTO^6#7MR(-RGE*K6<@0$J=3Y:I$4P$H0@E)7=:7/BI1D-8;4]T M3N+PN4A-^TGFV_.')04 JASGQH''Q AM+$Z4-=Z'P'MK\O@F*9TR]ES$Y%&D M(5\K_=?/R>9ZQ]8EY^"WHP&D$2?8J& 3Y],_ F$C.+7 2"BZ?.:"4\&'*4Y- M<[LS"7] OU?U7P\6>SM^77\RR)Q#)&T M-2-!- @:#,'!F\""MDSB>O[?Z\N\;DD&VF;?N6P;_?HDH)P-!NOT_Q(0 FDL M:)2XAX2TGG=ZS]XYQ4V'N3&4\O=<9.9>)^3V3*W+S(MO1811$)QCZ:P&9*1. MKAU6.6!,%*=%ER(,W2\YTR!7*0_/12X>R?^S8X[U+OII/AFO3FJNNPP1UYQ, MI+E!LDC*"0L%R7S5+H'$V5PI(E7ZJPM.ZCE3R6J=R1OW+6TQ*#G.1S!"9 M:X&U21:"UU22('*/,O36-:5/S/-]NC)A(M6&YHL-YY E(X MQ05FC%.+A$Y_*KGM[6)3QPC$.JL$0L*68!2V *J61T^H-7OQF"8\#1X#3X7GW,-&H+@ M'@$WQJ%.FXR]25'7_.Q4=OX\O.8_C]Z3/U<_1I-\7U*^!#53X'9T\[6:_R"' M)*K;V41GF21,6$@^-AB?[ 1A)556"DN]M25.W="+4 8"^&UB.&@0G(MP[M[6 M=U$"MRB<)\PF*BP=4]H%[A4XJ92B7"..L48RD/#6R.?98X MB2A%*WE+OR@G][=O\U62[KLT^\ET,1FORH/WF)$=?#7I->253OYP\H:!$:&E M 5>*V1U4*AD<^/'RD]B\Y^S"S8CA\?/_;1B*4A#B.,6#(V MB/:22^^\E@1C%+CNK9GR:Q:G(7"Z4WFJ%1J_BW%B*0TXGC9_[,%8(S$Q8 /6 M(5@EBVI>TN*X.$B]\<<_OCO:9*R[Y.?F=7^R\=/C]SEU97N^]3& MB:^,CEJ$"758 P>1J!20D,8E;2F0]]TV]SBOX'YM?#W7.-VPJJM=;;4EYT9D M^J_)8@]"GSP7,Y6"XYYZ;H!"T%)B2K!DFEDM<*>=\MO?V]IG^:PY8G<.'#?+ M\;8ZT+E[,DKJ%.-&4P $6CNCB*%:JJ"\LD3W=E#2#GA.Y.4N1)Q$PQ-#F:;Z M-IGF2&I(P![=_'QN/'(O#DBWEMK-,.& -C%1$.(Z2) M/A@I4LY2X"H+B=19(P)0RQ"#X*@L@='0PR.G<74'-$XBYXD;3)C=SI??]8]5 M /3KOV=?O\]N%Z/IE9Y>AWR41CD,E%@F(:G?)"?&*6D5$U@& M[$OLCW-!Q[&,G;5/YTX#&%_3)^M$OM;/1281,\H@[KT& 41;X:PU*"T,>4-+ M/-C!%]OV$@8[D?*#25G9623XL+KI5>W]K8W/12>\YTGZ44@Z0 #/4HH15@B82B.&)ZEKJ8(/@ M"A->TM-NZ,CK%S.S=CATHLGWJ9JOCL.GX\_3R?+A;OGWL-O M\NH?IK[ZU5[P-?N1B)$S'&N#+!+@A=#*,2N9QTG.N&63H8 M:W47L=]/IM6[9?5CGZ-4_O*(* N.(R2E$X# &!\< HL(9L@Y?LD5WYU[5YVS MJ^N"FKN>NQ^O5W^[L+/;:2X2^I84Q&*I?XTF-YE\839?M45[/_DQ6:8_^%_5 M_/?':;4:M'K-UNL AC&Q2 4Q%EEB-%80F-#!L:1D* OL<2@#_@V49C3 M%]-/-:/RNCY>_VWTU^3'[8^TD-GM:D*C\?=G.]XN$ZGV"]*"(#A0QC)& 6&J M&6$,B.1.(JQH;X<]%P7>2AFO^:C*OM9-S?SW.2OT MPVSYW]7R?9M._G?O;2^M?3,:20EQFA/K%6"A@ 4F31>3?LW GC:4A4#,@Z:X3R.-#-6BR(WJJ&.HWN=0:(O3?VBIG8ZQ7$\&G*&/J>.,:\,(AP >:M!BO5* M'*>]95B\BLV\@!-#3]GG4D!(+KPR'#/)*#48-B3QH:0-_]#WS].XNC]E_SAR MGGA8]#3P<3L??T]P/YBH?V!4%-I9SGW('8J82PX7!;>>>D#TDBVI4YDX:XNZ M@_$ >DY0"A02B)-E()/I2XL(,_MNE]U^N)+S\*)ON_ M?E8Y;ZVU-LP'/QH%HL1C3@*W6"JEM=-T0V7J+[GLKDN,-M61KVF&#GZSV+;@ MSY/%/\.\RLT(JP2]Y>?1LI6VL76_'3D#9PU0$Y+YYYF@6C]H2:Q+SC O,RNF M2&X&Q,JS%)^UOOC'[":]YB8IV2X%:/O7H\$D6;7)@_(X,X]PJ6+-P?WN5VY?6Z";6= MCU8K!U/?K":7?OIX_3S+ C*2,KNG+5.BM.^CP M\]1J(_-P,^O.^=B5J?%NFC1B4H*)GIEX[^]7\^H**P0 21@@YVTS%JT M3@](5 97-;VM%I_FLZO;\7+OJ?J>$1$8 IW6[XTE7F!! M&=Y,F1KHK=U.IY XEGVS-FC;"!SN5>X1<'@R(A+!'65"8*2#I2$@1MUZRI*H M$C@,/86K;6R4$+JK/>ASXESZUG<]O7)IVC>SGYD4]R[@P3S4&J,CLD[E6F)I MO="(,2,17J];2%YB( T]6Z)9@+5']*[ ]D:CFS1Q??5C,IUDQV4Y^575 MA5NM\=%) M09SAD%2S%*5J-8KYUX>LG]8]H!7!MD'U3Q\T'/Y'V-Q+*&OQ0# M#H$E-]XQ2D.2X<2Q#;>PE)=XU>4P'B7#)[FEO0'I>!=@&IP:ET+^._C)IT[J>+$/BPG$X;N8# MT4':8(G1% <;-=@-8!33.1D/9RXS*3A$MM:;FJM\,W! M#-T_=V3HWC6/F]TWC]OP]?J>KY]G-S>)Q_G)'6&@#KX<5XG\THK J$EN)V+6 MV#49"3*U;NP]G^AB5YA[WGMP4$P"BB"T<]9:1K$'P@4V0M&2#6A %1,7+T:-NXE 1 MW"KOV@.CS8U[;VY*X+AY100D.55>.!VP3=23BLCUHIPINA-OJ" M3N0MIA<#T9XR[Q7A1+K$K9 OUTZ&(\W5@ZA6&Z$SR=5/W#;IF7]VF:^__F9$ M C0W%FAPB'F@!BNQIC-AXI)SH+M":-LY^R?RLC/[84O?F<B!@4,1AYU]OUJ5 MC8*O1N\\E\$12KEGSABD"5[368&_Y)Y: Q64[KAY:E1DRP)VG'D?A'C1^R)) M.D$)E!8M-&%,<4O09KG>E>0T#35>TA-XN^13G\K\,2D?[UAZO)S\2APMTMG' MO3PBQURR!$%2KGT@RAEEUE0+W):@NZA)P>6ANS>F]03U%Y&D9Q?NZNG5MBMX M2X6@T<]&31DD;KJ C6&*"$WE9J_SM.@2-_XF'C7$HT]V=A#M>]&WIO/PWF8& MCZX=KA&\VSA '$4)"K)6>FQWJZVC9/:.BPYY"HR; MU3UEWEI%1U7'],F,KZ=SR?3;^F!#[/I?/W'9(Q-#K;&:>P;41BNJ=,,$0I4I#\IP^_I M*$UPO751[D%5U(;4+E71,3..,ZH7U?@_OLU^_9^K:I*QS/(/&<+L$833K^+[ MZMOHQD^726?OZ%JSY:G(E:(^<(.("@%QBXA'ZYDC@7L[H6D91MUQ?-84[=M! MS=UT=G:6>?Y(Q)HI9&5:H5&0&, $]ILY8]Q;E5ZS>"GBUJP1TIT8^_S'RK[X M6W4U&8]NOOQ>Y"JI=]/Q?^QM [)_4#2(8J:UY2K99#I-F B\F;CBM;;L\^#Y M:?R:M43)KH(O=G:;^Y$G\BQ_U[CH:]OCD8ODH6L' -0S(3PG&M8KO]SA@)]I$CN?AO?K?ZS.H;>OD%M?2X: MGZ;.:;!*2]!$.LPW>RXAN"339H#7//2W,S5!_\%47EOD&=:X80_'CS%V-ZO7N6&'WTET5R: F^5+9V#\IY4 MJX/EE\LXZ' <]9ZH&$/)SO82DE?OL51!KF-#"GEW8*Z1Y3X(28WC09#U.JDVG0;J?U7S/V==@:Q9%.S" M6C'%.XNFY*JU QOKYIGHF!0 *-D((#W!/M%)K]? =9%B&N ]0OWOG:=2OE/T M'.[>_/!4%"A@:RBR7C*@EGB&Q4:+$]9I0YH.(BO'\V\; DZB75<8^-MD.OEQ M^^,@"IX\ES-GA!)2&*:<"'Q?)@MJ\7[V6B: M-] PF8ZFX[0YIDVSFOS*FZ/Y_?#SUS3# \9(R6NC\S:H0+"50LJDB$707C4?%9DT)0;I0U(P]8K4U1>F!'4 M#0A>'#X6T_W$<\:OU?Q'7N7>L\:G#T7J%%AMB0(EN=SAJC8E<)8P?YAR0=MHZW/1X("04X9;(5CW NB-DFIZ:>B Z,AVDA-(*1) M@G8>Z"O8LM_7N$2DT>]$)1"F6E$D&0I(8BS(QKEU&I5D:XGA@;-_LZI/[G4E M">]GTV]9O[OJSV6:?)YZM;%J6R]=,$+=QL<"4-+T<=J"[ M6VS,6F!&ISMT)E2V31\VBC_FL\6B%O3JO2!Y^]0'8#0P)S2G@0N^(283[$): M!@\+B*VPIBM@NFJ>IINO0/M<91,HD>5OH^5MKJ/$>^"X;UB4UFM/-1$L."X0 M$&:OE8.P089T%KU[U.+DR^BF^I))LJ+:OMC:,\= M!!#"IW^KS8FJ)!P*8'>A63?EL&N,'3UOQ!^J>A9@G>'1<0*)H!X33K#6%AA2 MZY4#^)+\W0L]PFYM$RYA3*>U]'MHIY>;QQZ1<46W"ZRV#XR!M3ZYK!P9G4PE M)QBA5(<$!VMQCXUNSZO:/@!8H@W#+%\L89245&WHR&W)9>AGW:6C-KY:*[T_ MCC,]Y$8_RE\+\^I?M]5TO*M _XC1R2 %)SV&! 80ST%NUFW,D7;X@!/('K MR^ZLZ(9XTF=*]&;>)R5"/QL=;?*&F)06/()@9&Z0A>[7G8L>+J1 O!4DU,A] M+J-VKXGW&WFLG_J\9WBT@C)M"6"CM70^&&;D>N6@Y855>3:*A3HY]F7DOK2R M(^XT=\0;I8.E'@>OPH:TEM8SG<^T0_N@=MOF>'39-4@&)&)8><0$EA:9M,^( M-2V(DR5X/1L7I2&T%!4D'<>'/@N2\$D%2?>C(M:0]@4@E"DO?2#"*;O9'2SJ MS>CK$F_- J)&;=)IQ#_?JC M+_,LVN'+@'!YT*VH_8ZH@ &*>C40;ME0+D-,/)-F"<>;]9.G*]&?WG!HF&"'PB"O2G MVBC8]FC$W#$#SI"@)2,H*"LWJP4L>[/*SQ$%#1#X1!3\41\%VQZ-A")/$TRI MY8XKKH3$9J.P0M'U*$>G(791#= N#AH@\5MAU;Z$NZ 0,.R\2H:AH4R!91MO MEH:B[L-#O_"Q?]>N3U8.52Q6BSHFB_"4]T9B! [ *:+(@M JV9)Z32NNU27? M\]X3Z JA7\*^Y7X\9K-ATJ1EN@3I4U-B@# ]$2#U"QJ. MXT;W!5QW=-J#M.>/QD"E%&"QE1J! DB&65BO" ,IZ0DQ0+>U'T 5$KTSU;6: MW);,Z7V::]>8B)&T25@P=L$JQR5Q8IV'19@J:C9RO"<\6XYN+A!835&_>T7U MB#JUM-6CYZ,!I4+RV!'Q0#E0)/E:>HB3164-]=T5=8>L:?4MWPU\@=AJ@O8G MAE_L;+I,ZUA=$#)=3!)G[JNJ[N;QD"ZU(R93>WR.+'O-G"96,"(2B;AV";8)D,ZZQ+R0)_CML?] Y,=X)(-D"]*X @KC;%'ZY@! MX8QV<]GZ,_A=Z%;9*">Z+ M-=)A-QVGJJU.-N8_%A6WRC2*R#MI[YUCG20#7L_GB MR0GR02/AT- HD0/J42!>(4R]MPS;]8H%+\HP/1>,]HFC7;D"S;"K!^]]$X2W M-Z/%H?JPO>.B#" Q5T$8!LH23 1VZ[4&ZTN*JP>8_#P$HZ))?G2.O1IA_P/$ M>[[J^IY^6]^.)B".M5:@M2,Z2SU#&V]%\MYZ[K4>)RC!WRY4#X1+S1YC[RTG MV#LF>HF8)](JIIG P1!&]8:@&%\JN/J'P>&S[),XU%/^]8E$?']\84+IER(S M@:C/GVVS\;':. Y((*Q&\5M:BS6$EDN12&UIVC=-6Y*41EO9Y#O)?D^7W M%VM3*]=:7QM?2H:8T@PRCLD@[&:4\[-FJ(4LTXO:OI9S2>SJR_+ MT7S96TU%3WBM<5;3(9O/4' ^W<['WT>+O>G3;7PN8HJ((H$AD]PZC:@!%=:4 M)01?6)^#2Y>64_EZCA*STK;OIN-Y>E7EJKO_=B0^6[\=#3B@R=&4F%.!"%%( ML,WI,T(EF]'%!DP'+$M-,/D,!:MS&\X+BX7&/) -OT+&4[O*2I)T)W>\G5G MP_GIU9L%UR>3ARXVBZ?KW$0CVY*=O=^+2AL:' -0A.?VF$8(M*&M(]W<3O:T M[N33"U_H37@ZY?+0)6C'4KOS@UY^,N:&4U[QP%C@0FFDD-E0V'E2<6\TR$OM M4DP/ME20>[ MYQ^SV=6_)SJQV4"M==11,,>]**9%8PQ2"NDT6*!&!&4"51JC)$NLMZ*$ M#G;+EJ#SO)ZF37[TJSST>#GYE7CT\7K]D/G]N?HYFZ\*.S[^7"583K]]J;YE MMZ3GWB7]*)R@.,L5*L+S!!-/%=6.&$$%E(Z" 0:9)5 M9[5.1AP5S(KU&M/2>ZN]&YP*J0V&G19X">&[LJ6_)"ZNXA#F=C&95HO%O?P? MJE#:.RXBP0VV!A "P_.%8+FYR]U:==*0EWS]8S'[G\.I04)W!JK[/>10F="3 MYZ+V6+$ G!CN=3")*EZMUT)$N.0[:AMB\G/H%)#WQ%J7WXN< M[;NW!F?KLU$2SK%62&LL,7(DR+"6$XUY4<1Z\"@XC5^S9DEZ(N?_L;)$/XWF MR\GXIOKZ/9F3/W_OY?^>$5'I@#F$X'(7$L$5EGRS>,F+2EP'&"@I9WQSM.RL MV\7][OB^1K73BV4%GC)5_\V;6"4$K=KP-2K -KR M=$QR)4%Q< X+Y+%!9&/1:Q"NEGMW/H4[!7S=@9#3:=DU1FH (ZI\CQGW@4/> M&A67R&]6@(SIM/UF+Q4J16S= 9$CJ=HU+O3X7[>3Q!1WFP\*[C(1ZD2/M@R+ MG#$6B$IJ5UF'M:/<;*1)"D8ORT1I RP-D+5K *6E5Y-O4WN;6#,=__XZ'TT7 M=_DAZPXZ->!T^"51>3_+K1S;OI]6S^8_7N5WF. MX[!33!'%7+ YV,$90M@3DGYG@H)!G..$R72RK-Y/?E4O5E3_:.?02R*GBGOA M&$[8U30?33J_I@0FHM/FWEWGPY-J'7JN>_ZS M_PU1@!)*$NL=4R$M&CF)U^M/Q"ZQD@?H<[$/3@V>IF6QA!PB8U12('G?+UF88NNQ!LBQ!J#P'9L-4;HSA*/=ROU.L<8 M=89',,H)3*1&W@4IDBMJ]7KETLB24_"CPTI=6&P=;)DMT+VS#M<_9O/EY']7 MG,S]E+?G V_K;[UW8#3,&(."E9@E4GKD@8CU:JT*G9IEW5]WW2@>GG>J;I+P M_084PNTR>TN/%N3_^EE-<\^-'%1X;>GH@E%"@T/..P]")'QHFQ@9#&=.4JBE MF3O?E[9P[W.5-^\DJUGE+L:CF_^N1GOOTRE_>P2=6TOPP#&60+55)E@-*)D. M7H%%EYS;U1+(ZN]Q+3%I $;7EI7EA7S]]ZPQ.-^_+VHI"<;((&)-UP0T >)M/,B13AB0KAE** M+2$42O*DSN4<<7"P/8$QPP5NF-TV9SNL7Q@E%4HA:[0D!D0RF8-S--\;YQ&1 MCI;DYA2U(W_%L#V!+P-&;7JV6=2F9Z-#((E@F#BMP'&37,= O+% @_? 2Y1M M_79?;Z@MY,LP4:NO$T<;A^Z3MT;@2G&<_FW2KH2)DH1Q++UQ0$C:IDKR8^NW MV7K#;Q/,&0"(/U1[F^SL'9A$EN=[8:F5VD#:8Q3%Z=_:!(($QZ*D44;]OE5K M*,Z6HYL!92VT@+[C2=YO9/*/^6RQL*/Y_'<^EOHQNYTNTU-Z/+[]D=MU55?[ MH["O,BE*!0(A6&6XI9!8K'':%)$B5F/'73U7\#*2HC !B@UCWF$*AFO-&4/I M-R3D^JJB+CR7%8RL#9G3\Z..X\4 MC7S^V^C_YG-:]WB6?\MD6&IL!>&\&27 M8LF3.F,TYNN2>0ZW ICXT&V!'5_#\6HV_3U>EYV:TV+*20ZE7 MM<9'PP$!>*<4(\"P4EH*X9%!3CI,_"6?(K8&DUG[C.@*A/9VL9S]J.:?J[O: MGL7WR<_#T-LS*EJ?1%IJKA+- ".0@*066;Z]-K;H!HP!UOAUA;'F*-X5LCXN MOU?SHY7:GE%1)-\]>?#,2Z:!)A>>&V^D=#8X1;0HR20=^L%<5S!KCOP#,/+> M-Y5?JI#@Z?/>$$, '!@&6DGOK:&$DV N.)&A7T?C5!8, 'RK<-MIP%L-C8P) MZL ++K$$X9A4*DD@3X)F)&*DMRJ@H22;UD9$?;B=0O@!0&U'#/?$$Z_M+XM> M!!:0IHRX+.=$.L21H4HY$H*!DOL Z^O K??)7# @FV'& "!:=+ E6="*$H$- MIX!M(FRV8D+ VH+&J*2QV?%VWZ.#K0L&WO%D[PID[Z97U?7NB?N_QC>W5Y/I MMQI=((Y]50Q@C.9.6F1Y=N6E]CF54C)&N#90$M8[.L6JBSJC5M'7,O6[P^,6 M&^(X%-9Y013YHB3LN4AV"80@#,=!)JW/E>66Z9(XWO&)4JV?[K>,O!8HWA?> MDJ8N0=NVX1$H15X+H[!.GIQ2,B AB;0\8*8"+PGA'9_4=%E8:X#>_::1]'P_ M64^7'!@!VC%,%%5 C39:(0(F_8@#6%)KXV\[#V33V?2H^\A>C$KN+P,BL1%& M6E $) E(!6W3YNMI\+UU_!QZP>"E@?>7%C;;H(SKUG.&A, M*;!$".$H(D)I3;P113>8#_V8JFO ML64KL$ZV[>2G2T%CD9Q$Y^)PC//I4VF MKR= TB[E,+,$>4^=R9?\]E5G=@F([H%!'7@3[Z;IQS3+OWKT&S9S.,I+V#,J MD5DCIIP#Y#0 *!V4H)X8PWSZ;;V,Z,[66D=+[!L6$:8LIR\KG=Q?ZA*RN5", M2B>E4=Y>^R9 XGHJN.0]('B M>F?O+:_UKA'0C-4[1HY^2:)\6BQ/-Q,=NN J+A@TB$:.&68CTUJ$N M^F$7<1&D :*Y"U0RC)@Q/E<>W:TUZ?#>[KX[ MEPVK2>IVA21_?5WE[LO59O*?DS;>UD!Y#ZSJOR1B(;R7E"%M+0/@X9%X>@>7 M7"+=$#QF'='^, *W7M>Z?3Z?J_%L.I[<3%93&2U#E5@VNLE;_VUB\._-P^9F MY1#G,9^J>=+)V[S35KX3D<9*61I,+@$!PKWU&[&G5%W8O6O-HG$('#D1L)D$ MM\N%GE[]W]F?"SU>?KS.NG(UKY\WU;+2XW'N Y)H9+^/$J'>3>^7YNXYFOZX M"CY_FL]^31;W<9_[5=U'GTTUK:XGN[#_M MY.U<8#Y@9K4O :L+[E:QS30HF[^=XUE2HP:H[Y3!12!:_3WLD"AN"27[-V7W,_;EU2%5+4.?)<0-TS0[KR M O\^G:U.]U/>7%W5:/IU:H7P:,Y)9;?Y&,3C5"^?HL:(D5RYP)E!@4-%W:+7A%,9@-B M1+=*H.\+@,IU@0I8V*1=J1$,&:_$ZF22,# ^RQX82QL*815;3$*CT355 ;)3NS>MND>%=F9]TU MF-^/UI-F>" =H^2U$7$=,,+&:$>(5)J%(->40EI?6-9&ZWAZ?HE==ZSI"L1/ M)WHPZV/;XU%JI0&#(\%+H7R^]I3-T[PI1*[H\S/=@ M1LC6YZ.3CE-IM49"!A42FR1:KTU;=V$)(67LG35/T%[VT"1'*WEZF/O[&EDA M=5\1)0%& K+>..H-UCY8OZ&GPA=66-CKWM@<&[H&XL.,#W5WVS$B6L*E#BIG M]3-+!0D!Q'I].37GLC17\VS?@:LR,G<&HYN;V;^38%5A-G>SVS^7U[P M#U6U7A"1DL0YP@P)P)360EE8KYY[Z";;8VNKMG.%61MT[T]Y[6_&MO7Y2)07 MV%$BG384\X!D,E+OU^9"*&D_5-2#[5P1U0"1>P60O9W/MV>PU1D6L14^^3HT M%\DZQ8D5L#$X2> E M/ZQ7AU"R 0XP-: ?;)U,[IY"#?LWO9V](<"MIUVO@MDG]84*SG!1SYJI@DD!'K,%,&A#&Y M4&Q]OF88U47'1N@5:L26&=!M>E;/?6W+L[-,(-8HZ0UH &RYDA8+;:74H!BW M/?:C.N&TZ:C6C$>_-1)F6?"4"U!Y%,"P )*K/ !'L,4H:4\2^M$ MJGB %+0 &G1G.J M*0'O1:VKD]NAQ:>TA+L%K+*!/\W2C#7?,%T*V":]<*7[A7)$)OD=:]C('[L L'^%4QM9L_[YTEVN[F,5].7G;+J8S=]G4&2"[L\J/S@V,LF= MQU@CR_)%8$8)89@P$KA$A*B26,X L=@Q3EZD\S;+C4$@L$;R^,'1D6@OD:1( M4&M &2-SE2<2AG"@5)4%< 9NCS4(BF/@=A+ANP+0OGHU*,J\T M04XG\41<2V8?W2!;2MBN\G*36GS;7?U\CY[S)ST2M M&+*>: 7YVC$*.3A+,3%,&2=E4V3*X4)B7)>0/4C/UP?=86.[J/=CR$A#]4 MR[ON')/Q_6ILHN#BU44^XB+QI,@G:88,,]5):$)P#Q[6J/-H^BMD"^R,B M'$>])SIJD.5*8RHD($VE4XHR)C3AW 7HK2A^8''4VK#9>2;3/#/Z<1YK5,)O M'Q #EZ 4TY(*!R@D-6EMD"(MD!$#],).]EKB_%X/\412]P>D(T,/CXILC4C[ M>=#*$./!$J$8IM@1JJE&P;L+B\"6LOD@:DZB:E>XN3^,NI.<)\)T,+9P:&A4 MR@0D!.4*.P EE+0!F% &!<(\ZDTI=1ZW.@4%VP\-FR)V?[&'!_5\6E!AR_@H MK.""46F2H((07@+#(2V<:9\+$DMB6D71@@Z ULU6V 8;^H/@EVK^:S*NLI-V M%/0>C8O,)@_7Z^2(TD1)2:4G', S%KCAQO?65*@#R#4,AH-0.YWL_4'LW30Q MI5HLC\;8XX$1(>UQD%R&[!D)HKE&3 J/TG*Q8R7'CT/7:UV#K(#N_:$L]\T> M+ZOL7M_.IQ]7UL'=I;E'86[W:Z(0A#@4*!$2@Z=88X:2?RY!*B68+3EZK%__ MOK6GP@5BL#$^](?(Q]]?(/P:X4#WIY8]UWMU?RB)&0E))=@0C%:64J7PNV]PU1:NR5"5HCGUP:*P1B:D,#[RXY$-L*5'8> M1#;)A@YTPY?J6R;%HVJ-WA3#_50^5S^S?3G]5D,+[!H2):;:(4*T8!HX59IE MSXDBB1$GS/?9L/_9E(\KZ*HQ.FK-O7.&(V8I"".U4DA)A4%8X%!D 0Q=U,OQ M\%RN&Z=W+S(]Q+*L)L4=>/(JC0L2K /&J<[M>BD)6DBLTK_[$_>[A+:/UW=S MSIO!_2+V.9J[!T5JD_=LF+=2);]:@%)V%18*4C#/^\M0[%.X:W/_>5^;ILC< MBTPG533Z]FV>??Q5(.9S]:N:WE9]7[;3I%A;)@ACE'*CA.6")=T- MJM8-"BUY]-N)?[ \ MD6;8_MSL:Y# G8'I;HH'<_Z>/!<# 2YSJ J4\Y*#3-[O>BT87=J%(@WQ=;N3 M$%-H% MF_['/5E/V9=U@!I@75TYXYNC96<)O?/9U>UX^7%]+'O FMCV>-0",1&(3ELG M()Z/,?#:"J-2HY)KG >(DE:,B ;HVC%B*",S=LQ4TS4$W>:_QS-K_Z=5KUW>8=4$T5,AI+C;5"FWT3 MBN[V'>!NT"R/BTAY*H_OIKV?Q8^?B1EJ@AD%3*;=#6/-25A/BP MR3,^_I:C M<^-P 24[#S7]4S[9NJ.GEF*BU40ZD4,Y)L,(ZZM5&S+R_L!9$#?!Z>\BI MF+)=H4?_J.9IDKL#5=L?C)IK'02V5N>;E9(FAK"QB&3RXR\,)^5"@:[95EQ#""-44428G8>A6@B_J7#= :;1X4)Y.R,VVQF(P^ MC<:3Z\GXL,)X_FP$9S&6#F/CB-3.)]O8;X)RUI2UW<+4]&,,8&YC&#@#%%P)C9G-@H3DK.O09X0V9S7&^&GEWIAJ^3'Y/I MMX_77^>CZ>(Z)WG],9M=U3T1J3$Z C(>% 9,,9),@J-F[>8S+W%)V'. VJ,5 M%[AY,@\$7@<=XUKCH_#"4>>109"HFAS#W#CF?NV4L5K-],['^6D4#<P.[M8;&+D67#'AK.1<>@)$D+74,BCK+'%^Z#H6 M <_QU22I>P#6QU_5_%A,/1T3>4@2&:36+K<14AJ;X-9K9%B59*\.T"GO#$Y% M5.ZLOGF[=?"^3G>O T.C]UH9SK0SC-AD92K@:*/R'2M)5QJ@O=Z*G=4PC;M" MU?TT][="O7LD$BZY)EPG/\2SW)N1;?(M6+YQ\[(VL^88^J)SY4GT[*7^Y>// M:CY:KBY<7-PF.#WZJS";^]'X^XNZGDNJ> .%(!"-D?/@!94,P.=[H*A"2L$@ M:MJ?3_X1A\SO^[^LWVZ[]MNB)5(::;"Q*%$BT89[BKF01GG#TV[B0-L'Q*"9MTZF+1=3(+#*VY'.:PSI MEPC5*BT_5W2U"899"]3O#UL'0T"[AD1N:++D!3&.,! \)"J))+<:J^ 5]Y=< MX5O*\X,0.HG$78%H8]"LBY(.>N,[1D0FJ74H?298!BQ0X[@ A*7$A!!+>ZLD M[05"Q_)\U@:-S[NB5'%,\TT<#&,/!I!",CD8Q 06&+*XMY*A"]ORFF3"L*M. MG9%86RO!:0346"T$=4Y0[(T1QERTA=X,D_>6H!Y'WOY*4"EUA@;CP#G(.SQ! MP0?F#6)$AM!;"6IW?MJQ_#I5[T1L-$/#CNV&;=94G6.C.L.CH019CK!#C@-%U/C@O (.7":KC)18 M&47HN32SM7E>#/&(B1O+A0I.TX"2PT>VP1. M.:U[.;?LN?UVHUUVE??$L618> K2&DDLL9"[+DK.@ZAU ]8@#B&/:K1]U!LC M*&%EDAR*13Y'IYI017V^5 @("/,*G-P"W)0=1I[(@YZSIFJW?J\U/BK'!3&: M),>0@[9.)=V*$3]QV1,A*PE5((Z2%8+PEAX+'15E@/OK?..QUL+:%>NVIZG(V',!<84)YXSS[D.#*VG*RB_Y&R.4QDW:YJJG96MC\?53?9) MJZO5Q),5*E6*@JEFB?F.EVRT )^/(#D)E(9!ZY M@F_0.P!&-(6&8*#30Q+&H775O)DU%Y)KK1/)OWS4WCFZ(V'5T9OW1OV#\'&V MTFMEH98(,PF0MW".UPP830QGE;"QV5*(G%;5E[M??H@3^ MNYA>E?K9LID>.)&ROANL@#SJD98R9[6A3C.%*JRH4&=+"38X%5O09Y?Y.Y @ MSDO:3T7:P*--W!=[3_T%@5,'A8_H 6&8P,@@K>I#P/FA3 R MK\Z>'Y^[ %A;QPY"TB)N#7*<:^\%M50@C)4'C"-C&EU4]#.CWV>+S07SL MS>+.]@$:Y:WG!@@)K 8,(P&K^1E$+LS":BO[&K M7XAS5)IM:LL0B+61*.Y3CW/E\2\NBS:9\M[WH*(#9(=BT8NA'G7O[&P?34P/ MF4?*>\6PCX!AI:NY.03.5NZ[IUO?;N3\,DUJ!\@.Q9K=ND"#K)C[NP6'.36( M(6(Y]LXBI*2L9DHLN["<&IG2?I4;LS-@AZ+0RZWWD+OH:)]@D 0&1,M0.6&P M@L@J_SC'%-=Y(>9-/\=65Z@.Q9QWB^ME$>TI6VS__6[QVHSY%%>"+Y=_39:' M;.L3OQ0(%9X0JS 4CB"JJ!&DP@/"K C_$6Y1'?"B'!+O05T^/XPYSFM^/XT[ M[\<4!A;ENEXO9U_N-[F KLK=F_-)(3EM?D%(OF('0$IE (BA<>=WH):2S4J1 M=S);[XKEK)Q&Q6FY[I6SO3'L:"3/ "(:3+LKUD\Q[IEVZ-"ST=\XY^?I^4XV2 Y\*W@ M",- ZY3N#@#K+:&&(DR00!8SCW/8.<(GHH-QLVV?<#$QX8+:+1"(F+5H#DK#Y(@+ YKP6;IX?_<=.\>O/L M/*>(?BFS/YY%:;D[%U>WC/]#D'*%:]D)EU7_X.2\O%MEUBTN0R\XBX#.YRNX M*FY3OH+E0YZC8/]G B!81+.8 @TU,PYB"&NU"5.44T?A#?BB^O 2= ;V4+1[ M,6 S62X?TO.PV_(^/UUT" 82!."$/5%2=F!3,U)J3YC@GE&&$&^HY M>-@6ZY9VU8O?_E35XH ^V:A?4,P9GM[[(*NM9YQ3R[9FH<;&>W[IYGF'5.D# M\#/M/ALCSGR;++X>S+USH%>(^RO32FG$(4$NE:.TJ$)/0IAS(HZP_MHY]J , MN'^I=0U5!4U%(_._MZ>=^Z7Q=#=T+-[XE,\$2IB@V )$ MD*(\W29I)04QS#").;KD\A5M>?'Z@6=?<+_M4&5F.6:4$40LIE!XK5%41:/: M*8C"@)ZM7ND U.J'$R>%,Y^&_ML*9X[GK:24>Z$XHEIB371Z2P"<=T!$S?2" MF=61T!O%-I\&\X )$*JU98N;V:*8ZF(1_[#^.(_6[]-58!O%[FB$=/^_/$1C M"D+F /2*4JJQ],I(%O?O/XG&(YPR+XH]B_5O$,)TO M*3##3%;?_+S\ZS^+:33<^UX4/?WRH*0A@G!*%)<4:JD4<-!@'*U!##&[L+2% MO2V*<8CG#(O"E\MB]G5A[J.4%]??C.ONXP3BJ5A]NKB9_-PM8.^$K 7OG#+!*64\I M=%QY Y6 P$+MC==G\Z.=E8LM:/*2C[V)X%=L\(^AIX ;G2!SCG-JO). ,,\4 MY_'LD=3F!'V,-EJM%W;U$QE\FGB&(O>AQ:^+FS(E9;R>3U:KVD.+QQ]' M< ]0.N>S@4I@%-$,)N>/HQ$VR*7&P,?])NXX9XL<'D)%&(#/ \IF*!:_''#R MNC0XX;8VZ?KC9K-J0NM.?T^PV@&@G+78&6J<4=&@I]Q5!PXK? RG>?]^& .9. *NR\@!0+ MF8JR5V@!H 9UZH^7SZ=2JR-&MY+1VWYMX)2$7FWJ<0+$N?4IA\7C7"%W.2FN MQ^Z;/X_NT*4XWM;S XLET7$U4QJG0B&%P->(07C1-E1'0F_T_. TF'\]/^@F MOMT:RCARRD*)*(M;@XA'QB/J#*!!4\M\+Y9?RK-$Y37FWO /$$X3T*\'"-U$ MN!,K#+. >^%5/"E3\C12H>[AL GLW_2R&(> SF6]/>T 396T#PM;+&??8^_O M1:/ U[Y^94"66,B\M8H)$*T81CVH$.8DZ]HUZ]G!Q6K8(Y%DRR12IES%07XJ MOA>+^R(ED/APERKJQI7K_KZ+@]R9ZJ=9Q\"IMYA3@;W1TGIB!/3U!!BYL#>2 MY^=!V:-TAMN*MT,^N'5NFP1I!#>82$-@/#JD8"S5Y=G.(%6$O*SGAJ/A5Z8< MAF+2#YGZ#]#IAW8AA:2#.&_,,?50:2R\JQ44(',,J]./SW(]F?]XPK M>X;V)A?6>K;\$?>M4(Y%CS7\3(" 0B(0-HX2*JF20J>-#UK,-,5F4 5G.'/S M=#("7(WH^#A61G7PMDD85?[ 9U1Z5^,2O!(P)1,Y0B#VAR@*% M#&1((&",A0[F/*P=H?Z229[^ 1XT G;/+/XUF=\?"BL[VC=P*ZWAD>#:0*HY MD)Q@P(RB@J/XHYP2#Z--.]#YCI0+Z\A4D8V#X^TI&T1)!ZQ'REA#M?62**^8 M5T@28AEN9-\UV_[3;O$D_BU>5Q$A';O_N6^W/]@I$&ZQM 1+(^,Y!8$T7DAD M% +40D(N+#"NK>3*GO <;"]OEJ3UQ>O\0]3JZ,M!(XJ ]%A"8:+>) 1@D"C! M%:>>>Y9S#HP]TB*3C.>1P-@CU1H3MYM?$*AC1#@O%1"(:L U]8!P PTF.I[G M.9%"8[_'Z(B_9Q%$6P.L7FN/N>O?+0[I,D?/YI:?"Q#KJ-=))K#"%+N4:D=+ M8('$ #,F5 &BC.^[I$ MD6I) 3!,8Z$TML8YC;V*)Y)%2)PSC?K+(3?2B?;U"= HA0@B #!$(,3 MP,&.NYL%12;0B2#B.8=SNG8OFW./LE,JR2-[2&FTLY,-KM VF0]D8 M^GXU6Q2KE;J."L9JMA'6X5<#>WH$8#DTABG (;4RXL.]C/,CB'/C&,G?'>82&9%=L! M8TH<=)=/B)8"+'N =Z@]YGVY^!K!OK7%E_55_,U'SJ1=S0,"<1]FPA*M.;$0 ML[B$ZM.;GN\!VQLXD#K \UQ,.7H$[>X0+-2:170@!,1:R!5[TO4(TVIT*NIHHC-GQES"[F@?#O2.*,ZD]BRTD^N9_/D;S^L=KQN'(37+,Y+:Q^U*"HQU\351%8H MAR,CC.GI5.G(1O,\'#FJ<.QJ'N)*$=#% Y911PCC2.GZK/4$7U@.^AS1'F1) M*S0'?"!3SK_'K>_',3=()'.@7S $(V^$IYX"IP6G2*-JK@B#G'O/T3/G5'&_ M?@;3&;!#D2@=O^\6J_7R/KWU.'(@O6X<*'0(<>:(LT8"H35!M#ZOC<27=4W> MZ8&4C>9Y./+'I$'RM7U=@M&& (L$%MS$W5D)YVJUS#LW:+J*_OF2(^*#;&F- M:$O;1J6?G'K@-.L8G+=1TZ?$")<0(9 _^04X@A=VLY,OQ[)'=#/HP=O2XW#' M0##S!G@M.7(8,@RI$;7;B."SA:^^$7ITBNY@P=0OSMGC+OH]/8+R0!IG(+!" M:&_C$8U--3\F08XA='+R]C>FGW0#Z1DI6_35;TL>9TPK7,W'GJ 6]LWV(,!'BN<-,>N\)LH"K>FZ>7W944QL9'V9- M*U3/Q)CW#?(\[>L2(&9 ,1QA$H9PHYT']L;0ILU; MMX_+V?6A(,J#_0( 4'M &09.*ZZM$F(;8L$8,!A>V'5AOLB/QS2U!GKK[-EM.(T_I!SZ;3O49ZNX\%):V$&G,'#<+8 M"Z<)V0898HQ=ECXT_KO*]D0:#/'SN(^OBN5M8\=Q:AP 9T2D._N4GUI0R:#F MM0>+BYS*!>._8LC?D+(1'2QT*DZUBMNIO523OV>W][>Z7"[+%.5A)G?Q;]8/ MAT*J3OA,D$A"1IFC%'A.- .:U* "@G-\S^-W#^5SJT>LVWJBI]/-=CF9IV"@ M%V,RY>WM;)/4;EMO;Y]3^I1O!$8]A=Y#1 WP'E%&41U;YG26AW'\YEO>,=#[^@1GJ.782JFE@2D&3C-61ZTYDZ,S\0LF M4]? #A?"<_=H+GRX:4J>O7V"YD9H";QU#CE.:)0(J*^6@P@ M3Y]O;R?+AP\WGV=?%YNT'G&7O+Y.V^0F&?]\=CT[8YJOUT-I\!9Z?Z> "3#0 M$!M7,*>*4@FAH89R3!Q-1;J:$+LG/_ A_!LE,FCT@<"%1TA[+!FB%$(EA(Y[ M&/!:&T'%L/E%!\Z!TP4O7KJ-^P!]-,O^2:MZM[@IE[>;7W/NY A=;PE"*XZB MY*FP!%!"&,0"4V-!*B0"9".G0#\SW:9.J@MOZK MZWFYNH] D"5EY "QK@RU%:: M ^607MK3P.XX])J=@TIB*/;V?]X<.?Z'&4"P'#$;L6>159IC)I)5]HB^%S[' MK3;"N+FQ:Q&C%/I9E)%C\VCV,+S=%P.ASC,+,$<<2P^)$+C>DC D.15>1W@X MC(UTA_2?WH38,@+L7Q'AO]_=3K[&$1U\>_RZ81!* 902?T"%G93,8 ^J 5II MO!(JO9'P[<.86HM1ZO:D^NXF$7Z4%$?\C#BV]YIG,YYNI'B3=B5]) M'B>F7%PPF%'KH1&&U:L'>I_C@?LI/0]Y-.Q7>L.]_ML*W<\6"=Y4E7OU1W$H MZF]/CX!TW-H%Y<1C 3@'WAI3VPLTRS_\4^JI[=G9K:1&%#C[7_>KS8NCS0.2 M[;.CU<=E\7U6WJ_F#Y^*NW(958]+BZ7U7$.+D?82,4X$!%A+)%+\A@- @T8+ MJY^91L7OV;B7Y2+^\;K8OM%8;LM,OEL\;S%;7,_NYL6Q"-FL[P;E)&3<0,T1 M(P9@BDB-%Z)9&>E&:#5T09SR?/ /YS>*&_)DKN[NYH_7>-MCV6R+[,Z^%^[F MIKA>7T5=LE$AM'8?#%Y["K5);R&8-,"Q^*\*'>'LA9%S(":]\M$,()KQ$O?H M)4_;3P9-C1%2<4HA)B"JLS"EO-PBY!BYL!" OFF4S=I64AGN;G*3!R4N=UVL M_RJ*Q:?B>Q$UW-_N9].DC;Y;;*>CBYMR622=^2:*]*J\FUTSP!K$L^1_/E!- M,!/2 4Z0!)Y(IDR%' 7^PJH^]4^P5_>0@\MHL 2#E>&WK

      S?^[#7F&-&J[D18"[L/6!'9$GZ5M*(#2 <_U#Y?%XM)5 V:'F;/VP?@ M<#R9I84*>D*],O'LKN;&=%;AU1'>4ISY$,M ?C!6/0[QGXO577$]NYD5T^.9 MW_?U"8XA;*&0C(L(E722"%5;5^+2WAEGRODE:SI"=6CFO';Q'T\!?Z1KH"R> M_E!AA 2D7D+C9&730,8N+AM\ON3W<*DC@(?3B5;5DGJZ3FJ@&.WM%1!#BEC# M4LR!XY@@PBI-$FKL+BT?<^=$Z@[;H3CT_!ZR7!Y0 (ZH3R=])R4Q 5P!"22D M*FJ<46N %1:&N)R#;X37Z^=1J_J4R%#L3)4^/MRH:7F7I'QT:]O5/"!'.)<< M"H&)= #[;!U?.O0NU6_[R;QDTZMB= 'N54H_X! M.P6P4-&DEI(P&RUJJVH@HTY[623+$__+?:H'@%M&0AX:"@,R+JB;8K:^7Q:? MXL\.UQH\_4M!I=IX7$8;R&LA8SO#?:UDRDL+S.V$0\- /=16U59/>-_@D4_V MMX,UV@I!K*+11(=4>*DJ-Q_T("L#WPC3UY]'9QM:2L-9JIN[TB:Q@R^;!N>I M!ZDJ.L#):2V%HK6.PJ"],"?9@ QX75$^!_C!_&B3>;&J[M[+,$PZPT:S>_K6PX+(HU5ZP+]UD^5B>@R6?B^7WV75Q E&>]0@HSH-H M2:54DBC@I,=5R ;DFEU:7K8^N-(>SJ'/IP;G4L#("1452X4T508:#96N9H Y MR#F/3B;$]V+YI;SX$^E$R(I434,"%E#);?1%&4@Z6L&BGH/Q3PGW$:($X 17\V%36;V/PTS/FD)^/9AQ+;=U>3O8N7^CKMRE/9L,5D^;/#YHURDM^-1)'%\7]\MHDB+U2$N M]OA; W0*>TL(<-9K;$FT>^LU:O&EU=H\'[?'(\-AUTJP3'M.5>6*V)3'2#'2'5?AGQ>FHH1EO \-T=S\1_/7EQGZ_A8+C=R7V]3 M7:7+JZNRAVVXS2\,SACB)1(NVE\.I=<$OKI%0]CK'-?("&N,GIO=9Q;?>1;' MGORC1=35XVIO3/G#GPD *9 *PP*O/7+<4%@_T$):@IQ7)/(7D0<1RE#TW"KY M:0H'R/?4*,01NP@5QAISA*(ER0Q\FH7(2:@*P2]N=8#Y<-%#ZR?^'XP$>M8N M"&8UY$P(@"WT4D.IGS9IX+.B*T;H,3X??W)@'X_B^+%8VMD\Y43=ERVW];<" MH%(K2"SQF'NG@,6Z5J:%98W*[.ZC8G,7M=Q2<5&L+Y2(?0MFL,#NU:I8-\I& M]T/#X!405%MMF84048NLA4]+#V?1[.0;U\N^P,]"?N ' JM/Q74Q^YXLFKA5 MF_ME@O;XNX"=W0(!GALC.?0(F B5AJK6+2G%.:'_0R@"SR' M.RZ_Q\&5RX?#D67/FP6$HNJH5?+9.R0=@=Q6'DE$-+BPLHT=<2,#P>'LMN)N M,IL^^@?58KHI>;:=__'-I$'OP"@@%@BNE9"""*?MD]4!9%8@X@@#A3IB3O? M#D6H*M]Q[7K>#KI9.NO7G8*1).IN%$'A%=>82(6J,QQ!9W-\4".\Z.^(/IWA M.11KWL\F7V;SV3IESEU,/Z_+ZS^_E?,HI=4V%5 #=;GI)X(1PBIH@#$ $ZP% M=* *@T%Y))@.JV,O[*,BG6332KW?W"4Q1!@&!4EHF#7*> MD2H:&%GCLUR>X]O)NA?]:\6[$Z"'BW-;;";\?V?K;^9^M8X;\[(:_,-Q7C7I M'B3D*3TGA)HA@!V'&%<9TI B.H=BHXSQ[YUD/: ^%-\V&N,S@-)MYU&6[>\4 MHDKI#4]%P"V % K(3;VJ.(,Y_J<1ZO&],ZLSI(=[:_1C%L6X_VYS%J=B'S>S MZX.!0,<[!PT%35%.RC"M=)PW ;[VE1B6$^@]0D6_=WYUCOA@Y^2+3-@?%B^G M4EV%PT/'9?.O!.P,4E9K!W4T@8R!'%7A] M/:9U?\H4<@I7&W\T59=16"AO ;&,0Z"MK5'"WF05@_@5[7L.&0WMI\NO.4<0 MH1A+B@UB.AY)TM+ZDH-XGI72_%"+8F4O)5?_^<7AON$:G'L3]L_WD5(=?Q]_YY8-;-/A \-10[ MX+B-&YZ@BF!415PX[TF.#I_EXKJ+6_(R:M4;-T9/GOL.>%$. /I0YXN?K:XG M\[VE=WV /M%5G.YT6PBI M\6YTJ%L@&BE.+ ;"$,PMT1#6<"&052DCRT_U-DG4(=1#D>J?J^+#C5NM9[>3 M]<%, S\V#)Y "@04V!A+!,',\DHMZAO@XK9JFUTW1?HOU_&%C MY!?3XZQI]9U ,6311$3)_P4DX0C:ZB; $9IUYS)"[TZ'#!H"[N$>R.QU.)QJ MQIWZJ: 8(RJ5E'!.:.&@LW661*<5SGEF,T+73@];6,^(C\:9\ZE(!4C2#XKE M3;F\30ZJ#U_FLZ_;IQDV^?GGYW/U/)XDU0=XK;1VG MT>9*:46AIA9JA2AM%N[:L[)S2%(IXO0Z;HU7L]OTMN;F<_SIZB9.+/[=)D=T M$XTHZQ<$(*QC&%.J!:$>&\VJ=##2F4P?7WMI.+ MFL%R;:.%_*$2+V5*T+0Q!@;&"$DZ541APH"A %TGQP2C8]0K(D=V; M60GO&Q1CZ.Z7!. @1XYK@PVFTEFI!5=* "FQ,7+8;,2_5D!?J8E&[[1&>C1N)'622[B;WQ1HU#*\H00#R2F%1MA460Q" M+[$'7&8]^1]C.'\7].K%_&DKDJ'.O\_7WXKI_;QX%97V0^7$Q70;GK3:&9^T M:L+P;G]1,(3R>!I(3Z)H,8V8$@( 2G%L*3DTEZ5=T_OL\IC@*/T7W?K]^5D MD::0'M-O*X2>T8M8Y7AH5A'L5>O N>5>:R&(0A0SKN)_046B^6@Y9+95B-C. M.ZM_?;S: '?L3NI5N^"EXPY' S=J4)1Q*!T4D!DMTU EMY>FY68(J>P.QW.M M)36=;BY6)_-WB\W!F/YCZZU_P\L,J&@.(\VPA@0:KB2"$"MK@.94ZG-&8CYM MV/]*XOF2(L:W>4==W)77E5W0Z @^^(5@K#-<"*@\0M@P:XT1%08"LZQG[B,/ M9\FBQ-X3MDNXA\V,]SE*<*,*O$]23K(\[.T^T"M0J &UR$G$/"=6 ,Y5C2.! M%U;6LG/I[TQJUP729V:4+9.!=3JGMOTV9;(9 $I8Z[F3,*4BJ>9*F3G;9M4/ MJSJ1>C,FM<)W,+.UV&3>_JU8%,O)/.HE:AH-\%G:L3CU+-*BP8UUG//=\,UT[EQI/,XXYR4;>N^)M*=EL-AS M"RU56" KK0,(UD-DZM+.G#PIE5U".9@J4QVPGZ^+1=P@RR/GR<[VP6A#L2#8 M8B93+B&?'%"5\F>R7@R,,,=.WT=*%Q@/=X.S'>(_%ZN[XGIV,RNF1X^6O7T" MUSCN7X8QQIWF6#BNT>,<&<+LPD(H,^7\RN'3#:I#,\>7R^)ZLEH?MY9V=@B. MQ4DH!!GQ4CHI+=(57HRKK+UGC)S)E_(>WF3!.A1I?HLS3:44/BR>K@)6^L'$ MA?2U7!XSAAKT#I8YOPG$<<8H+KV!OK+Y&*8BQT\XPG1>?1]EW2-^5J;5==E^ MGRS_+#;EV#X7U_?+*A_:LZ;_6KR?-9'CW:CW4- M2%!BB$(:4D ]%A:JRGABPK*K*J1@ MFY0JPOIT^:H?GOY\%4=X1*O(^6RPGG@@B5.I]D'4N;21M9KE-,M1-T;XUKYO M=6- 40SW1.#Y0(\J#;N:1],@0@B 0 Q'6\ ZE[([/\[,8#9,>:2APQ5[)L&K M>-ULW(>[O5S,RN7G^R_;BN[K8KI!JL%MY8%^06FG/=+8*RZ '8I$FW7UA,)1\NQL'X!Q-.K6P$:@!.$2,&5K!01GQ6R.\"JR M4])T >AKLKP=)WPG8 YU5[/S9FZ[[/ULN5J_GQ6+H_=S>]L'C37@GEA'B+&4 M:,U-?6@!!B\L!7UGDN\*T/,=W)M-H,7!_:Q?P!Q0SN/9PJ*-YB'50K!JKIID M*8[0OQ1>%]\GV'TYLA[/74?"R2:".2&L\ MH8@P"91/[^4>QYPN#G,*58[(<,N25MD)="UW^(_+:R^ELGL06\I\LU/%@V8ZNY[,/S^L4C:* M=XOK?QP4_.%.P3IF.='&84PM =Y)+>J!2Y23NVE$MG8GTN\4R984,!^OS$%Q M/S4(' (7#RY"L","@ZB11&/_<4!.F9P#?426?R>B;8W:4$:>GLQ3DH?/WXJB MZ;.W?5U"G ?A$KJ4*S].$&'!03U#WNS5]MO)@MKWY5)',)^32$>OC_9W"BK. M$COL*%$>>@009+:>)6F6('3\VD-WPF[ GE;(#L6?3:'/;?WUHQZF5VT#I5(S MCN,\)#.628^%J>9$#;BPJ,PNA+NKSFH&I(U]^R-2WGJ$\XV&K'Q<%G>3V;1Z MEZ@6TPTO'BLX-UR=S3^23&).@4)4&N8$ 5&[]16\2K^L9_]6->=8;UH-N M^\\2 *;ZSI/5MZOE9+':9A9;Z8=_+F;_OB]LL;I>SNX::*CM/QJ4\<9IQYUU MR#DCD2>N5O*%RM%AQ?@8V;<..Y@@QD/7/R:WQ\.F3OE,$ 1ZH# DR@H,M:*V M?AJ1SHH+TVV&H,S)+&TMC=:O:*_GD]5J,Y[T^U/:^_?EXFNZ$ZKBS9XNFMXM M_L_]HH@?84<>W.9\- ACK;!"R!2LI@6WT-='%(-950??) W;<*(\DS0&>_2? MAETL(\3KAX3/L6P1.YH')T$JS&N%I@Y+#](?JIFE-(\9/)/CXUGO^2+R(1XN M]/CN?GG];;(JU-=EL7FI^G+T#>*1&WXC,(RA]0HRHCG$FCNN:GOF06'!12J+IQD02 $(4.WPL'&+ MORQ&]"#$5Q>:V2"W59\^7ID&S\'V-0T"&FP0I!8+$"=-M"-5$D2>$IT.>7?!;$0&93;9DO(H*W>3NX9&3ASAQK%O QE"!M/>0.2,D(3=B%!:'TRX:N4&Z[*4R6#_/)8KI+-S@6KM:H M;P!4:.X)51@S9+TPLK9&A*$ZQZ=Y\FW/VU?T^\"\L3XW0M]>OVB//K3P]\E_ ME^'GRK'L$NP\/NC&?'C>,D!/A$1<:<"<<1)12)X6A=0Y-P]9X9:7PH<,L//X M8!KSX7G+$.TIQ:1@@$>]D#(L",*UR2WDA>6W'H0"&?CF4< VIL#SEL%%39X[ M*"T'\:04GCF':@/;^YPKJ!%ZO@>A0 :^[9Y.SS89$).RBA__G%B"GZFIVY^& M9W4&=QM$.]L%[J.IZ"E@GANE"49"J7HGPSY+C1CAC75?EDX7X Y&D+W6RIZ6 MP1+,3,1".@<5P$Q25R\8PL&%%*++E.$^)K3"L.5YH9H'+>QJ&G \RQAFP*8[ M=>.)-[IVR1I O9GVY_/S#J]GWLT7Q+N5%.>"G/^D[ 4.#E;;(>D6U=]H2 MY6I#TJ&L_ *909X7<&O4IRR&XN7^D1\@X?Y.P4ND#!2$6 \]?$P\K5F:1$8 MIKBAW!)N4:P'LM4[E?^^5_:Y8+<\_7=D>=\469M^BO_8HPP<[!/BY@RBOL(< M8XH1J7%*"KP=MB1Y.=-&I.(/PY*NT1YLWTFO]M_=WDUFRTW(R+?)\NOA/6=G MAZ"UY @#"JDW"""'-1#I_R%F5'B68RZ.R(X8>,?I NJV$=23ATTUG76IKO]] M/UL6C_F T_2*:7*;[XNC/MHQ0"B=LI+95'.<4Z1Q[0Z75G)_&3;)+/Y?W=^OKAWWFZRG?"$10 M3R345%!K""3:@7I:D)F<2XD1&6C#,:E/]-MZJE\]3T^/UW<:$OLX=)=$Z[/OOV>W][?MBD+DC/78[^,\*7 /TSI2.@N[.U4JJ, MYE96:AVXMUP932P'1D;E+&75KX;*C1@TX/\2.-$-SD-95I56=E5I9?MAV:-. MM_Q20(AB;9P7!A.'G$1*5>Z("(_,X=T('SX,8XOU*X/S>QG3H#-]CC]^(@ D M%(9 "XHD8X!14E]_2HBS$G?GO9-XRS3L"?V6Q^0_%U]F\V@K/.W'JYM3E?.3 MOA&,@X8SK"%E%C*G*3,5;E+"K.O,<4>A]76F]@G_8"?MLKPNBNDJV1()FT-H M'3MJ3_Q4\!92IX@T2-JH?4A/Z@?+TK"LRA.GW^R]=4(.)(6A>+FI=*H6TQ?E M+/\H-@G^MEES#W"Q2?<@$$+0 "X<41Y+S03GM9&,9=;-\D_K>.\!^?-SSF00 M[K%O<-0K9S@G$4X H$14QM, 4.L4=L!E[78_G>N^+]C/<>R:,BH1FTRE'VXV M\WF:1\/3]L 7@C!$*,L,UG$WE]I A6I/H' HJ_[V3^?G[Q?\[AQN?]RG,++R M1BT6]Y-Y97\W=\'M[A^T%])Y)EPJ*T$C8P>J'B'NND9@C@14G''FC!&R]C9;D65O_I1^_>[ ;LF/S?:V.6HG MB^F.T3R>N?$OGW2]>!3OX4[+KP4H);).PZ@R>@ZLU1K4[AE.\Y(W_)1W \,( MHB7GTKC\Y'HV3XGN3KMP;-(U3D)AEDJW*$\QLW&+-?4%"%4PZS763^?Q[PGU MH;3R32V!JV^3Q55Q>U OU7^RM''=#:._H-00)/!% < M&2>BQ>PCFK5B:1#+2D3QTUX0G$+CYN!K5)ABFKG?C^;?$G+ M+Z7R6:WN;XOIEX>T!*.8]NR4[3X6K%#,,PP5T=&XQH"KNO*<9""/A3_EC<(@ M]1^@+_A%0L+H83D];/BQTN5R6?\4?KS[A/-0 !C&@GNJ1.Z?DKC6-9S2O337D,,*I.A&+Q-[/1[L?Y63I\4WP]_+:+0 MOLWN/A;+ZT2"KX=N*1I_(W#AD-"&4ZZ!TX2F.M MRF.&N7UV\,MFP6&IK(9 *<4=CELSKQ,0*AM_G$.,G_(.(Q/A(;6W=XO5>GF? M-LP][Q?V-PY,>L\%D\1ZI"&S"#-3S\JYG%MW]-/=472&\QB.K=:A1,][!X)( M/*HQ-Y)& U0E%15957<3K,\;S_=K45_P+=^0#Z+=L&?L\6TMA[JT3SJ;'L. ML 8]@W?<".T@QEQ[H!U3LGIZJHB7647Q?KJ[@WY S[B?_R$V8'(_7S\W0 ^3 MIVGW8+C24"MFJ' ,.VH$];6Q8&&.K89_2K]_3\CW%.:QW1#+U5I/5CNS()_^ MD1"5?TV)$59&-1 !3K$#3_8GS@DMPS_=6X#>\1_6!>4GL^6_)O/[PLY6U_-R M=;\\[G+:T2<8@H3 SG("(/9QAHY5+QV4!%G5@O%/ZZ?O"N[S>C4/Q6SLZ1&B MX6$M4$1J!9W$,"Z?>B]6DN,<.IWL21^B*-TY?9:GPCT4G=XMKLO;(D6'I%CP MT\G5J']@D'E"%.<^ F<5CGC65@?E+B-]0)_IGM3E9#G]7$S6J_\L MYM,O#^MOQ6/RH",.R_T=@W#>*&JH98):R"&DL()'"4.RE/6?SK?="^:=D:8Q M20+"0AH$-4=20:RUY;;>3*G+(\5/[==NC?$3"?[7?[R"-X[MS\U?[?R;Q^^\ M0NQ[>HB^^$?/XBK_7*=IL^C_[ M/U.?O:=77U;KY>3ZD+MT1^M I(32>LT)5#RN/##6UTU"[.O(0L.47 [(0, RQ, ZRR$T"):LPLA#FJ*\C].%DL61_SNP> M$1]*@]63>1QN\?E;4<3-X'HKR\/E?O=U"7%72U@R YUUS$@@I:YF*('-.59& MR*G>>5#V OLYB76TAN_^3B'5DC 28^\%X3#^04I7S1(9>+9BK/V0*U_8#=C3 M"ME!7^-LX0\9(XP"1Q#+BJSEY1H9)XG]6MIPJW%VO83(@ M'2Z50G$WF4W=WW?%8K6YO]V,_/'"MB%_FG\D .8<8! 9S$%TC&OZMU;1J1S MKMY_"F+UAO50C#/IK"^6$<#UPQ^3V^*(MK2K>?IQ6:[+Q57<0"=W#Z9( MX_F]+B2VQR'8J&] QE&J+51..JF,M$#4QSV&;% -:HCKK1X$7/:+>4OJ?&I> MP'97TX!$U $%8I#:.#[C4(I%>1PD\5DI$T9X=O5+BPX ;KN!_+ZEXKOW[X_L M%J\:!LF!0D!Q=8(3!!?V+O36T+67^6W-=<%?3H( CPB.FHTG%)"., %L- MDE&2L^Q/CB-X^T9"!Q /EMVEH2-'/SQSZL01'G&6Y7PV>,R$0Q8Y$6TERXP6 ML#XB(:=9+UO&MQD-[50;4#3#.=^>#[2!G^UU\V#BU@P! 6J3;X1PIB2M9J8$ MNK XBF%(\,KUEHW[4(QZ\7;PZ,73SO8!04UL- $],Y(Z$K6 *GY0$$I!3CZ" M$7(J3[QE]X"V]:L5W\OY]Y2K[9@2O:-EX)AP$E5["K@U6"*B4#UAJ[(JWHW2 MJ]:!S+N!LJ6TT_OSHX+^L5& 0"ML+9">> 81E1[B:F"$6WI9"DIG,LY"\;2= M?U5<_^-K^?T_9IL V;3OX\<_)P;@9SO^]J?A*9)VCV:[LUW ,IKMQG+'!8@\ M14CI>D,2#N1$$8S09S:4JMH%UH/Q9:^ZN:=ET'$'\E1K+A0E2F%.F*KFH;V] MD "X3!GN8T(K#%L>#:JY4V57TR CY:636!$"/.1085IO<%SIG'RF8Q;TJ2(J M.X7QM:S'KTUU">$YO(_VT_9W'EXC+UH%YA #V& ?]3O!B>6*L?K\ER:G7OB( MM*@N99N'8,9UPM&KA,KFV N\L M#N+7697>5\_MFCJ##WPBR&C".\]QU!"M-'&G,J3RM1/)<4ZZM9,O'P=^B3^\ MZ[<[0?24GV:8,D366.JP8]':#M#\NT*YMTM<<=]!KQ.'[M4L#:XQ20 MR@H./5V7+]>3^=ND33]P#Z;][\VS<4C?W]LI>!L55&2PUII!8 EAWM;KPF3Y MRT<87MC[7M09TJVO2I/A&[G\X4YVB>P: ,+:HCG M#!--@.&J]UUN@2Z.WZD :1I-F='U2-HFEY28$",()AR33"L MS%[*C"60FYX-H2314 MDIU&8T%R7,"#T_. M]O^F"=8?Z&,@6YLC-O=%;3@69"F\X MR:%RCM'TA%XQ#PVAW$KD?;.4=(U6V].=W YI;^VGCU?;!_^K#:I7$4<=/_WG MGD79_H-! THA$)0P..I%.G$&!!2*)[JCX@+2WZ5)?;R#( W6,R/?Y'^\66R M*O[W__C_4$L! A0#% @ :(JH3(=R8J]